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HOST SELECTION, DEFENSIVE BEHAVIORS AND FEEDING 
SUCCESS OF CULEX QUINQEFASCIATUS IN EXPERIMENTAL 
TRIALS
Joseph R. McMillan1, Paula L. Marcet2, Uriel Kitron1, Gonzalo M. 
Vazquez-Prokopec1
1Emory University, Atlanta, GA, United States, 2Centers for Disease Control 
and Prevention, Atlanta, GA, United States
Studies describing common blood sources of field collected mosquitoes 
are inconsistent in their description of the host selection behavior of 
Culex quinquefasciatus. Host selection is an important determinant of 
pathogen transmission, and this knowledge gap in mosquito behavior is 
limiting our understanding of vector-host contacts and the importance 
of reservoir hosts in West Nile virus (WNV) transmission. We conducted 
host-choice experiments under semi-natural conditions to quantify host 
feeding preference by Cx. quinquefasciatus mosquitoes when presented 
with an array of common passerine hosts: Northern Cardinals, American 
Robins, Blue Jays, Brown Thrashers, and Gray Catbirds. The experimental 
design consisted of: 1) a 1.5m x 0.75m x 0.75m enclosure inside of 
which two bird cages were placed, 2) 30 recently emerged female Cx. 
quinquefasciatus originating from wild eggs, and 3) an infra-red camera 
recording system. We performed 12 two-bird choice experiments in which 
we calculated the feeding index for each potential host and tested the 
null hypothesis of random host selection. We also quantified the number 
of defensive behaviors exerted by each bird. The blood sources for the 
168 mosquitoes that successfully obtained a bloodmeal were assessed 
by amplifying a fragment of the 16s ribosomal gene using generalist 
avian primers, sequencing each amplified fragment, and comparing the 
fragment to reference sequences. Host selection differed significantly 
from random, exhibiting the following preference structure: American 
Robins preferred over Blue Jays and over Northern Cardinals, and Northern 
Cardinals preferred over Brown Thrashers. The most common types of 
defensive behaviors were those protecting the feet and head, but the 
number of defensive behaviors did not differ significantly between hosts. 
Further experiments are needed to determine the role of these defensive 
behaviors in host selection and feeding success by vectors. Our results 
indicate a non-random pattern of host selection by vectors that needs to 
be considered when modeling WNV transmission.
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INTERACTIVE TOOLS FOR IDENTIFICATION OF MOSQUITO 
AND SAND FLY VECTORS OF INFECTIOUS DISEASES
Leopoldo M. Rueda, James E. Pecor, Richard C. Wilkerson, Lewis 
S. Long, Jason H. Richardson
Walter Reed Army Institute of Research, Silver Spring, MD, United States
Computerized interactive tools to identify mosquito and sand fly vectors of 
infectious human diseases were developed for various regions of the world 
(see Walter Reed Biosystematics Unit/WRBU website, www.wrbu.org). 
Using LUCID programs, WRBU identification keys for mosquito and sand 
fly vectors and their associated groups included morphological diagnostic 
characters primarily of the head, thorax, abdomen, legs and wings. 
Automontage images of diagnostic characters of various insect body parts 
were attached to each key. Genus and species pages for selected vectors 
and related groups were developed, including brief basic taxonomy, 
distribution, bionomics, medical importance, selected references, and 
detailed photos of habitus and other morphological parts. World catalogs 
of mosquitoes and sand flies, with updated taxonomy and hierarchic 
classification were linked to each key. In addition, comprehensive lists of 
known and potential vectors, and their associated taxonomic information, 
were included in the WRBU website. New LUCID identification keys were 
recently developed, namely: African Anopheles adult and larval keys 
(include 140+ species and groups for adult key; 120+ for larval key); 
South American Culicine mosquitoes (include vector adult and larval keys 
of Aedes, Culex, Coquillettidia, Haemagogus, Mansonia, Psorophora, 
Trichprosophon); South American Phlebotomine Sand flies (include male 
and female keys of genera, subgenera, and vector species of Dampomyia, 
Evandromyia, Helcocrytomyia, Lutzomyia, Nyssomyia, Pintomyia, 
Psathyromyia, Psychodopygus, Sciopemyia, Trichophoromyia, Verrucarum 
Group). Diagnostic characters, updated taxonomy and related information 
of new vector identification tools are noted and discussed.
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SRPN2 DEPLETION REDUCES MOSQUITO FITNESS AND 
BITING FREQUENCY
KaraJo Sprigg1, Andrew F. Read2, Kristin Michel1
1Kansas State University, Manhattan, KS, United States, 2Pennsylvania State 
University, University Park, PA, United States
The mosquito’s immune system is at the vector-pathogen interface and 
largely determines susceptibility. One consequence of its manipulation can 
be the reduction in vectorial capacity. Therefore, the mosquito immune 
system provides potential targets for novel intervention strategies aimed to 
reduce vector-borne disease burden. Melanization is a powerful immune 
response in arthropods that leads to encapsulation and killing of invading 
pathogens. This process renders some mosquito species partially or 
completely resistant to infection with pathogens of global public health 
significance. One of its rate-limiting steps of melanization is the activation 
of prophenoloxidase (PPO), which is controlled by an extracellular 
proteinase cascade and serpin inhibitors. The molecular composition 
of this system is largely unknown in mosquitoes with the exception of 
Anopheles gambiae SRPN2 and CLIPB9, which constitute the first known 
regulatory unit that controls melanization. If uncontrolled, e.g. by the 
depletion of the inhibitor SRPN2, melanization can kill adult females late 
in life, and thus potentially reduce the vectorial capacity of An. gambiae . 
This feature makes PPO activation, which is a rate-limiting step in melanin 
production, a potential target for novel malaria control strategies. 
Using life table analyses, we determined the consequences of SRPN2 
depletion by RNAi on several demographic growth parameters under 
standard laboratory settings. Net reproductive rate (Ro) was decreased by 
29%, while mean generation time was unaffected. As a consequence, 
doubling time (Td) was moderately increased by 9%. The negative 
effect on net reproductive rate is largely attributable to a significant 
decrease in bloodfeeding propensity. Bloodfeeding propensity and 
survival were disproportionally reduced in older mosquitoes after the first 
two gonotrophic cycles. As a consequence, the number of potentially 
infectious bites is at least reduced by 83%. Taken together, these 
data suggest that SRPN2 constitutes a viable target for novel malaria 
intervention strategies.
752
SPATIAL DISTRIBUTION, SEASONALITY AND BEHAVIOR 
OF NOVEL MALARIA VECTORS IN THE WESTERN KENYAN 
HIGHLANDS
Jennifer C. Stevenson1, Brandy St. Laurent2, Neil Lobo2, Lorna 
Culverwell3, Mary Cooke1, Samuel Kahindi4, Chrispin Owaga4, 
Elizabeth Ayoma4, Robin Oriango4, Ralph Harbach3, Chris 
Drakeley1, Jonathan Cox1
1London School of Hygiene and Tropical Medicine, London, United 
Kingdom, 2Eck Institute for Global Health, University of Notre Dame, 
South Bend, IN, United States, 3Natural History Museum, London, United 
Kingdom, 4Centre for Global Health Research, Kenya Medical Research 
Institute/Centers for Disease Control and Prevention, Kisumu, Kenya
Results from a light trap study carried out in 2010, presented previously, 
revealed the presence of previously unidentified mosquito species carrying 
Plasmodium falciparum sporozoites in Kisii district in the western Kenyan 
highlands, an area prone to epidemics of malaria. The majority of these 
specimens could not be definitively identified to the species level using the 
commonly used morphological keys, and sequencing revealed that there 
were no matching published sequences available at ribosomal ITS2 and 
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mitochondrial CO1 loci. To further morphologically describe these species, 
study their behavior and investigate their temporal and spatial distribution, 
mosquitoes collected during both longitudinal and transect studies were 
identified morphologically and sequenced at rDNA ITS2 and mtCO1 loci. 
To study spatial and temporal distribution of any novel vectors, monthly 
pyrethrum spray catches were made to sample indoor resting mosquitoes 
in 10 villages across Kisii Central, Kisii South and Rachuonyo South districts 
over an 18-month period between 2009 and 2011. To determine host-
seeking activity and peak biting times, mosquitoes were collected from 
light traps set up indoors and outdoors over a 12-month period from 
June 2011. To fully describe larval and adult stages, a wide range of larval 
breeding sites were sampled across Rachuonyo South in November 2011 
and 400 Anopheles larvae were reared to obtain adults with associated 
larval and pupal exuviae. For specimens found to have novel unpublished 
sequences, taxonomic studies were conducted to establish the identity of 
the species. Results on the presence of unusual species, their associated 
behaviors, spatial distributions and seasonality are presented.
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INVESTIGATING THE ROLES OF ANOPHELES GAMBIAE G 
PROTEIN-COUPLED RECEPTORS IN GUSTATION
Kimberly Regna, Marc A.T. Muskavitch
Boston College, Chestnut Hill, MA, United States
Vector-targeted control strategies remain our most effective tools for 
reduction of malaria transmission and incidence. However, the threat and 
continuing increase in insecticide-resistance motivate discovery of novel 
insecticides. G protein-coupled receptors (GPCRs) are well known as one 
of the most “druggable” targets in many organisms. Numerous GPCRs 
mediate developmental, sensory or other physiological pathways that 
can greatly impact vectorial capacities of Anopheles gambiae and other 
malaria vectors. Gustatory GPCRs are central to the ability of insects to 
identify foods, including sugars, and detect noxious compounds in the 
environment. We are investigating the abilities of An. gambiae to detect 
various sugars and noxious compounds when given a choice between 
sugar meals, or between a sugar meal and a sugar/compound meal. Dye-
labeling of meals enables colorimetric detection of intake. By using RNA 
interference to independently knockdown individual gustatory receptors, 
we will identify specific GPCRs required for sugar and noxious compound 
gustation. We have begun by analyzing sugar preferences among 
glucose, sucrose, fructose, galactose and mannose. Among these sugars, 
preliminary results imply mosquitos prefer glucose and sucrose. Initial data 
suggests that mosquitos exhibit strong aversion to berberine, a canonical 
noxious compound used in insect gustatory preference assays. We will 
report further progress in the analysis of sugar preference and noxious 
compound sensing in An. gambiae, and initial RNA interference results 
characterizing requirements for different GPCRs in sugar and noxious 
compound gustation. The overall goal of this project is to understand 
the functional roles of the mosquito gustatory GPCRs and exploit this 
system to enhance development of sugar-meal based, vector-targeted 
interventions that will decrease vectorial capacity of An. gambiae and 
other malaria vectors.
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OUTBREAK CLUSTERS OF FASCIOLA HEPATICA IN 
ARGENTINA
Jose Debes1, Liliana Nieto Sosa2, Andres Barnes2, William 
Stauffer1, Leonardo Marianelli2
1University of Minnesota, Minneapolis, MN, United States, 2Hospital 
Rawson, Cordoba, Argentina
Fasciola hepatica is a trematode responsible for the human disease 
fascioliasis. It differs from other human liver flukes in that it is present 
worldwide. Fascioliasis is transmitted through the ingestion of the 
metacercaria stage parasite found in infected vegetables such as 
watercress. Although it generally presents as chronic indolent individual 
infections, outbreaks of acute fasciolasis can occur in endemic areas 
related to ingestion of a contaminated food item. Despite the high 
prevalence of F. hepatica in many areas, its importance has been largely 
neglected. We investigated clusters of F. hepatica which occurred in 
four family groups in rural Argentina. A total of 34 confirmed cases 
of acute fascioliasis from 4 different families (15, 6, 8, and 5 affected 
members) were investigated. Three of the four families were residents 
of endemic areas, while a fourth family vacationed in an endemic area. 
All members from the 4 families reported ingestion of watercress. The 
most common clinical symptoms were right upper quadrant pain and 
fever, present in all subjects. All cases had elevated liver transaminase 
tests as well as absolute eosinophilia. Fasciola ova were detected in stool 
samples in all 34 subjects. Serology was performed in 16 subjects and was 
positive in 13 (81%). Abdominal ultrasound (performed in 22 subjects) 
showed diffuse hepatomegaly in 19 cases (86%). Twenty patients were 
treated with intravenous emetin and 14 patients with triclabendazole. 
Of 29 subjects who presented for post-treatment stool ova and parasite 
examination at 60-days, 26 (90%) became negative, with the remaining 
3 patients becoming negative by 90-days post-treatment. In the 
triclabendazole group, 2 subjects had relapse with one subject needing 
repeat treatment and another subject needing two additional treatments. 
In the emetin group one patient needed repeat treatment, however three 
individuals developed hypotension as a treatment complication requiring 
hospitalization. F. hepatica remains an under-recognized infection. In fact, 
most subjects reported here did not seek medical care since they had 
only mild clinical symptoms and were only detected through the outbreak 
investigation. There is a need for increased education and awareness of 
fasciolasis in patients living and traveling to endemic areas.
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SCHISTOSOMIASIS AND SOIL TRANSMITTED HELMINTHIASIS 
IN KAÉDI, SOUTHERN MAURITANIA
Sunkaru Touray
Swiss Tropical and Public Health Institute, Basel, Switzerland
We report findings of a cross-sectional parasitological study on 
schistosomiasis and soil transmitted helminthiasis among school aged 
children since the establishment of irrigation schemes in Kaédi, located at 
the confluence of the Gorgol and Senegal Rivers in Southern Mauritania. 
Stool and urine samples were obtained from 246 children between 
the ages of 5 to 15 years recruited from randomly selected households 
followed by administration of a parental questionnaire. Urine samples 
were analysed the same day using the centrifugation method, while stool 
samples were collected early the next morning and analyzed by the Kato-
Katz technique. We found a low prevalence of Schistosoma haematobium 
(3.7 %) with a mean infection intensity of 38 eggs per 10 mls of urine, 
while no cases of S. mansoni were detected in all participants. Only one 
participant was infected with a soil transmitted helminth (A. lumbricoides). 
Working in the rice paddies during the annual flood recession (Oualo 
farming) was the strongest predictor of infection intensity among 
participants when we fitted a zero-inflated negative binomial (ZINB) 
model for egg counts with potential confounding factors controlled 
for in multivariate analyses.Prevalence of S. haematobium seems to 
have decreased compared to last estimates before the establishment of 
the irrigation schemes (14 %). These findings highlight a need for an 
integrated surveillance system aimed at transmission control targeting 
various aspects of the transmission cycle S. haematobium.
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DEVELOPMENT OF A RECOMBINANT PROTEIN VACCINE 
AGAINST SCHISTOSOMA MANSONI INFECTION USING 
CATHEPSIN B AND PEROXIREDOXIN 1 ANTIGEN
Alessandra Ricciardi, Bibiana G. Santana, John Dalton, Momar 
Ndao
McGill University, Montreal, QC, Canada
Schistosomiasis is a fresh-water-borne parasitic disease caused by 
trematode worms of the genus Schistosoma. Due to its morbidity and 
mortality, Schistosomiasis is the most important helminth infection. The 
pathology of the disease is due to egg deposition, by the female worm, 
which will trigger an immune reaction and consequently cause progressive 
damage to the organs. The lack of therapeutic drugs and preventative 
measures, as well as the high disease burden caused by the infection 
are justifications for developing a vaccine against schistosomiasis. The 
development of a recombinant protein vaccine against this parasitic 
disease has the potential to contribute a long-lasting decrease in disease 
spectrum and transmission. Furthermore, it would relieve some of the 
concern surrounding the potential emerging resistance to praziquantel; 
the drug which is solely being used to treat the infection. Our group has 
chosen to focus on the S. mansoni antigens Cathepsin B and Peroxiredoxin 
1 (Prx1) as vaccine candidates. It is hypothesized that immunization with 
either recombinant Cathepsin B or recombinant Prx1 in the presence of 
an adjuvant can elicit protective immunity against Schistosoma infection. 
The objective of this research project is to develop a safe recombinant 
protein vaccine against schistosomiasis that will stimulate an optimal 
immune response which will prevent pathology. Upon cloning, expressing, 
and purifying the proteins of interest, mice were firstly immunized 
with recombinant Cathepsin B in the presence of either synthetic 
oligodeoxynucleotides (ODN) containing unmethylated CpG dinucleotides 
or Montanide ISA 720 VG. The mice received two booster injections 
following the first immunization. The vaccine formulations were not toxic, 
and all of the mice survived until the end of the study. The vaccine elicited 
a pronounced production of S. mansoni Cathepsin B specific antibodies 
whereas no antigen-specific antibodies were found in the control animals. 
Splenocytes proliferated in response to Cathepsin B and produced elevated 
levels of Th1, Th17, and inflammatory cytokines. These results highlight 
the potential of S. mansoni Cathepsin B as a promising vaccine candidate 
for schistosomiasis. The investigation concerning Prx1 is ongoing.
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PROJET-CREVETTE: AN INTERNATIONAL COLLABORATION TO 
REDUCE PARASITIC DISEASE, RESTORE THE ENVIRONMENT 
AND IMPROVE LIVELIHOODS IN WEST AFRICA THROUGH 
AQUACULTURE
Susanne H. Sokolow1, Elisabeth Huttinger2, Shawn Coyle3, James 
Tidwell3, Kyle Schneider3, Oumar Talla Diaw2, Mouhamadane 
Mbacke Seye2, Djibril S. Faye4, Kevin Lafferty5, Armand Kuris1
1University of California Santa Barbara, Santa Barbara, CA, United States, 
220/20 Initiative, California, CA, United States, 3Kentucky State University, 
Frankfort, KY, United States, 4Ecole Doctorale de la Vie, de la Sante et de 
l’Environnement, Dakar, Senegal, 5Western Ecological Research Center, 
United States Geological Survey, Santa Barbara, CA, United States
“Projet-Crevette” is a collaborative research project to investigate novel 
ways to combat the spread of schistosomiasis in rural Africa. In 1986, 
the Diama Dam was built on the Senegal River in West Africa in order to 
stabilize river flow, reduce drought conditions, and support a growing 
agriculture industry. Within 5 years after dam construction, schistosomiasis 
spread rapidly, leading to an epidemic that has persisted until today, with 
> 90% prevalence among some rural villages along the river. River prawns, 
which at one time were voracious predators of snails, have recently been 
decimated in the Senegal River due to habitat loss above the Diama 
Dam. Thus, Projet-Crevette aims to develop an aquaculture program to 
supplement prawn reproduction and re-introduce native river prawns 
to the Senegal River basin as predators of snails that carry schistosome 
parasites. Projet-Crevette has monitored the distribution and abundance 
of prawns, snails, and schistosome parasites at 11 sites throughout 
the Senegal River Basin over the course of one full year during 2011. 
This baseline data will pave the way for development of an innovative 
parasite-control strategy that promises to simultaneously combat disease 
transmission, restore the environment, and improve livelihoods by 
restoration of an artisanal prawn fishery.
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COMPARISON OF USEFULNESS OF SCHISTOSOMA MANSONI 
SOLUBLE CERCARIAL ANTIGENS AND SOLUBLE EGG 
ANTIGENS IN ELISA FOR SERODIAGNOSING SCHISTOSOME 
INFECTIONS
Michael John Doenhoff, Emily M. Dawson
University of Nottingham, Nottingham, United Kingdom
Diagnosis of schistosomiasis is problematic since no method is yet 
available that gives both 100% sensitivity and 100% specificity. The 
traditional, most widely used method is microscopy, but because of 
inherent insensitivity this technique often wrongly diagnoses patients 
as uninfected. Use of serological assays involving detection of specific 
antibodies is now increasing since the putative sensitivity of these tests 
is much higher than that of other alternative methods of diagnosis. They 
are routinely used in travellers’ medicine clinics where often only light 
infections are encountered and which microscopy is not sensitive enough 
to detect. ELISA incorporating schistosome soluble egg antigens (SEA) 
is often the antibody-detection test of choice. The use of SEA-ELISA for 
diagnosis of schistosomiasis in developing countries is however restricted 
since SEA is relatively expensive to produce. We have investigated whether 
a cheaper alternative prepared from S. mansoni cercariae, namely cercarial 
transformation fluid (SmCTF), could potentially replace SEA in ELISA. Our 
results demonstrate that SmCTF performs equivalently to S. mansoni 
SEA for the detection of both anti-S. mansoni and anti-S. haematobium 
antibodies, and that SmCTF is even comparable to S. japonicum SEA for 
schistosomiasis japonica. These results have laid the foundations for the 
development of a rapid diagnostic test (RDT) incorporating SmCTF for 
detection of anti-schistosome antibodies. Such a RDT would meet all the 
ASSURED criteria for diagnostic tests, particularly with regard to being 
Affordable and User-friendly, and could thus be useful in the developing 
world where the majority of the disease burden lies.
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IN VITRO, HUMAN EOSINOPHILS DOWN MODULATE 
PERIPHERAL BLOOD MONONUCLEAR CELLS RESPONSES TO 
SCHISTOSOMA MANSONI ADULT WORM ANTIGENS
Robert Tweyongyere1, Shona Wilson2, Peter Naniima3, Stephen 
Cose3, Edridah M. Tukahebwa4, Alison M. Elliott3, David W. 
Dunne2
1Department Vet. Pharmacy, Clinical and Comparative Medicine, Makerere 
University, Kampala, Uganda, 2Department Pathology, Cambridge 
University, Cambridge, United Kingdom, 3Uganda Virus Research Institute, 
Kampala, Uganda, 4Vector Control Division - Ministry of Health, Kampala, 
Uganda
Eosinophils have been regarded as terminally differentiated non-replicating 
effector cells observed in a number of health disorders including parasitic 
infections and allergic diseases where they play a beneficial role in the 
host defence against helminth infections or cause a harmful inflammatory 
response respectively. In schistosomiasis eosinophils have been associated 
with direct or indirect killing of schistosomula. However, there is growing 
evidence that eosinophils can play an additional immunoregulatory 
role in both adaptive and innate immunity to parasitic infections. Here 
we report results of a study, using samples from Schistoma mansoni 
infected individuals, in which we investigated the effects of co-culturing 
human eosinophils with peripheral blood mononuclear cells (PBMC) 
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on in vitro cytokine production in response to S. mansoni adult worm 
antigen. PBMCs obtained from 26 S. mansoni infected adults were 
examined for cytokine responses to S. mansoni adult worm antigen 
(SWA) when stimulated alone or when enriched with autologous 
eosinophils. Production of IL-4, IL-5 and IL-13 was lower (p=0.017, 
0.018 and <0.001 respectively) in PBMC+eosinophil cultures than in 
PBMC-only cultures stimulated with SWA. IL-13, IL-10, IFN and TNF 
were released in eosinophil-only cultures but none of these cytokines 
produced by the eosinophils showed a significant association with the 
observed eosinophil-induced drop in cytokine responses of PBMCs. This 
preliminary study shows that eosinophils can exert a down-modulatory 
effect on schistosome specific responses. The mechanism of this immune-
modulation remains to be elucidated.
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SCHISTOSOMA HAEMATOBIUM RECOMBINANT PROTEINS 
AS A VACCINE CANDIDATE FOR HUMAN SCHISTOSOMIASIS
Kwaku B. Ahmed1, Iain W. Chalmers2, Martha Turscott2, Maria 
Yazdanbakhsh3, Cornelis H. Hokke3, Daniel A. Boakye1, Karl F. 
Hoffmann2
1Noguchi Memorial Institute for Medical Research, University of Ghana, 
Accra, Ghana, 2Institute of Biological Environmental Rural Sciences, 
Aberystwyth University, Aberystwyth, United Kingdom, 3Leiden University 
Medical Center, Leiden, The Netherlands
In Sub Saharan Africa human schistosomiasis is largely caused by 
Schistosoma mansoni and S. haematobium. The current strategy for 
controlling morbidity of the disease is through mass drug administration 
using praziquantel, the drug of choice. This dependency of using only 
one drug can possibly induce praziquantel resistance of the parasite and 
could render this method of intervention ineffective. This has therefore 
necessitated the urgency for the development of a vaccine to combat the 
disease. With the focus of most schistosomiasis vaccine developments 
on S. mansoni parasite, it could be challenging for identified putative 
vaccine candidates to elicit the required immunological responses in S. 
haematobium-endemic communities in African populations, where the 
disease is caused by either S. haematobium or in regions of co endemicity. 
If this condition arises, it could lead to the detriment of full potential 
of S. mansoni vaccine candidates. It will therefore be complementary 
for vaccine design efforts to strive into proteomic and immunology of 
S. haematobium counterpart as well. Here we discovered 17 orthologs 
hits (5 Tetraspanin proteins, 5 CD59-like proteins, 2 MEG-8 proteins, 2 
Saponin proteins, 1 FOG precursor, 1 Stomatin-related protein) from S. 
mansoni sequences. This bio-informatic lead analysis was performed using 
tBLASTn search of Wellcome Sanger S. haematobium ESTs libraries against 
52 S. mansoni vaccine candidates (with e-value 3.90e-30-3.00e-110 and 
identity value 56%-93%). These 17 orthologs were characterised by non-
allergen, had no human orthologs and was expressed during vertebrate 
infections (definitive host). 3 of such orthologs (1-Tetraspanin, 1-MEG and 
1-CD59 like proteins) were produced as recombinant proteins and being 
used as lead proteins towards the discovery of S. haematobium vaccine 
candidates. In conclusion, if vaccine candidates are identified from S. 
haematobium, it will not only mark a crucial milestone in terms of vaccine 
development for disease but will drastically facilitate the reduction of 
schistosomiasis in Africa.
761
VACCINATION WITH RECOMBINANTLY EXPRESSED GLYCAN 
ANTIGENS FROM SCHISTOSOMA MANSONI INDUCES 
GLYCAN-SPECIFIC ANTIBODIES AGAINST THE PARASITE
Nina S. Prasanphanich1, Anthony Luyai2, Megan L. Mickum3, 
Ziad S. Kawar2, Jamie Heimburg-Molinaro2, Yi Lasanajak2, 
Xuezheng Song2, David F. Smith2, Richard D. Cummings2
1Emory University Department of Biochemistry, Emory University Graduate 
Program in Immunology and Molecular Pathogenesis of the Graduate 
Division of Biological and Biomedical Sciences, and Emory University 
Medical Scientist Training Program, Atlanta, GA, United States, 2Emory 
University Department of Biochemistry, Atlanta, GA, United States, 
3Emory University Department of Biochemistry, Emory University Graduate 
Program in Immunology and Molecular Pathogenesis of the Graduate 
Division of Biological and Biomedical Sciences, Atlanta, GA, United States
Schistosomiasis caused by infection with the parasitic helminth 
Schistosoma mansoni is a major global health problem due to inadequate 
diagnosis and treatment, and lack of a vaccine. Vaccine candidates have 
failed due to the worm’s complex architecture and life cycle, exquisite 
modulation of host immunity, and our incomplete understanding of 
antigens targeted during infection. The immune response to schistosomes 
is primarily directed against glycans, rather than protein antigens, and 
evidence suggests that glycans could be valuable diagnostic markers and 
protective vaccine targets. The di- and tri-saccharide motifs LacdiNAc 
(GalNAcβ1,4-GlcNAc; LDN) and fucosylated LacdiNAc (GalNAcβ1,4-
(Fucα1-3)GlcNAc; LDNF), are expressed throughout the S. mansoni life 
stages and are densely distributed among many glycoconjugates in 
monomeric form or as repeating units (poly-LDNF). Such determinants are 
lacking in mammals. LDN and LDNF are antigenic in several S. mansoni-
infected mammals, yet, how to make such glycans antigenic in the 
context of a defined vaccine has remained elusive. We have developed a 
recombinant expression system in which a Chinese Hamster Ovary (CHO) 
cell mutant termed Lec8 expresses repeating forms of LDN (Lec8GT) and 
LDNF (Lec8GTFT) abundantly on its glycoproteins. Immunizing mice with 
these cells induced glycan-specific antibodies and a sustained booster 
response. The Lec8GTFT anti-sera were cross-reactive with S. mansoni 
and displayed exquisite specificity for particular presentations of LDNF 
antigen on glycan microarrays. We are currently investigating the cellular 
mechanisms supporting this anti-glycan antibody production, including 
T-cell dependence and memory B cell compartments, and we are using 
glycan microarrays to more specifically define the structures that comprise 
antigenic LDNF in S. mansoni infection. Our recombinant expression 
system has proven to be successful at invoking antibodies to the 
antigenic glycans of S. mansoni, and can be adapted to study many other 
pathogens and novel glycan antigens for use in vaccines and diagnostics.
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HISTONE MODIFYING ENZYMES AS PUTATIVE DRUG 
TARGETS FOR SCHISTOSOMIASIS
Marina M. Mourão1, Luiza F. Andrade1, Laila A. Nahum1, 
Adhemar Zerlotini1, Raymond J. Pierce2, Guilherme Oliveira1
1Fundação Oswaldo Cruz, Belo Horizonte, Brazil, 2Institut Pasteur de Lille, 
Lille, France
Histone modifying enzymes (HMEs) play key roles in the regulation 
of chromatin modifications. Furthermore, aberrant epigenetic states 
are often associated with human diseases, leading to great interest in 
HMEs as therapeutic targets. The availability of the genomic data of 
three Schistosoma species provides an opportunity to identify new drug 
candidates against schistosomiasis. In this work, we have identified and 
characterized all enzymes involved in histone acetylation and methylation 
that include: histone acetyltransferases (HATs), deacetylases (HDACs), 
methyltranferases (HMTs), and demethylases (HDM). We analyzed the 
predicted proteomes of the parasites in order to identify and classify 
the HMEs through computational approaches, mainly by using Hidden 
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Markov Model profiles. We were able to identify around 60 HMEs with 
some variation within the three Schistosoma species. From the identified 
enzymes, 24 were tested individually as therapeutic targets using RNA 
interference in cultured larval stages (schistosomula) to invalidate each 
corresponding gene. Although, gene knockdown of up to 90% could 
be achieved, no phenotype could be observed after 7 days of dsRNA 
exposure. Loss of motility could be observed as a phenotype for two HDMs 
after 30 days of dsRNA exposure. In addition, in order to assess the role 
of genes in the presence of the host environment under immunological 
pressure, knockdown parasites for four HMEs (HDAC8, KDM1/ KDM2 
and PRMT3) were tested in vivo. A significant reduction of worm burden 
(50%) could be observed in mice infected with knockdown parasites for 
HDAC8 when compared to unspecific control. Finally, egg count was 
significantly reduced in mice livers for all tested HMEs. In conclusion, our 
work improved the functional annotation of over 20% of S. mansoni HAT 
and HDAC proteins. Parasites with reduced levels of HDAC8, KDM1/KDM2 
and PRMT3, seem to diminish the oviposition and ability to survive (for 
HDAC8) in the host milieu, indicating that these enzymes could be good 
target candidates for drug development.
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SCHISTOSOMIASIS COLLECTION AT THE NATURAL HISTORY 
MUSEUM (SCAN)
Aidan M. Emery, Fiona E. Allan, Muriel E. Rabone, David 
Rollinson
The Natural History Museum, London, United Kingdom
The Natural History Museum, London, maintains one of the largest 
biodiversity collections in the world and is a WHO Collaborating Centre 
for the identification and characterisation of schistosomes and their 
intermediate snail hosts. SCAN, the Schistosomiasis Collection at the 
Natural History Museum is a new initiative to make existing schistosome 
and snail host specimens available to the research community, facilitate 
new monitoring and research projects by providing a sample repository, 
and make samples available to the research community. Many of our 
archived schistosome specimens, representing a legacy of decades of 
field sampling, are suitable for molecular genetic applications, and new 
schistosome collections, concentrating on the accessible larval stages, 
are being archived using ambient DNA storage methods. Monitoring and 
research projects that accompany schistosomiasis control programmes 
generate specimens and data used to fulfil the objectives of the project. 
These specimens can also have a value beyond these immediate 
requirements as new questions emerge, tools improve, or wider 
comparisons become possible. To facilitate future use, an infrastructure 
to consolidate, maintain and distribute them is needed. SCAN aims to 
provide this infrastructure. At present, working primarily with SCORE, 
the Schistosomiasis Consortium for Operational Research and Evaluation, 
SCAN is providing support as follows: provision of a central specimen 
repository for several SCORE sub-projects; assistance with collection and 
transportation; data entry and consolidation; methods development. 
Additional to the benefits of an archive, SCAN’s collection management 
priority has immediate advantages for collection, training and data 
curation activities within SCORE sub-projects. The success of SCAN and 
depends on the support and trust of control teams, researchers and 
funding agencies. 
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REDOX BIOLOGY AND DRUG DEVELOPMENT FOR 
SCHISTOSOMIASIS
David Williams
Rush University Medical Center, Chicago, IL, United States
Schistosomiasis remains an important neglected disease with 200 
million infected individuals. Individual treatment and large-scale control 
campaigns rely primarily on the use of praziquantel, the only available 
drug for schistosomiasis treatment. There is concern that praziquantel 
resistance will evolve and, in the absence of alternative therapies, 
control measures will be imperiled. Enzymes in the redox pathways of 
schistosomes have been found to be suitable targets for schistosomiasis 
drug development and schistosome antioxidant enzymes have been 
shown to be essential and druggable proteins. Of particular interest is 
thioredoxin glutathione reductase (TGR), which plays a central role as a 
multifunctional protein entirely providing the activity of several distinct 
enzymes present in the human redox network. Therefore, TGR is a redox 
bottleneck in schistosomes. Oxadiazole 2-oxides have been identified as 
TGR inhibitors, acting through both nitric oxide production resulting from 
TGR activity and TGR inhibition. We will present results defining the role 
of nitric oxide in the action of oxadiazole 2-oxides and other nitrosating 
agents both in the local context of TGR S-nitrosylation and global context 
of other schistosome proteins susceptible to modification by nitric oxide. 
In addition, a rescreen of the NIH Chemical Genomics Center compound 
library has identified many new classes of small-molecule TGR inhibitors. 
Mechanisms of action, activities against ex vivo parasites, and structure-
activity relationships of these compounds will be discussed.
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SIGNIFICANCE OF THE SO-CALLED “APO-AMEBOCYTE 
PRODUCING ORGAN” IN BIOMPHALARIA GLABRATA
Samaly S. Souza, Zilton A. Andrade
Oswaldo Cruz Foundation, Salvador, Bahia, Brazil
Internal defense against microorganisms are performed in mollusks by 
a single cell type: the hemocyte or amebocyte. Their place of origin in 
Biomphalaria glabrata has nowadays become a matter of controversy. 
Initially, the hypothesis maintained by several authors was that the 
amebocytes had a multicentric origin. However, more recently it has 
been postulated that B. glabrata amebocytes are instead formed within a 
central special organ. The initial argument for the Amebocyte Producing 
Organ (APO) being considered as the locale of origin for hemocyte 
production in B. glabrata was the finding of hyperplasia and mitoses 
in its cells during the course of Schistosoma mansoni infection. The 
present investigation was concerned with a morphological analysis, with 
histological, immuno-histochemical, morphometrical, and ultra-structural 
findings, from the so-called B. glabrata APO. Its structure was identified 
as a collection of epithelial basophilic cells, disposed on one-cell-thick 
layer or in small round collections, covering a small area of the pericardial 
surface in the reno-pericardial region. Sometimes it vaguely resembled the 
epithelial component of the vertebrate juxta-glomerular apparatus of the 
kidney. During our studies, mitoses were only occasionally found, either 
in normal or infected mollusks. Also our quantitative studies failed to 
demonstrate the presence of APO cellular hyperplasia, either in normal or 
schistosome-infected B. glabrata. Therefore, our findings did not provide 
evidence in support of the so-called APO being considered the central 
organ for hemocyte production in B. glabrata. Multi-focal proliferation 
of hemocytes was found in many other areas of the mollusk during S. 
mansoni-infection. By contrast, several structural details from the “APO” 
region in B. glabrata were found to be consistent with the suggestion that 
it is indeed a filtration organ, more related to the kidney, as evidenced in 
other species of mollusk, such as Lymnaea truncatula, rather than bone 
marrow.
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ASSESSING THE HEALTH IMPACT OF IMPROVED RURAL 
SANITATION: DESIGNING AND CARRYING OUT A CLUSTER-
RANDOMIZED, CONTROLLED TRIAL IN ORISSA, INDIA
Thomas Clasen1, Sophie Boisson1, Paramita Routray1, Jeroen 
Ensink1, Miriam Jenkins2, Matthew Freeman3, Wolf-Peter Schmidt1
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2University of California, Davis, Davis, CA, United States, 3Emory University, 
Atlanta, GA, United States
Despite progress on other MDG targets, sanitation coverage continues 
to fall behind with 2.6 billion people still lacking access to even basic 
sanitation. More than one billion people still practice open defecation, 
including an estimated 636 million in India alone. One possible reason for 
the slow progress in sanitation is the lack of clear, compelling evidence 
about the effectiveness and cost-effectiveness of sanitation. To date, there 
is no randomized controlled trial of sanitation interventions to prevent 
diarrhoea diseases. We describe the design and execution of a large-scale 
study that seeks to help close the evidence gap on rural sanitation in low-
income settings. Using a cluster-randomized trial design, the study aims 
to assess the effectiveness of a project by Water Aid India to promote the 
construction and use of individual household latrines in accordance with 
the Indian Total Sanitation Campaign. The study population consists of 
100 villages (about 12,000 people) in a costal district of Orissa, India. The 
main objective of the trial is to assess whether improved sanitation reduces 
diarrhoeal and helminth infection among young children. The presentation 
will emphasis five additional aspects that we believe necessary in designing 
evaluations of sanitation interventions: (a) comprehensive process 
evaluation_carefully documenting the manner in which the intervention 
is actually implemented rather than intended or reported by the program 
implementers; (b) documenting uptake_the actual use of the intervention 
by the target population_since there is widespread evidence that latrine 
use is sub-optimal in India; (c) assessing whether the intervention has 
actually reduced exposure_a condition to securing health outcomes; (d) 
spatial analysis and spill-over effects from sanitation interventions, and (d) 
longer-term assessments due to (i) the longer time required to implement 
the intervention, (ii) the potential persistence of excreta-related pathogens 
in the environment even after the widespread uptake of an effective 
sanitation intervention, (iii) the need to investigate longer-term changes 
in uptake, and (iv) the need to follow whether safe and effective pit-
emptying is underway.
767
STUDIES ON THE PRESENCE OF CRYPTOSPORIDIUM SP 
AROUND WATER TREATMENT PLANTS THAT SUPPLY WATER 
TO GREATER ACCRA REGION OF GHANA
George T. Mensah
Council for Scientific and Industrial Research - Water Research Institute, 
Accra, Ghana
Cryptosporidium sp a Protozoan has emerged in recent times as zoonotic 
parasite. These parasites of the Apicomplexan family were found in 
association with diarrhea in calves and are water-borne. The organism 
is second only to rotavirus as a causative agent of diarrhea in newborn 
calves and infants. As such, it is a potentially serious contaminant in 
water where cattle graze. In order to estimate the human health risk in 
cattle rearing areas around water treatment plants, we measured the 
prevalence of Cryptosporidium oocysts in the fecal matter from four 
cattle ranges upstream in Joma near the Densu Dam at Weija in the 
Ga South Municipality and Kpong in the Lower Manya District all of 
Southern Ghana. The Modified Ziehl-Neelsen staining technique (MZN) 
for Cryptosporidium oocysts was used. Of the 320 fecal samples for 
each species screened, 63 (19.7%) were positive for Cryptosporidium. 
Prevalence was higher in calves younger than three months of age, as 
compared to weaned calves and adults. Oocysts were detected in both 
diarrheic and non-diarrheic samples, with a significantly higher prevalence 
(p< 0.05) of oocysts shedding in diarrheic samples.
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LACK OF EDUCATION OF HOUSEWIVES CONCERNING THE 
TRANSMISSION RISKS FACTORS OF TYPHOID FEVER IN THE 
DR CONGO
Michel Mandro
University of Bunia, Bunia, Democratic Republic of the Congo
DRC is still characterized by a critical socioeconomic situation impacting 
negatively the quality of health services offered to the population, 
createing a permanent problem of hygiene and prevention of diseases. 
Every year the Country faces various epidemic outbursts of avoidable 
diseases such as typhoid fever (TF).In addition, more than 50 % of 
Congolese women are illiterate, whilst it is established that the mother’s 
education level is the most determining factor for the family’s health 
and nutritional status. A proper washing of the hands especially before 
preparation of food, before the meal, after the toilet; access to healthy 
source of water; safe elimination of human excreta, are the key factors 
to help reduce the frequency of diseases with oro-faecal transmission. 
To assess this assertion, we conducted a Community based survey from 
June 1st, to August 31st, 2008 to assess the knowledge and practices 
relative to the prevention of TF transmission by questioning 500 domestic 
women of the City of Bunia in the northeast of the RDC.The Study 
used a randomization method for the selection of the Housewives by 
Quarter of the City of Bunia (40% subset of the Quarter population) 
Of the 500 women interviewed: 288(56.7%) were 20-24 years old; 
325(65%) unemployed; 261(52.2%) have not attended school or only 
primary school; only 198(39%) have some sufficient knowledge of the 
transmission of TF; 267(53.40%) have little or no knowledge of the 
good qualities of drinking water ; 265(53.00%) are unaware of the 
rules of food hygiene; only 137(27.00%) practice correctly the washing 
of the hands; all households use unsafe sources of drinking water and 
380(78.8%) among them do not treat the drinking water (boil or treat 
with Chloramines); 202(42.60%) of women use non hygienic latrines 
and 85(17%) of households do not have latrines at all. The promotion of 
hygiene and specifically education of housewives remain fundamental in 
the improvement of national educational strategies in the DRC.This finding 
might be relevant to all Stakeholders involved in the fight against TF.
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AN UNUSUAL PARTNERSHIP TO ENSURE SAFE DRINKING 
WATER TO THE RURAL POPULATION IN INDIA
Camille A. Saade
FHI 360, Washington, DC, United States
Water treatment at the point-of-use (POU) can reduce diarrhea caused 
by waterborne pathogens by 30 to 50 % (WHO 2007). The goal of the 
project was to demonstrate a comprehensive strategy aiming at increasing 
use of POU water treatment methods among poor urban and rural 
populations and thereby reduce childhood diarrhea in the state of UP in 
India. The at-scale goal was to achieve 30 % rural and 40 % urban use of 
an effective POU method. By January of 2009, the partnership between 
POU manufacturers and NGO partners was formalized through MOUs. The 
project reached 674,064 households residing in 1120 urban slum areas 
and 1350 rural villages in UP. A quantitative study of 1400 households 
at baseline, showed only 2.5 % of households (4.1 % urban and 1.1 
% rural) reported ever using a POU method promoted by the project 
(boiling, disinfection products, or filtration). In contrast, the outcome 
evaluation found very high rates of POU use in both the intervention and 
comparison areas, with 96.8 % of intervention households reporting 
they had ever used a recommended POU method, along with 71.0 % 
of households in the comparison areas. The biggest difference between 
intervention and comparison districts was in the use of chlorine liquid for 
232
www.astmh.org
disinfection (56.9 % versus 0.3 %). No difference was found in the use 
of water filters (about 7 % in both areas). Among urban households, 50 
% reported current use of chlorine tablets, vs. 3 % of rural households. 
Conversely, 60 % of rural households reported current use of liquid 
chlorine, vs. 11 % of urban households. This clear preference for different 
products cannot be explained by any difference in intervention approach, 
and bears further investigation. An engaged commercial sector was able 
to reach a substantial new market by partnering with NGOs and micro-
finance institutions. NGOs can be trained to become effective product 
demonstrators and micro-distributors. The long-term viability of NGO POU 
product distribution should be monitored. Commercial partners are now 
expanding the model in other states in India
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DO THE CHILDREN GETTING WHAT DO THEY NEED 
TO WASH HANDS IN SCHOOL? EXPERIENCE FROM 
BANGLADESH
Sadika N. Akhter
International Research Institute, Mohakhali, Dhaka, Bangladesh
Schools are common sites for the spread of gastro-intestinal and 
respiratory diseases. There are a variety of hygiene interventions linked to 
hand washing, respiratory hygiene, sanitation and water quality, which 
have shown some success in preventing and /or reducing these diseases. 
However, little research has been done on the feasibility and effectiveness 
of these water, sanitation and hygiene interventions in school settings in 
Bangladesh. The objective of this study was to understand the current 
practice regarding hand washing and facilities needed to wash hands 
from primary school children in a low income country like Bangladesh. 
The study used data from in-depth interviews and observations conducted 
with purposively selected school children in Bangladesh. The interviews 
were conducted with a topic guide line developed based on existing 
literature and in consultation with study investigators. Transcripts were 
processed using a thematic-analysis approach. Major findings indicated 
that increasing hand washing in low resource setting is a complex process, 
it included that after giving knowledge, knowledge increased but lack of 
hand washing facilities in school premises influence the practice of hand 
washing in school. A greater number of informants stated that availability 
of resources like soap and water supply is important to keep the practice 
of hand washing in school. Most of the schools do not have fund and 
capacity to supply soap and water. Children are motivated to wash hands 
due to school hygiene program but cannot practice their knowledge as 
schools are not able to supply those facilities. School Authority suggested 
for better communication with government before implementing 
intervention so that government can help to generate fund to continue 
the program.
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PRELIMINARY ASSESSMENT OF THE POTENTIAL 
EFFECTIVENESS OF WATER FILTERS TO REDUCE DIARRHEAL 
DISEASE BURDEN IN CHILDREN YOUNGER THAN FIVE YEARS 
OLD IN A PACIFIC ISLAND NATION
Rebecca Psutka1, Patricia Priest1, Tieren Davies2, Teretia 
Rakunuea2, Andre Reiffer3, Steven Iddings4
1University of Otago, Dunedin, New Zealand, 2Ministry of Health, 
Bikenibieu, Kiribati, 3World Health Organization, Bikenibieu, Kiribati, 
4World Health Organization, Suva, Kiribati
A novel household water treatment device was proposed for use in the 
Kiribati, a small, remote pacific island nation. In collaboration with the 
Kiribati Ministry of Health and the WHO (South Pacific) we conducted 
a field study to understand the extent to which water-borne diarrheal 
disease is an important health issue, and whether a domestic water filter 
used in this setting is likely to reduce the incidence of diarrhea. As far 
as we are aware, this is the first investigation of its kind in any pacific 
island nation.In this field study of 97 randomly selected households of 
802 individuals we found that 7% of participants, and 25% of children 
under 5 years old had experienced diarrhea in the past month and 7% of 
children under 5 had experienced diarrhea in the past week. Participants 
reported high levels of open defecation (59% children) combined with 
low knowledge of the danger of childrens’ feces and low levels of 
handwashing, especially after defecation and the handling of childrens’ 
feces. It is highly likely that contamination from hands and flies goes on to 
contaminate food and individuals directly leading to high levels of ‘water-
washed’ (rather than water-borne) endemic diarrhea. Most individuals we 
interviewed (86%) reported that their household normally boils their water 
for drinking. Water samples were highly contaminated, and there was 
not a statistically significant difference in fecal coliforms between source 
water and drinking water. In households that boiled their drinking water, 
it was less contaminated than the source water in only half the samples, 
suggesting that significant recontamination occurs following boiling, this 
would likely happen following filtration. Almost all (91% of households) 
store drinking water and only 24% use safe storage containers, while the 
remainder access drinking water by dipping dirty cups, vessels, and hands 
into the water container. Information on behaviour and water quality 
indicates that the transmission of endemic diarrhoea is likely to be through 
many pathways other than drinking water, and even treated water is 
highly susceptible to recontamination. Filtration as a form of household 
water treatment is likely to have limited effect in this setting.
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DEVELOPING A SOCIAL ECOLOGICAL MODEL FOR 
VIBRIO CHOLERAE TRANSMISSION DYNAMICS IN HAITI: 
IMPLICATIONS FOR CONTROL STRATEGIES AND PUBLIC 
POLICY INTERVENTIONS
Annette M. Ruth
University of Notre Dame, Notre Dame, IN, United States
An evaluation of Catholic Relief Service’s (CRS) post-earthquake cholera 
education programming in Haiti was conducted in June 2011 to evaluate 
the efficacy of their social marketing efforts for cholera prevention. A 
Knowledge, Attitude, and Practice (KAP) survey implemented throughout 
Haiti provided cholera incidence data as well as social and behavioral data 
that indicate sources of disease transmission and water contamination. 
Evaluation results indicate that there remain gaps in practices such as hand 
washing and open defecation. These results highlight the importance of 
monitoring of incidence data and surveillance in countries where poor 
infrastructure and a lack of proper sanitation facilities necessitate changes 
in routine behavior to prevent outbreak. Monitoring and prevention, 
coupled with mathematical compartmental models of transmission 
dynamics, would enable prediction of future cholera outbreak risk per 
commune and also would enable the Haitian Ministry of Health, HSPP, 
and the population to take preventative measures well in advance. Thus, 
a novel SIR-type social ecological model for Vibrio cholerae transmission 
dynamics in resource-poor settings has developed, incorporating 
behavioral data from the KAP evaluation. Furthermore, the behavioral 
and ecological factors that have been integrated into the base model 
ensure greater predictive ability at the commune level when the model is 
back-fitted to prior incidence data. Such models hold the key to affecting 
control strategies and public policy interventions in ways that ensure a 
given population is prepared for a potential outbreak when conditions are 
ideal.
233
www.astmh.org
773
CHOLERA OUTBREAKS IN URBAN BANGLADESH IN 2011
Farhana Haque1, M. Jahangir Hossain2, Subodh Kumar Kundu3, 
Abu Mohd. Naser2, Mahmudur Rahman3, Stephen P. Luby4
1International Centre for Diarrhoeal Disease Research, Bangladesh and 
Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, 
Bangladesh, 2International Centre for Diarrhoeal Disease Research, 
Bangladesh, Dhaka, Bangladesh, 3Institute of Epidemiology, Disease 
Control and Research (IEDCR), Dhaka, Bangladesh, 4Centers for Disease 
Control and Prevention, Atlanta, USA and International Centre for 
Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
 In February 2011, an outbreak of severe diarrhea was reported at a 
tertiary medical college hospital campus in Bogra District in northwest 
Bangladesh. In April 2011, a similar outbreak was reported at 3 urban 
communities in the northeastern district of Kishorganj. We investigated 
these outbreaks to determine the etiology and pathways of transmission. 
We visited the tertiary hospital in Bogra and the secondary hospital 
serving the affected communities in Kishorganj. We listed the admitted 
cases of severe diarrhea (passage of ≥ 3 loose stools per day) from the 
affected areas. We interviewed the admitted cases, physically examined 
them and collected rectal swabs in bacterial transport media to test for 
enteric pathogens including Vibrio cholerae. We visited the affected 
communities to explore the water supply and sanitation. We collected 
water samples from selected cases’ household taps, tube wells and central 
pumping stations to test for microbes including Vibrio. We identified 21 
cases from Bogra and 84 cases from Kishorganj. The median age was 
23 years in Bogra and 21 years in Kishorganj. There were no reported 
deaths. We isolated Vibrio in 29% (5/17) of the rectal swab samples from 
Bogra and in 40% (8/20) of the rectal swab samples from Kishorganj. We 
found Vibrio in 1 out of 8 tap water samples from Bogra and both the 
tap water samples from Kishorganj. We did not find Vibrio in the water 
samples from central pumps or tube wells. Ground water extracted from 
deep tube wells was supplied intermittently through interconnected pipes 
without treatment in both outbreak areas. We found visible leakages in 
pipelines in Bogra. Though we found no visible leakages, but pipes passed 
through open sewers in Kishorganj. The rapid onset of severe watery 
diarrhea in adults and isolation of cholera organisms from their rectal 
swabs confirmed that the outbreaks were caused by Vibrio cholerae. The 
detection of Vibrio in the tap water samples but not from central pumps 
or tube wells, suggested water contamination in the pipelines. Safe water 
provision is difficult in municipalities where water supply is intermittent, 
and where pipes commonly leak; and requires actions outside of the 
health sector. Collaborative research exploring effectiveness of water 
purification strategies, including chlorination in areas with intermittent 
water supply, may identify appropriate approaches for ensuring safe water 
until improvement of the water and sanitary infrastructure.
774
ACCEPTABILITY, FEASIBILITY AND SUSTAINABILITY OF DUAL 
PIT LATRINES FOR RURAL HOUSEHOLDS IN BANGLADESH
Faruqe Hussain1, Stephen P. Luby1, Thomas Clasen2, Elli 
Leontsini3, Milan K. Barua4, Tania Naushin1, Mahfuzur Rahman1, 
Samir Ghosh1, Shahinoor Akter1, Leanne Unicomb1
1International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, 
Bangladesh, 2Faculty of Infectious and Tropical Diseases, London School of 
Hygiene and Tropical Medicine, London, United Kingdom, 3Department of 
International Health, Johns Hopkins Bloomberg School of Public Health, 
Baltimore, MD, United States, 4BRAC Centre, Dhaka, Bangladesh
In Bangladesh, single pit pour-flush latrines that separate human feces 
away from a child’s environment are commonly installed. But latrine water 
seals are frequently broken by owners to reduce the volume of water 
used, thus extending the time for pits to fill. They also break the pit liner 
and allow latrine contents to overflow. Up to 70% of rural households 
have visible feces on or around latrines. Latrines with two pits, one for 
current use and a second for subsequent use when the first is filled and 
composting, may reduce fecal exposure. We investigated an on-going 
dual pit latrine construction project to identify the acceptability, feasibility, 
sustainability, perceived benefits and barriers among impoverished rural 
households. From October 2010 to April 2011 we enrolled households 
in a communities where BRAC, a non-governmental organization, 
implemented a project in 2007 providing dual pit latrines for households 
that met the Government of Bangladesh definition of ‘hardcore poor’ 
who shared the cost of transportation and labor. We conducted group 
discussions (5), interviewed household members (15) and observed 
their latrine use at four key stages: immediately after installation, upon 
switching to the second pit when the first was full, during decomposition 
of the first pit contents, and during emptying and disposing of the first pit 
contents. None of the households reported latrine overflow or breaking 
the pit liner or water seals and we observed no visible feces on or around 
latrines. Participants perceived the main benefit of using the dual pit 
latrine was when the first pit became full; households immediately started 
using the back-up pit without having to empty the fresh feces. After 
approximately one year, households could empty the decomposed pit 
contents themselves. This saved money and the decomposed excreta of 
the first pit could be used as manure. Disgust when switching pits was 
described as a barrier, but did not discourage switching: 8 households 
successfully completed pit switching at least once. Subsidized dual pit 
latrines were acceptable to impoverished households in rural Bangladesh 
and provided safe and effective separation of feces from the environment. 
The dual pit latrine should be evaluated among other groups on a larger 
scale.
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MOTIVATING CONTINUED USE OF POINT OF USE WATER 
TREATMENT IN RURAL BANGLADESH
Shaila Arman1, Leanne Unicomb1, Elli Leontsini2, Pavani K. Ram3, 
Fazlul K. Chowdhury1, Md. A Mamun1, Smriti Roy1, Subas C. 
Biswas1, Rouha Anamika Sarker1, Sania Ashraf1, Thomas Clasen4, 
Peter J. Winch2, Stephen P. Luby1
1International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, 
Bangladesh, 2Johns Hopkins Bloomberg School of Public Health, Baltimore, 
MD, United States, 3University at Buffalo, State University of New York, 
Buffalo, NY, United States, 4Faculty of Infectious and Tropical Diseases, 
London School of Hygiene & Tropical Medicine, London, United Kingdom
Point of use (POU) water treatment can prevent diarrhea, though most 
interventions fail to achieve continued use in low income countries. In 
October 2010, we undertook a 13-month pilot POU water treatment 
intervention with sodium dichloroisocyanurate (NaDCC) tablets in 3 
rural communities in Bangladesh. Trained local female community health 
promoters (CHPs) made 2 household visits and conducted 1 courtyard 
meeting per month. They encouraged water treatment by appealing to 
both health benefits and non-health values including convenience, nurture 
and modernity; addressed barriers; and provided a free supply of NaDCC 
tablets for daily use. At the last visit, CHPs gave study participants enough 
NaDCC tablets to last for two months. We assessed barriers to long term 
POU water treatment uptake and evaluated the effectiveness of the 
intervention in addressing these barriers during and at the end of pilot 
intervention activities. We assessed use by testing for residual free chlorine 
in stored drinking water in study households at the 2nd month (n=129) 
and 14th month (n=91). We also interviewed mothers of <5 children 
(n=30) and conducted group discussions (n=6) with both male and female 
study participants at 14 months. At months 2 and 14, 82% (106/129) and 
62% (56/91) of households had detectable free residual chlorine in stored 
treated water, respectively. Respondents reported that they had become 
accustomed to the smell, taste and temperature of stored treated water 
and no longer perceived them as barriers. Respondents reported reduced 
episodes of illness, especially stomach aches, compared to the previous 
year, ease of dosing with provided storage vessel and clarity of treated 
water as factors that motivated continued use. Respondents welcomed 
regular household visits by CHPs whom they knew as neighbors. They 
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emphasized that the encouragement provided by the CHPs motivated 
them to use NaDCC tablets in spite of their initial reaction to stored 
treated water, their heavy workload, and the reluctance of males to drink 
treated water. Despite initial concerns with smell, taste and temperature, 
the majority of study participants continuously treated their water for 13 
months and at least one month after active promotion ended. Combining 
access to effective, easy-to-use water treatment technology with trained, 
confident and knowledgeable local community health promoters can help 
improve the uptake of POU water treatment.
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THE NEED FOR POINT OF USE WATER TREATMENTS IN 
AREAS OF PERI-URBAN POVERTY: CASE STUDY OUTSIDE 
IQUITOS, PERU
Kimberly F. Faldetta1, Derek A. Reighard1, Katie L. Dickinson1, 
Chloe Q. Wang1, Daniel R. George1, William H. Strosnider2
1Pennsylvania State College of Medicine, Hershey, PA, United States, 2Saint 
Francis University, Loretto, PA, United States
This study aimed to determine the water collection and home treatment 
methods in Belen, Iquitos, Peru to elucidate the cause of the high 
incidence of gastrointestinal diseases in this neighborhood. The results 
of this study emphasize the importance of point of use water treatment 
in the home. Belen is a sector of urban poverty on the outskirts of 
Iquitos, capital of the Loreto region of Peru, where people suffer from 
gastrointestinal diseases at higher rates than the rest of the city. While 
many previous studies have highlighted the prevalence of several specific 
pathogens in this neighborhood, there is little information regarding 
water-collection methods and treatment in this region. In July 2011, 
50 households located in Belen were surveyed using stratified random 
sampling. Surveys were administered to the head of household in Spanish. 
In each house, a water sample was collected from the primary drinking 
water source in a sterile cup with an airtight screw cap then transported to 
the Universidad Nacional de Amazonica Peruana microbiology lab for fecal 
coliform (FC) testing. The American Public Health Association guidelines 
were used for FC testing. The overall rate of contamination was 11.1%. 
Most of the water samples (92.5%) that were negative for FC were 
untreated in the home, suggesting that treatment methods used by the 
local water provider are sufficient at the point of treatment. The positive 
FC sample results most likely represent contamination during the time of 
storage or use in the home. No sample that had been treated at home had 
a positive FC test. Therefore, it will be critical to emphasize to residents 
of Belen the importance of home water treatment before consuming 
water. It is possible that water is contaminated during storage, so residents 
should be urged to keep their water storage containers disinfected as 
well. Iquitos boasts a water plant with treated water, but the amount of 
chlorine may not be adequate to cover contamination en route or in the 
home. Although a region may have access to treated water, residents 
should continue to practice point of use treatment to ensure the safety 
of their drinking water. Point of use contamination could be a substantial 
source for fecal contamination and therefore point of use treatment 
should be encouraged in the homes of communities of peri-urban poverty 
similar to Belen.
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MEASURING CONTAMINATION OF CHILDREN’S TOYS TO 
EVALUATE HOUSEHOLD SANITATION IMPROVEMENTS IN 
RURAL BANGLADESH
Jelena Vujcic1, Pavani K. Ram1, Leanne Unicomb2, Faruqe 
Hussain2, Partha Sarathi Gope2, Zahid Hayat Mahmud2, Jaynal 
Abedin2, Md. Sirajul Islam2, Stephen P. Luby3
1University at Buffalo, Buffalo, NY, United States, 2International Centre 
for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh, 3Global 
Disease Detection Branch, Centers for Disease Control and Prevention, 
Atlanta, GA, United States
The impact of modest improvements in sanitation  facilities and practices 
on community health are unknown. As one step to better  understand 
the potential contribution of such modest improvements, we evaluated  
whether different levels of sanitation are associated with environmental  
contamination, as indicated by fecal contamination of children’s toys, in 
rural  Bangladesh. We assigned 100 households to the “clean” category 
if they had an  improved latrine and no visible human feces in the living or 
adjacent space, or  to the “less clean” category if they had an unimproved 
latrine and visible  human feces in living or adjacent space. We distributed 
two non-porous toy balls  to each household, washed each toy in 200 
ml of Ringer’s solution 3-4 days later,  and repeated the process with 
two new toys. We enumerated fecal coliforms and  fecal streptococci in 
the wash fluid from each toy following standard  procedures. Toys from 
39 clean households had lower average fecal coliform  contamination 
than toys from 61 less clean households (mean of log10transformed  
values 2.4 versus 3.2, p= 0.03). Fecal streptococci contamination was 
not  significantly different between clean and less clean households 
(mean of log10transformed  values 4.7 versus 4.8, p = 0.37). There was 
substantial variability in fecal  coliform contamination of two toys in 
the household at the same time  (Coefficient of Variation (CV)=36.5), 
and toys in the household at two  different times (CV=37.6). In rural 
Bangladesh improved sanitation structures  and practices were associated 
with less environmental contamination. Whether this  level of difference 
in environmental contamination improves child health merits  further 
study. The level of variation of this measure was typical for measures  of 
environmental contamination, such as measures of water quality. Sentinel 
toy contamination may be a useful  objective measure to assess the ability 
of sanitation interventions to reduce  fecal contamination.
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ETHNOGRAPHIC AND DIARRHEA PREVALENCE RESULTING 
FROM COMMUNITY BASED WATER TREATMENT SYSTEMS: 
A COMPARISON BETWEEN FINDING IN UGANDA AND 
HONDURAS
Jeffery L. Deal
Water Missions International, Charleston, SC, United States
Using a combination of ethnographic methods, healthcare facility chart 
reviews, and individual waterborne parasite tests, this paper presents 
the results of a three year investigation comparing the health impacts of 
providing water treatment systems for communities in Uganda versus 
Honduras. The Honduras project provided treated water and flush toilets 
for an approximated 340,000 people. Improvements in health were 
documented in Honduras by ethnographic findings, parasite surveys, and 
medical chart reviews, and were confirmed by local public health officials. 
In Uganda, no such impact was documented despite provision of access to 
treated water meeting US, EPA standards and the universal knowledge of 
waterborne illnesses and their causes within the six communities studied. 
Ethnographic data and subsequent KAP survey data confirmed accurate 
local understandings of water and health issues as well as significant gaps 
in the water safety behavior. A total of 19,420 patient interactions were 
searched for possible waterborne illnesses within both test and control 
communities and showed no significant differences in rates of diarrhea 
and/or dysentery. Random selection of subjects for parasite surveys by 
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rapid stool tests also showed no significant differences between test and 
control communities. Likely causes of these findings will be discussed 
including the probability that exposure to contaminated water in Lake 
Victoria, animal feces, and open-air food sources contribute to ongoing 
disease loads within the test communities. Methods developed and 
implemented for this study represent a significant advance over commonly 
used survey techniques.
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CLINICAL TOLERABILITY OF ARTESUNATE-AMODIAQUINE 
VS. COMPARATOR TREATMENTS FOR UNCOMPLICATED 
FALCIPARUM MALARIA IN SUB-SAHARAN AFRICA, AN 
INDIVIDUAL PATIENT DATA ANALYSIS
Julien Zwang1, Grant Dorsey2, Djimdé Aboulaye3, Corine Karema4, 
Andreas Mårtensson5, Jean-Louis Ndiaye6, Sodiomon Sirima7, 
Piero L. Olliaro8
1Drugs for Neglected Disease initiative, Geneva, Switzerland, 2Department 
of Medicine, University of California, San Francisco, CA, United States, 
3Malaria Research and Training Center, Department of Epidemiology 
of Parasitic Diseases, Faculty of Medicine and Pharmacy, University of 
Science, Techniques and Technology of Bamako, Bamako, Mali, 4Malaria 
and Other Parasitic Diseases Division-RBC, Ministry of Health, Kigali, 
Rwanda, 5Infectious Diseases Unit, Department of Medicine, Karolinska 
University Hospital, Karolinska Institutet, Stockholm, Sweden, 6Department 
of Parasitology, Faculty of Medicine, Cheikh Anta Diop University, Dakar, 
Senegal, 7Centre National de Recherche et de Formation sur le Paludisme, 
Ministère de la Santé, Ouagadougou, Burkina Faso, 8UNICEF/UNDP/WB/
WHO Special Programme for Research and Training in Tropical Diseases 
(TDR), Geneva, Switzerland
The wide-spread use of artesunate-amodiaquine (ASAQ) for treating 
uncomplicated malaria makes it important to gather and analyse 
information on its tolerability. An individual-patient tolerability analysis 
was conducted using data from eight randomized controlled clinical 
trials conducted at 17 sites in nine sub-Saharan countries comparing 
ASAQ to other antimalarial treatments. All patients who received at least 
one dose of the study drug were included in the analysis. Differences in 
adverse event (AE) and treatment emergent adverse event (TEAE - AE 
which were absent pre-treatment or worsened with treatment) were 
analysed by Day 28. A total of 6,179 patients were enrolled (74% <5 
years of age), of whom 50% (n=3,113) received ASAQ, 20% (n=1,217) 
another ACT, and 30% (n=1,849) a non-ACT (combination or single-
agent) treatment. Overall, 8,542 AEs and 3,943 TEAEs were recorded. 
The proportion of patients experiencing at least one gastro-intestinal 
AE on ASAQ was 43% (higher than with artemether-lumefantrine and 
dihydroartemisinin-piperaquine at two sites only), and was 23% for any 
other AEs (not different from other treatments). Specifically, the risk of 
diarrhoea, vomiting, cough and weakness was lower with artemether-
lumefantrine; artemether-lumefantrine and dihydroartemisinin-piperaquine 
carried a higher risk of pruritus, chloroquine-SP of nausea. Parasitological 
recurrence increased the risk of occurrence of any AE. No other difference 
was detected. Comparing AE to TEAE in patients who had pre-treatment 
occurrence and grades of intensity recorded, AEs were significantly 
more related to the pre-treatment prevalence of the symptom (p=0.001, 
Fischer test); AEs overestimated TEAEs by a factor ranging from none to 
5-fold. The overall incidence of serious AEs (SAEs) with ASAQ was nine 
per thousand (29/3,113) and a mortality of one per thousand (three 
deaths, none drug-related) and similar to other treatments. ASAQ was 
comparatively well-tolerated. Safety information is important, and must be 
collected and analysed in a standardised way.
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TOWARDS RATIONAL USE OF ANTIBIOTICS FOR SUSPECTED 
SECONDARY INFECTIONS IN BURULI ULCER PATIENTS
Ymkje Stienstra1, Yves Barogui2, Sandor Klis3, Honoré Sourou 
Bankolé4, Ghislain Sopoh5, S. Mamo6, Lamine Baba-Moussa7, 
Willem L. Manson8, Christian Johnson9, Tjip S. van der Werf3
1University Medical Center Groningen, Department of Internal Medicine/
Infectious Diseases, Groningen, The Netherlands, 2Programme National 
de Lutte contre l’ulcère de Buruli, Cotonou, Benin, 3University Medical 
Center Groningen, Groningen, The Netherlands, 4Département de Génie 
de Biologie Humaine, Ecole polytechnique de l’université d’Abomey-Calavi, 
Cotonou, Benin, 5PNLB, Cotonou, Benin, 6Agogo Presbyterian Hospital, 
Agogo, Ghana, 7Laboratoire de biologie et de typage moléculaire en 
microbiologie, Faculté des sciences, Université d’Abomey-Calavi, Cotonou, 
Benin, 8University Medical Center Groningen, Department of Microbiology, 
Groningen, The Netherlands, 9Fondation Raoul Follereau, Cotonou, Benin
The emerging neglected disease Buruli ulcer is treated with streptomycin 
and rifampicin and surgery if necessary. Frequently other antibiotics are 
used during treatment.  Information on prescribing behavior of antibiotics 
for suspected secondary infections and for prophylactic use was collected 
together with cultures from ulcers. Of 185 patients that started treatment 
for Buruli ulcer in different centers in Ghana and Bénin 51 were admitted. 
Forty of these 51 admitted patients (78%) received at least one course of 
antibiotics other than streptomycin and rifampicin during their admission. 
The median number (IQR) of antibiotic courses for admitted patients was 2 
(1, 5). Only twelve patients received antibiotics for a suspected secondary 
infection, all other courses were prescribed for use as prophylaxis during 
10 days on average after excision, debridement or skin grafting. Antibiotic 
regimens varied enormously per indication. Cultures from superficial 
swabs showed the expected bacteria from a chronic wound, but 13 of the 
34 (38%) S. aureus showed to be MRSA. A guide for rational antibiotic 
treatment for suspected secondary infections or prophylaxis is needed. 
Adherence to the proposed guideline may reduce and tailor on antibiotic 
use other than streptomycin and rifampicin in Buruli ulcer patients. It may 
save costs, reduce toxicity and limit development of further antimicrobial 
resistance. This topic should be included in general protocols on the 
management of Buruli ulcer.
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THE ASSOCIATION BETWEEN MALARIA PARASITEMIA, 
ERYTHROCYTE POLYMORPHISMS, MALNUTRITION AND 
ANAEMIA IN CHILDREN LESS THAN 10 YEARS IN SENEGAL: A 
CASE CONTROL STUDY
Roger C. Tine1, Helle H. Hansson2, Magatte Ndiaye1, Michael 
Alifrangis2, Babacar Faye1, Cheikh T. Ndour3, Jean L. Ndiaye1, 
Pascal Magnussen4, Ib C. Bygbjerg2, Oumar Gaye1
1Service de Parasitologie, Faculté de Médecine de Dakar, Dakar, Senegal, 
2University of Copenhagen Faculty of Health Sciences Department of 
International Health, Immunology and Microbiology, Copenhagen, 
Denmark, 3Clinique des Maladies Infectieuses, Centre Hospitalier 
Universitaire de Fann, Sénégal, Dakar, Senegal, 4DBL - Centre for Health 
Research and Development, Faculty of Health and Medical Sciences, 
University of Copenhagen, Copenhagen, Denmark
Malaria and anaemia (Haemoglobin<11 g/dl) remain frequent in sub-
Saharan Africa. the ethiology of anaemia is known to be multi-factorial, 
most studies in malaria endemic areas, have been confined to analysis 
of possible associations between anaemia and individual factors such 
as malaria. A case control study involving children aged from 1 to 10 
years was conducted to assess some assumed contributors to anaemia 
in the area of Bonconto Health post in Senegal. Study participants were 
randomly selected from a list of children who participated in 
a survey in December 2010. Children aged from 1 to 10 years with 
haemoglobin level below 11 g/dl represented cases (anaemic children). 
Control participants were eligible if of same age and their haemoglobin 
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level was >= 11 g/dl. For each participant, a physical examination was 
done and anthropometric data collected prior to a biological assessment 
which included: malaria parasitemia infection, intestinal worm carriage, 
G6PD deficiency, sickle cell disorders, and alpha-talassemia. Three hundred 
and fifty two children < 10 years of age were enrolled (176 case and 
176 controls). In a logistic regression analysis, anaemia was significantly 
associated with malaria parasitaemia (OR=5.23, 95%CI [1.1-28.48]), 
sickle cell disorders (OR=2.89, 95%CI[1,32-6.34]), alpha-thalassaemia 
(OR=1.82, 95%CI[1.2-3.35]), stunting (OR=3.37, 95%CI [1.93-5.88], 
age ranged from 2 to 4 years (OR=0.13, 95%CI[0.05-0.31]) and age > 5 
years (OR=0.03, 95%CI[0.01-0.08]). No association was found between 
G6PD deficiency, intestinal worm carriage and children’s gender. Malaria 
parasitaemia, stunting and haemoglobin genetic disorders represented 
the major causes of anaemia among study participants. Aneamia control 
in this area could be achieved by developing integrated interventions 
targeting both malaria and malnutrition.
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ASSESSMENT OF THE ULTRASOUND EXAMINATION AS 
AN EPIDEMIOLOGICAL TOOL FOR THE SECONDARY AND 
TERTIARY PREVENTION IN A MALIAN RURAL AREA
Yaya I. Coulibaly1, Siaka Y. Coulibaly2, Boubacar Fofana3, 
Modibo Keita1, Mahamadou M. Keita1, Ilo Dicko2, Moussa B. 
Sangare2, Seydou Doumbia2, Adama Dao1, Oumar Maiga1, Samba 
O. Sow1, Thomas B. Nutman4, Amy D. Klion4, Adama D. Keita3
1Centre National d’Appui a la lutte contre la Maladie (CNAM), Bamako, 
Mali, 2Malaria Research and Training Center, Bamako, Mali, 3Hopital du 
Point G, Bamako, Mali, 4National Institutes of Health/National Institute of 
Allergy and Infectious Diseases, Bethesda, MD, United States
Rural populations have less access to preventive health care and routine 
medical tests than residents of large cities. Ultrasonography is a non-
invasive method that can aid in the diagnosis of a variety of conditions 
that require medical intervention. To assess the utility of ultrasound as a 
diagnostic screening test in a rural setting, five ultrasound examination 
visits were held in the 11 villages of Sabougou health area in Kolokani 
district (population 10,999 inhabitants in 2010). The village chief provided 
the examination site in 10 of the study villages and the local health clinic 
(CSCOM) was used in Sabougou. The motorcycle of the CSCOM was 
used, as well as a power generator and a portable ultrasound machine 
equipped with two probes of different frequencies. All volunteers (n=782) 
underwent a brief medical examination and ultrasound examination of 
the abdomen and heart performed by two physicians, including a well-
trained ultrasonographer. In addition, women older than 15 years of age 
(n=416) underwent uterine ultrasound, male subjects of all ages (n=272) 
underwent scrotal ultrasound and all individuals older than 15 years of 
age (n=588) underwent thyroid ultrasound. Of the 782 subjects examined, 
194 (25%) were less than 15 years old, 64 (8%) were pregnant women 
and 53 (7%) were > 65 years old. The overall prevalence of cardiac 
valvular calcification was 5% (39/782), and 0.64% (5/782) subjects had 
evidence of ventricular dilatation. Among the 272 men examined, 22 
cases (8.09%) of subclinical hydrocele, 11 cases (4.04%) of hydrocele, 5 
cases of testicular cysts (1.84%),3 cases of prostatic adenoma (1.1%) and 
1 case of prostatic cancer were identified. Two of the 510 women (0.39%) 
examined had uterine fibromas and one case of uterine malignancy was 
detected. Among the 64 pregnant women, one case of fetal demise 
(1.6%) and one case of extra-uterine pregnancy (1.6%) were detected. 
One case of multiple abnormalities of the thyroid, heart and testis was 
also observed. A total of 117 and 28 subjects were referred for further 
management to the Sabougou community health center and the Kolokani 
district reference center, respectively. Given these results, ultrasound 
examination in remote rural areas is a practical and non-invasive method 
for the identification of individuals requiring referral for medical care in 
rural Mali and its use should be considered at a regional and national 
scale.
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EVALUATION OF NEW TECHNOLOGY MULTIPLEX NUCLEIC 
ACID TESTS FOR EMERGING AND TROPICAL BLOODBORNE 
PATHOGENS 
Elena Grigorenko1, Carolyn Fisher2, Sunali Patel1, Clark Tibbets3, 
Moussa Kourout2, Anjan Purkayastha3, Hira L. Nakhasi2, Robert C. 
Duncan2
1Life Technologies, Corp., Beverly, MA, United States, 2Food and Drug 
Administration/CBER, Rockville, MD, United States, 3TessArae, LLC, 
Potomac Falls, VA, United States
Testing of bloodborne pathogens has reduced the risk of transfusion-
transmitted infections significantly and use of molecular diagnostic tools 
has further improved the accuracy of diagnosis. However, with increasing 
numbers of emerging pathogens that can impact blood safety and 
the potential for multiple infections in a tropical setting, it is becoming 
burdensome to conduct separate tests for each agent. Devices that 
allow simultaneous testing for multiple pathogens (multiplex testing) 
can potentially streamline blood donation and diagnostic testing. We 
evaluated two devices, the OpenArray® by Life Technologies Corp. 
(Carlsbad, CA), and the Resequencing Pathogen Microarray (RPM) by 
TessArae, LLC (Potomac Falls, VA), for their potential ability to enable 
multiplex testing in whole blood and plasma samples. The OpenArray® 
system can perform approximately 3,000 individual real-time polymerase 
chain reaction tests simultaneously on a microscope slide-size metal 
wafer. The RPM utilizes an Affymetix© GeneChip© base and a particular 
arrangement of oligonucleotides. Hybridization to these oligionucleotides 
leads to sequence identification. We assembled and tested a blood 
pathogen OpenArray® with primer and probe sets for viruses (HIV-1, HCV, 
HBV, WNV), parasites (Trypanosoma cruzi, Leishmania, Plasmodium), 
and Gram negative bacteria. Simultaneous detection of these 4 viruses 
in plasma specimens and 5 bacterial or parasite species in whole blood 
specimens was achieved at limits of detection equivalent to individual 
assays. An RPM was designed and tested with tiles for 22 viruses, 53 
prokaryotes and 25 eukaryotes. We correctly identified nucleic acid from 
10 pathogens simultaneously. These two multiplex detection devices are 
highly specific for known bloodborne pathogens. Future testing will reveal 
whether the sensitivity of these platforms is adequate and whether they 
are feasible for use in clinical diagnostic and blood donation settings.
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CENTRE-BASED CLINICAL MANAGEMENT OF CYSTIC 
ECHINOCOCCOSIS
Thomas Junghanss
University Hospital, Heidelberg, Germany
Cystic echinococcosis (CE) is one of the world’s most neglected diseases. 
The lesions, predominantly in the liver and lungs, develop clinically silently 
over long periods of time until complications suddenly precipitate. The 
challenge for health care services, in particular in low-resource settings, 
is twofold, early detection and treatment of cases and very demanding 
management of complications of late stage disease. In high-income 
countries mostly migrants from CE-endemic areas are affected. In this 
setting CE is not only neglected but also rare and health services are, 
as a rule, not experienced to diagnose, stage and manage this disease 
appropriately. A centre-based approach of CE is presented with our 
interdisciplinary clinical CE unit at Heidelberg University Hospital as an 
example. Infectious disease / tropical medicine physicians, radiologists, 
abdominal and thoracic surgeons, gastroenterologists and parasitologists 
work very closely together to stage patients (ultrasound-based cyst 
classification) and to tailor currently available mostly expert-opinion based 
treatment options (medical treatment with albendazole, percutaneous 
cyst-sterilization techniques, surgery and ‘watch and wait’) to the needs 
of the individual patient. This approach can serve as a model for the 
clinical management of many other NTDs / NIDs in highly mobile global 
populations.
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TUBERCULOUS MENINGITIS AND RABIES ARE THE MOST 
COMMON CENTRAL NERVOUS SYSTEM INFECTIONS IN THE 
NATIONAL REFERRAL HOSPITAL FOR INFECTIOUS DISEASE, 
THE PHILIPPINES
Emi Kitashoji1, Nimfa M. Putong2, Efren M. Dimaano2, Maiko 
Kojiro1, Motoi Suzuki1, Benito J. Villarama2, Koya Ariyoshi1
1Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki 
University, Nagasaki, Japan, 2San Lazaro Hospital, Manila, Philippines
Central nervous system (CNS) infections are significant causes of mortality 
and mobility in low-middle income countries. To improve clinical diagnosis, 
management and public health intervention, it is essential to clarify the 
comprehensive picture of CNS infections. However most published studies 
focused limited pathogens. The objective of this study is to describe the 
present picture of whole CNS infections in the Philippines. We conducted 
a hospital-based retrospective descriptive study in San Lazaro Hospital 
(SLH), the national referral hospital for infectious and tropical diseases 
in the Philippines. We collected demographic and clinical information of 
all patients who were admitted with any suspected CNS infection from 
1st January 2008 to 30th September 2011. It included all patients who 
were diagnosed CNS infections as initial and/or final diagnosis and all 
hospitalized patients who required a lumbar puncture (LP) examination, 
except for patients in HIV ward. A total of 1,264 patients were analyzed, 
937 of them showed CNS infections as final diagnosis. There were more 
males (62%) and nearly half of the cases (43%) was under 12 years old. 
Tuberculous meningitis (TBM) and Rabies were the most common CNS 
infections with 312(27%) cases of TBM and 217(19%) of rabies. This was 
followed by other bacterial meningitis 169(15%) and viral encephalitis 
135(12%). Case fatality rate (CFR) for rabies was 100%; likewise, the CFR 
for non-rabies CNS infection was also high at 238/703(33.9%). 187(16%) 
of the patients who were initially diagnosed as CNS infections were 
confirmed not CNS infection in the final diagnosis. Febrile convulsions 
and seizures were the most common non-CNS infections. 131(11%) of 
the patients who were initially not diagnosed as CNS infections were 
later diagnosed as CNS infection: typhoid fever was the most common 
misdiagnosis upon admission. LP was performed in 277(22%) cases 
but its performance was often substantially delayed since many of the 
patients were critically ill upon admission and none of CSF was positive 
for bacterial culture. There is ample room for improvement of clinical 
diagnosis and management of CNS infections.
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DENGUE AND DIARRHEAL DISEASE RISK FACTORS IN RURAL 
AND SUBURBAN VILLAGES IN THAILAND AND LAOS
Hans J. Overgaard1, Nsa Dada1, Nanthasane Vannavong1, Razak 
Seidu1, Ram Rangsin2, Theeraphap Chareonviriyaphap3, Audrey 
Lenhart4, Thor Axel Stenström1
1Norwegian University of Life Sciences, Ås, Norway, 2Department of 
Military and Community Medicine, Pramongkutklao Medical College, 
Bangkok, Thailand, 3Department of Entomology, Faculty of Agriculture, 
Kasetsart University, Bangkok, Thailand, 4Liverpool School of Tropical 
Medicine, Liverpool, United Kingdom
Diarrheal diseases and dengue fever are major global health problems. 
Household drinking water (DW) storage can be a determinant for both 
diseases if water is fecally contaminated and the storage containers 
provide breeding sites for dengue mosquitoes. The aim of this project is 
to assess health risks associated with household water storage practices 
by identifying relationships between household water management, 
contaminated DW, and mosquito production. In 2011 we collected 
entomological, bacteriological, and socioeconomic data from one rural 
and one suburban village in northeastern Thailand and southern Laos, 
respectively. In rural Thailand, almost 100% of the study population 
use rainwater as DW. In rural Laos 83% use unprotected wells in the 
dry season and 92% use rainwater in the rainy season. In the suburban 
settings DW sources are rainwater and bottled water. There was an 
average of 2.5 DW containers per household. Only 6% of households 
in rural Thailand and 43% in rural Laos treat their DW. These figures 
were higher for the suburban areas (Thailand: 65%; Laos: 84%). Water 
holding containers were found in >93% of the households, of which 
~19% were positive for Aedes aegypti immatures. The most productive 
containers were cement tanks in both countries, representing 15-17% 
of all encountered pupae. The Breteau index (BI) was higher in Thailand 
than in Laos (140 vs 845, p<0.01). In Thailand the BI was higher in the 
rural area than in the suburban area (147 vs 134, p<0.01), whereas in 
Laos the opposite was observed (112 vs 56; p<0.01). In Thailand almost 
10% of the Aedes positive containers were used for drinking, whereas in 
Laos as many as 25% were used for drinking. Of the Aedes infested DW 
containers 26% in Thailand and 51% in Laos were also contaminated 
with Escherichia coli. The results suggest an intricate relationship between 
water contamination and mosquito production in household water 
storage containers. This relationship and the role of domestic water 
management practices as risk factors for both dengue and diarrheal 
disease will be discussed.
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SAFETY AND EFFICACY OF ARTEMETHER-LUMEFANTRINE 
AGAINST UNCOMPLICATED PLASMODIUM FALCIPARUM 
MALARIA DURING PREGNANCY: A SYSTEMATIC REVIEW
Christine Manyando1, Kassoum Kayentao2, Umberto 
D’Alessandro3, Henrietta U. Okafor4, Elizabeth Juma5, Kamal 
Hamed6
1Tropical Diseases Research Centre, Ndola, Zambia, 2Malaria Research and 
Training Centre, Bamako, Mali, 3Medical Research Council Unit, Fajara, 
Gambia, 4Department of Pediatrics, College of Medicine, University of 
Nigeria, Enugu, Nigeria, 5Kenya Medical Research Institute, Kisumu, Kenya, 
6Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
Plasmodium falciparum malaria during pregnancy, linked to increased 
morbidity and mortality, must be reduced by preventive measures and 
effective case management. Although, the World Health Organization 
(WHO) recommends artemisinin-based combination therapy (ACT) to treat 
uncomplicated P. falciparum malaria during the second and third trimesters 
of pregnancy, and quinine plus clindamycin during the first trimester, 
the national policies of many African countries currently recommend 
quinine throughout pregnancy. Our objective is to analyze available data 
on the safety and efficacy of artemether-lumefantrine (AL) in pregnancy. 
English-language search identified 16 publications from 1989 to October 
2011 with reports of artemether or AL exposure in pregnancy, including 
randomized clinical trials, observational studies, and systematic reviews. 
There were 1,103 reports of AL use in pregnant women: 890 second/third 
trimester exposures; 212 first trimester exposures; and 1 case where the 
trimester of exposure was not reported. In the second and third trimesters, 
AL was not associated with increased adverse pregnancy outcomes 
compared with quinine or sulphadoxine-pyrimethamine, showed improved 
tolerability relative to quinine, and its efficacy was non-inferior to quinine. 
Few reports suggest that the pharmacokinetics of anti-malarial drugs may 
change in pregnancy, however, the majority of studies reported high cure 
rates and adequate tolerability. Additional data are required to assess 
the potential to use AL in the first trimester. These findings reinforce the 
WHO recommendation to treat uncomplicated P. falciparum malaria with 
quinine plus clindamycin in early pregnancy and ACT in later pregnancy.
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MICROBIAL ETIOLOGY OF TRAVELERS’ DIARRHEA: 
EXPERIENCE OF A TRAVEL CLINIC IN TOKYO
Yasuyuki Kato1, Hidemasa Izumiya2, Taiichiro Kobayashi1, Mugen 
Ujiie1, Nozomi Takeshita1, Shuzo Kanagawa1
1National Center for Global Health and Medicine, Tokyo, Japan, 2National 
Institute of Infectious Diseases, Tokyo, Japan
Travelers’ diarrhea (TD) is the most common illness in international 
travelers visiting developing regions of the world. Published studies 
provide relatively limited data on the microbial etiology of TD from 
South and Southeast Asia, which is popular destinations for tourism and 
business from Japan, compared with that from Africa and Latin America. 
Travelers who visited at the Travel Clinic of the National Center for 
Global Health and Medicine, Tokyo, with acute diarrhea (<14 day) that 
started during or shortly after a stay abroad during December 2009 and 
March 2012 were eligible for this study. After the participants provided 
informed consent, clinical data and stool samples were collected. The 
stool samples were screened by PCR for conventional diarrheagenic 
bacterial pathogens and cultured by standard methods. Commercially 
available antigen detection kits for Giardia, Cryptosporidium, rotavirus, 
norovirus, and adenovirus were also used. A total of 121 cases were 
analyzed. The major destinations included Southeast Asia (44%), South 
Asia (30%), and Africa (13%). Diarrheagenic pathogens were detected 
in 66% of the TD cases. In 23% of them, multiple pathogens were 
detected in the stool samples. Enterotoxigenic Esherichea coli was the 
most common pathogen in all the destinations (36%). Enteroaggregative 
E. coli was the second most common pathogen overall (12%) and more 
frequently detected in the cases who had returned from Southeast Asia. 
Campylobacter, Shigella, and rotavirus followed in this order. Rotavirus 
was more frequently detected in the cases who had returned from South 
Asia (P <0.05). Ciprofloxacin resistance in diarrheagenic E. coli was rare in 
all the destinations, but broad-spectrum β-lactam resistance was found in 
the strains from South Asia. Further investigation focusing on antimicrobial 
resistance of pathogens of TD is needed.
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DISTRIBUTION OF RUBELLA INFECTIONS IN RWANDA SINCE 
2003
Zena Uwimana, Jean-Frederic Flandin, Odette Mukabayire
National Reference Laboratory, Kigali, Rwanda
Rubella virus is the causative agent of the disease known more popularly 
as German measles and is predominantly a childhood disease, endemic 
throughout the world. Natural infections of Rubella occur only in humans 
and are generally mild but complications, most commonly polyarthralgia 
in adult women, do exist. RV infection of women during the first trimester 
of pregnancy can induce a spectrum of congenital defects in the newborn, 
known as congenital rubella syndrome (CRS). Since 2003, the National 
Reference Laboratory of Rwanda has been involved in the surveillance of 
Rubella infection throughout the country. Cumulative data show that of 
the 1,778 samples suspected of Rubella, 382 were positively identified by 
ELISA (21,5%). In Rwanda, geographical data indicates that the Rubella 
is equally distributed in all provinces of Rwanda with small pockets of 
infections in Kigali city and Ruhango district, close to the border of 
Burundi. According to sex and age, infections occur equally in males and 
females but the majority of infections were in patients older than 5 years 
old (69,9%).
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ESTABLISHING A TROPICAL MEDICINE TRAINING PROGRAM 
FOR THE US DEPARTMENT OF DEFENSE (DOD) IN KINTAMPO, 
GHANA: OVERCOMING CHALLENGES
Eyako K. Wurapa1, David Brett-Major2, Bradley Lloyd3, Damien 
Punguyire4, Karl Kronmann5, Chris Duplisis6, Naakai Tagoe6
1GEIS Kenya, Nairobi, Kenya, 2Uniformed Services University of the 
Health Sciences, Bethesda, MD, United States, 3Landstuhl Regional 
Medical Center, Landstuhl, Germany, 4Kintampo District Hospital, Ghana, 
Kintampo, Ghana, 5Naval Medical Center Portsmouth, Portsmouth, VA, 
United States, 6Naval Medical Research Unit 3, Cairo, Egypt
Endemic diseases remain key concerns when deploying US  forces. 
A critical challenge for us is to maintain a solid fund of knowledge 
in  tropical medicine. DoD has courses that provide such training. 
We discuss  challenges of developing a Ghana field site as part of an 
advanced course,  Military Tropical Medicine-Field. Logistics: The annual 
2 week event  launched in August, 2008, at War Memorial Hospital in 
Navrongo. This provided a  remote setting. However, an 18 hour  drive 
from Accra was problematic. The  site was moved to Kintampo, 7 hours 
from Accra. The right partner: We  initially partnered with the Ghana 
Army at the 37 military hospital. This  lacked the disease burden for 
the course objectives. The Kintampo site had a District Hospital and a 
Clinical Research Center  (CRC). Our partnership began at CRC. It  had 
a strong lab program. However, the students already complete a lab  
curriculum during pre-requisite courses. Direct patient contact embedded 
in  Ghanaian conduct of clinical care and public health was critical. A 
stronger  relationship with the hospital resulted. An exchange program: 
The Ghana  team is limited to ten physicians. While  team backgrounds 
vary, the course faculty focuses on Preventive Medicine and  Infectious 
Diseases. The hospital provides additional focus in Surgery,  Pediatrics, 
and through educational collaborations, Emergency Medicine. Neither  
the US students nor the faculty practice independently. Through active  
shadowing, Ghanaian led care delivery teaches the team. Differences in 
care and  differential diagnoses are discussed. Nurturing the relationship:  
Continuity is important and we maintain contact with our hosts during 
the 11  month hiatus. Each year we execute a planning visit. We also 
support our Ghanaian partners. For instance, we nominated our host  
physicians to activities such as the University of Florida epidemiology 
course.  Humanitarian Assistance: In 2008,  we provided US led direct 
care in a village. We have discontinued this activity  because of the risk 
of undermining host medical infrastructure and difficulties  following 
patients. Financial resources restricted by law instead are applied  to 
resource our hosts with locally procured consumables based upon their 
and  our needs assessments as well as the course’s curricular objectives. 
This  durable and multi-faceted relationship has allowed us in the last four 
years to  optimize this episodic learning environment on the ground.
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DECREASING OCCURRENCE OF TROPIC NEUROINFECTIONS: 
CEREBRAL MALARIA, MENINGOCOCCAL MENINGITIS AND 
SLEEPING SICKIES IN SOUTH SUDANESE RURAL HOSPITALS
Emilia Ceploova1, Alexandra Mamova2, George Benca3, Lubica 
Alumbasi Timona3, Pavlina Bukovinova4, Jana Kralova1, Eva 
Smrekova2, Jaroslava Sokolova5, Nada Kulkova5, Gertruda 
Mikolasova3, Inocent Nkonwa4, Vladimir Krcmery6
1Lady of Fatima AAA and SEU Hospital, Gordim, South Sudan, 2Marial 
Lou Hospital, Tropical programme of Trnava University and St. Elizabeth 
University, Mapuordit, South Sudan, 3Slovak Tropical Institute, St. Elisabeth 
University College of Health and Social Sciences, Bratislava, Slovakia, 
4Tropical Program in Buikwe, St. Elizabeth University of Health and Social 
Sciences, Buikwe, Uganda, 5Department of Clinical Disciplines, School 
of Health Care and Social Work, Trnava University, Trnava, Slovakia, 6St. 
Elizabeth University of Health and Social Sciences, Bratislava, Slovakia
With advantages of AIDS treatment, 20 years ago some of tropical 
neuroinfections (e.g. cryptococcal meningitis, tuberculosis meningitis, 
CNS toxoplasmosis or CMV encephalitis) showed increasing incidence. 
However, with the era of HAART they again become to be rare. Also 
severe malaria, manifesting as cerebral malaria with hypoglycemia acidosis 
and severe anemia, is less frequent after the introduction of intermittent 
preventive treatment (IPT) and artemisinin in early treatment. In this study, 
two rural hospitals - Mapuordit in Yirol country and Gordim in Aweil 
country (both with 5-20 beds) - were compared. Totally, 18 027 patients 
were treated in Mapuordit and 9358 in Gordim. Most patients (90%) were 
treated on outpatients’ basis, the rest as inpatients. Both hospitals offered 
two doctors with surgical and medical qualification and mobile team from 
Italy is coming for elective surgeons two times a year. Occurrence of severe 
malaria in Mapuordit (close to Nile River) cases was more common in 
Gordim. Trends in malaria occurrence correlated with dry and rainy season. 
Diarrheal diseases showed slight increase in 2011. Pneumonia represented 
about 20-25% of all respiratory tract infections. Skin and soft tissue 
infections (SSTI) were fifth common infection after RTI, diarrheal diseases, 
malaria and sexually transmitted diseases with urinary tract infections 
showed stable trend and not significant difference between Mapuordit 
(40-50 a month in average) and Gordim (33-40 per month). Only 1 case of 
tetanus occurred in both hospitals during observational period. Diphtheria 
was also sporadic, as well as meningococcal meningitis, tuberculosis and 
leprosy appeared in 442 patients in Mapuordit and showed a relatively 
stable trend. HIV was only rarely detected in Mapuordit however 
only surgical patients were tested as a part of the hospital screening. 
Commonest ID of both south-Sudanese hospital was malaria and RTI, 
followed by diarrhea; however, these hospitals are located in different 
climatic and vegetation areas (close to Nile versus Savannah - Satel type 
vegetation). Sporadic cases of cholera, meningococcal meningitis and 
tetanus were observed in Gordim and outbreak of meningitis in 2009 in 
Mapuordit as well. Occurrence of tuberculosis and leprosy showed a stable 
trend in both hospitals between periods (2009-2011). HIV was exceptional 
probably due to isolation and civil war independence declaration in 2011.
792
HEALING OF CUTANEOUS LARVA MIGRANS AFTER A SINGLE 
DOSE OF IVERMECTIN IS ACCOMPANIED BY CHANGES IN 
CYTOKINE PATTERNS IN PERIPHERAL BLOOD
Hermann Feldmeier1, Rieko Shimogawara-Furushima2, Nobuhide 
Hata2, Angela Schuster1, Nobuo Ohta2, Nobuaki Akao2, Silas 
Guedes3, Ralf Ignatius4
1Department of Microbiology and Hygiene, Charité University Medicine, 
Berlin, Germany, 2Tokio Medical and Dental University, Tokio, Japan, 
3Fundação de Medicina Tropical do Amazonas, Manaus, Brazil, 4Institute of 
Tropical Medicine and International Health, Berlin, Germany
Cutaneous larva migrans (CLM) is a neglected tropical skin disease caused 
by the migration of animal hookworm larvae in the epidermis. The disease 
is common in resource-poor communities in developing countries. Patients 
with CLM were identified through active case finding in two resource-
poor communities in Manaus, Brazil. Patients were diagnosed clinically, 
and severity of the disease was assessed using a semi-quantitative 
severity score. Clinical pathology was assessed and hematological and 
immunological investigations were performed before, and two and 
four weeks after treatment with ivermectin (200µg/kg). Leucocytes and 
eosinophils were counted and total serum IgE was determined. The 
concentration of IL-4, IL-5, IL-10, IFN-γ, TNF-α and TGF-β was determined 
in serum using commercially available ELISA kits. 92 patients were included 
in the study: 69.6% were male and 30.4% were female. Median age was 
9.5 years (IQR 5-44). At baseline, 93.4% of all patients complaint about 
severe pruritus and 73.6% about insomnia. The median severity score was 
4 points (IQR 3-6). 87.8% of the patients had eosinophilia. Patients with 
CLM had significant higher concentrations of IgE, eosinophils, IL-4, Il-5 
and IL-10 in serum than age- and sex- matched controls living in the same 
community. Four weeks after treatment, clinical pathology and eosinophila 
decreased significantly. While the serum concentration of IL-4, IL-5 and 
IL -10 decreased, the concentration of IFN-γ increased significantly. It is 
concluded that in an impoverished community CLM is associated with 
considerable morbidity. After treatment with ivermectin, clinical pathology, 
eosinophilia and cytokine patterns normalize rapidly.
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SPECTRUM OF TROPICAL NEUROINFECTIONS AND 
OTHER INFECTIOUS DISEASES IN OUR LADY OF FATIMA 
HOSPITAL, GORDIM, SOUTH SUDAN, BEFORE AND AFTER 
DECLARATION OF INDEPENDENCE
Emilia Ceploova1, Alexandra Mamova1, Miriama Balazova1, 
Petra Stullerova1, Nada Kulkova2, Jaroslava Sokolova2, Vladimir 
Krcmery3
1Our Lady Fatima Hospital, St. Elizabeth University College of Health and 
Social Sciences Tropical Program, Gordim, South Sudan, 2Department 
of Clinical Disciplines, School of Health Care and Social Work, Trnava 
University, Trnava, Slovakia, 3St. Elizabeth University of Health and Social 
Sciences, Bratislava, Slovakia
For 10 years, the area of South Sudan was under control of Sudan´s 
People Liberation Army (SPLA) and medical serviced were served by 
Médicins Sans Forntiéres (MSF) and other humanitarian organizations 
after the declaration of independence in May 2011, when country was 
completely opened for foreign travel. Aim of this study is to compare the 
spectrum of tropical infectious diseases (ID) before and after independence 
declaration (2010 vs. 2011) in rural hospital in Gordim, South Sudan. In 
2010, together 5097 outpatients were compared to 3612 outpatients 
treated in 2011. Diagnostic of malaria, geohelmints and tuberculosis 
(TB) has been performed by microscopy, as rapid diagnostic tests (RDT) 
were not available until spring 2012. HIV was not observed in none of 
outpatient department (OPD) patients. Trends in TB were stable with 
30 - 60 new cases per month. However, trends in malaria correlated 
with rainy season, with maximum of 329 and 367 cases in August and 
September, respectively. Fortunately, complicated malaria (cerebral malaria, 
renal failure) were extremely rare, probably because of early treatment 
with artesunate or artesunate/lumefantrin. Second commonest diseases 
were respiratory tract infections (RTI) with mostly stable occurrence of 
260 - 293 cases per month, followed by diarrhea and sexually transmitted 
diseases (STD). Only 1 case of tetanus occurred during 2010 - 2011. There 
was observed only 1 case of cerebral malaria, 8 cases of meningococcal 
meningitis and 1 case of sleeping sickness in period of 2010 - 2011, 
which is very low in comparison with 32 cases of cerebral malaria, 119 
cases of meningococcal meningitis and 9 cases of sleeping sickness in 
period of 2005 - 2006. We can conclude that in Gordim there was no 
significant difference in tropical ID incidence before and after South Sudan 
has been completely opened for foreign travellers. Also, occurrence of 
tropical neuroinfections, such as sleeping sickness, cerebral malaria and 
meningococcal meningitis, was sporadic.
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EPIDEMIOLOGY OF FEBRILE ILLNESSES AMONG INFANTS: A 
CASE CONTROL STUDY IN KINTAMPO NORTH AND SOUTH 
DISTRICTS
Princess R. Mahama, Harry Tagbor
Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
Information on the burden and risk factors of febrile illnesses in infancy is 
scarce. Young infants are relatively protected against infant illnesses during 
the first six months of life due to the presence of maternal antibodies 
and foetal haemoglobin, and have received relatively little attention with 
respect to research and treatment guidelines. To add to the limited data 
available, this study therefore sought to determine the predisposing 
factors to febrile illnesses among infants (0-11months). A case control 
study was conducted in Kintampo North Municipality and South District. 
We randomly selected 230 cases and 454 controls from infants with and 
without infant febrile illnesses and were participants of an ongoing study. 
Standard questionnaires were administered by blinded interviewers to 
randomly selected cases and controls. Variables compared in both groups 
included birth weight, breastfeeding practices, immunization status, 
household background characteristics and socio-economic status of 
mothers. Data collected was entered on Microsoft Access and analysed 
using STATA Version 11.Results of the study showed that malaria was the 
most prevalent febrile illness. Analysis showed that 70% of febrile cases 
were above 6 months of age, whilst 91.85% were exclusively breastfed. 
A significant difference was shown between cases and controls in terms 
of age and breastfeeding status. Apparent similarity was shown between 
cases and controls with respect to birth weight, household background 
characteristics, immunization status, ITN use and socio-economic levels 
of mothers. The study showed that infants above 6 months and those 
not exclusively breastfed are more likely to develop febrile illnesses. 
Information on the epidemiology of febrile illnesses among infants will be 
essential for designing and interpreting results of clinical trials of drugs, 
vaccines and other interventions for this vulnerable group.
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PROVIDING HIV EDUCATION TO HEALTH CARE PROVIDERS 
IN COCHABAMBA, BOLIVIA IN EXCHANGE FOR AMERICAN 
STUDENT ROTATION AT THE MAIN LOCAL PUBLIC HOSPITAL
Wayra Y. Salazar Moreno1, Rosario Castro2, Edgar Valdez3, 
Andres Vargas3, Douglas Golenbock1
1University of Massachusetts, Worcester, MA, United States, 2Hospital 
Clinico Viedma, Cochabamba, Plurinational State of Bolivia, 3Instituto de 
Desarrollo Humano, Cochabamba, Plurinational State of Bolivia
American physicians in training seldom experience the florid variety of 
infectious diseases found in developing countries and tropical areas. The 
management of patients is also different in limited resource settings. 
The number of reported cases of HIV in Bolivia is growing exponentially, 
but the number of HIV providers is not. Hospital Clinico Viedma is a 
public hospital in the heart of South America that serves the most 
underprivileged population in the city. It also is a referral center for the 
surrounding tropical areas. In February, 2012, the Division of Infectious 
Diseases at the University of Massachusetts coordinated an elective for 
UMass Medical Students in Cochabamba Bolivia. The elective consisted of 
3 medical students, 4 faculty members and a Bolivian Infectious Diseases 
fellow who served as the course coordinator/director. A major goal of the 
interchange between the two institutions is to provide basic HIV education 
for Bolivian health care practitioners in the Cochabamba area in Spanish, 
the main native language. We accomplished this by teaching an intensive 
course, involving 10 hours of didactics and 5 hours of case presentation. 
This course was judged to be outstanding by the participants, although 
they felt that the course should be expanded to teach the care of pediatric 
patients with HIV. This year we are expanding our course to pediatrics 
and live state of the art recording. A secondary benefit of expanding 
our HIV course will be that UMass faculty members will be on site to 
precept UMass students on elective in Cochabamba in the diagnosis and 
management of infectious illnesses not commonly seen in the US setting. 
This DVD will then be available for distribution to additional health care 
providers in Bolivia and other Spanish speaking countries.
796
THE HEALTH AND DEMOGRAPHIC SURVEILLANCE SYSTEM 
IN RURAL WESTERN KENYA: RELEVANCE TO PUBLIC HEALTH 
AND RESEARCH ENDEAVORS
Peter M. Sifuna, Louis Macareo
USAMRU-K, Kisumu, Kenya
The Health Demographic Surveillance System (HDSS) set up in Kisumu 
West district, rural western Kenya, is designed to track on a bi-annually 
basis, evolving health status, demographics and health threats within the 
catchment area. The program has GPS-located every dwelling unit that 
exists within the catchment area and has conducted baseline population 
and housing survey that is monitored through regular surveys. The primary 
goal for the program is to provide an exhaustive health and demographic 
data set throughout the catchment area that would be of great interest 
to potential research collaborators and the local ministry of Health. 
This paper examines the contributions made by the program towards 
advancement of public health and research agenda in the catchment 
area. The Kisumu West HDSS has provided the first steps in developing 
the linkage of extensive demographic and health data that is tracked 
over time to patient health care records, beginning with PEPFAR subjects 
and later expanding to all patients in the study area. The linkage will 
greatly aid in subject/patient tracking and linking of disease and patient to 
specific locations with a view of designing targeted interventions. During a 
recent polio outbreak in western Kenya, the Kisumu West HDSS provided 
information towards the successful implementation of the immunization 
campaign. The information included baseline population figures for the 
target population and village maps to aide movement of the MOH staff 
in the field. The KWHDSS provides an ideal research platform for clinical 
and epidemiological studies. Specific examples of how the KWHDSS 
supports these studies-including the Phase III Malaria vaccine trial will be 
provided to showcase its relevance to research endeavors. In conclusion, 
the KWHDSS continues to provide a central analytical framework for work 
on clinical trials, disease surveillance and public health intervention in 
the Kisumu West District. The longitudinal nature of the KWHDSS allows 
better matching of volunteers for clinical trials such as those involving 
post-marketing surveillance and studies assessing the impact of other 
health care interventions.
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BEYOND SIMPLE PREVALENCE: ENHANCED DISCRIMINATION 
OF INFECTIOUS DISEASE-RELATED DATA PATTERNS BASED 
ON THREE-DIMENSIONAL ANALYSIS
Ariel Rivas1, Gabriel Leitner2, Daniel Schwarz3, Kevin Anderson4, 
Renata Piccinini5, Jeanne Fair6, Almira Hoogesteyn7, Prakasha 
Kempaiah1, John Ong’echa1, James Hittner8, Douglas Perkins1
1Center for Global Health - University of New Mexico, Albuquerque, NM, 
United States, 2National Mastitis Reference Center, Kimron Veterinary 
Institute, Bet Dagan, Israel, 3Division of Microbiology and Animal 
Hygiene, Department of Animal Sciences, Faculty of Agricultural Sciences, 
Goettingen, Germany, 4Population Health and Pathobiology, North 
Carolina State University, Raleigh, NC, United States, 5Animal Pathology, 
Università degli Studi di Milano, Milan, Italy, 6Biosecurity and Public Health, 
Los Alamos National Laboratory, Los Alamos, NM, United States, 7Human 
Ecology, CINVESTAV, Merida, Mexico, 8Department of Psychology, College 
of Charleston, Charleston, SC, United States
One important challenge in infectious disease research is to reduce the 
rate of information loss and/or errors associated with data analysis, 
including those generated by prevalence-based analyses. To develop and 
evaluate an alternative approach that addresses these issues, leukocyte 
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data collected from humans, birds, and bovines affected by different 
pathogens were assessed with two approaches: (i) non-structured 
indicators, such as the neutrophil percent, which were determined with 
bi-dimensional plots and considered the overall (population) disease 
prevalence, and (ii) structured indicators (indices designed to generate a 
single line of observations), which were explored with three-dimensional 
(3D) plots and considered subset-specific prevalence. These approaches 
revealed that population-based prevalence analyses did not distinguish 
the leukocyte profiles of disease-negative (D-) and disease-positive (D+) 
subsets. In contrast, structured indicators assessed with 3D plots revealed 
patterns which, when used to partition the data, enhanced discrimination 
of infection: (1) non-overlapping D- and D+ subsets were generated, 
(2) observations suspected to be false were detected, and 3) in humans 
infected with malaria, four disease classes were distinguished. Results 
presented here demonstrate that patterns previously unrecognized in D+ 
and D- individuals can be identified with structured, 3D analysis, leading to 
more informative, subset-specific prevalence estimates.
798
METRICS OF SUCCESS FOR SOCIAL DETERMINANTS OF 
HEALTH AND TROPICAL DISEASES
Eileen Stillwaggon1, Larry Sawers2
1Gettysburg College, Gettysburg, PA, United States, 2American University, 
Washington, DC, United States
Numerous measurement problems emerge when considering neglected 
tropical diseases (NTDs) on their own, and especially in the social 
determinants of health (SDH) framework. Burden of NTDs is miscalculated 
because of underestimation of mortality, long-term sequelae, effects 
on fertility and on pregnancy, cross-generational effects, and synergies 
of multiple morbidities. In addition, burden-of-disease methodology 
specifically abstracts from socio-economic context. Disability-Adjusted 
Life Years (DALYs) attempt to aggregate the effects of every disease on 
mortality and morbidity, based on prevalence and specific effects of each 
disease. DALYs were derived so that a life has the same value, and a 
disease has the same burden, regardless of place of residence, occupation, 
or income. The SDH framework embodies a different principle of fairness 
that requires society to prioritize problems of poor and marginalized 
people. In the SDH approach, it is necessary to allocate investment 
disproportionately to diseases of poverty and also to the structural 
determinants that promote poor health in poor populations. Invisibility 
of socially excluded populations and their health concerns is another 
methodological challenge. National and subnational averages can show 
important progress in achieving disease-reduction goals, while obscuring 
the persistence of NTDs and the concentration of multiple NTDs in family 
and community clusters. Global campaigns, including the Millennium 
Development Goals, state targets as national and global averages. Reliance 
on them as sole indicators of progress in disease reduction reinforces 
invisibility of persistent clusters afflicted with multiple morbidities of 
diseases of poverty, even while national statistics improve. ‘Elimination as 
a public health problem’ is a term that definitionally could be at odds with 
the spirit and practice of reducing health inequities. Continued existence 
of even low levels of impoverishing and often stigmatizing diseases is 
evidence of persistent inequities.
799
RECLAIMING THE ‘BETTER HEALTH FOR ALL’ MANDATE: A 
CASE FOR INTEGRATING GLOBAL HIV PROGRAMMING WITH 
COMPREHENSIVE PRIMARY HEALTH CARE SYSTEMS IN SUB-
SAHARAN AFRICA
Kenechukwu O. Chudy-Onwugaje
Simon Fraser University, Burnaby, BC, Canada
Twelve years into the twenty-first century, our world is still grappling 
with an HIV/AIDS epidemic that has placed great strain on global human 
and material resources and compounded human suffering; especially 
in sub-Saharan Africa. While the discovery and improved access to 
antiretroviral therapy and allied treatment has significantly reduced 
mortality and morbidity from this disease, it is still positioned to continue 
to garner prime attention in health discourse and in the allocation of 
global resources. However, competing health demands in developing 
countries such as the rising threat of non-communicable diseases and 
often-neglected communicable diseases amidst a slowly recovering global 
financial economy are timely prompts for a careful reconsideration of 
the prevailing approach to HIV funding and programming which has 
so far privileged this disease to the detriment of overall health. At this 
critical juncture, a re-evaluation is invaluable if we are to make the smart 
health investment decisions that would protect better health in the 
future. I argue that a departure from the current vertical nature of HIV 
programming is needed to curb its detraction from the development of 
effective health systems that are sensitive to the totality of local health 
realities and needs in sub-Saharan Africa. Using support from relevant 
literature, I trace the evolution of this vertical handling of HIV, its origins 
in the selective health care model that eclipsed the Alma Ata affirmation 
and its deleterious effects on health systems; present policy options 
and recommendations in making the case for an integration of HIV 
programming with comprehensive primary health care and discuss some 
of the few available cases that have pursued integration in various forms. 
Despite the litany of practical difficulties that may dissuaded a global 
adaptation of such integration, this step is vital if developing countries are 
to achieve sustainable, efficient and locally owned comprehensive health 
systems capable of safeguarding better overall health.
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COMBINING HIV/AIDS AND MALARIA INDICATOR SURVEYS 
IN TANZANIA TO LEVERAGE EXPERTISE AND MAXIMIZE 
EFFICIENCY IN LARGE HOUSEHOLD SURVEYS
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Development assistance to Tanzania for HIV/AIDS and malaria ($2.3 billion 
in 2005-10) has permitted intensive scale-up of multiple interventions. 
Separate, labor-intensive, nationally-representative household surveys are 
a cornerstone of monitoring and evaluation (M&E) for National AIDS and 
Malaria Control Programs. In 2007/8 and 2011/12, the National Bureau 
of Statistics (NBS) and Zanzibar’s Office of Chief Government Statistician 
(OCGS) succeeded in meeting the needs of multiple stakeholders by 
creating a combined Tanzania HIV/AIDS and Malaria Indicator Survey 
(THMIS). The THMIS used a two-stage probability sample design 
implemented by NBS/OCGS, overseen by the Tanzania Commission for 
AIDS, with technical guidance from Mainland and Zanzibar malaria and 
AIDS control programs, and MEASURE DHS. Demographic data and 
HIV/AIDS and malaria knowledge and attitudes, risk behaviors, and 
intervention use were collected from adults aged 15-49 years. Dried 
blood spots for HIV testing of adults and malaria rapid tests, thick blood 
films, and hemoglobin measurement for children were prepared from 
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fingerstick capillary blood specimens. In December 2011, data collection 
for the 2011/12 THMIS was initiated in over 9,700 households, with 
approximately 10,800 women and 8,000 men expected to be interviewed 
and tested for HIV and 7,500 children tested for malaria and anemia by 
April 2012. The 2007/8 HIV and malaria prevalence (5.7% and 17.7%, 
respectively) will be compared to 2011/12 estimates. The THMIS required 
four months to complete data collection compared to three to four 
months per each stand-alone survey. In-country costs for 2011/12 THMIS 
($2.1 million vs. $900,000 for 2003/4 AIDS survey) were shared by two 
U.S. Government initiatives (74%), Government of Tanzania, and others. 
Careful coordination and planning by multiple stakeholders from HIV/
AIDS and malaria control produced a single, mutually appealing, nationally 
representative household survey. This efficiency helps conserve resources 
needed to document progress toward Millennium Development Goals.
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EVALUATIONS OF HEALTH RESEARCH CAPACITY 
DEVELOPMENT: A REVIEW OF THE EVIDENCE 
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Izugbara4, Margaret Thorogood5, Imelda Bates6
1University of Toronto, Toronto, ON, Canada, 2University of Melbourne, 
Melbourne, Australia, 3University of Witwatersrand, Johannesburg, South 
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Local research and innovation capacity is essential to improving 
health outcomes prompting significant investment in strengthening 
health research capacity (HRCS) in low and middle income countries 
LMICs. Although funding agencies need to show value for money and 
implementers want to demonstrate HRCS impact, empirical evaluation 
evidence on HRCS seems scarce. We conducted a scoping review of 
published evaluations of HRCS to learn lessons about how to assess 
its effectiveness and impact especially in the longer term. We searched 
electronic bibliographic databases, reference lists of relevant articles, 
reports of funding agencies, and websites, and consulted ‘experts’ 
to identify relevant publications using search terms covering training, 
mentorship, collaborations, partnerships and networks. We assessed the 
quality of these evaluations using an instrument developed for reviews of 
community interventions, and synthesized information about the types 
and design of the evaluation, and the measurement tools and indicators 
that were used. We identified 593 publications from health, education 
and management literature that focused on evaluating the development 
of health research capacity. 31 were primary studies; only 4 (0.7%) were 
from LMICs; Ghana (2), Vietnam and Pakistan and the quality of these 
four studies was variable. None used a comparator group; two were 
retrospective and two used validated tools. All four studies specified 
objectives and outcome measures, and stressed the importance of 
engaging senior managers in developing research capacity. Most provided 
descriptive analyses including both qualitative and quantitative results. 
HRCS literature is dominated by recounting of programs and experiences 
with little published evaluation. A much more substantial evidence base 
on HRCS interventions reported in peer-reviewed publications is needed 
before we can develop robust evaluations of impact and value for money 
of investments in HRCS.
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A strong research culture within teaching hospitals, supported by robust 
research infrastructure and the ability to demand and utilise research, 
is essential to promote evidence-based practice and improve health 
outcomes. For 10 years senior managers and academics at Komfo Anokye 
Teaching Hospital (KATH), Ghana have been strengthening the hospital’s 
research systems and creating a critical mass of research expertise among 
mid-career health professionals (eg. doctors, nurses, managers, ancillary 
cadres). The research capacity strengthening programme was designed 
prospectively using a rigorous implementation research approach for 
designing and monitoring complex interventions. We adapted a published 
framework for institutional change and used this to design and monitor 
the programme in collaboration with key stakeholders. The framework 
enabled us to use mixed methods flexibly and systematically to plan, 
regularly review and adapt the programme, to identify and prioritise 
gaps in KATH’s research systems and infrastructure, and to derive and 
use indicators to monitor progress in closing the gaps. One component 
of the programme was an innovative 1 year, part-time Professional 
Diploma course (UK award) which taught ~20 students/year to undertake 
a research project important to their department. Our published course 
evaluation demonstrated graduates were competent and confident to 
design and conduct research. Through the programme KATH now has a 
dedicated research support office and administrators, a biostatistics unit 
and better successes with exams, grants and publications. By 2007 the 
Diploma course was managed and taught entirely by Ghanaian faculty 
(KNUST) and it is sustainable through locally generated funds. KATH/
university faculty have extended the course to other sites in Ghana and 
Zimbabwe (2009-12). There has been some impact on clinical practice 
(eg. birth injury prevention programme; reduced needlestick injuries). Next 
priorities are to strengthen systems for utilisation of research results and to 
consolidate departmental research incentives.
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The quality of health care at African health facilities is often reported to 
be poor, linked to low patient attendance and poor health outcomes. In 
western settings, patient centred approaches, focused on communication 
between health workers and care seekers, have been advocated to 
improve quality of services. Such approaches have received little attention 
in Africa. Rigorous evaluations are required to inform best practice 
for improving quality of care in resource limited settings. A cluster 
randomised trial of the PRIME intervention to enhance quality of services 
is underway at health facilities in rural Uganda. One component of the 
intervention is a Patient Centred Services package, intended to improve 
communication with health care seekers, increase attendance at health 
facilities and improve overall population health indicators. This paper 
presents the first step in this hypothesised mechanism of change: the 
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impact of the intervention on health worker communication. We assessed 
communication between health workers and care seekers at baseline 
and immediately after the implementation of the intervention at 20 
health facilities randomly assigned to intervention or standard care. A 
total of 26 health care workers and 213 health care seekers participated. 
Consultations were recorded and rated using the Measurement of Patient 
Centred Communication method and care seekers were interviewed on 
exit to provide their assessment of the quality of communication. Patient-
centred communication was rated 10% higher (p<0.008) by care seekers 
consulting with health workers who had recently participated in the PRIME 
intervention compared with those in the standard care arm. A per protocol 
analysis suggests this increase may be plausibly attributed to the Patient 
Centred Services component of the intervention. Improvements to quality 
of care in resource limited settings may be achieved by approaches that 
reorient services towards patients.
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If properly trained, equipped and utilized, community health workers 
(CHWs) delivering integrated community case management (ICCM) for 
children with diarrhea, pneumonia and malaria can potentially reduce 
deaths from these infections by 60%. To achieve this outcome it is 
essential to maintain CHW performance and retention. The inSCALE 
project aims to increase sustainable coverage of ICCM in Uganda and 
Mozambique by designing and evaluating innovations for increased 
CHW supervision and motivation. A combination of participatory 
research methods were used to identify program gaps, best practices 
and potential interventions. Quantitative baseline surveys with household 
members, CHWs and health facility staff were conducted to establish 
key outcomes and to inform the randomization process. Following 
extensive formative research and national stakeholder consultations, two 
interventions were developed in Uganda and one in Mozambique. In 
Uganda approximately 3500 CHWs in 39 clusters were randomized into 
a mobile health (mHealth) arm, a community engagement arm, and a 
control arm. In Mozambique 300 CHWs in 12 clusters will be randomized 
into a mHealth arm and a control arm. The mHealth interventions in 
Uganda and Mozambique encompass three main activities: 1) closed 
user groups to enable free two-way communication between CHWs 
and their supervisors; 2) weekly ICCM data submission using phones 
with automated motivational feedback, SMS to supervisors flagging 
problems for target supervision, and summary ICCM statistics made 
accessible online to district statisticians; and 3) monthly motivational and 
constructive SMS to CHWs. The community engagement arm in Uganda 
will establish health clubs which seek to improve child health and identify 
health challenges through a community led model with the CHW as 
its focal point, potentially resulting in 1) improved status and standing 
of CHWs as key health assets; 2) increased demand for CHW services, 
and 3) communication to CHWs and other village members that CHW 
work is important, of value and appreciated. In both countries process 
evaluation will be conducted and endline surveys will establish impact 
after 12 months. Main outcomes will be the proportion of sick children 
appropriately treated, CHW performance and motivation, and cost 
effectiveness of interventions.
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Dengue and influenza are major problems worldwide. The Pediatric 
Dengue Cohort Study began in 2004 as a collaboration between the 
University of California, Berkeley, the NGO Sustainable Sciences Institute, 
and the Ministry of Health in Managua, Nicaragua, to study the natural 
history and transmission of dengue in children in a community setting in a 
developing country. In 2007, the Nicaraguan Influenza Cohort Study was 
added to study the burden and seasonality of pediatric influenza. These 
studies provide critical epidemiology and transmission data to support 
detection and prevention approaches around the world, and clinical 
data and biological samples are used to study viral and immunological 
determinants of protection and pathogenesis and for development of 
novel diagnostic assays and algorithms. Currently, ~3700 children aged 
0-14 receive medical care through the studies, and data from all clinical 
visits are systematically recorded. Participants with suspected dengue, 
influenza or undifferentiated fever are tested by serological, virological, 
and molecular biological assays, and yearly blood samples are analyzed 
to detect inapparent infections. To facilitate the logistics and operations, 
a set of information technologies have been implemented by the study 
team since 2004. These eHealth tools - electronic medical records, 
patient and sample tracking systems using barcode and fingerprint IDs, 
and field logistics support tools for household visits - help to maintain 
quality control and facilitate compliance with established Good Clinical 
Practice (GCP) and Good Laboratory Practice (GLP) standards. In the 
2012 annual blood collection conducted in the study Health Center and 
through household visits, a mixed methods approach was used to assess 
the impact of a new mobile data collection and management technology 
package using low-cost Android tablets and cell phones with the free 
open-source software ODK Collect and OpenMRS. Specific advantages 
in data entry/processing time, accuracy and accessibility, user experience, 
and cost savings were observed compared to paper and PDA-based 
tools. Results were shared with the Ministry of Health, along with lessons 
learned about implementation, for potential scale-up for routine data 
collection needs in the national public health system.
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The overuse of antibiotics is associated with the increase of resistant 
pathogens. In developing countries, antibiotics are commonly purchased 
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at private pharmacies, which are important suppliers of health tips and 
low-cost medicines. The objective of this study was to determine the 
prevalence of purchase of antibiotics without a prescription for use in 
children under 5 years in private pharmacies of peri-urban areas of Lima, 
Peru. A survey was applied in adults who bought an antibiotic for a child 
up to five years in a private pharmacy close to a health center in a peri-
urban area of Lima, Peru. 287 of the surveyed bought an antibiotic. The 
prevalence of purchase without prescription was 13.2%. From these 
1.7% were due to self-medication and 11.5% were due to indication of 
the pharmacist. The diseases that were most often associated with the 
use of antibiotics were 45.8 common cold (45.8%) and acute diarrhea 
(18.5%) and bronchospasm (18.5%). Diseases that were mostly associated 
with use of antibiotics without prescription was common cold (50%) and 
watery diarrhea (28.9%). An overuse of antibiotics in children less than 
5 years exists in this setting, especially in diagnoses as watery diarrhea, 
common cold and bronchospasm, mainly due to medical prescription. 
Self-medication was found in a very low percentage as well as pharmacy 
personnel recommendation. Training of medical personnel should 
be prioritized and legislative measures in relation to the purchase of 
prescription antibiotics should also be strengthened.
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Vietnam has seen the emergence of new diseases such as SARS and 
highly pathogenic avian influenza. Other infectious diseases are endemic. 
Many parties, including the Vietnamese Ministry of Health (MOH) have 
a strong interest to conduct clinical trials in Vietnam. The MOH is faced 
with an urgent challenge to develop a system of oversight that follows the 
Principles of Good Clinical Practice (GCP), which protects the rights and 
well-being of human subjects. The MOH also recognizes a need to develop 
the capacity of local research institutions and their personnel to conduct 
quality research. With the cooperation of FHI 360 and other partners, 
MOH has made several interventions to improve capacity to conduct 
clinical trials in Vietnam. As part of the Southeast Asia Influenza Clinical 
Research Network (SEA ICRN), a new role titled Clinical Trial Support 
Specialist was developed within FHI 360. Local health professionals were 
trained in clinical trial regulatory, ethics and operations processes and then 
provided formal as well as side by side training to study staff of the local 
hospitals. Existing health system structure and operation were challenges. 
In a separate but complimentary effort, MOH partnered with FHI 360 to 
host a series of workshops which included government regulators, and 
other stakeholders. Open discussions among the groups revealed and 
prioritized gaps in ethics knowledge, systems, and infrastructure, from 
which an MOH strategy to build capacity developed. In 2008, MOH issued 
a GCP document for Vietnam and a regulation to define and operate an 
Independent Ethics Committee (IEC). The MOH committed to developing 
an independent ethics system consistent with international standards. 
Further workshops hosted by the MOH built capacity within the ministry 
for ethics review. In conclusion, theoversight of clinical trials in Vietnam 
and the related capacity of Vietnamese institutions have shown significant 
improvement since 2005. This has been enabled through a coordinated 
and strategic approach by the MOH and included partnerships with 
several international institutions. For next steps in the emerging model the 
MOH will need continuing partnerships that provide technical assistance, 
monitoring, and support in order to continue this growth.
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Trans-border migration is increasing rapidly worldwide and already  
involves almost one-quarter billion people.  Ethnic diversity among 
migrants and between migrants and national  majority populations 
into which they move, plus legal eligibility for residence  and access 
to services pose numerous problems for providing health services and  
control of transmissible diseases. Transborder  migration to Thailand, 
mostly from Myanmar, now accounts for at least 3 million  people from 
many different ethno-linguistic backgrounds. Transborder migration is 
expected to increase  markedly in 2015 following the opening of borders 
between ASEAN countries. Migrants to Thailand have significantly higher  
prevalence of malaria, TB and probably HIV  than non-migrant residents. 
PHPT’s Access to Care Project to date has  surveyed 998 women and 
men from Chinese, Hmong and Lahu minorities and from the  ethnic 
Northern Thai majority. Survey  data show statistically highly significant 
differences between different ethnic  groups, between minorities and the 
ethnic  majority in socioeconomic characteristics (e.g., income, household 
possessions,  education, Thai language ability, health insurance), and 
between migrants and  non-migrant members of the same ethnic group 
living in the same communities,  with respect to: health information, (e.g., 
knowledge of HIV transmission,  prevention, diagnosis and treatment); 
use of health services (antenatal care, HIV  counseling and testing); 
and reported constraints to use of health services (e.g.,  service delays, 
transportation, direct and indirect costs, lack of knowledge of  health 
and health services, language).  Analysis of hospital records allow analysis 
of differences in delays and  interruptions in services and severity of 
illness associated with ethnicity,  location and migration status. Effects  
of interventions (e.g., to date, health education) tailored by results from  
surveys (e.g., ethnicity, education, Thai language ability, knowledge of 
health  and health services, migration status) are evaluated by before and 
after assessment.
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  Malaria cases in the  last 7 years are on the decline in Namibia due to 
interventions in malaria  control implemented by the Ministry of health 
and Social Services (MoHSS). There  is a shift from control of malaria 
to its elimination; hence it is necessary  for interventions to reflect this 
shift. Early and proper malaria diagnosis and  case management are of 
paramount importance in reducing the parasite reservoir  for elimination 
of the disease. The knowledge and perceptions of Health Care  Workers 
(HCWs) regarding the prevalence of malaria, its diagnosis and treatment  
were investigated to provide a basis for aligning the training of health care 
workers to the objective of elimination of malaria. Three malaria endemic 
regions of Namibia namely Omusati,  Caprivi and Kavango representing 
different malaria risk strata as well as cultural  differences and practices 
within the country were selected. Six  Focus Group Discussions (FGDs) 
and 7 Key informants Interviews (KI) were  conducted. FGDs  consisting 
of 6-10 participants were conducted using semi-structured questions to  
collect data. Three FGDs were conducted in Caprivi region (Katima Mulilo), 
2 in Kavango region (Andara) and 1  in Omusati (Onesi). Each group was  
primarily composed of registered and enrolled nurses from  rural clinics, 
health centres and regional hospitals. Staff members who were managers 
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were excluded from  the FGDs but were still included in the study and 
interviewed as key  informants. There was a general perception that less 
malaria  cases were presented with 90 % of Health Care workers having 
knowledge of the  four species of Plasmodium although 80%  of had not 
participated in a formal, organized malaria case management training  
session. Only 60% adhered to negative RDT results regardless of persistent 
symptoms of malaria. There is a need for initial and continuous training 
of HCW  on malaria diagnosis using RDTs, differential diagnosis and 
unambiguous case  management guidelines to increase their confidence in 
handling negative results  and adherence to RDT results.
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A well designed vaccine pricing architecture can ensure more equitable 
vaccine prices and result in greater access to new vaccines globally. Pooled 
procurement is a mechanism that is commonly used to achieve lower 
vaccine (and medicine) prices for lower income countries and consequently 
allow country programs to immunize more people with a given budget. 
Under pooled procurement, several countries bargain collectively as one 
unit to achieve one (supposedly) lower price. Currently, there is very little ( 
if any) analytical or empirical research to guide policy around the optimal 
buy-side market structure for vaccines. Existing vaccine procurement pools 
are organized in several different ways, each with different implications 
in terms lowering prices for countries in the pool, and for ensuring more 
equitable vaccine access globally. Some procurement pools, such as PAHO 
and GCC, are organized regionally (geographical proximity-based), with 
high income heterogeneity among the countries in the pool. Other pools 
such as UNICEF are organized by country income level (income-proximity 
based), but have to rely on a third party i.e. a UN or multilateral agency 
led procurement structure. Using game theoretical models this research 
attempts to answer the following questions: (1) What form of buy-side 
market structure (single purchasing pool vs. multiple purchasing pools; 
pools organized by income vs. pools organized by geo-spatial proximity; 
differential pricing within pools vs. single price within pools) maximizes 
overall social welfare and vaccine availability? ;(2) For each type of 
purchasing structure what is the distribution of welfare benefits across 
countries in different income groups?; and (3) What opportunities exist 
for improvement in the current organization of global vaccine pricing and 
procurement that will increase total social welfare, create more equitable 
distribution of welfare/benefits between the manufacturer(s), low income 
countries and middle income countries?
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Microsatellite  genotyping of Trypanosoma brucei gambiense, the 
causative agent of human  African trypanosomiasis or sleeping sickness, 
and population genetics tools, are  useful for inferring population 
parameters such as population size and  dispersal. Amplifying parasite 
DNA directly from body fluids (i.e. blood, lymph  or cerebrospinal fluid) 
allows avoiding costly and tedious isolation phases. It  is however 
associated to increased frequencies of amplification failures  (allelic 
dropouts and/or null alleles). In this paper, we present a study focused 
on improving microsatellite loci amplification of T.  brucei gambiense 
from Guinean sleeping  sickness foci. We checked for the real nature of 
blank and of apparent  homozygous genotypes of parasite DNA directly 
amplified from body fluids. We tested the effect of three different DNA 
quantities  for different microsatellite loci of trypanosomes from different 
body fluids.  Our results show  that some initially blanks and  homozygous 
genotypes happen to be actual heterozygous  genotypes. In Guinea, 
lymph from the cervical nymph nodes, known to contain the  highest 
concentrations of parasites, appeared to provide the best amplification  
results. Simply repeating the PCR may be enough to retrieve the correct  
genotype, but we also show that increasing initial DNA content provides 
better  results while undertaking first amplification. We finally propose an 
optimal  protocol for amplifying T. brucei DNA  directly from body fluids 
that should be adapted to local characteristics  and/or constraints.
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VISCERAL LEISHMANIASIS IN BRAZIL BASED ON MAXIMUM 
ENTROPY (MAXENT) 
Maria E. Bavia1, Moara S. Martins2, John B. Malone2, Marta 
M. Silva1, Luciana L. Cardim1, Deborah D. Carneiro1, Jennifer 
McCarroll2, Michael T. Kearney2
1Universidade Federal da Bahia, Salvador, Brazil, 2Lousiana State University, 
Baton Rouge, LA, United States
Leishmaniasis are diseases of great medical, social, and economic 
importance in endemic areas and are considered serious public health 
problems due to its clinical impact and epidemiological diversity. They 
belong to the group of neglected diseases intrinsically associated with 
poverty as well as health iniquities. The goal of this work was to identify 
environmental and socioeconomic factors that may be associated with 
the occurrence of cutaneous (CL) and visceral (VL) leishmaniasis in Brazil 
from 2005 to 2009, using ecological niche models to predict the risk of 
disease at the municipality level. A GIS database was constructed using 
records of CL cases by municipality available in the national notifiable 
diseases information system (SINAN) database. Records from the Brazilian 
Institute of Geography and Statistics (IBGE) and the Pan-American 
Health Organization (PAHO) unsatisfied basic needs data for people 
(UBNp) and housing (UBNh)) were used as socioeconomic data variables. 
Environmental data included long-term normal monthly climate from 
WorldClim and MODIS remote sensing annual composite image data. 
Probability distribution models for CL and VL based on environmental 
and socioeconomic features were executed using Maxent and ArcGIS 10. 
From 2005 to 2009, a total of 96,351 cases of CL and 13,563 cases of 
VL were registered by SINAN. No cases of either disease were reported 
in 83% of municipalities; CL was reported in approximately 13% of the 
municipalities, mainly in the North and Northeast regions, and VL was 
reported in less than 1% of the municipalities and mostly in the Northeast. 
Maxent results showed that variables that contributed most to the 
environmental model for CL were precipitation of September (26.2%) and 
annual precipitation (17.3%)(AUC 0.80); for VL, precipitation in October 
(11.6%) and mean temperature of warmest quarter (14.5%) were the 
most influencing variables (AUC 0.948). The Maxent socioeconomic model 
was most influenced by the variables UNBp education (39.6%), UNBH 
plumbing (11.3%) and number of health units (8.8%) for CL (AUC 0.864) 
and the variables that most contributed in the VL scenario were human 
development index (25.7%), literacy rate (24%) and sewage services 
(18.9%) (AUC 0.928). Results suggest Maxent can be used to generate 
the probability distribution maps based on limited distribution point data 
and that models then can be used to improve the allocation of resources 
in control programs.
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We have previously described a multiclonal population structure among 
genotypically polymorphic Leishmania braziliensis from an area with high 
endemicity for American tegumentary leishmaniasis (ATL) in Bahia, Brazil, 
named Corte de Pedra. Based on RAPD (Randomly amplified polymorphic 
DNA) profiles, we also found an association between clinical outcome 
of ATL and parasite genotypes in this region, indicating a role for the 
intra-species variability among these microorganisms on form of disease. 
In order to further explore the hypothesis of association between form 
of ATL and strain of L. braziliensis, we cloned, sequenced and compared 
homologous RAPD bands previously explored for genotyping the L. 
braziliensis of Corte de Pedra. With this strategy we found six genomic 
loci that were polymorphic between representatives of the different clades 
(i.e. subpopulations) of parasites described in that region. PCR primer sets 
were designed for the specific targeting of each locus identified. Using 
these primers each locus was re-amplified, electrophoresed and had the 
band corresponding to the amplicon gel extracted and cloned into pCRII 
vectors. Then six clones of each locus were sequenced per leishmania 
isolate. The cloned amplicons permitted identify that the SNPs and indels 
defining the polymorphisms at each locus segregate within the population 
of L. braziliensis in Corte de Pedra according to haplotypes. Several SNPs, 
indels and haplotypes displayed significant associations with disseminated 
leishmaniasis (DL). In particular, patients infected with L. braziliensis 
containing certain SNP genotypes and haplotypes found in the locus 
starting at position 425451 in chromosome 28 presented significantly 
increased risk ratios for developing DL. Thus this rapidly emerging form 
of ATL may have its outcome driven in part by the infecting L. braziliensis 
strain.
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ECOLOGY AND TRANSMISSION DYNAMICS OF VISCERAL 
LEISHMANIASIS IN ETHIOPIA: RESULTS OF A PROSPECTIVE 
STUDY TO DETERMINE HUMAN INFECTION RATES IN AN 
ENDEMIC AREA OF NORTH ETHIOPIA
Asrat Hailu1, Workagegnehu Hailu1, Welelta Shiferaw1, Shewaye 
Belay2, Aysheshm Kassahun1, Asrat Bezuneh1, Hirut Wondimu1, 
Ibrahim Abassi3, Samar Aramin3, Alon Warburg3
1Addis Ababa University, Addis Ababa, Ethiopia, 2Mekele University, 
Mekele, Ethiopia, 3The Hebrew University of Jerusalem, Jerusalem, Israel
Globally, visceral leishmaniasis (VL),  a systemic protozoan infection 
caused by Leishmania donovani spp. is  estimated to afflict some 500,000 
persons annually. In Africa, the worst  affected regions are southern 
Sudan (15,000-20,000 cases/yr) and Ethiopia (4,000-5,000  cases/yr). VL 
is considered an emerging disease in north Ethiopia where it is  associated 
with seasonal migration of agricultural laborers to endemic areas and  HIV/
AIDS. A prospective cohort study of VL in North Ethiopia was designed 
to  elucidate the VL infection dynamics in an endemic setting. A cross-
sectional  survey was conducted around the town of Sheraro during 
March 2011 involving 4,883  individuals living in 18 villages. Participating 
households (1,386) were numbered  and their coordinates were recorded. 
Demographic and socio-economic data were  collected. Screening for VL 
by physical and laboratory examination was  performed and previously 
treated VL cases (PTC) were noted. Exposure to Leishmania  was assessed 
by Leishmanin Skin Test (LST). Sera and dried blood spots were tested  by 
Direct Agglutination Test (DAT) and RT-PCR. The LST rate among 4,554 
individuals was 10.1%  and remained surprisingly low (35%) among 126 
PTCs. Serological screening of 4,788  individuals by DAT identified 3.9% 
positives. Of 4,757 dried-blood samples  tested by RT-PCR, 680 samples 
(14.3%) were found positive for Leishmania  k-DNA. Of those, 119 (2.5%) 
harbored over 100 parasites per ml of blood. To validate  these findings 
ITS1/PCR products were sequenced and 90% (19 of 21) were  confirmed 
to be L. donovani. From March 2011 to February 2012, a total  of 34 
new VL cases (22 males, 12 females) were found amongst the study  
population. The mean age of these  patients was 16. 8 (±12.5). Of these 
34 cases, 38.2% were DAT positive in March  2011. Similarly, 15.6%, 
were positive by LST, and 27% were positive by k-DNA  RT-PCR. Based on 
these data, the annual incidence of VL in the study localities  is at least 
7.0/1000. The study is ongoing, more data will accrue and the  results of 
in-depth analysis will be reported.
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SAND FLY DENSITY REDUCTION IS LESS MARKED IN 
PRECARIOUS HOUSING AFTER INSECTICIDE THERMAL 
FOGGING
Luis F. Chaves1, A. Saldaña2, C. Rigg2, R. Rojas2, A. Valderrama2, 
Jose E. Calzada2
1Hokkaido University, Sapporo, Japan, 2Instituto Conmemorativo Gorgas 
de Estudios de la Sálud, Panama, Panama
Insecticide thermal fogging (ITF) is a tool to control vector borne diseases. 
It is generally assumed that ITF reduces vector density independently 
of housing conditions. Few studies have been focused on Sand Flies 
while also looking at housing characteristics. We conducted a 15 month 
longitudinal study that included two deltamethrin based ITF interventions 
in 12 of the 24 houses at Comunidad de Trinidad Las Minas, Capira, 
Panamá, an hyperendemic cutaneous leishmaniasis transmission village. 
During the study we followed sand fly (SF) abundance. We found a 50 
to 80% reduction in SF density at fogged houses when compared with 
control houses, while controlling for seasonal changes in SF abundance 
associated with rainfall. We found some heterogeneities in the reductions, 
as abundance changed according to SF species, with Lutzomyia gomezi, L. 
panamensis, L. dysponeta and L. triramula reducing their density between 
40% and 90% after ITF, in contrast to L. trapidoi whose density increased 
5% after the ITF. Differences in the impact of ITF were associated with 
housing quality, the most precarious houses, i.e., those with features that 
ease insect entrance, had a disproportionally larger SF abundance, in some 
cases with an increased domiciliary SF density following the ITF. Our results 
suggest that ITF success potential to control SF density and Leishmaniasis 
transmission could be dependent on housing quality.
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THE ECO-EPIDEMIOLOGY OF TRYPANOSOMA CRUZI 
INFECTION IN RURAL COMMUNITIES OF THE HUMID CHACO 
OF ARGENTINA
Victoria Cardinal1, Marcela Orozco1, Gustavo Enriquez1, Leonardo 
Ceballos1, María Sol Gaspe1, Julián Alvarado-Otegui1, Juan 
Gurevitz11, Uriel Kitron2, Ricardo E. Gürtler1
1University of Buenos Aires, Buenos Aires, Argentina, 2Emory University, 
Atlanta, GA, United States
The eco-epidemiology of the domestic transmission of Trypanosoma 
cruzi in the humid Chaco region has seldom been investigated. We 
assessed the household distribution of bug, dog and cat infection in 
two local ethnic groups (Tobas and Creoles) and investigated differences 
in transmission risks between them, tested the role of domestic dogs 
and cats as reservoir hosts, and identified transmission risk factors. We 
conducted a cross-sectional survey of house infestation with Triatoma 
infestans bugs and T. cruzi infection in bugs, dogs and cats in a well-
defined rural area in northeastern Argentina including 323 households. 
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Bug infection prevalence among 1,869 bugs examined was highest in 
domiciles (43%) and in storerooms and kitchens (24%), and was marginal 
elsewhere (<3%). The composite prevalence of infection was similar 
for 481 dogs (26%) and for 87 cats (29%) that were examined using 
serology and/or xenodiagnosis. Vector and host infections were highly 
aggregated at the household level. Using a catalytic irreversible model, 
the annual force of infection in dogs was three times higher in Toba than 
in Creole households, in agreement with other transmission indices. The 
demography of dogs and cats differed between ethnic groups in several 
respects. Random-coefficient multiple logistic regression analysis showed 
that infection in dogs increased significantly with age of the dog, number 
of infected dogs or cats in a household, and the relative abundance of 
infected bugs. The fraction of infected bugs increased significantly and in 
a dose-response fashion with number of infected dogs in a household. 
Infected cats also increased transmission to bugs when no infected dog 
was present. Our results reveal the persistence of domestic transmission 
of T. cruzi in northern Argentina, especially among Tobas; the occurrence 
of a peridomestic transmission cycle, and the key role of dogs and cats 
as domestic reservoir hosts, risk factors and control targets in the humid 
Chaco.
817
CHAGAS DISEASE: KNOWLEDGE, ATTITUDES, AND 
PRACTICES AMONG LATIN AMERICAN IMMIGRANTS LIVING 
IN LOS ANGELES
Mahmoud I. Traina, Daniel R. Sanchez, Salvador Hernandez, 
Haneen Khamag, Aiman M. Smer, Sheba K. Meymandi
Olive View-University of California Los Angeles Medical Center, Sylmar, CA, 
United States
This study was undertaken to examine the knowledge, attitudes, and 
practices associated with Chagas disease (CD) among Latin American 
immigrants living in Los Angeles. Background: It is estimated that more 
than 300,000 individuals are infected with CD in the United States (US), 
though most were infected via vector-borne transmission in Latin America 
where it is endemic. We assessed the knowledge, attitudes, and practices 
associated with CD among 2712 individuals in Los Angeles County, ages 
18 to 60 years, who had previously resided in Mexico, Central America, 
or South America for at least 6 months. Sixty-two percent of participants 
recall seeing triatomine insects in Latin America, and 27% of participants 
reported being bitten by triatomine insects at least once per year while 
living in Latin America. Eighty-six percent of participants had never 
heard of CD. These results were significantly affected by the participant’s 
country of birth. Of the 13% of participants who had heard of CD, 62% 
thought CD was a problem in their native country, 55% thought CD was 
a problem in the US, and 81% thought CD was not serious. Over 90% of 
participants who had heard of CD would want to be tested and treated 
for it. In conclusion, the majority of Latin American immigrants residing 
in Los Angeles recall seeing the insects that transmit CD in their native 
country, yet they have never heard of CD. Of the participants who had 
heard of CD, the majority believe it is a problem in their native country 
and the US but do not believe it is a serious problem overall. Nevertheless, 
they would want to be tested and treated for CD.
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MODELING THE DISTRIBUTION OF CUTANEOUS 
LEISHMANIASIS IN BRAZIL BASED ON ENVIRONMENTAL 
AND SOCIOECONOMIC RISK FACTORS
Maria E. Bavia1, Moara S. Martins2, John B. Malone2, Marta 
M. Silva1, Luciana L. Cardim1, Deborah D. Carneiro1, Jennifer 
McCarroll2, Michael T. Kearney2, Joara S. Santos1
1Federal University of Bahia, Salvador, Brazil, 2Louisiana State University, 
Baton Rouge, LA, United States
Cutaneous leishmaniasis (CL) presents a variety of casual agents, reservoirs 
and vectors with different transmission patterns. Out of the 12 new world 
species known to cause disease in humans, seven can be found in Brazil 
which makes control of this endemic difficult. Thus, the necessity of a new 
methodology which would consider a better definition of transmission 
and risk areas. This study aimed to model the distribution of CL at the 
municipality level in Brazil based on environmental and socioeconomic 
factors. The GIS database was constructed using records of CL cases 
available in the national notifiable diseases information system (SINAN 
from 2005-2009); records from the Brazilian Institute of Geography and 
Statistics (IBGE) and the Pan-American Health Organization (unsatisfied 
basic needs for people (UBNp) and housing (UBNh)) were used to compile 
the socioeconomic data. The environmental database was constructed 
using long-term normal monthly climate data from WorldClim and 
MODIS annual composite data. Distribution models for CL were executed 
using Maxent and maps of spatial distribution and prediction models 
were created in ArcGIS 10. A total of 96,351 cases of CL were registered 
at SINAN (13% of the municipalities). Cases of CL increased as the 
number of health facilities and UNBp education increased (p<0.0001) 
but notification of disease decreased as UNBh improved (drinking 
water; plumbing; sanitation and electricity (p<0.0001)). CL was inversely 
correlated with Temperature Seasonality (p<0.0001) and directly correlated 
with annual precipitation (p<0.0001). The environmental variables that 
most contributed in the Maxent model were precipitation of September 
(26.2%) and annual precipitation (17.3%) (AUC 0.80). From the 
socioeconomic data the most influencing variables were gross domestic 
product per capita (23%) and literacy rate (22%) (AUC 0.795, IBGE 
model); sanitation (83.9%; AUC 0.76, UBNh model); subsistence (33.7%) 
and unemployment (26%)(AUC=0.77, UBNp model). A final model was 
executed combining environmental and socioeconomic data and it was 
found that the variables contributing in the model were UBNh sanitation 
(39.6%), UBNp subsistence (11.3%) and annual precipitation (8.8%) (AUC 
0.86). Socioeconomic factors may be playing an important role in the 
occurrence of CL in Brazil and together with environmental features may 
provide a better understanding of the dynamics of this endemic in Brazil.
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CONGENITAL TRANSMISSION OF TRYPANOSOMA CRUZI 
IN ARGENTINA, HONDURAS, AND MEXICO: AN ONGOING 
STUDY
Pierre Buekens1, Maria-Luisa Cafferata2, Jackeline Alger3, 
Fernando Althabe4, Jose Belizan4, Yves Carlier5, Alvaro Ciganda2, 
Eric Dumonteil6, Rubi Gamboa-Leon6, Elizabeth Howard1, Maria 
Luisa Matute7, Sergio Sosa-Estani8, Carine Truyens5, Dawn 
Wesson1, Concepcion Zuniga9
1Tulane University, New Orleans, LA, United States, 2UNICEM, Montevideo, 
Uruguay, 3Instituto Antonio Vidal, Tegucigalpa, Honduras, 4IECS, Buenos 
Aires, Argentina, 5Université Libre de Bruxelles (ULB), Brussels, Belgium, 
6Universidad Autónoma de Yucatán, Merida, Mexico, 7National Laboratory, 
Ministry of Health, Tegucigalpa, Honduras, 8Instituto Nacional de 
Parasitología “Dr. Mario Fatala Chaben”-ANLIS, Buenos Aires, Argentina, 
9National Chagas Program, Ministry of Health, Tegucigalpa, Honduras
Trypanosoma cruzi has been divided into different lineages: T. cruzi I (TcI) 
and non-TcI (including lineages II-VI). TcI is predominant in Mexico and 
Central America, while non-TcI is predominant in most of South America, 
including Argentina. Little is known about congenital transmission of 
TcI. The specific aim of this study is to determine the rate of congenital 
transmission of TcI compared to non-TcI. We are conducting a prospective 
study to enroll at delivery, 10,000 women in Argentina, 7,500 women in 
Honduras, and 10,000 women in Mexico. We are measuring transmitted 
maternal T. cruzi antibodies by performing two rapid tests in cord blood 
(Stat-Pak, Chembio, Medford, New York, and Trypanosoma Detect, 
InBios, Seattle, Washington), and, if at least one of the results is positive, 
we are identifying infants who are congenitally infected by performing 
parasitological examinations on cord blood and at 4-8 weeks, and 
serological follow-up at 10 months. We will also perform standard PCR, 
real-time quantitative PCR, and T. cruzi genotyping on maternal venous 
blood and on cord blood, and serological examinations on siblings. Study 
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enrollment has been staggered and began in Tucuman, Argentina in April 
2011, and in Intibuca and Santa Barbara, Honduras in May 2011. Study 
enrollment began in July 2011 in Merida and Valladolid, Mexico. As of 
April 2012, recruitment numbers per country are as follows: Argentina 
- 4,280 births; Honduras - 3,634 births (1,739 in Intibuca and 1,895 in 
Santa Barbara); and Mexico - 4,002 births (2,161 in Merida and 1,841 
in Valladolid). Argentina has reported 80 (1.9%) births of seropositive 
mothers (with at least one positive serological rapid test result in cord 
blood), Honduras has reported 144 (4.0%) births of seropositive mothers 
(96 (5.5%) in Intibuca and 48 (2.5%) in Santa Barbara), and Mexico has 
reported 28 (0.7%) births of seropositive mothers (21 (1.0%) in Merida 
and 7 (0.4%) in Valladolid). 
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GENETIC DIVERSITY AND POPULATION STRUCTURE OF 
TRYPANOSOMA BRUCEI IN UGANDA: IMPLICATIONS FOR 
THE EPIDEMIOLOGY OF SLEEPING SICKNESS AND NAGANA
Richard Echodu1, Mark Sistrom2, Jon S. Beadell2, Loyce M Okedi3, 
Serap Aksoy4, Chineme Enyioha4, John C. K Enyaru5, Elizabeth 
Opiyo1, Wendy Gibson6, Adalgisa Caccone2
1Faculty of Science, Gulu University, Gulu, Uganda, 2Department of 
Ecology and Evolutionary Biology, Yale University, New Haven, CT, 
United States, 3National Livestock Resources Research Institute, Tororo, 
Uganda, 4Yale School of Public Health, Yale University, New Haven, CT, 
United States, 5Department of Biochemistry and Sports Science, College 
of Natural Sciences, Makerere University, Kampala, Uganda, 6School of 
Biological Sciences, University of Bristol, Bristol, United Kingdom
Human African Trypanosomiasis has remained a major and long term 
public health problem in Uganda characterized by recurrent sporadic 
outbreaks in the traditional endemics areas and continued spread to 
new unaffected areas. Uganda harbors the two forms of Trypanosoma 
brucei subspecies; Trypanosoma bbrucei rhodesiense and T. b. gambiense 
causing two forms of sleeping sickness, the acute and the chronic forms 
respectively. The third T. brucei subspecies; T. b. brucei is the third leading 
cause of African Animal Trypanosomiasis or nagana and has a wider 
geographical distribution. T. b. gambiense remains localized in North 
West Uganda while T. b. rhodesiense is currently restricted to Central 
and Eastern regions, although it continues to spread towards the T. 
b. gambiense foci. All the three forms of parasites are closely related 
subspecies and remain a major challenge to human health and animal 
production in Uganda. This is the only country where all three taxa occur. 
Thus, understanding the population structure of T. brucei in Uganda is 
critical for disease control. We use a newly developed set of microsatellite 
loci to investigate two important hypotheses regarding the population 
processes affecting T. brucei in Uganda: 1) Do temporally distinct disease 
foci originate from similar or distinct populations of T. brucei? 2) Does 
host species influence the genetic population structure of T. brucei? 
By investigating these hypotheses we aim to inform on evolutionary 
processes at the population level, which will assist in developing effective 
control measures and treatment of T. brucei. Results are based on isolate 
collections from 18 Ugandan sites including 300 Trypanosoma isolates 
from infected tsetse, vertebrates and humans.
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INFECTIOUSNESS OF SMALL RODENTS TO THE SANDFLY 
LUTZOMYIA LONGIPALPIS REINFORCES THEIR ROLE 
AS SOURCES OF INFECTION LEISHMANIA (VIANNIA) 
BRAZILIENSIS
Maria S. Andrade1, Maria E. Brito2, Francisco G. Carvalho2, Ana 
I. Araujo2, Fabia C. Soares2, Ericka L. Almeida2, Helio F. Valença2, 
Fernando J. Silva2, Pietra L. Costa2, José C. Miranda3, Jeffrey J. 
Shaw4, Sinval P. Brandão Filho2
1Universidade de Pernambuco, Recife, PE, Brazil, 2Centro de Pesquisas 
Aggeu Magalhães, Recife, PE, Brazil, 3Centro de Pesquisas Gonçalo Muniz, 
Salvador, BA, Brazil, 4São Paulo University, Brasilia, DF, Brazil
There are many records of leishmanial infections detected in wild animals 
by molecular methods but a major question is: Are they infectious to 
vectors? The present study was aimed at characterizing the infectiousness 
of experimental infections of Leishmania (Viannia) braziliensis in the 
small rodents Necromys lasiurius, Rattus rattus and Nectomys squamipes. 
These animals are incriminated as the major reservoirs hosts of cutaneous 
leishmaniasis in an endemic area of Pernambuco, northeast Brazil. For 
these experiments we established colonies of the three rodent species and 
a colony of Lutzomyia longipalpis. A total of 30 animals (10 Rattus rattus, 
10 Necromys lasiurius and 10 Nectomys squamipes) and a control group 
of golden hamster Mesocricetus auratus were infected with cultured 
promastigotes of L. (V.) braziliensis (MBOL/BR/2000/CPqAM95): a stock 
previously isolated from the rodent Bolomys lasiurus (Syn. Necromys 
lasiurus) captured in the endemic study area, as reported previously. An 
average of 25 female sand flies was used to perform the xenodiagnosis. 
Ten days after feeding the sand flies were dissected and their intestinal 
tract was examined for the presence of promastigotes. Samples of the 
intestine were also preserved and were subsequently tested by Polymerase 
chain reaction (PCR) tests that were specific for the Lutzomyia cacophony 
gene and for the subgenus L. (Viannia) spp. Samples of skin, spleen and 
liver of each experimentally infected animals were tested by PCR for 
the presence L. (Viannia) DNA. Three Necromys lasiurius, 3 Nectomys 
squamipes and 5 Rattus rattus were infective for phlebotomine sand 
flies. The visualization of promastigotes in phlebotomine sand flies 
was confirmed by the PCR specific for the subgenus L.(Viannia). The 
results show that these 3 rodent species are infectious and strengthen 
their incriminated importance as natural reservoirs of L. (V.) braziliensis. 
They also indicate the potential use of molecular techniques to 
determine reservoir host infectiousness by comparing parasite load with 
xenodiagnoses results.
822
THE SYLVATIC TRANSMISSION CYCLE OF TRYPANOSOMA 
CRUZI IN THE HUMID CHACO OF ARGENTINA
Marcela Orozco1 Orozco1, Gustavo Enriquez1, Julián Alvarado-
Otegui1, Victoria Cardinal1, Alejandro Schijman1, Uriel Kitron2, 
Ricardo Gürtler1
1University of Buenos Aires, Buenos Aires, Argentina, 2Emory University, 
Atlanta, GA, United States
A wide variety of wild mammals (e.g., marsupials, edentates, rodents 
and primates) are reservoir hosts of Trypanosoma cruzi. Understanding 
the complex epidemiology of T. cruzi and the variety of transmission 
cycles requires a representative picture of parasite genetic diversity −
currently classified into six Discrete Typing Units (DTUs). We estimated 
the prevalence and diversity of T. cruzi infection in wild mammals of a 
well-defined rural area (Pampa del Indio) in Chaco, northern Argentina. 
A total of 195 mammals from 20 identified species were captured in 
four surveys conducted between 2008 and 2011 and examined for 
infection by xenodiagnosis and kDNA-PCR. A total of the 27 (14%) were 
xenodiagnosis-positive: 12 of 31 (29%) Didelphis albiventris opossums 
and among armadillos, 12 of 29 (46%) Dasypus novemcinctus, 2 of 
15 (13%) Tolypeutes matacus, and one of 16 (6%) Chaetophractus 
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vellerosus. A total of 15 xenodiagnosis-negative animals were kDNA-PCR-
positive, including 4 D. albiventris opossums, 1 Euphractus sexcinctus 
and 3 D. novemcinctus armadillos, 5 Thylamys pusilla (Chaco fat-tailed 
opossum), and 2 small rodents (unidentified species). Using SAT-DNA-PCR 
we confirmed T. cruzi infection in one D. novemcinctus and two T. pusilla 
positive by kDNA-PCR only. These are the first findings of T. cruzi in T. 
pusilla and TcIII in C. vellerosus and T. matacus from Argentina. A PCR-
based strategy showed that all opossums were infected with DTU TcI and 
all armadillos with TcIII, implying separate parasite transmission cycles. 
Wild mammals had no evidence of parasite DTUs infecting local domestic 
dogs, cats or Triatoma infestans bugs (TcV and TcVI). Sylvatic transmission 
cycles of T. cruzi in the dry and humid Chaco differ in the composition of 
the main reservoir hosts.
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LEISHMANIA BRAZILIENSIS IS THE ETIOLOGICAL AGENT OF 
CUTANEOUS LEISHMANIASIS IN LOS MONTES DE MARÍA, 
COLOMBIA
Eduar E. Bejarano, Lily Martínez, Margaret Paternina-Gómez, 
Luís E. Paternina, Alveiro Pérez-Doria
Universidad de Sucre, Sincelejo, Colombia
Cutaneous leishmaniasis (CL) and visceral leishmaniasis (VL) constitute 
important public health problems in the Caribbean coastal region of 
Colombia. These clinical presentations of leishmaniasis are endemic in 
rural and urban areas of the departments of Sucre and Bolívar, especially 
in Los Montes de María, an area that constitutes the most important CL 
macrofocus of the Caribbean coastal region. The objective of the present 
study was to use sequencing of the subtelomeric region to determine the 
Leishmania species producing CL among the inhabitants of Montes de 
María. Thirty-six CL patients from the municipalities of Carmen de Bolívar, 
Macayepo, Morroa, Sincelejo and Ovejas were analyzed, each receiving a 
direct parasitological examination before samples were taken for parasite 
culture in NNN medium to allow molecular identification of the species 
involved. A sequence from the subtelomeric region of approximately 388 
bp was obtained, presenting a 99-100% similarity with sequences of the 
subtelomeric region of three reference strains of Le. (V.) braziliensis. It was 
thus determined that is the species responsible for CL in the Montes de 
María area. Its presence in the area has important implications in selecting 
the correct medical treatment to be administered.
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HEALTHY LIVING TO CONTROL CHAGAS DISEASE IN 
ECUADOR
Claudia P. Nieto-Sanchez1, Darwin F. Guerrero-Jimemez2, Esteban 
G. Baus2, Mario J. Grijalva3
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States, 2Center for Infectious Disease Research, Catholic University of 
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Chagas disease is caused by the parasite Trypanosoma cruzi and 
transmitted mainly by the feces of triatomine insects. This disease affects 
~10 million people mostly in Latin America. Studies conducted since 2002 
by our group have described the biological and epidemiological factors 
that facilitate transmission of T. cruzi in Southern Ecuador, and have 
determined that insecticide-based control strategies are effective only in 
the short term due to frequent bug re-infestation of treated dwellings. To 
address this issue, we designed in 2010 the Healthy Living Initiative (HLI), 
a holistic process aimed at facilitating the socioeconomic development of 
rural communities affected by Chagas disease. The final goal of the HLI 
is to design, implement and evaluate a sustainable model to eliminate 
vectorial Chagas disease transmission in Loja province via improvement 
of the houses and the peridomestic areas. This model is based on 
community organization and socioeconomic participative development 
as basic conditions to promote human health. So far it has been possible 
to facilitate process in five areas: health (community promoters and 
entomological surveillance network); infrastructure (land entitlement and 
improvements to local water systems and access road); income generation 
(ecotourism, artisans’ groups, and local products commercialization); 
capacity building, and safety/security. Based on these advances, the 
current phase of the HLI identifies characteristics of a Healthy Housing 
Model adapted to the cultural and social realities of this area. Positive 
Deviance methodological framework was used with particular attention 
to existing knowledge, attitudes, and practices (KAP) of houses that 
have remained bug free during the last four years. In this process the 
HLI seeks to unite the efforts of various local, national and international 
organizations active in Loja by integrating their activities to government 
plans, as well as facilitating families’ participation through critical analysis 
of their own reality.
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EPIDEMIOLOGY OF ACTIVE TRYPANOSOMA CRUZI 
TRANSMISSION AND IMPACT OF INSECTICIDE SPRAYING IN 
AREA IN THE BOLIVIAN CHACO
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An estimated 8-10 million people are infected with Chagas disease. 
Prevention strategies rely primarily on insecticide spraying against vectors 
and risk factor reduction including housing improvements. We performed 
a cross-sectional survey to evaluate the prevalence and risk factors for 
disease acquisition in seven contiguous villages in an area of the Bolivian 
Chaco where active transmission persists despite an insecticide spraying 
program that operated from 2000-2007. Furthermore, we attempted 
to evaluate the effectiveness of the insecticide spraying program by 
modeling disease incidence on age-specific prevalence using a catalytic 
model. Survey teams performed a census of the 7 evaluated villages, and 
collected demographic, socio-economic, and risk factor data. We collected 
venous blood from 1578 persons aged ≥ 2 years, and performed Indirect 
Hemagglutination and Weiner ELISA on each sample for Trypanosoma 
cruzi diagnosis. Discordant results were confirmed by Weiner recombinant 
antigen ELISA. The population prevalence of T. cruzi infection was 51.8%. 
We limited our analyses of risk factors to the ≤15 year age group, in 
which prevalence was 19.5%, and assumed that infection was acquired 
relatively recently. Preliminary univariate analyses demonstrated statistically 
significant associations between T. cruzi seropositivity and village of 
residence (P < 0.0001), roofing material of metal as compared to straw 
(Odds ratio [OR] 0.57; 95% Confidence Interval [CI]: 0.33-0.99), and 
household ownership of ducks (OR 1.77; CI: 1.22-2.57). No association 
between serostatus and history of household insecticide spraying (OR 
1.03; CI: 0.63-1.67) was found in univariate analysis, and no significant 
decrease in risk of infection associated with the spraying campaign was 
detected in the catalytic model (χ2(1) = 0.42; P = 0.52). Failure of spraying 
to yield a decrease in transmission may be due to inadequate spraying, 
insufficient duration or frequency of the program, insecticide resistance, or 
reinfestation by sylvatic vectors. Multivariate analyses are forthcoming.
250
www.astmh.org
826
SPATIOTEMPORAL CLUSTERING OF VISCERAL 
LEISHMANIASIS AND LEISHMANIA DONOVANI INFECTIONS 
IN BIHAR, INDIA
Albert Picado1, Paritosh Malaviya2, Epco Hasker3, Rudra Pratap 
Singh2, Marleen Boelaert3, Shyam Sundar2
1Barcelona Centre for International Health Research (CRESIB), Barcelona, 
Spain, 2Banaras Hindu University, Varanasi, India, 3Institute of Tropical 
Medicine, Antwerp, Belgium
In the Indian subcontinent, visceral leishmaniasi (VL), also known as kala-
azar, is caused by Leishmania donovani, which is transmitted from man to 
man by the sand fly Phlebotomus argentipes. VL tends to cluster in certain 
hamlets in remote rural villages but the spatiotemporal dynamics of the 
disease and leishmania infection are not fully understood. We analysed 
the clustering of VL cases and L. donovani infections in a VL endemic 
area covering over 80,000 people in Muzaffarpur district, Bihar. The 
people living in the study area are regularly monitored and demographic 
information is been gathered as part of NIH funded project on VL in 
India. VL cases occurring from 2007 to 2011 were identified by yearly 
house to house surveys in the whole study area. Incident L. donovani 
infections were identified as seroconverters (using DAT and rK39 ELISA) 
in high transmission areas by means of two serosurveys in 2008 and 
2009 (n=11,000 people). Yearly edge-corrected kernel density maps, the 
K-function and the scan-statistic were used to evaluate the spatiotemporal 
dynamics of VL and L. donovani infection over the study period. The 
implications of VL clustering and spatial variation for the VL control 
program in the Indian subcontinent will be discussed.
827
EXAMINING LEVEL OF USE OF CHEMOTHERAPY, 
CHEMOPROPHYLAXIS AND INTERMITTENT-PREVENTIVE 
TREATMENT OF MALARIA IN PREGNANCY BY PREGNANT 
WOMEN IN NIGERIA
Obinna Onwujekwe1, Ogochukwu Onwujekwe2, Rebecca 
Soremekun3
1University of Nigeria, Enugu, Nigeria, 2University of Nigeria Teaching 
Hospital, Enugu, Nigeria, 3University of Lagos, Lagos, Nigeria
The study assessed the nature of health seeking for chemotherapy 
and chemoprevention for malaria-in-pregnancy (MIP), especially the 
acceptability and use of intermittent preventive treatment of MIP by 
pregnant women attending public and private health facilities. The study 
was undertaken in Enugu, southeast Nigeria. A total of 647 consenting 
pregnant women (321 in the public hospitals and 326 in the private 
hospitals) were administered with structured questionnaires. Data was 
analyzed for the levels of perceptions, acceptability and use of IPTp 
amongst the pregnant women. Bivariate analysis was used to examine 
whether the differences in the variables between pregnant women 
attending public and private facilities were statistically significant. The 
results showed that the knowledge about MIP was high among the 
pregnant women. Pregnant women attending private hospitals were 
less aware of IPTp as a preventive strategy for MIP (p<0.05), but there 
was no significant difference in the acceptability of IPTp by the pregnant 
women in public and private facilities (p>0.05). IPTp was consumed more 
by pregnant women in the private facilities (76.9%) compared to those 
in the public facilities (27.6%) (p<0.05). Blood tests were used more by 
consumers in the private facilities (71.3%) compared to those in the public 
facilities for diagnosis of MIP (50.2%) (p<0.05). It is concluded that health 
seeking behaviour for MIP by pregnant women attending private facilities 
was better than for those attending public facilities. Hence, interventions 
are needed to improve the management of MIP in public facilities, and 
also enhancing the services of private providers.
828
DESCRIPTIVE SURVEILLANCE ON USE OF ARTEMETHER-
LUMEFANTRINE IN PEDIATRIC AND ADULT RETURNING 
TRAVELERS WITH MALARIA
Alyson M. Gray1, Marc Cousin2, Paul M. Arguin1, Kamal Hamed3
1Centers for Disease Control and Prevention, Malaria Branch, Atlanta, 
GA, United States, 2Novartis Pharma AG, Basel, Switzerland, 3Novartis 
Pharmaceuticals Corporation, East Hanover, NJ, United States
Data from clinical studies show that artemether-lumefantrine (AL) is 
effective and well tolerated in children and adults with uncomplicated 
Plasmodium falciparum malaria. However, data on effectiveness and 
safety of AL in patients in non-endemic settings are limited. Our 5-year 
prospective surveillance plan includes AL-treated pediatric and adult 
patients with suspected or confirmed P. falciparum malaria in the US, as 
reported to the National Malaria Surveillance System at the Centers for 
Disease Control and Prevention. Descriptive analyses include demographics 
and baseline characteristics, including malaria immune status; treatment 
effectiveness; prior and concomitant medication use; and occurrence 
of adverse events. In the first 17 months (1 May 2010 to 30 September 
2011), demographics, treatment adherence, and safety data were 
collected on 24 patients. Treatment effectiveness data were collected 
on 21 (91.3%; 2 patients were lost to follow-up) of 23 patients with 
confirmed (smear 95.7%, PCR 4.3%) or suspected malaria. The mean age 
of patients was 40.3 years (SD=19.3; range 12-83) and the median BMI 
was 27 kg/m2 (range 16.8-33.8). The majority were male (58.3%) and 
malaria non-immune (91.7%). Half were non-Hispanic Black. The most 
common malaria species was P. falciparum (65%; others were P. vivax, P. 
ovale, and P. malariae, 22%; undertermined, 13%). Of 22 patients taking 
AL, 18 (81.8%) adhered to treatment. The overall cure rate of patients 
treated with AL was 83.3% (95% CI= 58.6-96.4%) on Day 7 and 82.4% 
(95% CI=56.6-96.2%) on Day 28 (patients with missing effectiveness 
data excluded from analysis). The most common prior and concomitant 
medications included analgesics, other antimalarials, vitamins, and 
supplements. There were no deaths, but 3 serious adverse events (severe 
malaria, incorrectly diagnosed as uncomplicated malaria) were reported. 
Treatment of P. falciparum malaria in non-immune patients with AL 
is effective and well tolerated without any unexpected or new safety 
findings with approved 3-day treatment regimen.
829
EFFICACY OF SHORT PROPHYLACTIC COURSE OF 
ATOVAQUONE- PROGUANIL 
Eyal Leshem, Eyal Meltzer, Shmuel Stienlauf, Eran Kopel, Eli 
Schwartz
Sheba Medical CTR, Ramat Gan, Israel
Current guidelines recommend continuation of Atovaquone proguanil 
hydrochloride (AP) prophylaxis for seven days after leaving Plasmodium 
falciparum endemic areas. Evidence from previous studies suggest that 
continuation for one day after malaria exposure ends may be sufficient. 
We conducted a retrospective survey of travelers who terminated AP 
prophylaxis one day after leaving malaria endemic areas to identify 
falciparum malaria cases. A retrospective telephone survey of travelers to 
sub-Saharan Africa. Travelers who visited our pre-travel clinic and used AP 
prophylaxis were included. After returning from their trip, travelers were 
contacted and questioned regarding prophylaxis adherence, duration, and 
malaria diagnosis during or after travel. In Israel, malaria is a reportable 
disease. A retrospective analysis was performed looking at all falciparum 
malaria cases reported to the Israeli ministry of health (MOH) between 
2003-2008. Information about prophylaxis use among these patients were 
retrieved. The survey included 454 travelers between the years 2010-2011 
(total 4771 days in endemic areas). AP was discontinued one day after 
leaving the malaria endemic areas by 341/454 (75%) travelers. No cases 
of malaria were noted. The MOH registry survey included 118 falciparum 
patients between the years 2003-2008. The majority (100; 85%) did not 
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take any malaria prophylactic. None of the patients had used malaria 
prophylaxis with AP (neither regular nor short AP course). 
Between 2005-2007, 2095 travelers to Sub-Sahran Africa consulted 
the Sheba Medical Center pre-travel clinic (total travel days to Sub-
Sahran Africa = 134,488). There were no reports of malaria among 
these travelers. In conclusion, we retrospectively studied a large group 
of travelers exposed to highly endemic malaria areas. Despite cessation 
of AP prophylaxis one day after leaving the endemic areas none of the 
travelers developed malaria. In addition, analyzing the passive surveillance 
data of malaria cases in Israel did not show any falciparum malaria case 
which occurred after AP prophylaxis (regular or short course). Based on 
pharmacokinetic properties and falciparum malaria pathophysiology it 
is reasonable to recommend use of AP prophylaxis ending one day after 
leaving the endemic area. Further prospective validation of our findings in 
larger number of travelers should follow.
830
IMPACT OF INTERMITTENT PREVENTIVE TREATMENT IN 
PREGNANCY WITH SULFADOXINE-PYRIMETHAMINE ON 
PLACENTAL INFECTION AND INFANT BIRTH OUTCOMES IN 
MALAWI
Julie Gutman1, Dyson Mwandama2, Ryan Wiegand1, Doreen Ali3, 
Don P. Mathanga2, Jacek Skarbinski1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Malaria Alert Center, University of Malawi College of Medicine, Blantyre, 
Malawi, 3National Malaria Control Program, Ministry of Health, Lilongwe, 
Malawi
Malaria in pregnancy is associated with severe maternal anemia, placental 
parasitemia, low birth weight, and increased perinatal mortality, especially 
among primi- and secundi-gravidae. Sulfadoxine-pyrimethamine (SP) 
is currently recommended for intermittent preventive treatment in 
pregnancy (IPTp), despite increasing prevalence of SP resistance that might 
compromise its effectiveness. HIV-uninfected women with a singleton 
pregnancy were enrolled at delivery and data on number of SP doses 
during the pregnancy collected via interview and review of the woman’s 
antenatal care card. The primary outcome was evidence of past or current 
placental infection by placental histology. Secondary outcomes included 
malaria parasitemia at the time of delivery in the cord blood, placenta or 
maternal peripheral blood, and composite birth outcome (any of small 
for gestational age (SGA) as assessed by Ballard exam, low birth weight, 
or preterm). Of 713 women enrolled, 22% received <2 SP doses; 33% 
were primigravid. About one-third reported sleeping under a bednet the 
previous night. Receipt of <2 SP doses versus ≥2 doses had no impact on 
placental infection as measured by placental histology (31.5% vs 31.8%, 
P=0.94) or blood films (3.8% vs 5.9%, P= 0.30) at the time of delivery. 
Receipt of IPTp-SP was associated with a dose dependent protective effect 
in primigravid women only on the composite birth outcome due to a 
reduction in SGA; using 0 doses as the comparison, adjusted prevalence 
ratio (aPR) =0.69 (95% confidence interval (CI) 0.5-1.01), aPR=0.43 
(95% CI 0.3-0.6), and aPR=0.32 (95% CI 0.1-0.9) for 1, 2, and 3 doses, 
respectively. Receipt of SP was not associated with stillbirths or adverse 
delivery outcomes. IPTp-SP did not reduce placental infection, but was 
associated with improved birth outcomes in primigravidae in Malawi, 
suggesting that IPTp-SP may work primarily by treating infection, rather 
than prophylaxis. Very few women received 0 doses of SP, so these results 
may underestimate the true effect of IPTp-SP. IPTp-SP should continue to 
be provided to pregnant Malawian women, but given the high prevalence 
of SP resistance in Malawi, alternative antimalarials should be investigated 
for IPTp.
831
EFFICACY, SAFETY AND TOLERABILITY OF 
DIHYDROARTEMISININ-PIPERAQUINE FOR TREATMENT OF 
UNCOMPLICATED FALCIPARUM MALARIA IN PREGNANCY IN 
GHANA: A RANDOMIZED, NON-INFERIORITY TRIAL
Joseph Osarfo1, Harry Tagbor1, Pascal Magnussen2
1Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, 
2University of Copenhagen, Copenhagen, Denmark
Pregnancy-associated malaria remains a challenge in endemic areas, 
resulting in low birth weights, maternal anaemia, foetal loss and increased 
infant morbidity and mortality. A major intervention recommended is 
effective case management with artemisinin-based combination therapy. 
One such option is dihydroartemisinin-piperaquine for which there is 
limited efficacy and safety data in pregnancy. With its introduction on 
the Ghanaian market and anticipated access by pregnant women, we 
assessed its use for treatment in pregnant women. Pregnant women 
of gestation15-32 weeks attending antenatal clinics in a moderate-
to-high transmission zone of Ghana were screened for peripheral 
falciparum parasitaemia using rapid diagnostic test (RDT) and microscopy. 
Those positive in both and eligible were randomized to receive 
dihydroartemisinin-piperaquine or artesunate-amodiaquine. Baseline 
clinical, haematological and ultrasonographic assessments are conducted. 
They are actively followed up on days 1, 2, 3, 7, 14, 28, 42, at delivery and 
at 6 weeks postpartum to ensure adherence to study drugs, assess adverse 
events, collect blood samples for haematological and parasitological 
assessments and gather data on neonatal morbidity and mortality. Of a 
sample size of 904, 254 (28.1%) have been recruited giving a baseline 
RDT positivity of 14% (254/ 1805) and mean haemoglobin concentration 
of 10.0mg/dl. Of the day 3 blood films, 23.4% (43/ 184) had parasitaemia 
while 7.9% (14/177), 1.0% (2/193), 2.3% (4/172) and 0.6% (1/154) of 
the day 7,14, 28 and 42 blood films respectively showed parasitaemia. 
Geometric mean parasite density decreased from 147/ul(CI 134, 162) at 
baseline to 88/ul(CI 71, 109) on day 3. Polymerase chain reaction work on 
filter paper blots to differentiate reinfection and recrudescence is yet to 
be done. Upon completion of the study, we will compare parasitological 
efficacy at days 28 and 42, low birthweight, maternal haemoglobin, 
adverse events and foetal loss in the two treatment arms for significance 
of differences.
832
MALARIA CASE MANAGEMENT PRACTICES IN PHARMACIES 
AND LICENCED CHEMICAL SHOPS IN GHANA
David Y. Mensah, Kezia L. Malm, Vivian A. Aubyn, Constance 
Bart-Plange
Ghana Malaria Control Programme, Accra, Ghana
Malaria is the single most important cause of morbidity and mortality 
in Ghana, especially among children under five years. Among pregnant 
women, malaria accounts for 28.1% of OPD attendance in Ghana. 
About half of the people first seek help from the pharmacies and licensed 
chemical sellers (LCSs) when they are sick. This study sought to assess 
the practices of pharmacies and LCSs with respect to malaria in Ghana. 
A random sample of 216 pharmacies and 306 LCSs were drawn from the 
register of pharmacies and LCSs in Ghana. A mystery client approach was 
employed in gathering information. The interviewers who acted as mystery 
clients were trained using a structured mystery client guide. Scenarios of 
children under five years, adults and pregnant women with malaria were 
presented at the pharmacies and licenced chemical shops, based on which 
purchases of ACTs were made. The data was captured in epidata and 
analyzed in SPSS. About 63% of LCSs and 56.9% of pharmacies asked 
the clients about the age of the patient (child under-five, pregnant women 
and other adults). About 54% of LCSs and 57% of pharmacies visited 
asked about the symptoms of the patient. Also, 26% of LCSs and 35% of 
pharmacies asked about the medication history of the patient. About 88% 
of LCSs and 90% of pharmacies visited recommended some drugs to the 
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clients after they had presented their symptoms. The rest did not. The rate 
of purchase of anti-malarials was not associated with the type of facility. 
The same proportion of LCSs and pharmacies (i.e. 2.3%) referred the 
clients to a clinic for diagnostic tests. Management practices of pharmacies 
and LCSs were encouraging however most of them did not ask about 
the medication history of the clients. Pharmacy council of Ghana should 
educate the pharmacies and LCSs on the need to ask their clients about 
the medication history of their illness before prescribing anti-malarials to 
them.
833
HOW PATIENTS TAKE MALARIA TREATMENT: A SYSTEMATIC 
REVIEW OF THE LITERATURE ON ADHERENCE TO 
ANTIMALARIALS
Katia Bruxvoort1, Catherine Goodman1, S. Patrick Kachur2, 
David Schellenberg1
1London School of Hygiene and Tropical Medicine, London, United 
Kingdom, 2Centers for Disease Control and Prevention, Atlanta, GA, 
United States
Artemisinin-based combination therapies (ACTs) are the first-line drugs for 
treatment of malaria throughout sub-Saharan Africa, and are becoming 
increasingly available in the private sector. However, there are concerns 
about sub-optimal patient adherence which may have consequences for 
treatment efficacy and the development of antimalarial drug resistance. 
In order to identify patterns in how patients use antimalarial drugs and 
highlight gaps in current knowledge, a systematic literature review was 
performed. A search was conducted in PubMed using MeSH and free text 
terms. Of 1242 studies initially identified, 40 met the inclusion criteria 
of providing quantitative data on patient adherence to antimalarials 
obtained for treatment. Manual search of reference lists and contacting 
researchers in the field yielded 11 additional studies. Patient adherence 
to ACTs was assessed in 23 studies, non-artemisinin-based combinations 
in 12, and chloroquine and other monotherapies in 20. Only two studies 
involved the private sector. Adherence measurement methods included 
self-report with and without dose timing, pill counts and biological 
assays. Although some studies found very high adherence to ACTs, others 
endeavouring to capture “real life” situations reported adherence of 
64-88%. Overall, adherence was higher in studies where consent was 
obtained at enrolment versus at follow-up, and in studies where patient 
consultations were observed by the study team. Comparison of results 
based on different measurement methods showed higher adherence when 
biological assays were used, but no other clear patterns. Multivariate 
models in 10 studies found 28 factors associated with adherence, 
but no factor was significant in more than one study. The suboptimal 
patient adherence to ACTs obtained in the public sector and the current 
dearth of data from the private sector represent significant challenges to 
ensuring ACTs are used appropriately and remain effective. To strengthen 
future studies, there is a clear need for awareness of the impact of study 
procedures on adherence outcomes, and the identification of improved 
measurement methods that are less dependent on self-report.
834
SONTOCHIN AS A GUIDE TO DEVELOPMENT OF DRUGS 
AGAINST CHLOROQUINE RESISTANT MALARIA
Michael Riscoe1, Sovitj Pou1, Rolf Winter1, Aaron Nilsen1, Jane 
Xu Kelly1, Yuexin Li1, Joseph Stone Doggett2, Erin Riscoe2, Keith 
Wegmann1, David Hinrichs1
1Veterans Affairs Medical Center, Portland, OR, United States, 2Oregon 
Health Sciences University, Portland, OR, United States
Sontochin was the original chloroquine replacement drug, arising from 
research by Andersag two years after chloroquine (known as “Resochin” 
at the time) had been shelved due to the mistaken perception that it was 
too toxic for human use. We were surprised to find that sontochin, i.e., 
3-methyl-chloroquine, retains significant activity against chloroquine-
resistant strains of Plasmodium falciparum in vitro. We prepared 
derivatives of sontochin, “pharmachins”, with alkyl or aryl substituents 
at the 3-position and with alterations to the 4-position side chain to 
enhance activity against drug resistant strains. Modified with an aryl 
substituent in the 3-position of the 7-chloro-quinoline ring PH-203 exhibits 
low nanomolar IC50 values against drug sensitive and multidrug resistant 
strains and in vivo efficacy against patent infections of P. yoelii in mice that 
is superior to chloroquine. Our findings suggest that novel 3-position aryl 
pharmachin derivatives have the potential for use in treating drug resistant 
malaria. A detailed structure-activity profile will be presented.
835
WEIGHT BASED DOSING CAUSES SIGNIFICANTLY LOWER 
CHLOROQUINE CONCENTRATIONS IN YOUNGER CHILDREN
Johan Ursing1, Poul-Erik Kofoed2, Amabelia Rodrigues3, Staffan 
Eksborg1, Lars Rombo4
1Karolinska Institutet, Stockholm, Sweden, 2University of Southern 
Denmark, Kolding, Denmark, 3Bandim Health Project, Bissau, Guinea-
Bissau, 4Centre for Clinical Research, Sörmland County Council, Eskilstuna, 
Sweden
Chloroquine (CQ) was previously the main drug for treatment of 
Plasmodium falciparum malaria but it is no longer recommended due 
to resistance. In Guinea-Bissau, West Africa double dose CQ (50mg/
kg) split into 2 daily doses for 3 days was well tolerated, as efficacious 
as artemether-lumefantrine and eradicated 87% of P. falciparum with 
resistant genotypes in 2008. As part of 3 previous clinical trials, 100 µl 
of blood was collected on day 7 from children aged 6 months-15 years 
that had taken 25 or 50 mg/kg of CQ. Whole blood CQ concentrations 
were analysed using high performance liquid chromatography. CQ 
concentrations were obtained from 188 and 293 children after intake 
of 25 and 50 mg/kg of CQ, respectively. CQ concentrations after intake 
of 25 mg/kg and stratification by age were: 545 (10y) nmol/l. Using the 
same age groups, concentrations after 50mg/kg were 834, 1220, 1164, 
1573, 1565 and1546 nmol/l. The increases with age were significant, 
nonparametric test for trend P=0.008 and P<0.0001, respectively. 
Using the same age groups, the dose of CQ taken according to body 
surface area ranged from 489-702 and 978-1405 mg per square meter 
after intake of 25 and 50 mg/kg, respectively. The CQ concentration in 
children 10 years of age after intake of 25 and 50 mg/kg, respectively. CQ 
concentrations were only 21% higher in children <2 years taking 50mg/
kg compared to children >10 years taking 25mg/kg. Dosing according to 
body weight rather than body surface area most probably accounts for 
the lower concentrations seen in younger children. Vomiting and spitting 
among the youngest children are unlikely explanations as treatment 
was repeated after vomiting and because it does not explain the trend 
throughout the age groups. Chloroquine should be dosed according to 
body surface area and the effect of dosing according to body weight 
should be assessed for other antimalarials.
836
RANDOMIZED, CONTROLLED TRIAL OF TREATMENT OF 
FEBRILE CHILDREN WITH A NEGATIVE MALARIA RAPID 
DIAGNOSTIC TEST WITH ARTEMETHER-LUMEFANTRINE VS. 
NO ANTIMALARIAL IN BAGAMOYO DISTRICT, TANZANIA
Meredith McMorrow1, Saumu Ahmed2, Peter Lyaruu3, Mussa 
Maganga2, Thomas Lyimo3, Salim M. Abdulla3, S. Patrick Kachur1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Ifakara Health Institute, Bagamoyo, United Republic of Tanzania, 3Ifakara 
Health Institute, Dar es Salaam, United Republic of Tanzania
Until recently, most national malaria control programs recommended 
treating all febrile children less than five years of age with first-line 
antimalarial drugs to prevent severe malaria, disability and death. In 2010, 
WHO recommended uniform confirmation of malaria parasitemia by blood 
smear or rapid diagnostic test (RDT) prior to treatment. Unfortunately 
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little is known about the epidemiology of other common causes of 
non-malarial fevers in malaria endemic areas. Moreover, the effect of 
withholding malaria treatment from febrile children, even when they test 
negative, may have unintended public health consequences. From January 
2010 to December 2011, we enrolled 1000 children aged 6 to 59 months 
with uncomplicated febrile illness and negative malaria RDTs from two 
health facilities in Tanzania. Subjects were randomized to receive either 
artemether-lumefantrine (AL) or no treatment and followed for 91 days 
to document symptom resolution, time to next malaria infection, and 
frequency of hospitalization or death. Subjects who missed more than two 
follow-up visits were not included in per protocol analyses. Preliminary 
results are available for 708 (70.8%) subjects. Among these 708 subjects, 
353 (49.9%) were randomized to AL, 457 (64.6%) completed 91 days 
of follow-up per protocol without developing malaria, 15 (2.1%) were 
healthy to day 91 but missed more than two visits, 14 (2.0%) withdrew 
consent, 8 (1.1%) were given a non-study antimalarial, 118 (16.7%) were 
lost to follow-up, 93 (13.1%) developed malaria during follow-up, and 3 
(0.4%) died of non-study related illness. Children randomized to receive 
AL had a lower risk of developing malaria during follow-up (RR=0.72, 
95% confidence interval 0.49-1.04, p=0.09). The time to malaria infection 
by 10% of subjects in each arm was 56 days for the AL arm and 28 days 
for those who did not receive treatment, but the difference was not 
statistically significant (p=0.07). Data are preliminary. Study results will be 
used to improve the management of non-malarial febrile illness.
837
AN INHIBITOR OF MULTIPLE CYTOCHROME P450S, 
1-AMINOBENZOTRIAZOLE, ALTERS THE PHARMACOKINETICS 
OF PRIMAQUINE AND CHLOROQUINE IN A RHESUS MODEL 
OF MALARIA RADICAL CURE
Charlotte A. Lanteri1, Susan Charman2, Montip Gettayacamin1, 
Rawiwan Imerbsin1, Brandon Pybus3, Jason Sousa3, Pattaraporn 
Vanachayangkul1, Larry Walker4, Colin Ohrt3
1Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand, 
2Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia, 
3Walter Reed Army Institute of Research, Silver Spring, MD, United States, 
4University of Mississippi, University, MS, United States
An unidentified metabolite of primaquine (PQ) is suspected to exert 
anti-hypnozoite activity to prevent Plasmodium vivax relapse. We 
previously showed that a nonselective inhibitor of multiple cytochrome 
P450s (CYP450s), 1-aminobenzotriazole (1-ABT), blocks PQ’s malaria 
causal prophylaxis activity in mice. Subsequently, we attempted to 
use this inhibitor to explore if CYP450 metabolism is involved in PQ’s 
anti-relapse activity in P. cynomolgi-infected Rhesus monkeys. Infected 
monkeys were administered 1-ABT prior to treatment with a 7 day 
radical curative regimen of PQ plus chloroquine (CQ). Efficacy +/- 1-ABT 
administration was determined via daily parasitemia readings and safety 
was assessed using clinical laboratory results, including % methemoglobin 
(metHgb). The 7 doses of 1-ABT and primaquine planned were halted 
after the second dose because some monkeys had elevated alanine 
aminotransferase levels, which returned to baseline after stopping dosing. 
Increases in metHgb occurred only in monkeys treated with PQ plus CQ. 
In contrast, metHgb decreased daily in animals pre-dosed with 1-ABT, 
suggesting 1-ABT blocks PQ-induced metHgb formation. Blood draws 
were included to assess plasma pharmacokinetics (PK) of PQ and CQ 
+/- 1-ABT. Pre-treatment with 1-ABT decreased PQ and CQ levels and 
prolonged half-lives. Animals pre-dosed with 1-ABT had a 4 to 7 day delay 
in onset of malaria relapse, relative to controls given CQ only, presumably 
because 1-ABT inhibits metabolism of the antimalarial active CQ parent 
drug. Besides PK interactions of 1-ABT with PQ and CQ, we noted a link 
between PQ and CQ metabolism. Animals given PQ plus CQ had a two-
fold greater plasma exposure to CQ’s major CYP450 metabolite (desethyl-
CQ) after 1 dose and 8-fold higher levels after 7 daily doses relative to 
animals given CQ alone. In contrast, pre-dosing with 1-ABT precluded 
formation of desethyl-CQ. We report that the CYP450 inhibitor, 1-ABT, 
alters PK properties of PQ and CQ, and that PQ potentially induces CQ 
metabolism. Our results also suggest PQ metabolism is linked to metHgb 
generation.
838
EXPLORING THE PERFORMANCE OF RETAIL SECTOR 
PROVIDERS EXPOSED TO A PILOT INTERVENTION TO 
PROVIDE SUBSIDIZED ARTEMETHER-LUMEFANTRINE 
THROUGH THE PRIVATE SECTOR IN WESTERN KENYA
Beth B. Kangwana1, Sarah Kedenge1, Abdisalan Noor1, Victor 
Alegana1, Andrew Nyandigisi2, Jayesh Pandit3, Gregory Fegan1, Jim 
Todd4, Simon Brooker1, Robert Snow1, Catherine Goodman4
1Kenya Medical Research Institute - Wellcome Trust Research Programme, 
Nairobi, Kenya, 2Division of Malaria Control, Nairobi, Kenya, 3Pharmacy 
and Poisons Board, Nairobi, Kenya, 4London School of Hygiene and 
Tropical Medicine, London, United Kingdom
To improve the quality of care received for presumptive malaria from the 
highly accessed private retail sector in Western Kenya, subsidised pre-
packaged artemether-lumefantrine (AL) was provided on a pilot basis 
to private retailers, together with a one day training for retail staff on 
malaria diagnosis and treatment. The pilot was assessed using a cluster 
randomised, controlled design with nine control and nine intervention 
sublocations, equally distributed across three districts. Provider and 
mystery shopper cross-sectional surveys were conducted at baseline and 
eight months post intervention to assess the impact of the intervention 
on retailer performance. Data were analysed based on cluster-level 
summaries, comparing control and intervention arms, while adjusting for 
covariates, including baseline values where a difference of 5% or more 
was observed between the arms at baseline. On average 564 retail outlets 
were interviewed per year. At follow up, 43% and 1% of respondents 
reported that at least one staff member had attended the intervention 
training, in the control and intervention arm, respectively. The intervention 
significantly increased the percentage of providers knowing the first 
line treatment for uncomplicated malaria by 24.2% points (confidence 
interval (CI):14.8%, 33.6%; adjusted p=0.0001); the percentage of outlets 
stocking AL by 31.7% points (CI: 22.0%, 41.3%; adjusted p=0.0001); 
and the percentage of providers prescribing AL for presumptive malaria 
by 23.6% (CI:18.7%, 28.6%; adjusted p=0.0001). No significant 
difference was observed between the arms at endline in the percentage 
asking for specified danger signs that determine need for referral to a 
health facility, and there remained substantial room for improvement 
in provision of appropriate dispensing advice to those who bought AL. 
Overall, subsidizing ACTs and retailer training can significantly increase 
the percentage of outlets stocking and selling AL for the presumptive 
treatment of malaria, but further research is needed on strategies to 
improve the provision of counselling advice to retail customers.
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COMPARATIVE EFFICACY AND ACCEPTABILITY 
OF ARTEMETHER-LUMEFANTRINE VERSUS 
DIHYDROARTEMISININ-PIPERAQUINE IN KENYAN CHILDREN 
WITH UNCOMPLICATED FALCIPARUM MALARIA
Bernhards Ogutu1, Kevin Omondi Onyango2, John Michael 
Ongecha3, Elizabeth Juma3, Godfrey Allan Otieno1, Charles 
Obonyo3, Lucas Otieno1, Fredrick Eyase4, Jacob D. Johnson4, 
Douglas Jay Perkins5, Willis Akhwale6
1Walter Reed Project-Centre for Clinical Research, Kenya Medical Research 
Institute, Nairobi, Kenya, 2Centre for Clinical Research, Kenya Medical 
Research Institute, Kisumu, Kenya, 3Centre for Global Health Research, 
Kenya Medical Research Institute, Kisumu, Kenya, 4Walter Reed Project, 
Kenya Medical Research Institute, Kisumu, Kenya, 5University of New 
Mexico, Albuquerque, NM, United States, 6Department of Disease 
Prevention and Control, Ministry of Public Health and Sanitation, Nairobi, 
Kenya
The primary objective was to compare the corrected Acceptable 
Clinical and Parasitological Responses (ACPR) on Day 28 of artemether-
lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) in children 
with uncomplicated falciparum malaria. This open-label, comparative trial 
study in Western Kenya randomized 454 children with uncomplicated 
falciparum malaria of age 6-59 months to receive either AL (n=227) or 
DP (n=227). Children were hospitalized for 3 days for observed treatment 
and 72-hour parasite kinetic monitoring, and actively followed up at 
scheduled visits after discharge from hospital on Days 7, 14, 28 and 42. 
Genotyping for determining treatment outcome was performed on Day 0 
and any other day the study participant had a recurrence of parasitemia. 
No significant differences were observed for the corrected ACPR rates 
on Day 3, 14, 28 and 42 for AL (99.1%, 100%, 97.8%, 96.8%) and 
DP (100%, 100%, 99.1%, 98.7%). Similarly, for the uncorrected ACPR 
rates no significant differences were seen on Day 3, 14, 28 and 42 for AL 
(99.1%; 98.7%; 81.1%; 67.8%) and DP (100%; 100%; 87.7%; 70.5%), 
(p>0.05 for all comparisons). Both AL and DP are efficacious treatments 
for uncomplicated falciparum malaria in Kenyan children. No signs of P. 
falciparum resistance to artemisinins were noted.
840
DRUG-DRUG INTERACTIONS BETWEEN PRIMAQUINE AND 
CHLOROQUINE: PHARMACOKINETIC AND TRANSPORTER 
INHIBITION STUDIES
Xiannu Jin, Brandon S. Pybus, Jason C. Sousa, Heather Gaona, 
ThuLan Luong, Theresa Bettger, Nicholas McCulley, Sean 
Marcsisin, Qigui Li, Colin Ohrt, Victor Melendez
Walter Reed Army Institute of Research, Silver Spring, MD, United States
The long established potentiation of primaquine’s liver stage activity 
when co-administered with chloroquine is still poorly understood after 
more than six decades (Alving et al., 1955). In the present study we 
have compared the pharmacokinetics of primaquine (8.8 mg/kg PO in 
C3H mice) and its primary plasma metabolite carboxyprimaquine after 
co-administration of 90 mg/kg of chloroquine (CQ). The overall effect 
observed was a decrease in Cmax with a corresponding decrease in Cl/F and 
increase in AUC. To better understand these effects, transporter inhibition 
studies were carried out using both MDR1-MDCK and Caco2 cell lines. 
Permeability experiments with increasing levels of CQ showed a marked 
dose dependence in B-A permeability, indicative of MDR1 inhibition. 
Results for a larger screen of the effects of CQ on various efflux and 
uptake transporters will be presented.
841
INHIBITORS OF PRIMAQUINE METABOLISM AS 
MODULATORS OF EFFICACY AND HEMOLYTIC TOXICITY
Brandon Pybus, Jason C. Sousa, Gregory Deye, Xiannu Jin, Qigui 
Li, Colin Ohrt, Victor Melendez
Walter Reed Army Institute of Research, Silver Spring, MD, United States
The 8-aminoquinoline drug primaquine (PQ) is the only drug approved 
for the treatment of relapsing relapsing malaria. However, PQ is known 
to cause hemolytic toxicity in G6PD deficient individuals. Proposed 
mechanisms of both efficacy and toxicity suggest a role for transient 
reactive oxygen species formed as a byproduct of metabolism. We 
previously showed that CYP 2D6 plays a major role in the production 
of the redox active metabolites most likely to produce oxidative stress, 
however the relevance of this role in vivo was not clear. To this end, 
the effects of Paroxetine (PX), a potent selective inhibitor of CYP 2D6 
metabolism, co-administration was tested in models of both in vivo liver 
stage efficacy and G6PD deficient hemolytic toxicity. In C57BL/6 mice, 
co-administration of PX at 25 mg/kg with PQ at 2.5 mg/kg showed a 
reduction in liver stage potency at both 24 and 48 hr post infection with 
P. berghei sporozoites. Co-administration of PQ with the MAO-A inhibitor 
Clorgiline (CG) however, resulted in enhanced liver stage efficacy. Further, 
significant mitigation of the hemolytic toxicity associated with PQ dosing 
in a G6PD deficient strain of C3H mice was also observed after co-
administration of PX. These data suggest that CYP 2D6 plays an integral 
role in the metabolic pathways necessary for PQ’s efficacy and hemolytic 
toxicity. While the effects of MAO-A inhibition on toxicity remain 
unknown, metabolic compensation may account for increased efficacy as 
a result of decreased primaquine clearance.
842
REPORTED ADVERSE EVENTS ASSOCIATED WITH 
ARTEMISININ COMBINATION THERAPIES (ACTS) IN 
NORTHERN GHANA
Nana Akosua Ansah1, Frank Atuguba1, Timothy Awine1, Patrick 
Ansah1, Victor Asoala1, Thomas Anyorigiya1, Abraham Hodgson2, 
Alex Dodoo3, Fred N. Binka4
1Navrongo Health Research Centre, Navrongo, Ghana, 2Ghana Health 
Service, Research and Development, Ghana, 3Ghana Health Service, Accra, 
Ghana, 4University of Ghana, School of Public Health, Legon, Ghana
Many African countries have adopted artemisinin derivative based 
combination therapy (ACT) as treatment for uncomplicated malaria, 
offering an opportunity to assess the safety of these drugs when in 
real life setting. Knowledge of side effects of these drugs is important 
for improved management of malaria. This study was conducted to 
document adverse events associated with Artesunate Amodiaquine 
(ASAQ), Arthemether Lumefantrine(AL) and Dihydroartemisin Piperaquine 
(DHP) through comprehensive pharmacovigilance in the Kassena Nankana 
districts of Northern Ghana. As part of INDEPTH Effectiveness and Safety 
studies, a cohort event monitoring study was conducted at selected public 
and private health facilities after administration of artemisinin combination 
therapy to participants to treat uncomplicated malaria during visits to 
the hospital. Participants were recruited if they were prescribed an ACT. 
Each participant was followed up between the 3rd and 7th day after 
enrolment to document adverse events. A total of 4951 participants with 
uncomplicated malaria prescribed ASAQ, AL and DHP were recruited 
across all age groups from August 2010 to June 2011. Out of the 4951 
participants recruited, 26.0 % reported at least one adverse event; none 
had a serious adverse event. Of the 1288 participants reporting an adverse 
event 78.0%, 19.4% and 2.6% took ASAQ, AL and DHP respectively. 
27.1% of females reported an adverse event compared to 19.8% of males 
recruited. Participants in the 15-49 years age group reported 43.3% of 
adverse events. The most reported adverse events were dizziness (24.2%) 
and weakness (23.5%) and these were more associated with ASAQ.The 
unadjusted odds ratio for participants who took AL are 2.3 (95% CI: 1.9- 
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2.8; p-value<0.001) times more likely to adhere to treatment compared 
to participants on ASAQ. Participants given DHP were also 10.7 (95% 
CI:4.4- 26.2; p-value<0.001) more likely to adhere to treatment compared 
to participants on ASAQ. 81.6% of those who had no adverse event 
adhered to treatment compared to those who had at least one adverse 
event, 18.4%. There were significantly more adverse events experienced 
by patients who took ASAQ compared to AL and DHP and this affected 
adherence to treatment.
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EVALUATION OF TWO QUALITY ASSURANCE APPROACHES 
FOR MALARIA RAPID DIAGNOSTIC TESTS IN PERIPHERAL 
HEALTH FACILITIES IN RURAL TANZANIA
Irene M. Masanja1, Mussa Maganga1, Debora Sumari1, Naomi 
Lucchi2, Venkatachalam Udhayakumar2, Meredith McMorrow2, 
Peter McElroy3, Patrick Kachur2
1Ifakara Health Institute, Dar es Salaam, United Republic of Tanzania, 
2Centers for Disease Control and Prevention, Atlanta, GA, United States, 
3U.S. President’s Malaria Initiative, Dar es Salaam, United Republic of 
Tanzania
WHO recommends parasitological confirmation of malaria before 
treatment. Limited availability of microscopy in malaria endemic countries 
has resulted in increased use of antigen-detecting malaria rapid diagnostic 
tests (mRDTs), but appropriate quality assurance (QA) systems for mRDTs 
remain a concern. Tanzania has begun a national scale-up of mRDTs at 
all government health facilities. We evaluated mRDT performance in two 
districts of Tanzania with low malaria transmission using two QA methods: 
a) reference microscopy and b) detection of parasite DNA by real-time 
quantitative polymerase chain reaction (qPCR). Blood samples were 
collected from patients undergoing mRDT during two to three consecutive 
days each month in 12 health facilities between January and August 
2010. Thick blood films were examined at the district headquarters and 
the Ifakara Health Institute (IHI) Bagamoyo Laboratory. A third blood film 
reader was consulted for discordant results. Molecular analysis involved 
extraction of parasite DNA from dried blood spots tested for presence of 
Plasmodium falciparum DNA with a pilot real-time assay targeting the 
tubulin gene. The assay was performed at IHI and about 40% of the DNA 
aliquots were sent to CDC for validation of IHI results. Samples from 1,837 
patients were analyzed. Malaria positivity rates were 6.5%, 3.4%, and 
2.7% for mRDT, qPCR, and microscopy, respectively. When qPCR was a 
gold-standard, mRDTs had higher sensitivity (68.6%; 95% CI: 55.0-79.7) 
than microscopy (53.7%; 95% CI: 38.7-68.0), but the difference was not 
significant. When microscopy was the gold standard, mRDT sensitivity was 
the highest (85.3%; 95% CI: 70.0-93.6). With qPCR as a gold standard, 
positive predictive values were significantly different between the two 
tests: microscopy vs qPCR-IHI (75.9%; 95% CI: 58.0-78.8), and mRDTs vs. 
qPCR-IHI (36.5%; 95% CI: 27.5-46.4). Higher inter-observer agreement 
(kappa=0.75) was seen amongst the microscopists. We identified many 
technical problems with qPCR analysis. QPCR may not be an appropriate 
QA tool to assess mRDT performance for routine care in this setting. A 
microscopy-based QA system may be a more suitable option.
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IMPACT OF INTENSIVE MALARIA MICROSCOPY TRAINING 
ON DISTRICT HOSPITALS LABORATORY STAFF IN TANZANIA
Sarah Chiduo, Awalludin Sutamihardja, Edward Sekonde, 
Tiffany Hamm, Colin Ohrt, Charles Massambu, Fidelis 
Mgohamwende, Robert A. Gramzinski
Walter Reed Program, Dar es Salaam, United Republic of Tanzania; Henry 
M. Jackson Foundation Medical Research International, Rockville, MD, 
United States; Walter Reed Army Institute of Research, Silver Spring, MD, 
United States; U.S. Military HIV Research Program, Rockville, MD, United 
States; Ministry of Health and Social Welfare, Dar es Salaam, United 
Republic of Tanzania; National Malaria Control Program, Dar es Salaam, 
United Republic of Tanzania
Malaria microscopy training of laboratory staff responsible for definitive 
malaria identification, quantification, and speciation has a direct impact 
on achieving proper malaria diagnosis. We investigated the impact of a 
malaria diagnostics training program developed at the Malaria Diagnostics 
Center in Kisumu, Kenya on the overall understanding and performance 
of malaria microscopists in Tanzania. The objective of this analysis was to 
determine the optimal course syllabus and training duration necessary 
for strengthening clinic laboratory diagnosis of malaria in Tanzania. Pre- 
and post-course test results from 2009 to 2011 were compared against 
trainees’stratified laboratory training background. The time dedicated 
to performing microscopy practical sessions was recorded to determine 
if the optimal training time was enough to maximize accurate malaria 
diagnosis. For the 78 course participants tested it was observed that there 
is an improvement on the performance of laboratory in reaching a proper 
malaria diagnosis. Individual average scores for sensitivity ranged from 
44.5% to 81.5% with an average improvement of 37% from pretest 
to post test. specificity test scores from 34.5% to 86% with an average 
improvement of 51.5%, written test scores from 53to 82.5% with an 
average improvement of 29.5% species identification from 40% to 71.5% 
with an average improvement of 31.5%, parasite detection from 64% to 
79.5% with an average improvement of 15.5%, and parasite counting 
from 42.5% to 74.0% with an average improvement of 31.5%. There is 
a clear need for conducting regular and standardized malaria microscopy 
training for all laboratory staff dealing with malaria microscopy on a day-
to-day basis. A two week training course can increase the level of malaria 
microscopy proficiency in Tanzania.
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THE ROLE OF BASELINE ASSESSMENTS ON MALARIA 
MICROSCOPY TOWARDS IMPROVING THE QUALITY OF 
MALARIA DIAGNOSTICS IN TANZANIA
Awalludin Sutamihardja1, Sarah Chiduo1, Derryck Klarkowski1, 
Edward Sekonde2, Tiffany Hamm2, Colin Ohrt2, Robert 
Gramzinski2
1Walter Reed Programs, Dar es Salaam, United Republic of Tanzania, 
2Walter Reed Army Institute of Research, Silver Spring, MD, United States
Well performed malaria microscopy has high sensitivity, can identify 
malaria species and quantitate parasitaemia which in turn will lead to 
appropriate clinical malaria management. Poor microscopic diagnosis of 
malaria results in both false positive and false negative results that directly 
result in poor clinical management and loss of physician confidence in 
laboratory results.  We performed baseline assessments at 22 district 
hospital laboratories in three regions in Tanzania (Coastal, Kagera, and 
Zanzibar) to determine the status of staff experience, malaria diagnostic 
knowledge, the availability of quality equipment and supplies, quality of 
malaria smear staining, laboratory documentation procedures, supply 
chain management, and other parameters. Our analysis of the baseline 
assessments indicate a need for focused improvement in malaria 
smear preparation and staining procedures, distribution of high quality 
microscopes, use of high quality malaria smear staining reagents, use 
of standardized laboratory operating procedures, the development of a 
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robust supply chain management system, and implementation of QA/
QC procedures. Areas that were performed well include laboratory 
registry documentation, generally consistent power supply, and patient 
safety procedures. The effectiveness of malaria microscopy training 
will be significantly augmented if the laboratory infrastructure enables 
microscopists to apply their training in routine practice. To this end there 
is an immediate need to improve the quality of laboratory equipment, 
supplies and improved standardized methodology to consistently 
prepare good quality stained malaria slides. The dual implementation 
of strengthened laboratory infrastructure and training will increase 
both malaria diagnostic capacity and competency that will directly 
lead to increasing accurate diagnosis. The duel focus on training and 
infrastructure strengthening will be the focus of ongoing WRAIR 
contributions to the PMI efforts in Tanzania and will directly improve the 
effectiveness of treatment and prevent over- or misuse of antimalarials.
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BASELINE ASSESSMENTS ON THE USE OF MALARIA 
RAPID DIAGNOSTIC TESTS (MRDT) IN HOSPITALS AND 
DISPENSARIES IN TANZANIA
Derryck Klarkowski, Awalludin Sutamihardja, Sarah Chiduo, 
Edward Sekonde, Tiffany Hamm, Colin Ohrt, Robert A. 
Gramzinski, Fidelis Mgohamwende, Sigsbert Mkude
Walter Reed Program, Dar es Salaam, United Republic of Tanzania; Henry 
M. Jackson Foundation Medical Research International, Rockville, MD, 
United States; Walter Reed Army Institute of Research, Silver Spring, MD, 
United States; U.S. Military HIV Research Program, Rockville, MD, United 
States; National Malaria Control Program, Dar es Salaam, United Republic 
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A key Tanzanian National Malaria Control Program (NMCP) objective 
is to increase the percentage of malaria microscopy and malaria rapid 
diagnostic test (mRDT) confirmed cases of malaria in public health 
facilities from 20% to 80% by 2012. Malaria diagnosis by microscopy 
requires well trained technicians and quality equipment, supplies and 
procedures. Increasingly Tanzania is relying on mRDTs for point-of-care 
malaria diagnosis in hospitals, health centres and peripheral dispensaries. 
Similar to microscopy, mRDTs can suffer from logistical supply chain 
problems, lack of quality assurance/quality control (QA/QC) procedures, 
and infrastructure deficiencies. In 20xx we conducted baseline assessments 
of healthcare workers’ performance of mRDT in 6 district hospitals 
in the Coastal Region, plus 7 regional/district hospitals and 13 health 
centers/dispensaries in the Kagera Region. Parameters assessed included 
testing procedures and performance, supply chain management, QA/
QC, staff training, documentation, and storage and waste management. 
Significantly 44% (7/16) of health facilities scored ≤60% for testing 
performance and only one of 16 health facilities achieved 90%. Our 
overall analysis of the baseline assessments indicate need for focused 
improvement in the support provided to testing staff, including job aids, 
timers and adequate ambient lighting; increased supervision of testing 
performance; increased availability of training; strengthened training 
in test interpretation; and the implementation of QA/QC procedures.  
Improving mRDT testing and supply management will directly lead to 
increasing accurate diagnosis to improve the effectiveness of treatment in 
Tanzania. Implementing these changes will be the focus of ongoing efforts 
to strengthen malaria diagnostic services in Tanzania.
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MISCLASSIFICATION OF PLASMODIUM SPECIES BY 
CONVENTIONAL MICROSCOPY
Peter Obare1, Bernhards Ogutu2, Christine Adhiambo1, Seth 
Owusu3, Fred Binka4, Jacob Johnson1
1United States Medical Research Unit, Kisumu, Kenya, 2Kenya Medical 
Research Institute, Nairobi, Kenya, 3Kintampo Health Research Center, 
Kintampo, Ghana, 4Malaria Clinical Trials Alliance, INDEPTH Network, 
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Microscopic differentiation of Plasmodium species relies on morphological 
characteristics manifested in stained blood films. Proficiency levels of 
microscopists as well as morphological variations within and between 
Plasmodium species may lead to misclassifications. Ten- day microscopy 
workshops were conducted from 2009 to 2010. Proficiency of the 
participants was assessed at the start and the end of each workshop 
using mono infection slide sets of P. falciparum, P. malariae, P. ovale and 
P. vivax. Each slide with densities between 1,000 to 30,000 parasites/µL 
was examined for 5 minutes. Errors observed on each of the Plasmodium 
species were false negatives, positive results with no species indicated, 
inability to differentiate between Plasmodium species and reports of 
mixed infections. Pre- workshop misclassification of P. falciparum as 
positive was significantly higher (p < 0.05) than all other reported 
misclassifications except P. malariae. Misclassification of P. malariae as 
negative was significantly higher than all other reported misclassifications. 
Misclassification of P. ovale and P. vivax as mixed infections was 
significantly lower than all the reported misclassifications. Post workshop 
misclassification of P. falciparum as mixed infections was significantly 
higher than all other reported misclassifications and there was no clear 
misclassification of P. malariae. P. ovale was highly misclassified as P. 
vivax and P. vivax equally misclassified as P. ovale. Microscopy workshops 
can minimize observed errors and improve reliability of both clinical and 
epidemiological data. Confirmation of results by expert microscopy in 
addition to molecular characterization of species is highly recommended.
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MALARIA MICROSCOPY QUALITY ASSURANCE USING A 
SMALL NUMBER OF SLIDES
Luis Benavente1, Nicole Whitehurst1, Chris Petruccelli1, Sean 
Fennell1, Joseph Valadez2
1Medical Care Development Inc., Silver Spring, MD, United States, 
2Liverpool School of Tropical Medicine, Liverpool, United Kingdom
WHO’s “Universal Access to Malaria Diagnostic Testing, an Operational 
Manual” released in 2011 recommends “cross-checking of 10 to 20 slides 
if time (during a supervisory visit) allows.” Weak infrastructure in most 
Sub-Saharan African countries’ will hinder adherence to the previous 
WHO’s Malaria Microscopy Quality Assurance (MMQA) protocol released 
in 2009 of selecting five negatives and five weak positives per lab and 
per month and sending them to a certified microscopist at a referral lab 
for cross-checking. For health facilities in many African countries, there 
are not enough slides available and no fuel or transportation to reference 
labs. Even if slides can be sent, there are not enough skilled microscopists 
at the reference labs to read all the slides received. The backlog of unread 
slides contributes to long delays feedback for their work. The Improving 
Malaria Diagnostic (IMaD) project tested if slide cross-checking during 
Outreach Training and Support Supervision (OTSS) visits could be used to 
identify underperforming labs and engage in on-the-spot problem-solving 
to address any deficiencies in slide preparation, staining or examination. 
As lab supervisors stayed in the lab for only one or two days, the number 
of slides cross-checked during the supervisory visit was on average 9.15 
(standard deviation 1.96 slides) 76% of facility visits saving slides of QA. In 
Benin, 78% of laboratories visited for OTSS cumulated 12-20 slides in two 
consecutive visits. A sample size of 12 slides per health facility identified 
facilities under the decision rule for 90% parasite detection, and/or below 
average parasite detection. If OTSS is done quarterly, the minimum annual 
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aggregate number of slides would be 24, out of a target number of 40 
slides (ten/visit), as opposed to 120 done by following the standard WHO 
MMQA 2009 protocol. Forty slides cumulated in a year selected randomly 
as per the LQAS stratified random sampling -with 50% slide positivity 
ratio- give a sufficiently precise estimate of parasite detection at laboratory 
level, allowing calculation of the % of laboratories attaining 90% 
agreement, and aggregate measurements at health zone level to focus 
MMQA efforts where they are needed the most. Resource-poor countries 
would be better served by considering a smaller sample size for MMQA 
selected with LQAS as opposed to not doing MMQA at all or doing 
MMQA in a way that fails to deliver feedback to participating labs.
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COMPARATIVE LABORATORY-BASED EVALUATION OF 
DIAGNOSTIC TESTS FOR G6PD
Cori A. Barfield, Jay Zimmers, Maria Kahn, Kathy Tietje, Gonzalo 
J. Domingo
PATH, Seattle, WA, United States
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most 
common human enzyme deficiency in the world, affecting over 400 
million people worldwide. It is characterized by abnormally low levels of 
G6PD, an enzyme involved in red blood cell metabolism. Individuals with 
diminished G6PD activity are susceptible to cellular oxidative damage, 
and can exhibit symptoms including hemolytic anemia and jaundice in 
response to a number of causes, most commonly infection or exposure to 
certain medications. In particular, treatment with anti-malarial drugs such 
as those in the 8‐aminoquinolone group (e.g. Primaquine, Pamaquine 
and Tafenoquine) can cause acute hemolysis in people with G6PD 
deficiency. Because of this risk it is imperative to identify individuals with 
G6PD deficiency prior to administering these anti-malarial agents. As 
such, there is a need for a test that is appropriate for G6PD deficiency 
screening in areas of the developing world where malarial treatments are 
frequently administered. To explore the suitability of G6PD tests for use 
in conjunction with malarial management we conducted a laboratory-
based evaluation to assess the performance and operational characteristics 
of several existing G6PD diagnostic tests. Tests evaluated included both 
qualitative and quantitative tests, utilizing a variety of test formats 
(fluorescent spot test, rapid point-of-care tests, dye reduction tests, and 
spectrophotometry-based tests). Our findings indicate that most of the 
currently available diagnostic tests for G6PD appear to have technical or 
operational shortcomings that may limit their applicability to low‐resource 
malaria management settings. Further adaptation and/or modification of 
existing tests or development of new tests to better meet the needs of 
clinicians and laboratory staff involved in malaria‐case management in the 
developing world may be needed. We present data from this evaluation 
and critical design inputs to guide development of new diagnostic tests for 
G6PD testing.
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DEVELOPMENT OF A READY-TO-USE GELIFIED REAL-TIME 
PCR ASSAY FOR SIMULTANEOUS SPECIFIC IDENTIFICATION 
OF PLASMODIUM FALCIPARUM, P. MALARIAE, P. VIVAX, 
AND P. OVALE IN CLINICAL SAMPLES
Cheysa Biondo1, Marco Krieger1, Viviane M. Goes1, Maniphet 
Xayavong2, de Almeida E. Marcos2, Naomi Lucchi2, Alexandre J. 
da Silva2
1FIOCRUZ, Curitiba, Brazil, 2Centers for Disease Control and Prevention, 
Atlanta, GA, United States
The use of PCR for identification Plasmodium spp. represents an attractive 
alternative for diagnosis of malaria. Some robust PCR techniques exist 
for this purpose, but they still based on complex procedures. This is not 
only time consuming, but increases the cost of PCR applications limiting 
its usefulness for laboratories in developing countries. Nevertheless, this 
can be drastically changed with PCR techniques designed to be executed 
under minimal quality control standards. We selected a previously 
published TaqMan assay and converted into a gelified format for 
robust, specific and simplified multiplex identification of P. falciparum, P. 
malariae, P. vivax, and P. ovale. Gelification consists in a process where the 
components of enzymatic reactions are stabilized by addition of different 
agents. In order to execute the procedure the laboratorian simply needs 
to add water and the DNA sample to the reaction tubes coated with all 
chemicals required for PCR amplification. Next, the vessels containing the 
re-solubilized mixture and the template are inserted into the real-time 
PCR thermal cycler for DNA amplification. The preliminary evaluation 
assay’s liquid format indicated that it was very specific compared to the 
nested PCR, since it did not produce any cross-amplification with samples 
containing other Plasmodium species such as P. cynomolgi, P. hylobati, P. 
inui and P. knowlesi (N=14); nested PCR primers for P. vivax cross-amplified 
P. cynomolgi (N=4). No false negative or false positive results were verified 
when this assay was compared to the nested PCR using approximately 100 
blood specimens sent to CDC for confirmatory diagnosis of malaria. This 
evaluation showed that the gelified assay had more efficient amplification 
profiles in addition to being simple to execute and providing results within 
2 hours, including preparation time. Also, the gelified format of the assay 
was stable for 7 days at room temperature and for 2 months at 4 C. We 
believe that the gelified assay format can streamline the use of real-time 
PCR for confirmatory diagnosis of malaria.
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A METHOD FOR IMPROVING THICK BLOOD FILM SLIDE 
ADHERENCE FOR MALARIA DIAGNOSIS
Andrew P. Norgan, Heather E. Arguello, Lynne M. Sloan, Emily 
C. Fernholz, Bobbi S. Pritt
Mayo Clinic, Rochester, MN, United States
The gold standard for malaria diagnosis remains the examination of thick 
and thin blood films. The thick film contains a greater amount of blood 
than the thin film and thus provides the greatest sensitivity for screening. 
Unfortunately, the larger quantity of blood may not adequately adhere to 
the thick film and some or all of the droplet may separate from the slide 
during staining. The possibility of sample loss has led to recommendations 
that thick films be allowed to dry from 3 hours to overnight to improve 
the blood droplet adherence to the slide. This delay in preparation of the 
thick film can delay diagnosis and treatment decisions if parasitemia is 
not evident on the thin film. Here we describe a simple and inexpensive 
‘scratch method’ for improving thick blood film adherence, ameliorating 
the need for extended drying times. Standardized blood droplets (35 
microliters) from twenty-six previously examined EDTA whole blood 
specimens (22 positive and 4 negative) were used to prepare Giemsa-
stained thick films either by a traditional or scratch method. By the 
traditional method, the droplet was gently spread to an approximate 
nickel-sized area (22 mm diameter) on the slide using the edge of a 
second glass slide. Using the scratch method, the droplet was smeared 
while forcefully grinding or ‘scratching’ it into the slide with the point 
of a second glass slide. All slides were dried for 1 hour in a laminar flow 
hood and Giemsa-stained using established protocols. Slides were then 
examined in a blinded manner for parasite identification, determination 
of percent parasitemia, and degree of blood droplet adherence by 4 
independent trained examiners. There was no difference in detection of 
parasites or parasite morphology between the two methods, but blood 
droplet adherence was significantly improved by the scratch method. 
The scratch method is a simple and effective way to improve thick film 
adherence and thus facilitate rapid screening. This method does not 
require additional equipment or significant changes in sample preparation 
methods.
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ANALYSIS OF DISCORDANT RESULTS BETWEEN MALARIA 
RAPID DIAGNOSIS TESTS (TDRS) AND MICROSCOPY
Laeticia C. Offouga, Denise P. Mawili, Marielle K. Bouyou Akotet
Faculty of Medecin University of Science of the Santé, Libreville, Gabon
The thick smear, a recommended blood test when diagnosing malaria, is 
a technique with some limits and that still is out of reach for people living 
in remote zones from endemic regions. Perfecting TDRs, means an easy 
and fast technique for malaria diagnosis, could, however help to make 
up these shortcomings. Nevertheless, their efficacy and effectiveness 
should be assessed in order to determine their performance. During 
a study conducted in Gabon, an HRP2 TDR (Aco® and the pLDH TDR 
Optimal-IT, 15% of discrepancies were found between TDRs and the thick 
smear. Our study aimed at analyzing these discordant results using the 
nested PCR, for amplification of the gene representing the small under-
unit of the ARN 18S. Out of the 415 analyzed samples (307 differences 
and 108 correspondences), 28,4% (38/171) were positive with the PCR. 
The Plasmodium falciparum infection was detected in 22,2% (38/171) 
of the positive samples with the Acon test, corresponding to 77,8% of 
false positive results and to more than 80% of bands with low intensity. 
The proportion of false negatives was 25,6%. The proportion of false 
positive with the test Optimal-IT (78,2%), was due to false detection of 
non falciparum species ; that of the false negatives was lower (33%). 
Sensitivity, specificity and negative predictive value of both TDRs with the 
thick smear corrected by the PCR considered as the reference exceeded 
90%, except for the detection of the non falciparum species with Optimal-
IT. Acon® and Optimal-IT remain of good interest for the biological 
diagnosis of malaria in areas where thick smears and well trained 
microscopists are not available.
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PLASMODIUM FALCIPARUM HISTIDINE-RICH PROTEIN 2 IN 
HUMAN MALARIA: DYNAMICS AND DETECTION BY RAPID 
DIAGNOSTIC TESTS
Louise Marquart, Alice Butterworth, James McCarthy, Michelle 
Gatton
Queensland Institute of Medical Research, Herston, Australia
Rapid diagnostic tests (RDTs) based on Plasmodium falciparum histidine-
rich protein 2 (PfHRP2) are popular for diagnosis of this most virulent 
malaria infection. However, concerns have been raised about the 
longevity of the PfHRP2 antigenemia following curative treatment in 
endemic regions. It is also unclear how early in an infection the PfHRP2-
detecting RDTs become positive. These are important questions for the 
widespread use of malaria RDTs in diagnosing malaria in clinical settings. 
We developed a mathematical model of PfHRP2 production and decay 
to mimic the kinetics of antigenemia during human infections. Fitting 
this PfHRP2 dynamics model to data from human infection studies 
in malaria naïve hosts allowed the amount of PfHRP2 produced per 
parasite to be estimated at g per replication cycle. The limit of detection 
for four commercial malaria RDTs was assessed in the laboratory; the 
minimum detection thresholds were between 6.9 and 27.8 ng/mL. The 
low detection threshold and long-half life of PfHRP2 is predicted to cause 
the RDTs to remain positive for at least 7 days after treatment. However 
the actual duration of positive test results following curative treatment 
is heavily dependent on the duration and density of parasitemia prior to 
treatment. Combining the model output and RDT sensitivity data, it is 
predicted that good quality PfHRP2-based RDTs should be able to detect 
parasites on the first day of symptoms in malaria naïve individuals, and 
that as few as 8 parasites/µL may be required to maintain a positive RDT 
in a chronic P. falciparum infection. The impact that host anti-PfHRP2 
antibodies may have on RDT positivity in endemic regions is currently 
being investigated.
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MOLECULAR DIAGNOSIS OF MALARIA BY PHOTO-INDUCED 
ELECTRON TRANSFER FLUOROGENIC PRIMERS (PET-PCR)
Naomi W. Lucchi1, Jothikumar Narayanan1, Maniphet Xayavong1, 
Simon Kariuki2, Alexandre J. Dasilva1, Vincent Hill1, Venkatachalam 
Udhayakumar1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Kenya Medical Research Institute/Centers for Disease Control and 
Prevention, Kisumu, Kenya
Malaria control and elimination programs require the use of diagnostic 
tools that are sensitive, cost effective and able to detect multiple species 
simultaneously in a simple and accurate manner. The real-time PCR 
methods are particularly robust for large scale screening and there is 
scope for improving these methods for field applications. Here, we have 
designed novel self-quenching real-time PCR primers for the detection of 
Plasmodium spp. and P. falciparum. This PCR assay uses the photo-induced 
electron transfer (PET) chemistry and therefore does not require internal 
probes, which are usually very expensive or intercalating dyes, which are 
often non-specific. A total of 115 clinical samples consisting of different 
malaria species and some mixed infections (9 malaria negative samples, 
81 P. falciparum, 9 P. vivax, 1 P. malariae, 9 P. ovale, 2 P. falciparum/P. 
malariae, 1 P. vivax/P. ovale, 2 P. falciparum/P. ovale mixed infections and 
1 P. knowlesi) were used to test the utility of the novel PET-PCR primers in 
diagnosis of clinical samples. The sensitivity and specificity was calculated 
using a nested PCR as a gold standard. Both primer sets showed 100% 
sensitivity and specificity. This malaria PET-PCR method can detect 
parasite densities as low as 10 parasites/µL of both Plasmodium spp. and 
P. falciparum. In addition, the reaction can be duplexed to detect both 
Plasmodium spp. and P. falciparum in a single reaction. Further validation 
of this technique in field settings will help to assess its utility for large scale 
screening for malaria parasitemia, potentially important for control and 
elimination programs.
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DEVELOPMENT OF A FLUORESCENCE IMMUNOASSAY 
FOR SEMI-QUANTITATIVE OF THE DIAGNOSIS MALARIA: 
PLASMODIUM FALCIPARUM AND PLASMODIUM VIVAX
Taek kyu Oh
Boditech Med Inc., Chuncheon, Republic of Korea
The rapid and accurate diagnosis of malaria is key to the central to clinical 
management and the prevention of drug-overuse, which may lead to 
resistance development, toxicity and economic loss. So far, microscopy 
of Giemsa-stained thin or thick blood smears is the gold standard. Rapid 
diagnosis tests provide an alternative, although they cost more and 
give qualitative instead of quantitative results. A fluorescence (FL) dye-
incorporated immunochromatographic assay (ICA) might offer a higher 
sensitivity than rapid device which can be used at the point of care 
testing(POCT). The fluorescence immunoassay was employed to detect 
and semi-quantitative Plasmodium falciparum (P.f) and Plasmodium 
viva x(P.v) malaria-infected whole blood. It consisted of a FL antibody 
detector buffer, a test strip housed in a disposable cartridge, and a laser 
fluorescence scanner. The whole blood mixed with detector, loaded 
onto a cartridge, incubated 10 minutes, and the semi-quantitative of 
P.f and P.v malaria parasites were measured in a fluorescence scanner. 
The comparability of the new method was examined with microscopy 
check and rapid device malaria diagnosis. By microscopy, Plasmodium 
was detected successfully in all 81 clinically suspected malaria patients, 
including 59 individuals with low parasitemia (1-100 parasites/µl) 
and 22 individuals with middle parasitemia (101-500 parasites/µl). 
At low parasitemia (1-100 parasites/µl), sensitivities for FL-ICA and 
microscopy check were 80% and 100%, respectively. The accuracy of 
semi-quantitative was 90%. At middle parasitemia (1-100 parasites/
µl), sensitivities for FL-ICA and microscopy check were 95% and 100%, 
respectively. In conclusion, while the approximate accuracy of semi-
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quantitative test was 95%, the new fluorescence immunoassay may be 
used as a POCT diagnostic tool and has potentials as a fast, accurate, 
reliable, easy, and suitable tool for the semi-quantitation analysis for P.f 
and P.v malaria diagnosis.
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MODELING HEALTH SYSTEMS BARRIERS TO SUCCESSFUL 
MALARIA MANAGEMENT
V. Bhargavi Rao1, David Schellenberg2, Azra Ghani1
1Imperial College London, London, United Kingdom, 2London School of 
Hygiene and Tropical Medicine, London, United Kingdom
A functioning and efficient health system is required to maintain 
reductions in malaria disease and transmission. Few models demonstrate 
how to deliver a proven intervention most effectively through an existing 
system. The “systems effectiveness framework” has previously been 
used to describe how a cascade of interacting health systems barriers 
may sequentially reduce the effectiveness of treatment interventions. 
We contrasted this approach with a decision analysis model of malaria 
treatment in the public sector. A common set of parameters for malaria 
management in Africa including access to care, diagnosis and treatment 
were obtained from the literature. The decision analysis model more 
accurately reflected reported levels of appropriate management of 
fever (malarial and non-malarial) in the public sector (>50% attendees) 
compared with a systems effectiveness approach (<15%). Modeling 
increases in availability and usage of rapid diagnostic tests (RDTs) improved 
overall management of fever (upto 80% attendees) and reduced over-
treatment of non-malarial fevers with anti-malarials (<12%), but had less 
impact on the proportion of malaria cases treated (<57%). In contrast, 
reducing stockouts of first-line anti-malarials had a substantial impact on 
the proportion of malaria cases treated (68%)even without increased RDT 
use. Improving adherence to test results was not predicted to substantially 
improve appropriate treatment rates for malaria since the risk of under-
treatment is low, and baseline utilisation of RDTs was assumed to be only 
40% as per the literature. Under conditions of perfect availability and 
use of RDTs, test adherence and drug availability, appropriate treatment 
rates were predicted to rise to 95%. Simple decision analysis models 
can provide insight into which aspects of delivering care are most likely 
to impact on care quality and treatment effectiveness, and at different 
transmission intensities. Further work into the amenability of health 
systems to change is required to explore the most cost-effective targets in 
expanding the delivery of anti-malarials.
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RAPID DIAGNOSTIC TEST PERFORMANCE IN THE SETTING 
OF DIFFERING TRANSMISSION INTENSITIES: THE MALAWI 
ICEMR EXPERIENCE
Atupele Kapito-Tembo1, Don Mathanga1, Jacqueline Fiore2, Karl 
Seydel2, Mike Liomba1, Andrew Bauleni1, Paul Pensulo3, Rabia 
Mukadam4, Osward Nyirenda3, Terrie Taylor2, Miriam Laufer5
1Malaria Alert Centre, University of Malawi College of Medicine, Blantyre, 
Malawi, 2College of Osteopathic Medicine, Michigan State University, East 
Lansing, MI, United States, 3Blantyre Malaria Project University of Malawi 
College of Medicine, Blantyre, Malawi, 4University of Malawi College of 
Medicine, Blantyre, Malawi, 5Center for Vaccine Development, University 
of Maryland School of Medicine, Baltimore, MD, United States
In Malawi, like many malaria-endemic countries, rapid diagnostic tests 
(RDTs) are used to confirm the diagnosis of malaria because access to 
microscopy is limited. Much attention has been given to the sensitivity of 
RDTs, but their positive predictive value has not been explored, especially 
in areas such as Malawi, where malaria continues to be endemic. RDTs 
may be positive for weeks following successful treatment. In cases of 
false positive RDTs evaluation and treatment of alternative diagnoses 
might be neglected because of the presumed malaria diagnosis. Through 
the Malawi International Center of Excellence in Malaria Research, we 
are conducting surveillance for malaria in three transmission settings 
using RDTs (Paracheck®), microscopy and molecular detection of malaria 
infection. Among all surveillance sites during the rainy season, 25-30% 
of people with symptoms compatible with malaria had had a positive 
RDT. We conducted a preliminary evaluation comparing RDT results to 
expert microscopy. Overall, the positive predictive value (PPV) of a RDT 
compared to microscopy was 76.1%. The RDT PPV was inversely related 
to transmission intensity. In the moderate transmission intensity regions 
of the rural highlands and urban highlands, PPV was 91.7% and 72.3%, 
while in the lowland area with intense malaria transmission the PPV was 
66.7%. In the areas of moderate transmission, the PPV was higher in 
adults compared to children under five years of age (97.9% vs. 84.2% 
and 80.5% vs. 55.6% in the highlands and urban setting respectively). In 
contrast, in the most intense transmission region, PPV was slightly lower 
in adults compared to children (64.2% vs. 73.5%). Microscopy is being 
conducted on additional slides collected from patients with positive RDTs 
in both the rainy and dry seasons. Sensitivity and specificity compared to 
molecular diagnosis will also be reported. The rate of false positive RDTs 
is high and is related to transmission intensity. This raises the concern that 
alternative causes of illness will not be pursued in patients with a positive 
RDT.
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IMPROVING ANTIMALARIAL DRUG RESISTANCE 
SURVEILLANCE THROUGH EXTERNAL QUALITY ASSESSMENT 
AND PROFICIENCY TESTING PROGRAMS
Chris Lourens, WWARN QA/QC Group
Worldwide Antimalarial Resistance Network, QA/QC Programme, 
Bangkok, Thailand
Comprehensive antimalarial drug resistance surveillance includes measures 
of recurrent parasitemia, in vitro drug susceptibility, drug concentrations 
to differentiate true resistance from inadequate drug exposure, and 
genotyping to distinguish recrudescence from re-infection. External 
quality assessment and proficiency testing (PT) are key components of 
quality control for laboratory procedures. The goals of the WWARN QA/
QC program are to improve and maintain high-quality antimalarial drug 
analysis, in vitro drug susceptibility testing, and genotyping, thereby 
improving the quality of data. The program includes PT for pharmacology 
laboratories, a reference material program that provides pure antimalarial 
drug standards, metabolites and internal standards for pharmacology and 
in-vitro laboratories, and a molecular PT program. WWARN is developing 
international networks of laboratories doing antimalarial drug testing 
and genotyping. The reference material program distributed accurately 
weighed quantities of antimalarial drug standards, metabolites and 
internal standards to 25 laboratories. The pharmacology PT program sent 
samples to 8 laboratories in 4 rounds of PT. The molecular PT program 
includes biannual PT to differentiate parasite recrudescence from re-
infection for 8 laboratories in 6 countries. Data will be presented showing 
how participating laboratories have improved significantly over subsequent 
rounds of PT. The benefits of the reference material program include 
cost savings for the laboratories and provision of a uniform standard of 
material, reducing inter-laboratory variability. Benefits of participating in 
the PT program include identification of technical difficulties encountered 
in the analysis of drug compounds and genotyping. Technical experts 
provide advice for correcting problems to improve performance in 
subsequent analysis, and ultimately improve the quality of drug resistance 
surveillance data and facilitate pooled analyses.
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PFMDR1 IS ASSOCIATED WITH RECRUDESCENCE AFTER 
TREATMENT WITH ARTMETHER-LUMEFANTRINE IN 
WESTERN KENYA
Fredrick L. Eyase, Ogutu Bernhards, Hoseah Akala, Angela 
Omondi, Luicer Ingasia, Dennis Wekesa, Agnes Cheruiyot, Charles 
Okudo, Redemptah Yeda, Ben Andagalu, Elizabeth Wanja, Jacob 
D. Johnson
United States Army Medical Research Unit, Walter Reed Project, Kisumu, 
Kenya
Single Nucleotide Polymorphsms (SNPs) in PfMDR1 and PfCRT have been 
associated with Plasmodium falciparum resistance to drugs including 
chloroquine (CQ), amodiaquine (AQ), lumefantrine (LU) and mefloquine 
(MQ). Artmether-Lumefantrine (AL) is currently the first line antimalarial 
used in Kenya with artesunate-amodiaquine (ASAQ) and dihydroartemisin 
piperaquine (DHA-PPQ) being readily available from private retailers. 
During an open-label randomized clinical study evaluating the efficacy 
of AL in Ombeyi, a malarial endemic district in Western-Kenya, we 
investigated the role of PfMDR1 and PfCRT in modulating tolerance to 
artemisinin partner drugs. All recurrent samples were genotyped for MSP1, 
MSP2 and GLURP at day 0 and day of recurrence. Additionally all samples 
were assayed for SNPs in PfMDR1 codon 86 and PfCRT codon 72-76 as 
well as copy numbers in PfMDR1. All day 0 samples were assayed for drug 
susceptibility using the SYBR Green method. Among the 454 subjects 
enrolled in the study, there were 162 recurrent cases of which 134 were 
reinfections while 17 were recrudescences and 11 undetermined. PfMDR1 
N86 was significantly associated with recrudescence compared to both 
day 0 and reinfection. There was no significant association between 
PfCRT and recurrent infections and amplification of PfMDR1 gene was 
not observed. Significant positive correlation was observed between LU 
and MQ (r=0.5, r2= 0.27, p<0.05). This data demonstrates an association 
between PfMDR1 N86 and recrudescence after treatment with AL in 
Western Kenya. Co-resistance between LU and MQ indicates that LU 
pressure may lead to MQ resistance, an important prophylaxis for malaria 
naïve visitors to Kenya.
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ANTI PLASMODIUM FALCIPARUM MO15-RELATED PROTEIN 
KINASE (PFMRK) AND P. FALCIPARUM PROTEIN KINASE 5 
(PFPK5) ACTIVITIES OF NATURAL PRODUCTS FROM PLANTS
Hoseah M. Akala1, Veronica M. Zhang2, Cassandra L. Woodard3, 
Fredrick L. Eyase1, Maud K. Kamatenesi-Mugisha4, Abiy Yenesew5, 
Bernard T. Kiremire6, Ben Andagalu1, Douglas S. Walsh7, Elizabeth 
Wanja1, Jacob D. Johnson1, Norman C. Waters8
1Kenya Medical Research Institute (KEMRI)/United States Army Medical 
Research Unit-Kenya (USAMRU-K), Kisumu, Kenya, 2School of Chemistry 
and Molecular Biosciences, University of Queensland, St. Lucia, 
Queensland, Australia, 3Division of Experimental Therapeutics, Walter 
Reed Army Institute of Research, Silver Spring, MD, United States, 4School 
of Biological Sciences, College of Natural Sciences, Makerere University, 
Kampala, Uganda, 5Department of Chemistry, University of Nairobi, 
Nairobi, Kenya, 6Department of Chemistry, Makerere University, Kampala, 
Uganda, 7Department of Immunology and Medicine, U.S. Army Medical 
Component, Armed Forces Research Institute of Medical Sciences, 
Bangkok, Thailand, 8Department of Chemistry and Life Science, United 
States Military Academy, West Point, NY, United States
There is urgent need to develop new chemotherapeutic anti-Plasmodium 
falciparum to replenish loses to resistance. Natural products, including 
flavonoids and quinones, currently being explored as anticancer agents 
inhibiting cyclin dependent kinases (CDKs) are also antiplasmodial, but 
information on their mechanism of action is scanty. This study assessed 
the in-vitro flavonoids and quinones inhibition of Plasmodium falciparum 
MO15-related protein kinase (Pfmrk) and Plasmodium falciparum protein 
kinase 5 (PfPK5) using luciferase-coupled kinase assay. These compounds 
were obtained from six East African plants. Compounds coded as BA-4E, 
0.26µM and BA-6S 0.22µM were the most active against Pfmrk and PfPK5 
respectively while BA-6U (0.4µM) and BA-4C (1.03µM) showed specificity 
against Pfmrk. Flavonoids of the subclass flavanones were the most active 
compounds. Flavanones having two prenyl substituents (diprenylated 
compounds) on ring B with a hydroxyl or methoxy group at position 4´ 
had highest activity regardless of these groups’ position. These findings 
suggest that inhibition of Pfmrk and/or PfPK5 may be among ways that 
flavonoids inhibit Pf replication.
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EFFICACY OF ARTEMETHER-LUMEFANTRINE FOR THE 
TREATMENT OF UNCOMPLICATED PLASMODIUM 
FALCIPARUM INFECTION IN TANZANIA
Abdunoor M. Kabanywanyi1, Martha M. Lemnge2, Deus R. 
Ishengoma2, Jabir Namamba3, Billy Ngasara4, Renata Mandike5, 
Ritha Njau6, Zul Premji4
1Ifakara Health Institute, Dar es Salaam, United Republic of Tanzania, 
2National Institute for Medical Research, Tanga, United Republic of 
Tanzania, 3Ifakara Health Institute, Ifakara, United Republic of Tanzania, 
4Department of Parasitology-School of Public Health, MUHAS, Dar 
es Salaam, United Republic of Tanzania, 5National Malaria Control 
Programme, Dar es Salaam, United Republic of Tanzania, 6World Health 
Organization, Country Office, Dar es Salaam, United Republic of Tanzania
Tanzania mainland through the ministry of health and social welfare 
(MoHSW) introduced artemisinin combination therapy (ACT) with 
artemether-lumefantrine (ALu) as first line treatment policy for 
uncomplicated falciparum malaria since 2006. Despite good profile of 
ALu on malaria control, there is a threat of ACT drug resistance. Due to 
recent report on the emerging drug resistance to ACT along the Thai-
Cambodia border it is critical to our region to monitor the spread of drug 
resistance to ACT. Five years after countrywide policy implementation in 
Tanzania there has been no systematically designed and implemented 
efficacy monitoring study to assess ACT. In 2011 Ifakara Health Institute 
in collaboration with other country based researchers conducted a 
round of assessment of anti-malaria through 4 out of 8 invivo MOHSW 
monitoring sentinel sites that recorded good performance of both ALu 
and amodiaquine-artesunate (ASAQ). Because coverage of ACT profile 
across the remaining 4 sentinel sites is envisaged to portray a countrywide 
ACT performance, beginning in May 2012 another round of efficacy 
monitoring is planned to be implemented. We therefore set up to conduct 
an invivo monitoring study at four sentinel representative National Malaria 
Control Programme (NMCP)’s sites in May-September 2012 to assess 
efficacy of ALu. This study will be conducted at sites in Kyela, Masasi, 
Chamwino and Butimba in mainland Tanzania. Participants are febrile 
patients aged 6 months-10 years presenting at the health facility to be 
followed up during 28 days. It is intended to elicit treatment performance 
using 2010 WHO protocol. Results of this study will be out by the time 
of American Society of Tropical Medicine and Hygiene conference in 
November 2012. We will elucidate the occurrence of recrudescence 
by PCR using msp1 and glurp. Results from this study will be used to 
assist the MoHSW assess the current national treatment guidelines for 
uncomplicated falciparum malaria and update the global initiatives to 
containment of ACT drug resistance.
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CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM 
MALARIA IN TRAVELERS FROM HAITI AFTER THE 2010 
EARTHQUAKE
Myriam Gharbi1, Dylan R. Pillai2, Rachel Lau2, Véronique 
Hubert3, Krishna Khairnar2, Eric Kendjo3, Alexandre Existe4, Sabina 
Dahlstrom5, Philippe J. Guérin6, Jacques Le Bras1
1WWARN - IRD - Université Paris-Descartes, Paris, France, 2Public Health 
Ontario, Toronto, ON, Canada, 3Centre National de Référence du 
Paludisme, Paris, France, 4Laboratoire National de Santé Publique, Port-
au-Prince, Haiti, 5WWARN, Paris, France, 6WWARN - University of Oxford, 
Oxford, United Kingdom
Chloroquine (CQ) associated with primaquine is recommended as first-line 
treatment for uncomplicated malaria in Haiti. CQ in vitro and molecular 
surveillance data collected over the past two decades suggest continued 
Plasmodium falciparum sensitivity. However, a 2006-2007 study showed 
around 6% (5/79) of P. falciparum isolates had the CQ resistance-
associated pfcrt76T genotype. The January 2010 earthquake and flooding 
following Hurricane “Tomas” later in the year may have created conditions 
for increased malaria infections. We have investigated the CQ sensitivity 
of P. falciparum parasites isolated from travellers recently returned from 
Haiti to France and Canada, using genotypic and phenotypic methods. 
Retrospective data was collected from the French National Malaria 
Reference Centre (CNR) and the Public Health Ontario, 1988-2010 
and 2007-2010, respectively. The definition of an infection probably 
acquired in Haiti was recent travel to the country prior to diagnosis with 
P. falciparum positive thin and thick blood smear. Basic demographic and 
epidemiologic data, clinic and parasitological information, treatment, 
history of travel and malaria infection were collected systematically. Prior 
to the earthquake, all isolates (n=29) had the wild-type pfcrtK76 allele, 
analysed by PCR-RFLP. The mean of the 50% growth inhibition (IC50) of 
CQ of the isolates (n=24) was 27nM (95% confidence interval[CI], 23 to 
31). After the earthquake, two of ten isolates showed CQ resistance in 
vitro after culture adaptation. Both isolates had high CQ IC50 (506nM 
and 708nM) and high CQ IC50 isolate:Pf3D7 (CQ susceptible clone) 
ratio (20 and 27). Resistance was confirmed by the molecular analysis 
demonstrating the presence of the CQ-resistant associated pfcrt76T 
allele (mixed K+T) only in these two isolates. Our data confirm the 
presence of CQ-resistant strains in Haiti. They highlight the importance to 
implement a therapeutic efficacy study for assessing in vivo CQ-sensitivity, 
essential for informing rational control strategies and guiding prophylaxis 
recommendations in Haiti.
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RETURN OF CHLOROQUINE SUSCEPTIBILITY OF 
PLASMODIUM FALCIPARUM STRAINS IN TRAVELERS 
RETURNING FROM WEST AFRICA
Myriam Gharbi1, Jennifer Flegg2, Véronique Hubert3, Eric 
Kendjo3, Jessica Metcalf4, Philippe J. Guérin2, Jacques Le Bras1
1WWARN - IRD - Université Paris-Descartes, Paris, France, 2WWARN 
- University of Oxford, Oxford, United Kingdom, 3Centre National de 
Référence du Paludisme, Paris, France, 4University of Oxford, Oxford, 
United Kingdom
Following WHO recommendations, most African countries have 
discontinued chloroquine (CQ), and now promote artemisinin-based 
combination therapy (ACT), as the first-line treatment for uncomplicated 
malaria. The policy changed in West Africa during the last decade (2002 in 
Cameroon; 2003 in Senegal and Cote d’Ivoire; 2004 in Mali). The aim of 
this study was to describe the evolution of CQ resistance in West Africa, 
through travelers returning from this region. The study was conducted 
by the Malaria National Reference Centre, France. The database collated 
in vitro response of reference and clinical isolates for CQ and the pfcrt 
K76 molecular marker for CQ susceptible Pf malaria. As a proxy of drug 
pressure, CQ intake for children under five years of age with fever was 
extracted from the Demographic Health Surveys (DHS) and Multiple 
Indicator Cluster Surveys (MICS). Logistic regression models were used to 
detect trends in the susceptible isolates proportions. From 2000 to 2011, 
around 700 isolates were genotyped for each country. The frequency of 
the pfcrt76 wild-type significantly increased for Cameroon (CM) (from 
10% to 41%, Slope=0.09, p<10-3), Cote d’Ivoire (CI) (from 37% to 
63%, Slope = 0.14, p<10-3), and Senegal (SN) (from 22% to 53%, 
Slope=0.17, p<10-3). The mean of the 50% growth inhibition (IC50) of 
CQ decreased from 314nM (95% confidence interval, 102-526) to 101nM 
(71-131) in CM, from 109nM (70-148) to 47nM (28-66) in CI and from 
144nM (91-196) to 75nM (36-115) in SN. Meanwhile, CQ use among 
children with fever significantly decreased during this period. An increase 
of CQ susceptibility following official withdrawal is observed in travelers 
returning from Cameroon, Cote d’Ivoire and Senegal. The length of time 
between policy changes and their subsequent implementation, as well as 
the cross resistance between antimalarial drugs, may affect the time for a 
significant recovery of CQ sensitivity. This information should be compared 
to country level CQ efficacy data.
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TRAVELER’S SURVEILLANCE: A TOOL FOR DETECTING 
EMERGENCE OF ANTIMALARIAL DRUG RESISTANCE IN 
ENDEMIC COUNTRIES
Myriam Gharbi1, Jennifer Flegg2, Magatte Ndiaye3, Bruno 
Pradines4, Cally Roper5, Véronique Hubert6, Eric Kendjo6, Philippe 
Brasseur7, Oumar Gaye3, Abdoulaye Djimdé8, Ako Berenger9, 
André T. Offianan9, Louis Penali10, Jacques Le Bras1, Philippe J. 
Guérin2
1WWARN - IRD - Université Paris-Descartes, Paris, France, 2WWARN - 
University of Oxford, Oxford, United Kingdom, 3University Cheikh Anta 
Diop, Dakar, Senegal, 4Institut de Recherche Biomédicale des Armées, 
Marseille, France, 5London School of Hygiene and Tropical Medicine, 
London, United Kingdom, 6Centre National de Référence du Paludisme, 
Paris, France, 7Institut de Recherche et Developpement, Dakar, Senegal, 
8Malaria Research and Training Center - University of Sciences, Techniques 
and Technologies, Bamako, Mali, 9Institut Pasteur de Cote d’Ivoire, 
Abidjan, Côte D’Ivoire, 10WWARN, Dakar, Senegal
There is growing concern about the emergence of resistance in Southeast-
Asia to artemisinin-based combination therapy (ACT), the first-line 
treatment for malaria. In the time since the widespread adoption of ACTs, 
a decrease in the systematic surveillance of antimalarial drug resistance 
has been observed in many endemic countries. Furthermore, high levels 
of host immunity complicate the identification of treatment failures 
associated with resistance. The aim of this project was to validate the use 
of travelers returning from Africa with malaria as an additional surveillance 
system for the emergence of drug resistance. We compared data collected 
between 1998-2011, from the French Malaria Reference Centre for 
traveler’s data versus field data from the literature and within the WWARN 
database. We compared temporal trends of the proportion of wildtype-
genotype isolates for CRT76 and DHFR108 molecular markers, as well 
as the in vitro response to chloroquine (CQ) of isolates using generalized 
linear models. Three countries were selected for the analysis: Senegal 
(SN), Mali (ML) and Cameroon (CM) based on a required sample size of 
600 isolates per group. For CRT76, no significant (NS) difference is shown 
between travelers and field studies in CM (slopeβ1=0.03, slopeβ2=0.03, 
respectively, p=NS), SN (β1=0.17, β2=0.21, respectively, p=NS) and ML 
(β1=-0.19, β2=-0.17, respectively, p=NS). These results are supported 
by in vitro analysis in SN (β1=-0.03, β2=-0.05, respectively, p=NS). An 
increase of CQ-sensitive isolates is observed, except for ML where only 
data up to 2004 was included. For DHFR108, no significant difference is 
shown between travelers and field studies in CM (β1=-0.24, β2=-0.10, 
respectively, p=NS), ML (β1=-0.17, β2=-0.11, respectively, p=NS) and 
SN (β1=-0.09, β2=-0.06, respectively, p=NS). A decrease of wildtype-
genotype isolates is observed. Our results show similar trends in resistance 
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between travelers and field studies. This work highlights the value of an 
international traveler’s database to assess and monitor the emergence of 
drug resistance in endemic areas where information is limited.
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MULTIPLE INSECTICIDE RESISTANCE IN WESTERN KENYA: 
IMPEDIMENT TO INSECTICIDE-BASED MALARIA VECTOR 
CONTROL PROGRAMS IN KENYA
Christine L. Wanjala1, Yaw Afrane1, Andrew K. Githeko1, Guiyun 
Yan2
1Kenya Medical Research Institute, Kisumu, Nairobi, Kenya, 2University of 
California, Irvine, CA, United States
Indoor Residual Spraying (IRS) and long-lasting insecticidal nets (LLINs) 
have been extensively used for malaria prevention and control in Kenya. 
However, the development of resistance by mosquitoes to recommended 
insecticides for IRS and/or ITNs/LLINs would affect insecticide-based 
malaria vector control. We assessed the effect of extensive use of IRS 
and LLINs on development of resistance in Anopheles gambiae from 
western Kenya. Wall bioassays were performed on artificial walls and 
filter papers sprayed with ICON and deltamethrin using mosquitoes 
collected from different sites from western Kenya and Kisumu strain as a 
control. Net cone bioassays were also performed on nets collected from 
the fields using mosquitoes from two sites and Kisumu susceptible strain 
as a control. Chemical analysis of the netting material was also done 
using HPLC to determine the concentration of insecticides on the net. 
Kisumu strain was susceptible to all the insecticides with 100% mortality. 
Mosquitoes from Chulaimbo, Ahero, chulaimbo, Emakakha and Kisian 
shows susceptibility to both deltamethrin and ICON with the mortality 
rates ranging between 80% - 85% but mosquitoes from Bungoma and 
Emutete shows resistance to both ICON and deltamethrin with mortality 
rates ranging from 69%- 74%. Sprayed artificial walls shows lower 
mortality rates compare to sprayed filter papers. ICON had high mortality 
rates on the mosquitoes compared to Deltamethrin. Mosquitoes from 
Bungoma and Emutete showed resistance in Net bioassays with the 
mortality rates ranging between 60% -75%, but the control strain was 
highly susceptible to the nets with 100% mortality. HPLC results indicated 
that the nets still had a high concentration if insecticides ranging from 
0.06 wt% - 0.19 wt%, the positive control net had the concentration of 
0.14 wt%. The observed resistance to insecticides used for IRS and LLINs 
in An. gambiae Populations from western Kenya could affect the malaria 
vector control programmes in Kenya; therefore there is need urgent 
implementation of resistance management strategies and intergrated 
vector control intervention.
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MECHANISM OF ARTELINIC ACID RESISTANCE IN 
PLASMODIUM FALCIPARUM IN VITRO 
Franka Teuscher1, Nanhua Chen1, Dennis E. Kyle2, Michelle L. 
Gatton3, Qin Cheng1
1Australian Army Malaria Institute, Brisbane, Australia, 2University of 
South Florida, Tampa, FL, United States, 3Queensland Institute of Medical 
Research, Brisbane, Australia
The emergence of Plasmodium falciparum parasites with decreased 
in vivo sensitivity in several South East Asian countries has raised the 
urgent need to understand the underlining biological mechanism. We 
investigated the processes involved in the development of artelinic acid 
resistance using laboratory generated resistant P. falciparum lines in 
vitro. Our results demonstrate that resistance to artelinic acid has two 
major characteristics: 1) resistance affecting early asexual stage parasites 
demonstrated by the insensitivity of ring-stage parasites to the induction 
of dormancy, and a faster recovery from dormancy when it is induced with 
higher drug concentrations. 2) resistance of late stage parasites which 
allows continuous growth and multiplication of parasites under continued 
drug pressure. These results demonstrate that changes in the dormancy 
profile of parasites are part of the resistance phenotype and suggest that 
the development of artemisinin resistance may involve two steps. The 
molecular events important in each step are currently being investigated 
to determine whether full artemisinin resistance develops as a stepwise 
process or whether the two stages arise independently of each other.
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PHARMACODYNAMICS OF ARTEMISININ COMBINATIONS 
FOR DRUG SENSITIVE AND RESISTANT PLASMODIUM 
BERGHEI IN VIVO
Anuradha Srivastava1, Ericka Oliver1, Robert Boyle1, Fabian 
Saenz1, David Fidock2, Dennis E. Kyle1
1University of South Florida, Tampa, FL, United States, 2Columbia 
University, NewYork, NY, United States
Artemisinin combination therapies (ACTs) combine a very potent, yet 
short-lived artemisinin (ART) derivative with a partner drug that usually 
has a longer half-life, yet established resistance in the field. This strategy 
enhances therapeutic efficacy and theoretically delays the emergence of 
ART resistant Plasmodium falciparum. Although ACTs are the first-line 
treatment globally, pharmacodynamic (PD) properties of the combinations 
are not well studied. In particular the impact of existing resistance to the 
partner drug on emerging resistance and reduced clinically efficacy is 
poorly understood. To examine the PD properties of ACTs we used drug 
sensitive and resistant P. berghei in standard mouse efficacy models. In 
these studies we examined the PD properties of artemether-lumefantrine 
(ATM-LMF), artesunate-mefloquine (AS-MFQ), AS-amodiaquine (AS-
ADQ), dihydroartemisinin-piperaquine (DHA-PIP), and AS-pyronaridine 
(AS-PND). First we used drug-sensitive P. berghei and identified minimal 
curative drug concentrations that rapidly clear parasite infections, prevent 
parasite recrudescence, and are not antagonistic. Secondly we evaluated 
the impact of resistance to the following partner drugs by using the MFQ- 
resistant N/1100, ADQ- resistant NAM, and PND resistant-NPN-10 lines 
of P. berghei. The data obtained thus far demonstrate that partner drug 
resistance significantly erodes the PD properties of the ACTs in current 
clinical use. For example with MFQ resistance, the minimal effective 
regimen of AS-MFA for sensitive parasites was poorly efficacious versus 
MFQ resistant parasites.These data demonstrate the utility of the rodent 
model to estimate PD properties of ACT combinations and to determine 
the most effective ACT regimens to delay emergence of ART resistance.
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HIGH THROUGHPUT ANALYSIS OF IN VITRO ANTIMALARIAL 
SENSITIVITY DATA IN THE ERA OF ARTEMISININ 
COMBINATION THERAPY: THE WWARN IN VITRO ANALYSIS 
AND REPORT TOOL (IVART)
Charles J. Woodrow1, Sabina Dahlström1, Richard Cooksey1, 
Jennifer Flegg1, Hervé Le Nagard2, France Mentré2, Philippe 
Guérin1, Jacques Le Bras1
1WorldWide Antimalarial Resistance Network, Oxford, United Kingdom, 
2INSERM-Université Paris Diderot, Paris, France
In vitro assessment of antimalarial drug sensitivity remains an important 
tool in the era of artemisinin combination therapy, providing a way 
to assess parasite susceptibility to a range of drugs that is largely 
independent of clinical factors. In addition, investigation of molecular 
mechanisms of resistance via transfection depends absolutely on accurate 
and relevant in vitro phenotyping. WWARN and its collaborators have 
established a repository of raw, in vitro data derived from a wide range of 
locations and readout methods. Analysis of this large and varied dataset 
has now been undertaken using WWARN’s In Vitro Analysis and Report 
Tool (IVART), an application that performs high throughput data analysis 
with calculation of standard IC50 parameters via non-linear regression. 
Here we describe the development and validation of IVART, and report the 
evidence base for its design features, including methods for curve fitting 
and quality assessment that, until now, have relied on expert opinion. 
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The data also reveal differences in efficacy between artemisinins and 
their partner drugs in several forms of assay readout, highlighting the 
importance of matching in vitro assay readouts to in vivo properties in 
areas of emerging drug resistance. Improvements in the standardization 
of in vitro assays are critically important and the development of a free, 
adapted software tool like IVART addresses the heterogeneity of analytical 
in vitro output. Such standardized in vitro outputs could play a major 
role in the validation of potential molecular markers of resistance to 
antimalarials including artemisinin.
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TRENDS OF THE FREQUENCY OF PLASMODIUM 
FALCIPARUM DRUG-RESISTANCE MOLECULAR MARKERS 
IN ISOLATES FROM PREGNANT WOMEN SIX YEARS AFTER 
INTRODUCTION OF INTERMITTENT PREVENTIVE TREATMENT 
WITH SULFADOXINE-PYRIMETHAMINE (IPTP-SP) IN GABON
Marielle K. Bouyou-Akotet, Denise P. Mawili-Mboumba, 
Marie-Lou Tchibola, Gladys Tsoumbou-Bakana, Rosalie Nikiema, 
Maryvonne Kombila
Department of Parasitology Mycology Faculty of Medicine, Libreville, 
Gabon
Following WHO recommendations for malaria control, gabonese Ministry 
of Health adopted ACTs, insecticide-treated nets and intermittent 
preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) in 
2003. Prevalence of triple dhfr and quintuple dhfr/dhps mutation 
were respectively of 86% and 22% in 2005. Six years after their 
implementation, the frequency of dhfr and dhps point mutations was 
assessed in Plasmodium falciparum isolates from Gabonese pregnant 
women according to the number of SP doses. Polymorphic codons of 
dhfr gene (51, 59, 108 and 164) and dhps gene (437, 540 and 581) were 
analysed using PCR-restriction fragment length polymorphism. Blood 
samples from 89 women were analyzed, 35 received 2 doses, 16 received 
3 doses and 18 none dose of SP. Among patients with 3 SP doses, 11 had 
submicroscopic infection. None sample had a quadruple dhfr mutation 
but the frequency of triple mutation (51-59-108) was 98%. All parasites 
carried a wild-type allele at codon 164. The same was true for the codon 
581 of dhps gene. These preliminary data indicate an increase in the 
frequency of multiple resistance markers to SP independently of the 
number of doses received during pregnancy. There is an urgent need to 
assess the in vitro susceptibility of P. falciparum isolates to SP, to study 
other factors associated with the presence of SP resistant parasites and to 
evaluate an alternative drug for IPTp for pregnant women.
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STUDIES ON AP2 ADAPTOR µ-CHAIN, A NEW CANDIDATE 
MOLECULAR MARKER FOR ARTEMISININ RESISTANCE IN 
PLASMODIUM FALCIPARUM
Gisela C. Henriques1, Khalid Beshir1, Teun Bousema1, Halidou 
Tinto2, Umberto D’Alessandro3, Paul Hunt4, Pedro Cravo5, Colin 
Sutherland1, Rachel Hallett1
1London School of Hygiene and Tropical Medicine, London, United 
Kingdom, 2Centre Muraz, Institute de Recherche en Science de la 
Sante, Bobo Dioulasso, Burkina Faso, 3Medical Research Council, Banjul, 
Gambia, 4University of Edinburgh, Edinburgh, United Kingdom, 5Instituto 
de Patologia Tropical e Saúde Pública; Instituto de Higiene e Medicina 
Tropical, Goiânia; Lisbon, Brazil
There is evidence of reduced susceptibility of the malaria parasite 
Plasmodium falciparum to artemisinin derivatives, expressed by delayed 
parasite clearance times in vivo. If artemisinin resistance spreads, it would 
threaten global malaria control. We lack validated molecular markers for 
monitoring these phenotypes. Using whole genome sequencing in the 
rodent malaria parasite Plasmodium chabaudi, we identified a mutation 
in the mu chain of the AP2 adaptor protein complex (pcap2-µ) that arose 
along with the experimental evolution of artemisinin resistance. We 
screened several field isolates of P. falciparum from an ACT clinical trial in 
Burkina Faso, that were tested in vitro for their response to artemisinin 
derivatives and other drugs, and in pre- and post- treatment samples 
from an in vivo ACT trial carried out in Kenya, for genetic polymorphisms 
in the pfap2- µ orthologue. Genetic polymorphisms in pfap2- µ were 
analysed for association with several endpoints in both trials that might 
indicate a drug resistant parasite phenotype. Preliminary results indicate 
that polymorphisms in this adaptor protein subunit may be associated 
with in vitro and in vivo responses to artemisinin derivatives, quinine and 
lumefantrine. Further evaluation of pfap2-µ as a potential molecular 
marker of artemisinin resistance is now needed.
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DHFR AND DHPS SELECTIVE SWEEPS IN MALAWI AT A TIME 
OF HIGH SULFADOXIME-PYRIMETHAMINE USE
Elena M. Artimovich1, Ananias A. Escalante2, Kristan Schneider3, 
Terrie E. Taylor4, James G. Kublin5, Miriam K. Laufer1, Christopher 
V. Plowe1, Shannon Takala-Harrison1
1Howard Hughes Medical Institute/Center for Vaccine Development, 
University of Maryland School of Medicine, Baltimore, MD, United States, 
2School of Life Sciences, Arizona State University, Tempe, AZ, United 
States, 3Department of MPI, University of Applied Sciences Mittweida, 
Mittweida, Germany, 4College of Osteopathic Medicine, Michigan State 
University, Lansing, MI, United States, 5Fred Hutchinson Cancer Research 
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Malawi and most other African nations have stopped using both 
chloroquine and sulfadoxine-pyrimethamine (SP) due to expansion of 
drug-resistant Plasmodium falciparum parasites. Directional selection of 
chloroquine resistance alleles in the form of a selective sweep has been 
shown, by analyzing variation in microsatellites flanking the chloroquine 
resistance gene, pfcrt. Similar selective sweeps of regions flanking dhfr 
and dhps, the genes that cause resistance to SP, have been identified 
in Africa, Southeast Asia, and South America. Here we report evidence 
of positive directional selection of dhfr and dhps resistance haplotypes 
and describe characteristics of the associated selective sweeps, at a 
time of high SP drug pressure in Malawi. Resistance alleles and flanking 
microsatellites were genotyped on 689 filter paper samples from children 
aged 6 months-12 years in Blantyre, Malawi from 1999-2001 when SP 
was the first-line treatment for malaria. All but one of the genotyped 
samples carried one or more SP resistance alleles. Dhfr triple-mutants 
conferring strong SP resistance predominated (51I/59R/108N), forming 
a quadruple mutant with dhps 540E. Dhfr/dhps quintuple mutants (dhfr 
51I/59R/108N+dhps 437G/540E) were also observed. A reduction in 
microsatellite heterozygosity was identified in the regions flanking both 
dhfr and dhps. The sweep flanking dhfr extended from 10kb upstream 
to 20kb downstream of dhfr. The sweep flanking dhps extended from 
approximately 10kb upstream to at least 9kb downstream. Extended 
Haplotype Homozygosity was estimated, and showed increased linkage 
disequilibrium (LD) in regions flanking both genes relative to genomic 
levels of LD. Selective sweeps of resistant dhfr and dhps indicate that these 
alleles were under recent positive directional selection. The characteristics 
of the selective sweeps reported here, which were detected during a 
period of high SP drug pressure, will be compared to those detected after 
removal of SP as the first line therapy and in settings with different levels 
of malaria transmission.
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EVOLUTION OF DRUG RESISTANCE IN MALARIA PARASITES
Mathieu Legros, Sebastian Bonhoeffer
ETH, Zurich, Switzerland
Efforts to relieve the burden caused by malaria rely critically on the 
availability of drugs targeting Plasmodium falciparum. The efficiency of 
these treatments is however seriously compromised by the appearance 
and spread of drug resistance. Resistance is observed today to some 
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extent against every available drug, including recent reports of resistance 
to artemisinin. Resistant strains of Plasmodium falciparum can spread 
in affected areas if they fare better than sensitive strains over the entire 
transmission cycle, including within-human and within-vector infection 
phases. Both hosts likely represent widely different environments for the 
parasite, particularly in terms of exposure to drugs and host-specific costs 
of resistance, which could notably affect the outcome of competition 
between resistant and sensitive strains and ultimately the evolution of 
drug resistance. To investigate this issue we present a model of malaria 
transmission combining between-hosts and within-hosts (human and 
vector) dynamics. The latter incorporates the impact of competition, 
treatment and immunity in a strain-specific fashion. We show how costs 
of resistance, particularly within-vector costs, affect the selection for 
resistant strains. We also explore how different drugs, acting on specific 
parts of the within-human cycle of P. falciparum, impact resistant strains 
(alone or in combination). Finally we also investigate the effect of vector 
control methods on the prevalence of resistance.
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IDENTIFYING DRUG RESISTANCE GENOTYPES IN 
ECUADORIAN MALARIA PARASITES
Gabriela Valenzuela, Fabián E. Sáenz
Infectious Disease Research Center, Pontificia Universidad Católica del 
Ecuador, Quito, Ecuador
Approximately 40% of the world population lives in malaria-endemic 
areas and recent estimates indicate that there are several hundred million 
cases and about 1.2 million deaths each year caused by this disease. 
Severe disease and resistance to antimalarials has been documented 
for Plasmodium falciparum and P. vivax and efforts to control malaria 
have become more challenging in recent years due to widespread drug 
resistance. Today, the vast majority of P. falciparum isolates in Latin 
America are resistant to chloroquine (CQ) and other drugs and resistance 
to CQ has been reported for P. vivax. It is also widely recognized that drug 
resistance has played a role in the reemergence of malaria in the Amazon 
basin at the end of the 20th century. The antimalarial resistance situation 
in Ecuador is not well known and genotypes for drug resistance from 
different parts of the country have not been studied. In order to identify 
and analyze genotypic markers for drug resistance in Ecuador we are 
doing PCR-RFLP from confirmed malaria blood samples spotted in filter 
paper using specific primers for Pfcrt, Pfdhfr and Pfdhps (P. falciparum) 
and Pvdhfr, Pvdhps (P. vivax). Our results so far show that the tested 
Ecuadorian P. falciparum isolates have a mutant PfCRT. In addition, we will 
present P. falciparum and P. vivax genotype data from different resistance 
markers. The study of the prevalence of drug resistance in Ecuadorian P. 
falciparum and P. vivax will enhance our knowledge of drug resistance in 
Latin America, a necessary task to improve the way malaria is treated in 
this region of the world.
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PERSISTENT PLASMODIUM FALCIPARUM INFECTIONS DRIVE 
EXPANSION OF ATYPICAL MEMORY B CELLS AS WELL AS 
EXHAUSTED T CELLS
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Recent epidemiological and animal studies suggest that Plasmodium 
parasites induce atypical/exhausted lymphocytes in their hosts, perhaps as 
an immune evasive strategy. Whilst these immunoregulatory lymphocytes 
may benefit the host by checking exaggerated immune responses and 
hence reducing immunopathology, they may also impede generation 
of protective immune responses. Thus such observations may explain in 
part: why naturally acquired immunity to malaria develops slowly, often 
requiring several years of repeated exposure to become effective, and 
why vaccines confirmed protective in animals and naïve volunteers fail to 
protect malaria-exposed individuals. Here, we compared frequencies of 
atypical memory B cells (MBC) and exhausted T cell phenotypes between 
well-characterised cohorts of children of similar genetic backgrounds and 
living in similar environmental conditions, but whose rate and/history 
malaria exposure differs. We confirm that current malaria exposure drives 
expansion of atypical MBCs, and provide evidence suggesting that these 
Pf-associated atypical MBCs are expanded at the expense of naïve B 
cells. We show that persistent Pf exposure drives expansion of both PD-1 
single, and PD-1 and Lag-3 double positive exhausted CD4 T cells, and 
to a lesser extent single-positive LAG-3 positive exhausted CD4 T cells. 
This expansion of PD-1, and double PD-1 and LAG-3 positive CD4 T cells 
is largely confined to CD45RA positive cells. The percentage of PD-1 and 
Lag-3 double positive CD45RA positive CD4 T cells correlated negatively 
with frequencies of activated and classical MBCs. Single PD-1, and double 
PD-1 and LAG-3 positive CD8 T cells were increased among the total, and 
TEFF CD8 T cells, respectively, but only in the presence of asymptomatic 
parasitaemia. Together, these results suggest that Pf drives expansion 
of atypical lymphocytes. The implication is that these cells may dampen 
inflammatory responses to malaria, thus reducing pathogenesis, but may 
also impede the generation of protective responses.
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THE EFFECT OF MATERNAL MALARIA AND HELMINTH 
INFECTIONS ON CHILDHOOD MALARIA: A BIRTH COHORT IN 
ENTEBBE, UGANDA
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Helminths and Plasmodium infections are common in the tropics, 
and positive associations have been observed between these parasitic 
infections in pregnancy. While malaria in pregnancy has been associated 
with adverse maternal and birth outcomes, knowledge on the effect of 
prenatal exposure to malaria and helminth infections on childhood malaria 
is still sparse. This study took place in Entebbe, Uganda. 2507 women 
were recruited in a trial on the effects of albendazole and praziquantel in 
pregnancy. Blood and stool samples were examined for helminth and P. 
falciparum infections. The offspring were followed up to age five years, 
and their malaria morbidity data collected prospectively. Clinical malaria 
was diagnosed as fever (≥ 37.50C) with P. falciparum parasitaemia, and 
asymptomatic parasitaemia recorded annually at scheduled visits. In 
multivariate analyses we adjusted for risk factors associated with malaria 
and helminth infections. Common parasitic infections in pregnancy were 
hookworm (45%), Mansonella perstans (21%), Schistosoma mansoni 
(18%), and P. falciparum (11%). Of 2345 liveborn infants, 69% were 
still under follow-up at age 5 years. The overall childhood malaria rate 
was 34 episodes per 100 child-years, and the cumulative prevalence of 
asymptomatic P. falciparum parasitaemia over the five years was 5%. 
Maternal hookworm and M. perstans infections were associated with an 
increased risk of childhood malaria (adjusted Hazard Ratio [aHR] 1.26, 
p<0.001 and 1.23, p=0.004 respectively), and increased cumulative 
prevalence of asymptomatic parasitaemia (adjusted Odds Ratio [aOR] 1.59, 
p=0.001 and 1.55, p=0.01 respectively). S. mansoni infection showed no 
such associations. Maternal P. falciparum infection was associated with an 
increased risk of childhood malaria (aHR 1.22, p=0.04) but not prevalence 
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of asymptomatic malaria (aOR 1.21, p=0.4). This study shows that the 
effect of malaria in pregnancy on childhood malaria extends to age five 
years, and is the first report of an association between helminth infections 
in pregnancy and malaria in the offspring.
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VALIDITY OF SELF-REPORTED USE OF SULFADOXINE-
PYRIMETHAMINE INTERMITTENT PRESUMPTIVE TREATMENT 
DURING PREGNANCY (IPTP): A CROSS-SECTIONAL STUDY
Fatuma Namusoke1, Muhammad Ntale1, Mats Walhgren2, Fred 
Kironde1, Florence Mirembe1
1Makerere University, Kampala, Uganda, 2Karolinska Institutet, Stockholm, 
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Malaria in pregnancy is a major health problem that can cause maternal 
anaemia, stillbirth, spontaneous abortion, low birth-weight and 
intra-uterine stunting. The WHO recommends use of Sulphadoxine-
Pyrimethamine (SP) for Intermittent Preventive Treatment of malaria 
during pregnancy (IPTp) in endemic areas. Towards monitoring and 
assessing IPTp coverage in the population, the Roll Back Malaria program 
recommends use of self reported data. In this study, we assessed the 
validity of self reported use of IPTp by testing for sulfadoxine in maternal 
blood at delivery. Two hundred and four pregnant women were consented 
and enrolled in a cross-sectional study. We excluded participants who 
reported a history of taking sulfa containing drugs, those who were not 
sure of dates relating to last menstrual period or who took IPTp before 
20 weeks of gestation. Data on demographic characteristics, obstetric 
history, and delivery outcome were collected. At delivery of the baby, we 
took the mother’s venous blood, carried out blood smear microscopy for 
parasites and tested the plasma for sulfadoxine using High Performance 
Liquid Chromatography (HPLC). We found that 17.2% of participants 
reported to have used IPTp and indeed tested positive by HPLC while 
30.4% reported not to have used IPTp and indeed tested negative for 
sulphadoxine. Participants possessing post primary education were more 
likely to have reported using IPTp. The low agreement between self 
report and actual presence of the drug in the blood casts doubt on the 
validity of self reported data in estimating IPTp coverage. We recommend 
further research of self reported data towards improving the accuracy of 
such information which is vital for guiding policy for malaria control in 
pregnancy since routine blood drug assays would be too expensive and 
impractical for population based studies.
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A SPATIO-TEMPORAL ANALYSIS OF PLASMODIUM 
FALCIPARUM AND P. VIVAX INFECTIONS AND TREATMENT 
SEEKING BEHAVIOR IN THA SONG YANG DISTRICT, TAK 
PROVINCE, THAILAND: 2008-2011
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Despite being relatively successful at controlling malaria in most of the 
country, the border areas surrounding Thailand continue to experience 
persistent, seasonal malaria. The heaviest malaria burden within Thailand 
is along the Thai-Myanmar border in Tha Song Yang District, Tak Province. 
This area is also a center of drug and multi-drug resistant malaria and 
recently decreased parasite sensitivity to artemisinin derivatives (largely 
considered the last defense against drug-resistant malaria) has been 
reported from Tak Province. Here we use exploratory spatial analysis and 
accelerated failure time models to evaluate spatio-temporal patterns in 
both Plasmodium falciparum and P. vivax case frequency and treatment 
seeking behavior. We are specifically interested in potential clustering 
of cases near the Thai-Myanmar border as well as the length of time 
between a patient’s reported onset of malaria symptoms and the time 
they actually visit a malaria clinic. Our temporal analysis is at the subdistrict 
level (within Tha Song Yang District) whereas our spatial analysis is at both 
the subdistrict and district levels (within Tak Province.) We find a general 
pattern of spatial decay, with general correspondence in both parasite 
species, and with the heaviest case-loads clustered in administrative 
units that touch the Thai-Myanmar border. However, this pattern isn’t a 
smooth gradient from the border towards central Thailand. Finally, our 
temporal analyses indicate an initial clustering of treatment seeking times 
around 2 to 3 days and several other clusters occurring after 8 days. For 
example, among those that seek treatment within 7 days after the onset 
of symptoms, Myanmar nationals are the quickest to seek treatment. 
Conversely, among those that wait until after a week of experiencing 
symptoms Myanmar nationals wait the longest to seek treatment. This 
discordance in treatment seeking behavior has important implications for 
public health and global health. Individuals who are carrying parasites in 
their blood for longer periods of time may increase the risk of infection 
for the populations surrounding them. These results are significant 
with regards to the increased potential of transmitting drug (potentially 
artemisinin) resistant malaria.
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UNDERSTANDING THE IMPACT OF SUBSIDIZING 
ARTEMISININ-BASED COMBINATION THERAPIES (ACTS) 
IN THE RETAIL SECTOR - RESULTS FROM FOCUS GROUP 
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There is considerable interest in the potential of private sector subsidies 
to increase availability and affordability of artemisinin-based combination 
therapies (ACTs) for malaria treatment. A cluster randomized trial of such 
subsidies was conducted in 3 districts in Kenya, comprising provision 
of subsidized packs of paediatric ACT to retail outlets, training of retail 
staff, and community awareness activities. The results demonstrated a 
substantial increase in ACT availability and coverage, though patient 
counselling and adherence were suboptimal. We conducted a qualitative 
study in order to understand why these successes and limitations occurred. 
Eighteen focus group discussions were conducted, 9 with retailers 
and 9 with caregivers, to document experiences with the intervention. 
Respondents were positive about intervention components, praising the 
focused retailer training, affordable pricing, strong promotional activities, 
dispensing job aids, and consumer friendly packaging, which are likely to 
have contributed to the positive access and coverage outcomes observed. 
However, many retailers still did not stock ACT, due to insufficient supplies, 
lack of capital and staff turnover. Advice to caregivers was poor due to 
insufficient time, and poor recall of instructions. Adherence by caregivers 
to dosing guidelines was sub-optimal, because of a wish to save tablets 
for other episodes, doses being required at night, stopping treatment 
when the child felt better, and the number and bitter taste of the tablets. 
Caregivers used a number of strategies to obtain paediatric ACT for older 
age groups. In conclusion, this study has highlighted that important 
components of a successful ACT subsidy intervention are regular retailer 
training, affordable pricing, a reliable supply chain and community 
mobilization emphasizing patient adherence and when to seek further 
care.
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COMPARISON OF MALARIA RISK FACTORS AND 
PARASITEMIA AMONG CHILDREN LIVING EITHER WITH 
NON-PARENT GUARDIANS OR WITH BIOLOGICAL PARENTS: 
ANALYSIS OF 2009 UGANDA MALARIA INDICATOR SURVEY 
DATA
Samantha B. Dolan1, Carrie F. Nielsen2, Adam Wolkon2, Sussann 
Nasr3, Denis Rubahika4, Steven S. Yoon2, Kevin Sullivan1, Achuyt 
Bhattarai2
1Emory University, Atlanta, GA, United States, 2Centers for Disease Control 
and Prevention, Atlanta, GA, United States, 3Centers for Disease Control 
and Prevention, Kampala, Uganda, 4Uganda Ministry of Health, National 
Malaria Control Program, Kampala, Uganda
As of 2009, approximately 2.7 million child orphans were living with one 
parent or non-parent guardians (NPG) in Uganda. These children may 
be at a higher risk of malaria than children living with their biological 
parents (BP) due to possible differences in access to malaria prevention 
measures and household characteristics. The 2009 Uganda Malaria 
Indicator Survey collected malaria prevention coverage and household 
data from 4,760 nationally representative households, and blood smear 
samples for malaria parasitemia from children under 5 years old (U5) living 
in those households. Data were analyzed in SAS 9.2 (proc surveylogistic, 
surveyfreq). Odds ratios (OR) of main outcome measures and associated 
95% confidence interval (CI) and p-values (p) were computed. Children 
under 5 years old were categorized as either living with NPG or BP based 
on their relationship to the head of the household. During the 2009 
MIS, 707 (18%) out of 3933 U5 were living with NPG. NPG head of the 
household were likely to be older [median age; 54 years, IQR: 28-40 vs. 
34, IQR: 47-63; p<.01] and female [54% vs. 18%, p<.01]. Fewer NPG 
households owned at least one insecticide treated net [76%, 95% CI: 71-
81 vs. 80%, 95% CI: 77-84; p=.33]; and fewer NPG children slept under 
any bednet the night before the survey (bednet use) [58%, 95% CI: 50-67 
vs. 75%, 95% CI: 72-79; p<.01]. Adjusting for children’s age and head of 
household’s age, NPG children were less likely to use any bednet the night 
before the survey than BP children (OR: 0.6, 95% CI: 0.4-0.9; p<.02). 
Adjusting for children’s age, head of household’s age and sex, household 
wealth quintile, and bednet use, the odds of malaria parasitemia was four 
times greater for NPG children than BP children (OR: 4.2, 95% CI: 1.8-
9.7; p<.01). The odds of parasitemia among NPG children were strongly 
modified by the interaction with age of head of household and bednet 
use (p for interactions<.001). NPG children may be at a greater risk for 
malaria than BP children, and may warrant special targeting of malaria 
intervention efforts.
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IMPLICATIONS FOR IPTP
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Efforts by the Zanzibar Ministry of Health to scale-up malaria prevention 
and treatment strategies, including intermittent preventive treatment for 
pregnant women (IPTp), have brought Zanzibar to the pre-elimination 
phase of malaria control. P. falciparum prevalence in the general 
population has been below 1% since 2008 and the diagnostic positivity 
rate among febrile patients was 1.2% in 2011. Zanzibar implemented IPTp 
using sulfadoxine-pyrimethamine (SP) in 2004 when malaria prevalence 
exceeded 20%. While coverage among pregnant women is low (47% 
received two doses SP), the value of this intervention in low transmission 
settings remains uncertain. Few countries in Africa have confronted policy 
questions regarding timing of IPTp scale-down. We designed a prospective 
observational study to estimate prevalence of placental malaria among 
pregnant women with no evidence of receiving any dose of SP for IPTp 
during pregnancy. From September 2011 to April 2012 we enrolled a 
convenience sample of pregnant women on day of delivery at six hospitals 
in Zanzibar (three in both Pemba and Unguja). Dried blood spots (DBS) 
on filter paper were prepared from placental blood specimens. DBS were 
analyzed via polymerase chain reaction indicating active Plasmodium 
infection (all species). To date, over 1,200 deliveries were enrolled at 
the six recruitment sites (approximately 12% of total, range: 8-26%). 
Two (0.19%; 95% CI, 0.05-0.69%) of 1,046 DBS specimens analyzed 
to date showed evidence of P. falciparum infection. Both were from 
HIV uninfected, multigravid women in Unguja. Birth weights for both 
deliveries were normal (>2500 g). Data collection will continue through 
the peak transmission season of May-July 2012. The very low prevalence 
of placental infection among women who received no IPTp raises policy 
questions regarding continuation of IPTp in Zanzibar. Alternative efforts 
to control malaria in pregnancy in Zanzibar, such as active case detection 
via regular screening and treatment during antenatal visits, should be 
evaluated.
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FINE-SCALE SPATIAL VARIATION IN TRANSMISSION 
INTENSITY, IN SECULAR TRENDS OF TRANSMISSION 
INTENSITY, AND IN THE AGE PROFILE OF FEBRILE MALARIA 
IN KILIFI, KENYA
Philip Bejon1, Abdisalan M. Noor1, Janet T. Midega1, Thomas 
N. Williams1, Mark Otiende1, Judith Peshu1, Mafudh Bashraheil1, 
Dave L. Smith2, Kevin Marsh1
1Kenyan Medical Research Institute, Kilifi, Kenya, 2Johns Hopkins 
Bloomberg School of Public Health, Bethesda, MD, United States
Malaria transmission is spatially heterogeneous. Maps of malaria episodes 
at fine spatial scales often show clusters of transmission comprising groups 
of homesteads or “hotspots”. These hotspots make malaria control 
measures less effective than might have been expected, but targeting 
intensive control interventions at the hotspots could be highly effective. 
At present, there are few epidemiological descriptions of the properties 
of hotspots. We have previously shown that hotspots of asymptomatic 
parasitaemia are stable over several years, but hotspots of febrile malaria 
are unstable. The risks of asymptomatic parasitaemia and febrile malaria 
were closely related to proximity of Anopheles larval sites, interacting 
with wind direction. We hypothesise that immunity offsets the high rate 
of febrile malaria that might otherwise occur in stable hotspots, whereas 
unstable hotspots necessarily affect a population with less prior exposure 
to malaria. We present data from 4,200 episodes of malaria among 4,800 
homesteads monitored from a local dispensary in Kilifi, Kenya, from 2003 
to 2011. There was marked spatial clustering of febrile malaria episodes. 
Spatial clustering of febrile malaria among younger children was more 
stable over time compared with among older children. Reasoning that 
febrile malaria risk in younger children was less confounded by immunity, 
we used data from children below one year of age to classify homesteads 
into high or low mean transmission intensity, and into rising or falling 
secular trends of transmission intensity. This classification predicted the 
age-profiles of febrile malaria by homestead. At high mean transmission, 
the peak febrile malaria risk was at 3 years of age, and at low mean 
transmission intensity the peak febrile malaria risk was at 8 years of 
age. A rising secular trend of transmission predicted a sustained risk 
of malaria in children above 10 years of age, whereas a falling secular 
trend predicted a falling risk of malaria. We conclude that aggregated 
febrile malaria incidence is inadequate to represent the complexity of 
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spatial heterogeneity of transmission intensity and secular trends in 
transmission intensity. Our results indicate fine scale spatial variation in 
the epidemiology of malaria in a 150 sq km area that was comparable 
with the variation seen on more coarse spatial scales across regions or 
countries.
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ESTIMATING TRANSMISSION INTENSITY FROM 
PLASMODIUM FALCIPARUM SEROLOGICAL DATA USING 
ANTIBODY DENSITY MODELS
Emilie Pothin1, Neil Ferguson1, Chris Drakeley2, Azra Ghani1
1Imperial College London, London, United Kingdom, 2London School of 
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Serological data are increasingly being used to monitor malaria 
transmission intensity and have been demonstrated to be particularly 
useful in areas of low transmission where traditional measures such 
as EIR and parasite prevalence are limited. The seroconversion rate is 
usually estimated using catalytic models in which the measured antibody 
levels are used to categorise individuals as seropositive or seronegative. 
One limitation of this approach is that the cut-off between positive and 
negative is arbitrary. Furthermore, the continuous variation in antibody 
levels is ignored thereby potentially reducing the precision of the estimate. 
To overcome these limitations we developed a series of age-specific density 
models which mimic antibody acquisition and loss. These were fitted to 
antibody titre data from multiple Plasmodium falciparum endemic settings 
to estimate the rate of acquisition of antibodies as an alternative measure 
of transmission intensity. Our results indicate that a model in which the 
boost in antibodies following exposure depends on the existing titre (with 
an exponential decline in the size of the antibody boost with higher levels 
of circulating antibodies) and that includes variation between individuals 
in the size of the response fits the data well. Furthermore our results show 
a consistent ordering of transmission intensities compared to those from a 
catalytic model. This approach, if validated across different epidemiological 
settings, could be a useful alternative model for measuring transmission 
intensity which avoids the need for an arbitrary cut-off value.
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PREVALENCE OF MALARIA AND ANEMIA AMONG 
PREGNANT WOMEN ATTENDING ANTENATAL CARE CLINICS 
IN THE EJISU-JUABEN AND SEKYERE-EAST DISTRICTS OF 
GHANA
Gifty D. Antwi1, Harry Tagbor1, Imelda Bates2
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Malaria and anaemia (haemoglobin concentration < 11g/dl) in 
pregnancy continue to be of public health importance in Ghana with 
malaria contributing to 9.4% of maternal deaths. Strategies are being 
implemented through the antenatal care system to reduce their occurrence 
but asymptomatic malaria parasitaemia and anaemia prevalence at 
term stand at 12.1% and 45.0% respectively. In preparation for a 
cluster randomised control trial to determine the effect of an enhanced 
antenatal care package on malaria and anaemia in pregnancy, a cross-
sectional study was conducted from December 2011 to April 2012 among 
pregnant women with gestation ≥32 weeks and prior to delivery. Trained 
research assistants determined malaria parasitaemia and haemoglobin 
concentration levels using the malaria rapid diagnostic test and the 
HemoCue 301. An interviewer guided questionnaire was also administered 
to determine the demography, bed net use, IPTp administration and 
self-reported adherence to iron and folate supplementation among 
the pregnant women. The prevalence of malaria parasitaemia and 
anaemia was 15.5% and 42.6% respectively. Parasitaemia occurred 
in a significantly younger age group (25.1 (6.21) yrs vs 27.4 (6.29) yrs; 
p=0.007) and these had a significantly lower haemoglobin concentration 
(10.5 (1.37) g/dl vs 11.2 (1.29) g/dl; p<0.0001). Although 61.2%of the 
pregnant women owned bed nets, only 39.3% slept under one during 
the night before the survey. A total of 81.2% received two or more 
doses of SP and 50.5% reported high adherence to iron and folate 
supplementation however these were not significantly associated with the 
prevalence of parasitaemia or anaemia. Malaria parasitaemia and anaemia 
are still prevalent in the study area despite the implementation of current 
strategies including ITN use, SP-IPTp, iron and folate supplementation and 
prompt diagnosis and effective treatment of malaria. Probably new ways 
of delivering these strategies to make them more effective need to be 
explored.
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REVITALIZING ROUTINE HEALTH FACILITY DATA FOR 
MALARIA CONTROL
Jessica Butts, Melody Miles, Carrie Nielsen, Achuyt Bhattarai, 
Steven Yoon
Centers for Disease Control and Prevention, Atlanta, GA, United States
Successful scale up of proven malaria control interventions across sub-
Saharan Africa since 2000 has resulted in rapid changes in malaria 
epidemiology. Because of these changes, national malaria control 
programs and their partners need effective tools to adequately monitor 
malaria burden for surveillance and program planning. Existing tools, most 
notably national-level household surveys such as the Malaria Indicator 
Survey and Demographic and Health Survey, do not provide information 
on longitudinal changes in malaria burden. Cross-sectional data do not 
reflect seasonal fluctuations in malaria burden nor typically provide district- 
or sub-district-level data useful for program monitoring and planning. 
In many countries, routine health facility data are of unknown validity 
due to reporting of clinical diagnosis without laboratory confirmation 
and incomplete or late reporting. Recognizing the need for improved 
approaches to measure longitudinal changes in malaria burden, the 
authors have undertaken a comprehensive examination of routine health 
facility data and are optimistic about its potential to complement existing 
data for malaria control. Using models from Benin, Ethiopia, Madagascar, 
and Uganda, the authors have critically assessed the strengths and 
weaknesses of different health facility-based surveillance systems and 
created a framework to assist countries in developing robust data 
collection systems that will meet country-specific data needs while taking 
into account resource limitations. The framework guides stakeholders in 
the decision-making process and is comprehensive in that it considers 
scope, indicators, data collection tools, supervision, and data use. The 
anticipated outcomes of providing a framework for strengthening facility-
based data collection systems for malaria include increasing the quality 
of routine system data, improving country capacity for planning, and 
sustaining the progress made in malaria control over the past decade.
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MOLECULAR EPIDEMIOLOGY OF PLASMODIUM VIVAX 
RELAPSES IN THE PERUVIAN AMAZON
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Plasmodium vivax accounts for 71-81% of malaria cases in the Americas. 
To determine the magnitude of P. vivax relapsing malaria in rural 
Amazonia, we carried out a study from 2005-2008 in four health posts 
in the Amazonian Region of Loreto in northeast Peru where the majority 
of nationally reported malaria cases originate. PCR-restriction fragment 
length polymorphism of PvMSP-3α (enzymes Hha1 and Alu1) and PCR of 
nine tandem repeat markers were compared for their ability to distinguish 
relapse vs. reinfection. Of 1507 subjects with P. vivax malaria, 354 
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developed >1 episode during the study. 97/354 (27.4%) were defined 
as relapses using Pvmsp-3α alone. Adding tandem repeat polymorphism 
analysis significantly reduced the number of definitively-defined relapses 
to 26/354 (7.4%) (p<0.05), allowing for more new infections to be 
identified. Odds of another episode of P. vivax malaria, whether due to 
relapse or reinfection, were 2.6 times higher in the more remote village of 
Mazan than in villages closer to Iquitos city (p<0.001) (OR=2.6, 95%CI: 
2.0,3.4). People in Mazan were 2.4 times more likely to develop a relapse 
(not reinfection) than people in other villages (OR=2.4, CI95%:1.1,5.5; 
p=0.03). The proportion of multiple genotype infections was 16.1% by 
TR, 4.5% by MSP-3α, and 18.8% using both. The use of highly resolving 
molecular markers of P. vivax allowed for finding an unexpectedly high 
proportion of multiple genotype infections, remarkable considering the 
current knowledge of transmission intensity and entomological inoculation 
rates in the region. Highly discriminatory molecular epidemiological tools 
will allow us to gain critical knowledge of the micro-geography of malaria 
transmission in this area of low transmission
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Epidemiological data on malaria in Bangladesh are sparse, particularly 
on severe and fatal malaria. This hampers the allocation of healthcare 
provision in this resource-poor setting. Over 85% of the estimated 
150,000-250,000 annual malaria cases in Bangladesh occur in Chittagong 
Division with 80% in the Chittagong Hill Tracts (CHT). Chittagong 
Medical College Hospital (CMCH) is the major tertiary referral hospital 
for severe malaria in Chittagong Division. Malaria screening data from 
22,785 inpatients in CMCH from 1999-2011 were analysed to investigate 
the patterns of referral, temporal trends and geographical distribution 
of severe malaria in Chittagong Division. From 1999 till 2011, 2,394 
malaria cases were admitted, of which 96% harboured Plasmodium 
falciparum (Pf) and 4% P. vivax (Pv). Infection was commonest in males 
(67%) between 15 and 34 years of age. Seasonality of malaria incidence 
was marked with a single peak in P. falciparum transmission from June 
to August coinciding with peak rainfall, whereas P. vivax showed an 
additional peak in February-March likely representing relapse infections. 
Since 2007 there has been a substantial decrease in the absolute number 
of admitted malaria cases. Case fatality in severe malaria was 18% from 
2008-2011 remaining steady during this period. A travel history obtained 
in 220 malaria patients revealed only 34% had been to the CHT in the 
preceding 3 weeks. Of all admitted malaria patients, only 9% lived in 
the CHT, but none in the more remote malaria endemic regions near the 
Indian border. The overall decline in admitted malaria cases to CMCH 
suggests recent control measures are successful. However, there are no 
reliable data on the incidence of severe malaria in the CHT, the most 
endemic area of Bangladesh, and most of these patients do not reach 
tertiary health facilities. Improvement of early treatment and simple 
supportive care for severe malaria in remote areas and implementation of 
a referral system for cases requiring additional supportive care could be an 
important component of further reducing malaria-attributable disease and 
death in Bangladesh.
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OF MALARIA ELIMINATION STRATEGIES IN THE LOW 
TRANSMISSION SETTING
Raul Chuquiyauri1, Maribel Paredes2, Pablo Peñataro3, Sonia M. 
Torres4, Silvia Marin2, Alexander Tenorio2, Kimberly C. Brouwer1, 
Shira Abeles1, Alejandro Llanos-Cuentas4, Robert Gilman3, 
Margaret Kosek3, Joseph M. Vinetz1
1University of California at San Diego, San Diego, CA, United States, 
2Asociacion Benefica Prisma, Lima, Peru, 3Johns Hopkins Bloomberg School 
of Public Health, Baltimore, MD, United States, 4Universidad Peruana 
Cayetano Heredia, Lima, Peru
This analysis presents a comprehensive description of malaria burden 
and risk factors in Peruvian Amazon villages where malaria transmission 
is hypoendemic. More than 9000 subjects were studied in contrasting 
village settings within the Department of Loreto, Peru, where most malaria 
occurs in the country. Plasmodium vivax is responsible for more than 75% 
of malaria cases; severe disease from any form of malaria is uncommon 
and death rare. The association between lifetime malaria episodes and 
individual and household covariates was studied using polychotomous 
logistic regression analysis, assessing effects on odds of some vs. no 
lifetime malaria episodes. Malaria morbidity during lifetime was strongly 
associated with age, logging, farming, travel history, and living with a 
logger or agriculturist. Select groups of adults, particularly loggers and 
agriculturists acquire multiple malaria infections in transmission settings 
outside of the main domicile, and may be mobile human reservoirs by 
which malaria parasites move within and between micro-regions within 
malaria endemic settings. For example, such individuals might well be 
reservoirs of transmission by introducing or reintroducing malaria into their 
home villages and their own households, depending on vector ecology 
and the local village setting. Therefore, socio-demographic studies can 
identify people with the epidemiological characteristic of transmission 
risk, and these individuals would be prime targets against which to deploy 
transmission blocking strategies along with insecticide treated bednets and 
chemoprophylaxis.
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FINE-SCALE SPATIAL HETEROGENEITY OF DRY SEASON 
PREVALENCE AND ENVIRONMENTAL RISK OF MALARIA 
AMONG CHILDREN IN RURAL MALAWI: A CASE-CONTROL 
STUDY
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Environmental risk factors for malaria during the dry season in rural 
Malawi remain relatively unstudied. We investigated the role of local 
environmental features, in particular active smallholder agricultural land, 
on malaria prevalence among children <5 years old living in villages in 
two neighboring rural Traditional Authority (TA) regions in southern 
Malawi during the dry season. Ten villages from TA Sitola and Msamala 
were randomly selected. All houses with children <5 were approached 
and informed consent was obtained from those who agreed to 
participate, after which the house location was recorded with GPS. At 
each participating house, a nurse administered a malaria rapid diagnostic 
test (RDT) to one child, and a questionnaire to parents. Environmental 
data were collected in and around each house, including land cover <50 
meters. Environmental variables found to be significantly associated with 
RDT status (+/-) at p<0.10 in bivariate analysis (X2 or Student’s t-test) 
were analyzed with multi-level multivariate logistic regression (MLLR). 
Geographic clustering of RDT status, environmental factors, and Pearson 
residuals from MLLR were calculated using the Getis-Ord Gi* statistic. 
A total of 390 children were enrolled from six villages in Sitola (n=162 
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households) and four villages in Msamala (n=228), of whom 178 (45.6%) 
tested malaria positive. MLLR was used to evaluate associations of RDT 
status and household proximity to agriculture (<25m radius), controlling 
for child sex and age (months), bed net ownership, elevation (meters), 
and random effects intercepts for village and TA-level unmeasured factors. 
Proximity to active agriculture was a significant predictor of being malaria 
positive (OR 2.80, 95% CI 1.41-5.55). Mapping of Pearson residuals from 
MLLR showed significant clustering (Gi* z>2.58, p<0.01) predominantly 
within TA Sitola, with a somewhat different pattern in TA Msamala 
on the other side of the Shire River. Evidence shows significant spatial 
heterogeneity of malaria prevalence and risk factors at very fine scales 
in this rural Malawi setting, suggesting the need to focus intervention 
efforts.
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INFECTIONS IN CAMBODIA
Jessica T. Lin1, Jonathan J. Juliano1, Oksana Kharabora1, William 
O. Rogers2, Sinuon Muth3, Chansuda Wongsrichanalai2, Steven R. 
Meshnick4
1University of North Carolina School of Medicine, Chapel Hill, NC, United 
States, 2Naval Medical Research Unit #2, Phnom Penh, Cambodia, 
3National Malaria Center, Phnom Penh, Cambodia, 4University of North 
Carolina Gillings School of Public Health, Chapel Hill, NC, United States
The propensity for Plasmodium vivax parasites to relapse is one of the 
major obstacles to malaria control and elimination in many regions of the 
world. Yet little is known about the nature of relapse. A key unanswered 
question is whether certain vivax variants are more likely to cause relapse, 
as many infections contain multiple variants. Using a newly developed 
P. vivax heteroduplex tracking assay (HTA) targeting P. vivax merozoite 
surface protein 1 (Pvmsp1), we genotyped 107 vivax infections in 
individuals from Chumkiri, Cambodia, 45 of whom developed recurrent 
parasitemia between day 28 and day 42 following chloroquine treatment 
without primaquine. The HTA, which is adept at uncovering minority 
variants, revealed multiple coinfecting genotypes in 83% of individuals, 
with a mean multiplicity of infection (MOI) of 2.8 (IQR 2-4). Genotypes 
of paired initial and recurrent parasitemias were compared to look for 
genotypic patterns of relapse. Despite high allelic diversity in the overall 
cohort (HE = 0.86), 86% (38/44) of paired isolates were highly related, 
sharing at least half their variants. At the same time, novel variants 
appeared in 30% (13/44) of recurrent isolates. When the genotypes 
from initial infections of 45 “relapsers” and 62 “nonrelapsers” (those 
who did and did not develop recurrent parasitemia within 42 days) were 
compared, two specific Pvmsp1 variants were associated with subsequent 
relapse. By accounting for the polyclonality of P. vivax in Cambodia, we 
find a complex scheme of relapse in which hypnozoites representing 
all or a subset of the multiple clones found in an initial infection can 
reactivate in concert to cause relapse. At the same time, the common 
appearance of novel variants supports the notion that latent hypnozoites 
may be reactivated at the time of relapse. Additionally, we have identified 
individual Pvmsp1 variants that demonstrate a greater propensity for early 
relapse, suggesting a genetic basis to relapse.
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Zanzibar’s recent population-based survey estimates of malaria prevalence 
(<1%) and diagnostic test positivity rates of parasitemia among febrile 
outpatients (<2%) are approaching pre-elimination levels. In 2008 
Zanzibar developed and implemented a mobile phone-based malaria 
epidemic early detection system (MEEDS) at peripheral clinics to facilitate 
weekly reporting of confirmed malaria cases and help ensure prompt 
detection, confirmation, and response to sudden increases in Plasmodium 
falciparum transmission. Our objective was to analyze 2008-2011 
MEEDS data and describe trends in several MEEDS attributes related to 
outbreak detection. System representativeness was the proportion of 
all public clinics in Zanzibar reporting data to MEEDS in a given year. 
Completeness of reporting was defined as submission of all weekly data 
elements submitted to the system, regardless of date. Timeliness of 
reporting was calculated as the proportion of expected reports received 
by the system by Monday of the following week. Finally, data accuracy 
was assessed through a manual count of weekly case totals from the 
routine health management information system (HMIS) registers compared 
to totals in MEEDS registers. Representativeness improved as MEEDS 
implementation moved forward from 10 (7%) clinics in 2008 to 52 
(37%) in 2009, 69 (49%) in 2010, 90 (63%) in late 2010, and finally 142 
(100%) clinics by late 2011. Completeness of submitted data was 100% 
each year except 2009 (84%) when technical problems prevented data 
transmission from many clinics. Timeliness of weekly reports received 
by the following Monday increased from 19% in 2009 to 43% in 2011 
(p<0.001). The MEEDS data accuracy as compared to routine HMIS 
increased from 89% in 2009 to 97% in the first-half of 2011 and fell to 
93% in the second-half of 2011. Despite accomplishments in reporting 
representativeness, completeness, and accuracy of the MEEDS over four 
years of implementation, additional efforts and resources are required to 
understand and address deficiencies in reporting timeliness, perhaps the 
most important attribute of an early epidemic detection system.
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DECREASE OF MALARIA INCIDENCE AMONG CONFIRMED 
CASES OF MALARIA IN MARY IMMACULATA CENTRE 
MUKURU KENYA IN 2007-2010
Moses Kiwou1, Johansan Mawole1, John Mutuku Muli2, Victor 
Namulanda1, Jirina Kafkova1, Mario Jancovic1, Daria Pechacova1, 
Jaroslava Sokolova3, Vladimir Krcmery4
1Mary Immaculata Centre, St. Elisabeth University Tropical Program, 
Mukuru, Nairobi, Kenya, 2Slovak Tropical Institute, St. Elisabeth University 
College of Health and Social Sciences, Bratislava, Slovakia, 3Department 
of Clinical Disciplines, School of Health Care and Social Work, Trnava 
University, Trnava, Slovakia, 4St. Elizabeth University of Health and Social 
Sciences, Bratislava, Slovakia
The aim of the study was to assess annual incidence of microscopically 
positive cases of malaria in urban area of Nairobi within last five years 
(2007-2011) and to compare malaria occurrence before and after 
intermittent preventive treatment (IPT) was initiated in this area. Mary 
Immaculata Centre is located in the slum area of Mukuru (Nairobi, Kenya) 
with about 40 000 inhabitants in height of 1900 meters above sea level. 
Traveling from Nairobi to down country of Rift Valley and back is usual 
1-2 times per year. Two experienced lab technicians investigated daily 
30-50 slides a day (15-25 per person). In 2011 also rapid diagnostic tests 
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(RTD) were used to confirm positive malaria slide. Within five years (2007-
2011), 56 668 samples were microscopically evaluated (8466 - 12333 
per year) and 905 were positive for malaria (1,60%). Annual proportion 
decreased from 1,96% (2007), 2,54% (2008) and 2,11% (2009) to 1% 
in 2010 and 0,79% in 2011 (P<0,001). Severe cases of malaria were seen 
only exceptionally. Number of cerebral malaria cases was 1-5 patients/
year and severe anaemia (<80 g/l) was also exceptional (15-30 cases/
year). Decreasing proportion of microscopically positive malaria cases 
was probably due to major improvement in infrastructure (disinfection of 
surface water, canalization, waste water drainage) as well as due to IPT in 
all four schools in Mukuru since 2009/2010 in all children coming to first 
school year age and also for all mothers coming to maternity check since 
2009. Seasonal variation has been observed as well with maximum in 
June - October (rainy season) and minimum in November - December. In 
conclusion, decrease of annual incidence of microscopically positive cases 
of malaria in 2010-2011 has been observed in slum area of Mukuru in 
Nairobi, Kenya. Sewage water drains and canalizations of surface water in 
this area as well as IPT in school children and pregnant women may play a 
role in this trend within last five years.
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ESTIMATES OF MALARIA MORBIDITY BEFORE AND AFTER 
THE IMPLEMENTATION OF A SENTINEL SITE INPATIENT 
MALARIA SURVEILLANCE SYSTEM IN UGANDA
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6London School of Hygiene and Tropical Medicine, London, United 
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University, Kampala, Uganda, 8University of California, San Francisco, San 
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In Uganda, the National Malaria Control Program (NMCP) relies on 
Health Management Information System (HMIS) data for planning 
and monitoring trends in malaria burden yet majority of malaria cases 
reported are based on clinical case definition. For the past 2 years, we 
have implemented an in-patient malaria sentinel surveillance program at 
select district hospitals with emphasis on laboratory-based case definition. 
To better characterize the quality of HMIS-based malaria data, and 
understand the true burden of malaria in Uganda, we compare HMIS 
data to malaria sentinel surveillance site data at four public hospitals. 
These hospitals are situated in districts with varying malaria endemicity: 
Tororo and Apac (high transmission), Mubende (medium transmission) 
and Kambuga (low transmission). At the four sentinel hospitals, >95% 
of inpatient children less than 5 years were tested for malaria, and only 
those children with positive laboratory confirmation were recorded as 
malaria cases. Based on HMIS data, the proportion of hospitalized children 
under 5 with malaria was higher 12 months prior to start of the program 
as compared to 12 months after: Tororo (94% vs. 85%), Kambuga (83% 
vs. 52%), Mubende (71% vs. 55%) and Apac (67% vs. 40%). Actual 
comparison of HMIS data to surveillance program data, 12 month after its 
start, showed that HMIS data overestimates the burden of malaria when 
compared to surveillance program data: 27 percent higher in Kambuga 
(25% vs. 52%), 24 percent higher in Tororo, (61% vs. 85%), 18 percent 
higher in Mubende (55% vs. 37%) and 7 percentage points higher in 
Apac (42% vs. 35%). Improved precision of HMIS estimates of malaria 
adopted after start of the program may have contributed, in addition to 
other factors, to the observed differences in disease burden determined 
by HMIS before and after the start of the program. Even then, HMIS 
overestimated the burden of malaria among hospitalized children after 
start of the program. In order to improve the quality of HMIS malaria data, 
a case definition based on laboratory confirmation should be adopted. 
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MALARIA AND RESPIRATORY TRACT INFECTIONS WERE THE 
COMMONEST TROPICAL DISEASES AND THE COMMONEST 
INFECTIONS IN AREA OF LOW HIV PREVALENCE IN SOUTH 
UGANDA: ANALYSIS OF 43,551 PATIENTS
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The aim of this study was assess reasons for hospitalization in rural 
hospital in South Uganda in area of low HIV prevalence among population 
(2-3 % HIV positivity). Since January 2008 to December 2010 all 43 550 
patients has been investigated, of them 6454 (14,8 %) inpatients and 37 
096 (85,2 %) outpatients. Total 32 938 (75,6 %) were children under 5 
years of age (2965 inpatients). Rapid diagnostic test plus microscopy has 
been used in the hospital laboratory with four florescent microscopes 
and six experienced laboratory technicians (analysis about 100-120 test/
samples per day). Total 20 421 (46,9 %) of malaria cases within 3 years 
(2008-2010) were diagnosed. Of all malaria patients, 17 321 (84,8 %) 
were treated on outpatients and 3100 (15,2 %) on inpatients basis. 
Altogether 31 960 blood smears were microscopically investigated and 
16 205 (50,7 %) of those were positive. Respiratory tract infections 
were diagnosed in 9255 cases (21,3 %), of them 3422 (36,9 %) had 
pneumonia and 5833 (63,1%) lower respiratory tract infections. Otitis 
media (862 cases) was observed only in children. Tuberculosis was 
confirmed in 102 patients and 30 of them were HIV co-infected. Other 
frequently diagnosed infections were skin and soft tissue infections 
in 3383 patients (7,8 %), urogenital tract infections in 3145 (7,2%), 
sexually transmitted infections 966 (2,2 %), of them 241 (24,9%) 
laboratory confirmed cases of syphilis. Totally 2126 patients (4,9%) have 
microscopically diagnosed geohelmints infections and 1387 (3,2%) had 
diarrhea. Together 4513 patients were tested on HIV and 1188 (2,7 %) 
of these were positive. Another diseases with low prevalence were ocular 
infections in 793 (1,8 %) patients, meningitis in 53 patients (0,1 %), 
measles in 14 (0,03%), schistosomiasis in 12 (0,03 %), sleeping sickness 
in 10 patients (0,02 %) and tetanus in 12 (0,03%) patients (4 of them 
neonates). In the area of Buikwe (Lugazi, Buikwe District, South Uganda), 
prevalence of HIV was surprisingly low (2,7%) as well as geohelmints 
infections (3,2 %) probably due to MDR with albendazol in all school 
children. Low HIV prevalence is probably result of outreach mobile HIV 
units and 5 years of voluntary counseling testing program (since 2008) 
as well as high proportion of patients on HAART due to five years of 
governmental program in South-East Uganda since 2006.
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DEPLOYMENT IN EAST AFRICA
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es Salaam, United Republic of Tanzania, 5The Rwanda Defence Force, 
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Malaria remains an important parasitic disease of public health concern, 
especially in Africa. Malaria is a problem for military forces because of its 
ability to cause sudden epidemics which can hinder or halt operations. 
During the Malaria Symposium hosted by the United States Africa 
Command in April 2011, representatives from several African militaries 
proposed formation of a multi-national Malaria Task Force to address 
common military malaria programmatic challenges. After assessing 
countries’ current malaria activities, willingness to participate, perceived 
needs and expected outcomes, five nations of the East Africa Community 
(Burundi, Kenya, Rwanda, Tanzania and Uganda) united to hold the first 
East Africa Malaria Task Force (E-AMTF) meeting in December 2011. The 
mission of the E-AMTF is to strengthen and expand effective malaria 
programs and provide support for military personnel, their families 
and communities. The E-AMTF intends to assist national and regional 
malaria programs in harnessing the full potential of the armed forces 
as behavioral and social change agents. In preparation for the second 
E-AMTF meeting in Tanzania, gap analyses of the various malaria program 
components (Prevention, Diagnosis, Treatment, Surveillance and Human 
Resources/Capacity Building) during both peacetime and deployment 
were conducted. The process of critically evaluating their programs helped 
identify, document, and evaluate program requirements against current 
capabilities. Based on the urgency and impact on partner nations’ military 
malaria programs, components were prioritized. Partner nations will take 
their accountability roadmaps and have a follow-up review meeting with 
key stakeholders to review, endorse and validate the roadmaps and define 
clear roles and responsibilities. This regional multi-lateral cooperation 
between the militaries of partner African nations, leveraging data-driven 
programmatic assessments of their malaria program needs, allow for the 
collaboration with US agencies’ assets to enhance and develop malaria 
programs.
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OCCURRENCE OF MALARIA IS DECREASING WITH HIGHER 
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of Health and Social Sciences, Gasura, Burundi, 4Department of Clinical 
Disciplines, School of Health Care and Social Work, Trnava University, 
Trnava, Slovakia, 5St. Elizabeth University of Health and Social Sciences, 
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Altitude above sea can influence the spectrum of infective diseases, 
especially those like dengue fever or malaria and other mosquito-vector 
transmitted diseases. We have monitored occurrence of malaria and other 
tropical diseases in 4 rural Burundian hospitals working within the St. 
Elisabeth Tropical Program. Buraniro hospital is the lowest localized one 
in average height of 1280 m, Gasura health center is in 1550 m above 
sea level, Rutovu hospital is placed in 2065 m and Murago in 2663 m 
above sea. Overall size of all hospital is similar, those counting for 80 - 
120 beds. In all four hospitals, the overall number of health consultation 
and gynecological consultation, number of malaria and other tropical 
cases are registered using form-filling. We evaluated incidence of malaria 
during December 2011 among all hospitals. During the December 2011, 
9524 health consultations and 1465 hospitalizations were carried out in 
those hospitals. Lowest proportion of malaria during December 2011 was 
detected in Murago (606 cases per month, 47,6%) and highest it was 
in Gasura (1559 cases, 91,3%), then in Rutovu (732 cases, 81,2%) and 
Buraniro (4436 cases, 78,6%). Comparing to other types of consultations 
(gynecological, AIDS, other tropical diseases), malaria was the most 
frequent disease, even though some patients received more than one 
type of consultation. In this study we showed, that occurrence of malaria 
negatively correlates with altitude above sea and was lowest in Murango 
hospital placed above 2500 m (P < 0,05), where we have noted 606 
malaria cases of which 499 (83,2%) were microscopically confirmed. 
Proportion of AIDS-consultations was lowest in remote hospitals of 
Rutovu and Murago where only few people are travelling to large cities or 
crowded places (such as Great Lake Tanganyika).
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AND PRACTICES OF TANZANIA’S DRUG RETAILERS: 
EXPLORING THE IMPACT OF DRUG STORE ACCREDITATION
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In Tanzania drugs can be purchased from 2 types of retail outlets: Part I 
pharmacies and drug stores. Since 2005 Tanzania has been upgrading the 
approximately 7,000 drug stores to Accredited Drug Dispensing Outlets 
(ADDOs), involving dispenser training, introduction of record keeping and 
enhanced regulation. ADDOs are permitted to stock 49 prescription only 
medicines, including artemisinin-based combination therapies. Non-ADDO 
drug stores can officially stock over the counter medicines only, although 
many stock prescription only antimalarials. By the end of 2011 ADDO 
conversion was complete in 14 out of 21 regions, but limited information 
is available on their performance. Here we examine the malaria-related 
knowledge and practices of Tanzania’s drug retailers, exploring variation 
between the different types of drug retailers. The data were collected 
as part of the AMFm Phase 1 Independent Evaluation, commissioned 
by the Global Fund to Fight AIDS, Tuberculosis and Malaria, which 
draws on methods developed by the ACTwatch group. We conducted 
a nationally representative survey of antimalarial retail outlets in Oct-
Dec 2011. We randomly selected 49 wards, and interviewed all outlets 
stocking antimalarials. As Part I pharmacies were relatively rare these 
were oversampled by including all pharmacies in the districts - larger 
administrative units in which the selected wards were located. Interviews 
were conducted in 334 Part 1 pharmacies, 148 drug stores in ADDO 
regions, and 261 drug stores in other regions. We will present findings on 
outlet characteristics (number of staff, staff education and qualifications); 
staff knowledge (of first line antimalarial drug and its dosing); and 
antimalarials and malaria diagnostics (availability, retail prices, markups, 
sales volumes and wholesale sources). ADDO conversion is frequently cited 
as a model for improving retail sector drug provision but there is concern 
that the impact may be constrained by staff turnover and inadequate 
regulatory supervision. This study will provide important information to 
inform future policy on drug retailers in Tanzania and elsewhere in the 
region.
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EVALUATING THE COST-EFFECTIVENESS OF INTERMITTENT 
SCREENING AND TREATMENT (IST) COMPARED TO 
INTERMITTENT PREVENTATIVE THERAPY (IPTP) DURING 
PREGNANCY IN PREVENTING LOW BIRTH WEIGHT: A 
MODEL-BASED ANALYSIS
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Malaria during pregnancy is the leading preventable cause of low birth 
weight in many areas of sub-Saharan Africa. The current recommended 
intervention is to administer up to 3 doses of Sulphadoxine Pyrimethamine 
(SP) to pregnant women during antenatal clinic visits (IPT-SP) to clear any 
existing infection and protect against re-infection. However, with the 
emergence of SP resistance in many parts of Africa, alternative strategies 
to IPT-SP are currently being evaluated. One such alternative is intermittent 
screening and treatment (IST), whereby long-acting artemisinin 
combination therapy is administered to women with a positive rapid 
diagnostic test (RDT). By linking a model of the progression of Plasmodium 
falciparum malaria during pregnancy to the risk of low birth weight, we 
explored the impact and cost-effectiveness of IST and IPT-SP in areas with 
different transmission intensity and levels of SP resistance. Our results 
suggest that in areas where the parasite is still sensitive to SP, IPT will be 
more cost-effective than IST. This is due to the limited sensitivity of RDTs 
to detect low-grade infections and the additional cost of the RDT relative 
to SP. However, in areas of East Africa with high levels of SP resistance, 
our results suggest that a switch to IST would lead to a reduction in the 
burden of malaria-attributable low birth weight. Whether IST is also more 
cost-effective depends mainly on the difference in cost between SP and 
the chosen RDT and less on the level of transmission, the level of immunity 
acquired or the relative cost of the antimalarial provided to those with a 
positive test. For example we found that in areas where SP fails to clear 
infections in 35% of parasitaemic women, IST would be cost-effective 
provided costs associated with an RDT are below $1 per test. In summary, 
our results suggest, conditional on our model assumptions, that a switch 
of policy to IST would only be effective in reducing the burden of low birth 
weight in areas where there are moderate to high levels of SP resistance, 
with the degree of resistance necessary to make such a decision cost-
effective depending primarily upon the cost of the RDT used.
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Childhood malaria is a major cause of mortality particularly in sub Saharan 
Africa, and we do not understand the intrinsic or acquired mechanisms 
of resistance. We have undertaken intensive longitudinal cohort studies 
to assess malaria risk factors and acquired protective immunity. A cohort 
of children aged 0-3 years of age was enrolled starting in September 
2010. During the 2011 malaria transmission season (July to December), 
thick and thin smears were performed every two weeks in under-ones 
children, every four weeks in older toddlers, and also at the time of any 
illness. Clinical malaria was defined as the presence of asexual stages of 
P. falciparum on blood smear with signs or symptoms of malaria. Poisson 
regression was used to assess the relationship between host factors and 
clinical malaria risk. During the season, 486 malaria episodes occurred 
in 265/479 (55.3%) enrolled children (incidence rate of 1.03 episodes 
per child per season), with some children experiencing up to six clinical 
episodes in the season. The risk of clinical malaria was lower in children 
less than 2 years of age compared to those of 2-4 years (0.84 versus 1.2 
episodes/child/season; adjusted incidence rate ratio (IRR) =0.70; 95% CI 
0.58 - 0.84; p < 0.001). The risk was also significantly lower in children 
with hemoglobin S, (0.68 versus 1.07 episodes/child/season; IRR = 0.63, 
95% CI 0.42 - 94, p =0.02). No significant association was found with 
blood group (ABO, Rh) or Fulani ethnicity. Preliminary analysis of this single 
season data indicates that hemoglobin S and age are associated with 
resistance to clinical malaria. Additional factors, such as iron status, are 
being assessed, and will provide a detailed definition of which subsets of 
children are or are not susceptible to malaria. This context will allow us to 
undertake detailed immunologic studies in the susceptible children, and 
define the targets and mechanisms by which children become resistant to 
clinical malaria.
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DEFINING THE MALARIA BURDEN IN NCHELENGE DISTRICT 
USING THE WHO MALARIA INDICATORS SURVEY
Michael Nambozi1, Phidelis Malunga1, Jean-Pierre van 
Geertruyden2, Modest Mulenga1, Umberto D’Alessandro3
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Malaria is considered as one of the major public health problems and 
among the diseases of poverty. In areas of stable and relatively high 
transmission, besides children under 5 years of age, pregnant women and 
their new born babies are among the higher risk groups. A multicentre 
trial on the safety and efficacy of several ACTs during pregnancy is 
currently on-going in 4 African countries, including Zambia, whose study 
site is in Nchelenge district. As the study outcomes may be influenced by 
the local malaria endemicity, this needs to be characterised. Therefore, in 
March-April 2012 we carried out a cross-sectional survey to determine the 
prevalence and intensity of malaria infection among <10 years old children 
in Nchelenge district, on the shores of Lake Mweru. The sampling unit 
was the household where all children < 10 were included in the survey. 
We used a simple random selection of households using the GPS coded 
list. Individual consent to participate was collected from parents/guardians. 
A blood sample for Hb measurement and the detection of malaria 
infection was collected as well as information on the use of preventive 
measures such as Long-Lasting Insecticidal Nets (LLIN). Three hundred 
twelve households were sampled and 358 children included in the survey. 
Malaria parasite prevalence was 31.3% (95% CI: 26.6-36.4%); anaemia 
prevalence (Hb <11g/dl) was 49.1% (95% CI: 43.8-54.6%), a higher 
value than those previously found in the province. Though malaria has 
declined substantially in Zambia, there are still pockets of high endemicity 
such as Nchelenge district. These areas should be targeted for achieving 
high coverage of preventive interventions such as LLIN and indoor residual 
spraying.
273
www.astmh.org
900
CHANGES IN MALARIA PREVALENCE AND HEALTH 
PROVIDER’S BEHAVIOR TOWARDS FEVER WITH THE 
INTRODUCTION OF ACT AND RDT AT PERIPHERAL HEALTH 
CENTRE LEVEL IN SOUTHWESTERN SENEGAL (2000-2011)
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During 2000-2011, the staggered introduction of ACT (artesunate-
amodiaquine, ASAQ) and RDT in Mlomp (~6000 inhabitants), South-
western Senegal coincided with profound changes in health providers’ 
behaviour and malaria epidemiology. Through 2006 ASAQ and microscopy 
were rolled-out on experimental basis; from 2007 ASAQ+RDT were policy 
and free of charge. Injectable quinine has been available throughout. 
The dispensary is the only health provider in the village. The dispensary 
registries recorded 67,015 consultations, of which 35,169 (52%) for fever. 
Fevers accounted for 62% of consultations in 2000 vs. 33% in 2011; 
fevers dropped -74%, consultations -51%. Of all fevers, 9147 (26%) were 
diagnosed clinically as non-malaria (from 10% in 2000 to 88% in 2011) 
and treated accordingly, and 26,022 were clinically-suspected malaria 
(from 5046 in 2000 to 176 in 2011, -97%). The number of confirmed 
malaria fevers dropped by >90% from 1365 in 2000 to 112 in 2011) 
Of these, 23,481 (90%) received an antimalarial treatment (-36% in 
2011 vs. 2000), of which 6893 (29%) were for parasitologically-proven 
malaria (P+), 10,122 (43%) for parasitologically-negative fevers (P-), 
and 6466 (28%) without a parasitologic diagnosis (P0). Overall, 18,859 
clinically-suspected malaria underwent parasitologic confirmation (72%). 
No change was seen in any of the above. ASAQ accounted for 12% of 
antimalarial treatments overall (41% of treatments for P+, 7% P-, 9% 
P0). Comparing 2007-11 (ASAQ + RDT deployed) to 2000-06, the yearly 
number of fevers halved, non-malaria fevers doubled, malaria treatments 
dropped -86%. ASAQ increased from 17% to 30% of antimalarial 
treatments and from 57% to 94% of P+ cases. There was no difference 
in the proportion of fevers tested parasitologically (75% with microscopy 
during 2000-06, 70% with RDT during 2007-11), nor in the P.falciparum 
positive rate (29% vs. 31%). Case management of fever improved 
(better detection of non-malaria fevers, few malaria treatments). Practice 
compliance with malaria policy increased (almost all treatments are 
ASAQ), ca. three-quarters of fevers are tested parasitologically. However, 
introduction of RDTs did not boost testing significantly (presumably 
because of prior successful training in microscopy), and confidence in RDT 
is still limited (presumably because the proportion turning out positive is 
low compared to clinical suspicion - the established prior practice).
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Prompt and accurate parasitological confirmation of Plasmodium 
falciparum malaria is essential for effective disease management. WHO 
recommends the use of malaria Rapid Diagnostic Tests (RDTs) in settings 
where microscopy services are not available. Following improved global 
malaria control and regional elimination efforts, there is a critical need 
for novel surveillance tools and strategies. Used RDTs have shown to be a 
reliable source of parasite DNA. Together with highly sensitive molecular 
assays, wide scale collection of used RDTs may serve as a modern tool 
for improved malaria case detection and drug resistance surveillance. The 
aim of this study was to compare and evaluate different methods of DNA 
extraction from RDTs and to test the field applicability for the purpose of 
molecular epidemiological investigations. DNA was extracted from two 
RDT devices (Paracheck-Pf and SD Bioline Malaria Pf/Pan), seeded in vitro 
with ten-fold dilutions of cultured 3D7 P. falciparum parasites diluted in 
malaria negative whole blood. The level of P. falciparum detection was 
determined for each extraction method and RDT device with multiple 
nested-PCR and qPCR assays. The field applicability was tested on 875 
paired RDT (Paracheck-Pf) and filter paper (Whatman 3MM) blood 
samples collected from febrile patients in Zanzibar 2010. Preliminary in 
vitro results show that DNA extraction efficiency varied with extraction 
method and RDT device. The method of P. falciparum detection influenced 
the detection limit by 1-2 log units. No apparent difference in quality of 
DNA extracted from RDTs and filter papers was observed, in terms of PCR 
results from both in vitro and field samples. The results support the field 
applicability of RDT-DNA extraction for the purpose of improved molecular 
surveillance of antimalarial drug resistance, malaria case detection and 
RDT quality control.
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PLASMODIUM FALCIPARUM EXPOSURE SINCE BIRTH AND 
RISK OF SEVERE MALARIA: A NESTED CASE-CONTROL 
STUDY ON THE COAST OF KENYA
Klara Lundblom1, Linda Murungi2, Victoria Nyaga2, Daniel Olsson1, 
Josea Rono1, Faith Osier2, Edna Ogada2, Scott Montgomery1, 
Anthony Scott2, Kevin Marsh2, Anna Färnert1
1Karolinska Institute, Stockholm, Sweden, 2Kenya Medical Research 
Institute, Kilifi, Kenya
Severe malaria affects mainly young children in Plasmodium falciparum 
endemic areas. The mechanisms by which immunity to severe malaria 
develops remain largely unclear, as does the number of infections needed 
to acquire protection. The aim of this study was to establish how exposure 
to P. falciparum infections during the first years of life affects the risk of 
severe malaria. A cohort of 5949 children born 2001-2008 in Kilifi District 
on the Kenyan Coast was followed with three-monthly visits from birth 
until 2 years of age. Infection patterns in children who subsequently 
developed severe malaria (according to strict criteria) were compared to 
three-monthly profiles of age-matched community controls in a 1:3 nested 
case-control design. Detection of P. falciparum by microscopy or PCR in at 
least one sample from birth conferred an increased risk of severe malaria 
and particularly if a multiclonal infection, as defined by genotyping of 
the polymorphic merozoite surface protein 2 gene, was ever detected. 
Antibodies to P. falciparum schizont extract were similarly prevalent in 
cases and controls, indicating the overall same level of exposure. In this 
area of moderate-low malaria transmission, parasite positivity and diversity 
since birth confer an increased risk of developing severe malaria. This 
study demonstrates for the first time with parasitological data differences 
in previous exposure between children who developed severe malaria and 
community matched controls.
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MEASURING PLASMODIUM FALCIPARUM TRANSMISSION 
IN LOW-ENDEMIC SETTINGS USING A COMBINATION OF 
COMMUNITY PREVALENCE AND HEALTH FACILITY DATA
Joshua O. Yukich1, Olivier Briët2, Michael Bretscher3, Adam 
Bennett1, Seblewengel Lemma4, Yemane Berhane4, Thomas 
Eisele1, Joseph Keating1, Tom Smith2
1Tulane University School of Public Health and Tropical Medicine, New 
Orleans, LA, United States, 2Swiss Tropical and Public Health Institute, 
Basel, Switzerland, 3London School of Tropical Medicine and Hygiene, 
London, United Kingdom, 4Addis Continental Institute of Public Health, 
Addis Ababa, Ethiopia
As some malaria control programs shift focus from disease control to 
transmission reduction, there is a need for transmission data to monitor 
progress. At lower levels of transmission, this becomes increasingly difficult 
to measure precisely, whether through entomological or other studies. 
Many programs conduct regular cross sectional parasite prevalence 
surveys, and have access to malaria treatment data routinely collected by 
ministries of health, often in health management information systems. By 
themselves, these data are poor measures of transmission. We propose 
an approach for combining annual parasite incidence and treatment data 
with cross-sectional parasite prevalence and treatment seeking survey data 
to estimate the incidence of new infections in the human population, 
also known as the force of infection, with limited supplementary data. 
The approach is based on extension of a reversible catalytic model. The 
accuracy of the estimates from this model appears to be highly dependent 
on levels of detectability and treatment in the community, indicating the 
importance of information on private sector treatment seeking and access 
to effective treatment.
904
SPATIAL AND TEMPORAL TRENDS IN MALARIA 
TRANSMISSION CAN BE CAPTURED BY THE DIAGNOSTIC 
POSITIVITY RATE REPORTED FROM SUMMARIES OF QUALITY 
ASSURED HEALTH FACILITY RECORDS RELAYED THROUGH 
MOBILE PHONES
Busiku Hamainza1, Aklilu Seyoum2, Gerry Killeen3
1National Malaria Control Center, Lusaka, Zambia, 2Liverpool School of 
Tropical Medicine, Vector Group, Liverpool, United Kingdom, 3Ifakara 
Health Institute, Biomedical and Environmental Thematic Group, Dar es 
Salaam, United Republic of Tanzania
Measurement of malaria incidence among humans is central to monitoring 
malaria control program implementation. Quality-assurance and rapid 
reporting systems are required to reliably measure malaria transmission 
through passive reporting systems as current health management 
information system reports are not sufficiently rapid or reliable. Weekly 
summaries of malaria Rapid Diagnostic Test (mRDT) results from 14 health 
facilities (HFs) in Luangwa and Nyimba districts of central and eastern 
Zambia were reported via mobile phone text message. Diagnostic positivity 
rates reported by this passive monitoring system were compared with 
both the detailed data from the facility patient registers and a longitudinal 
incidence cohort comprising clusters of approximately 1000 residents 
in the immediate catchment areas of each facility. While passive HF-
based surveillance reported fewer cases of malaria (10345 versus 12267, 
P=<0.0001), particularly non-febrile cases (33 versus 8311, P=<0.0001), 
the diagnostic positivity rates obtained correlated well with geographic 
(P=0.002) and temporal (P=0.000) heterogeneity in rigorously measured 
incidence rates. The HF surveillance system described adequately captured 
malaria transmission trends in local HF catchment populations and offers 
a cost-effective method for fine-scale program monitoring that can be 
applied on large scales. In conclusion, rapid, accurate reporting of quality-
assured HF records of mRDT diagnostic positivity could enable population-
wide, continuous longitudinal monitoring of malaria transmission so that 
integrated vector management programmes can be effectively managed, 
optimized by both local and national malaria control programmes.
905
SEROLOGY CONFIRMS MODELED RISK FOR TRANSFUSION 
MALARIA FROM BLOOD DONORS WITH TRAVEL TO MEXICO 
AND AFRICA
Megan Nguyen1, Bryan R. Spencer2, Tami Goff3, P. Dayand 
Borge3, David A. Leiby1
1American Red Cross, Rockville, MD, United States, 2American Red Cross, 
Dedham, MA, United States, 3American Red Cross, Baltimore, MD, United 
States
There have been only 7 cases of transfusion-transmitted malaria (TTM) 
reported in the US since 1998, most attributable to former African 
residents. The apparent efficacy of current US malaria policy in preventing 
TTM is counterbalanced by annual deferral of ~160,000 US blood donors 
for travel-associated malaria risk. Most deferred travelers have visited low 
risk areas, especially Mexico (66,000/yr), which recent models suggest 
presents malaria risk 1000x lower than Africa. We compared estimates of 
modeled risk with measured malaria risk based on antibody (Ab) testing 
of donors deferred for travel to Africa and Mexico. Blood donors deferred 
for malaria risk (travel/residency in an endemic country or past history of 
malaria) were recruited, consented and enrolled. Study subjects provided 
2 EDTA tubes of blood and completed a risk-factor questionnaire. Samples 
were tested for Plasmodium Abs by EIA (Lab21 Healthcare); repeat reactive 
(RR) samples were considered positive and tested by real-time PCR. Since 
2006, 6,077 deferred donors were tested by EIA, including 5,879 deferred 
for travel. Overall, 91 (1.5%) subjects were RR, with 49 (54%) reporting 
a history of malaria infection; none were PCR positive. Only two (0.2%) 
of 1,223 travelers to Mexico were RR, with both reporting prior infections 
acquired elsewhere (Turkey, 1976 & Ghana, 2005). Among 275 donors 
tested for travel to Africa, 9 (3.3%) were EIA positive, 6 reported a history 
of malaria; all 9 were infected in Africa. Travel to Mexico accounts for a 
large percentage of US donors deferred for malaria risk, but most visit low 
risk areas. Testing of travel deferred donors identified no cases of malaria 
acquired in Mexico, supporting modeled estimates of exquisitely low risk 
associated with travel to Mexico. In contrast, few donors are deferred 
for travel to Africa yet acquire infection at much greater rates from travel 
to or residence in Africa. A more effective approach to preventing TTM 
would be to defer donors reporting a past history of malaria or significant 
exposure in high risk areas (i.e., Africa).
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MAINTENANCE OF UNIVERSAL COVERAGE OF LONG-
LASTING INSECTICIDE TREATED BEDNETS (LLINS) IN 
RWANDA: PRELIMINARY RESULTS OF LONGITUDINAL LLIN 
DURABILITY AND EFFICACY STUDY 
Emmanuel Hakizimana1, Beatus Cyubahiro1, Alphonse 
Rukundo2, Allan Kabayiza1, Michael Green3, Raymond Beach3, Jon 
Eric Tongren4, Roopal Patel4, Corine Karema2
1National Malaria Control Program/Malaria and Other Parasitic Diseases 
Division, Kigali, Rwanda, 2National Malaria Control Program/Malaria and 
other Parasitic Diseases Division, Kigali, Rwanda, 3Entomology Branch, 
Division of Parasitic Diseases and Malaria, Centers for Disease Control 
and Prevention, Atlanta, GA, United States, 4Malaria Branch, Division of 
Parasitic Diseases and Malaria, Centers for Disease Control and Prevention/
U.S. President’s Malaria Initiative in Kigali, Rwanda, Atlanta, GA, United 
States
The use of long lasting insecticidal nets (LLINs) is a proven effective malaria 
control intervention. While LLINs are expected to last for 3-5 years or 
20 washes, the reality of net effective life in Rwanda could be different. 
Rwanda achieved universal bednet coverage (1 net per 2 people) in 
February 2011after distributing 6.1 million LLINs since 2009. In December 
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2010, Rwanda initiated a 3 year longitudinal study to track net efficacy in 
3,000 LLINs (1500 polyethylene/permethrin; 1500 polyester/deltamethrin) 
at 6 sites. At one month post-distribution, and every 6-monthly interval, 
10 LLINs are sampled from each site and tested for bio-efficacy (insecticidal 
effect) using WHO cone bioassay. A colorimetric field test (CFT) is used 
to assess surface deltamethrin levels. LLIN durability is assessed using a 
probability hole index (pHI) and theoretical cutoff values to identify the 
percentage of LLINs in good or serviceable condition. Preliminary results 
show that at one month, 6 months, and 12 months following distribution 
8.5%, 12.9%, and 17.8% of LLINs were missing. LLIN cone bio-efficacy 
decreased to an average of 84.3% (84.0-84.7) at 6 months and 83.8% 
(83.3-84.3) at 12 months. Deltamethrin surface levels show 50-80% 
depletion of insecticide after 6 months with little change at 12 months 
compared to the baseline. LLINs remain viable with effective insecticide 
surface concentration at least equivalent to10% of the baseline. The 
durability assessment indicates that in 5 out of 6 sites <10% (pHI>768 
threshold: polyethylene: 3-10%; polyester: 7-30%) of LLINs would 
require replacement after 6 months and 32% after 12 months (pHI>768 
threshold; polyethylene: 37%; polyester: 13-50%). The data suggest 
that LLINs remain effective after one year of use in Rwanda. However, 
projected CFT and durability trends indicate that approximately 50% may 
become ineffective in the next 6 months. These observations highlight the 
need to conduct LLIN efficacy and durability studies to guide strategies for 
LLIN replacement and ensure effective universal coverage.
907
STUDY ON PERSISTENCE OF INSECTICIDES (BIOASSAY TEST) 
IMPREGNATED NET-JACKETS FOR MALARIA PREVENTION IN 
RUBBER TAPPER GROUP AT SURATHANI PROVINCE
Suteera Poolthin, Boonserm Aumaung
Bureau of Vector Born Diseases, Nonthaburi, Thailand
This study aimed to find out persistence of difference insecticides that 
were taken to impregnate net-jackets and to compare persistence of used 
and unused impregnated net-jackets in laboratory and field trial. The 
net-jackets were impregnated by insecticides namely Permethrin 10% 
EC, Deltamethrin 1% SC and Alphacypermethrin 10% SC at dosage 300 
mg/m2, 30 mg/m2 and 30mg/m2, respectively. Impregnated net-jackets 
were tested at laboratory room temperature and some were given to 
rubber tapper volunteer group at Surathani Province in field trial. This 
volunteer group usually daily wore impregnated net-jackets while they 
had worked at night. Evaluation was conducted by bioassay test method 
that Anopheles dirus (laboratory stain) was tested to determine insecticide 
persistence. In laboratory trial, impregnated net-jackets were bioassay 
tested after impregnation 4, 8, 18 and 24 weeks. The result of persistence 
of three insecticides showed mortality rate of An. dirus that were more 
than 80% significantly at 24 weeks or 6 months. In field trial, impregnated 
net-jackets were bioassay tested after impregnation 2,4 and 8 weeks. 
The result of impregnated net-jackets could kill An. dirus effectively that 
were less than 4 weeks. Deltamethrin and Alphacypermethrin were higher 
effectiveness than Permethrin. Thus, persistence of unused impregnated 
net-jackets (Permethrin 300 mg/m2, Deltamethrin 30 mg/m2 and 
Alphacypermethrin 30 mg/m2) were more than 6 months at temperature 
room. The used impregnated net-jackets would have persistence at less 
than 4 weeks.
908
STRENGTHENING COMMUNITY SYSTEM COMPONENTS 
FOR MALARIA CONTROL: FIVE YEARS INTERVENTIONS IN 
PASTORALIST COMMUNITIES IN AFAR REGION-ETHIOPIA
Medhanit Getachew1, Kassahun Negash1, Sylla Thiam2
1AMREF Ethiopia, Addis Ababa, Ethiopia, 2AMREF HQ, Nairobi, Kenya
A community based malaria prevention and control programme has been 
implementing in Afar Region since 2005. The goal of the programme was 
to contribute to the reduction of malaria related morbidity and mortality 
among pastoralist population in Afar region, by specifically targeting 
children under five years and pregnant women.Interventions focused 
on improving case management of malaria, increasing ITN coverage 
at community level, and enhancing behaviour and social change in 
support of all interventions. A baseline survey was done followed by a 
midline survey in 2007 and a final evaluation in 2010. Both quantitative 
and qualitative data collection methods were employed to collect data 
from respondents to assess the impact of this five years programme by 
comparing the key indicators before and after intervention. The proportion 
of community members who correctly identified the transmission 
methods of malaria had increased from 27.4% in 2005 to 88% in 2010. 
ITN coverage of at least one had significantly changed from 7.5% of 
base line year to 76% in year 2010. ITN usage of pregnant women and 
children under five who slept under ITN had also considerably increased 
from 27% to 79% and 17% to 82% respectively between the two 
periods.Furthermore, treatment seeking behavior was also improved and 
the percentage of children under five with fever who took antimalarial 
drugs within 24 hours increased from 9% at baseline to 53.4% at end 
of the evaluation period. Mortality rate at health facility level decreased 
dramatically from 25% in 2005 to 2% at the end of year 2010.The results 
indicate that strengthening community system in pastoralist populations 
and linking them to the health system improve the capacity of the 
community to own their health and contribute to reduce malaria mortality.
909
MAN, ECOSYSTEM HEALTH AND MALARIA ON RUSINGA 
ISLAND, WESTERN KENYA
Evelyn A. Olanga, Wolfgang R. Mukabana
International Centre of Insect Physiology and Ecology, Nairobi, Kenya
Malaria is a leading cause of morbidity and mortality in Kenya. Existing 
evidence indicates that prevalence of the disease is greatly influenced 
by human and ecological factors. While it is well known that certain 
alterations on natural ecosystems aggravate malaria there is a dearth 
of information about the relationship between malaria and livelihoods. 
This study seeks to find the relationship between livelihoods, malaria and 
ecosystem health. The underlying objective is to generate an evidence 
base for reviewing malaria health and control policy. The study will 
be conducted on Rusinga Island, Lake Victoria, western Kenya, where 
local residents rely on fishing and small-scale farming to support their 
livelihoods. By carrying out fishing activities outdoors and at night Rusinga 
fishermen are exposed to a higher risk of malaria because (i) transmitting 
mosquitoes mainly bite at night, and (ii) currently deployed vector control 
tools are designed for indoor mosquito control. The apparently high risk of 
malaria posed by fishery and certain small-scale farming activities will be 
investigated. This will be accomplished by determining malaria prevalence 
and screening for mosquito saliva antigens among individuals associated 
with different livelihood practices. The specific livelihood-related groups 
of people that will be recruited for studies include subsistence farmers, 
fish traders, boat owners, fishing crew and stakeholders involved in 
fishery activities namely net/boat makers/repairers, transporters, and 
fish bait miners/traders. We will also attempt to explain how actions 
directed towards supporting livelihoods modify ecosystems in ways that 
may aggravate malaria. Communication tools will be developed to share 
knowledge generated from these activities among the local residents. 
An outcome mapping model will be developed to measure changes 
in behaviour among collaborating boundary partners namely Kibisom 
women group and the Mbita district public health office (Mbita-DPHO).
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SIMULATED COMMUNITY-LEVEL EFFECTS OF COMBINING 
LONG LASTING INSECTICIDAL NETS WITH INDOOR RESIDUAL 
SPRAYING FOR MALARIA CONTROL IN AFRICA
Fredros O. Okumu, Gerry F. Killeen, Sarah J. Moore
Ifakara Health Institute, Ifakara, Morogoro Region, United Republic of 
Tanzania
It is common practice to combine indoor residual spraying (IRS) with 
long-lasting insecticide nets (LLINs) in highly endemic communities, but 
there is limited evidence to suggest that the strategy confers greater 
protection against malaria than either intervention alone. Experimental 
hut trials have demonstrated improved personal and household protection 
with certain LLIN/IRS combinations, but it remains unclear whether there 
are proportionately greater benefits at community level. A deterministic 
mathematical model of mosquito life cycle processes was adapted and 
used to estimate how malaria transmission might be affected if LLINs are 
combined with IRS, relative to use of either method alone. The model was 
modified to use data derived directly from experimental hut evaluations 
where untreated bed nets are used as experimental controls. We simulated 
a closed community where residents own cattle, and the main malaria 
vector is Anopheles arabiensis, an increasingly important vector species 
in Africa, which remains a major challenge even with high LLINs and 
IRS coverage. Considering situations with either LLINs or IRS as the pre-
existing intervention, we calculated relative improvement in transmission 
control each time a complementary intervention was introduced. 
Transmission control is improved when the common pyrethroid based 
LLINs are added onto toxic IRS treatments such as pirimiphos-methyl and 
lambda cyhalothrin, but not DDT, which is known to be less toxic against 
mosquitoes. On the other hand, the outcome remains unchanged when 
IRS with lambda cyhalothrin or DDT is added to communities already 
using LLINs. Addition of pirimiphos-methyl IRS provided the greatest 
improvement relative to the LLINs alone. This in-silico assessment shows 
that whereas introduction of LLINs into communities with pre-existing 
IRS will generally result in improved control of malaria transmission, 
introduction of IRS into communities with pre-existing LLIN use will most 
likely be redundant unless the IRS is highly toxic to malaria mosquitoes.
911
EVALUATING PROGRESS OF INTENSE IMPORTED MALARIA 
TRANSMISSION IN SOUTH AFRICAN PROVINCES: 
RETROSPECTIVE ANALYSIS
Infanta M. Spence-Lewis, Ernest A. Alema-Mensah
Morehouse School of Medicine, Atlanta, GA, United States
For the past 50 years, because of national and global malaria strategies 
put in place vector transmission was low in South Africa. Successful 
early malaria control policies and strategies developed non-immunity to 
malaria amongst most South Africans. The results were an increased risk 
of complicated and severe infections from Plasmodium falciparum and 
other untreated vector species. Southern African populations consistently 
visit or migrate to and from malarious areas, including countries bordering 
South Africa. Exposure to mobile populations with malaria infections 
contributes to the burden of disease in South African Provinces. The most 
vulnerable are children under five, pregnant women and those with co 
morbidities such as HIV and TB. Imported malaria is identified as a major 
concern within endemic and non endemic Provinces of South Africa in 
regional mapping and by the Republic of South Africa’s National Malaria 
Programme Performance Review-2009. A geographical focus is used 
to identify high transmission areas in South African Provinces in low 
lying North East areas of: Limpopo, KwaZulu-Natal and Mpumalanga 
where malaria is endemic and seasonal. A literature review synthesized 
previous research from 1982-2012. The Study also analyzed trends in the 
understanding and knowledge of imported malaria in Southern Africa. 
Quantitative indicators are used to build on existing malaria control 
measures in South and Southern Africa while evaluating the progress of 
the intense burden of imported malaria in South Africa. This was achieved 
by analyzing: sentinel surveillance measures, malaria control interventions, 
and transmission rates based on data from mosquito breeding sites 
and climate. The Study emphasizes sustainable capacity building for: 
surveillance, quantification and local community participation. Cross 
border malaria initiatives from five countries bordering the Provinces of: 
Limpopo, KwaZulu-Natal and Mpumalanga were analyzed based on the 
quantitative indicators described. Studying imported malaria in South 
Africa is a regional and global contribution to: improving surveillance, 
human interaction with ecological systems that are breeding sites for 
mosquitoes, economic development, health outcomes and public health 
policies associated with malaria as a debilitating and potentially fatal 
infection.
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IMPACT OF TREATING PLASMODIUM FALCIPARUM 
ASYMPTOMATIC CARRIERS WITH ARTEMETHER-
LUMEFANTRINE ON MALARIA TRANSMISSION
Wamdaogo M. Guelbeogo1, Alphonse Traore1, Antoine Sanou1, 
John Lucas2, Sagnon N’Fale1
1Centre National de Recherche et de Formation sur le Paludisme, 
Ouagadougou, Burkina Faso, 2Sumitomo Chemical Company, Vector 
Control Division, London, United Kingdom
Asymptomatic Plasmodium falciparum carriers serve as parasite reservoirs 
for malaria transmission; and community screening and treatment of these 
asymptomatic carriers with artemether-lumefantrine (AL) may reduce 
the pool of infectious gametocytes and potentially malaria transmission 
in that area. To test this hypothesis, entomological parameters were 
assessed before and after AL treatment in a longitudinal entomological 
survey. Mosquitoes were collected once per week using the indoor 
spray catch method in 5 villages where mass screening and treatment 
of asymptomatic carriers was implemented, and in 5 control villages. 
Data collected were used to infer the human-biting rates. Mosquitoes 
collected were processed by ELISA assay to estimate sporozoite index 
and entomological inoculation rate (EIR) in each site and susceptibility 
of malaria vectors to insecticide was also determined. The population 
was provided with long-lasting insecticide treated nets (ITNs). A total of 
15768 mosquitoes were collected during the survey. After morphological 
identification, 90% were confirmed as Anopheles gambiae s.l. The 
remaining catch were not Anopheles. The temporal analysis shows that 
the density of mosquitoes increases from January to August, which 
is mainly due to the rainy season creating an abundance of breeding 
sites. The comparison of vector composition, human-biting rates, EIR 
and insecticide susceptibility between the control and the intervention 
zones is done to measure the impact of the intervention on the malaria 
transmission. Results will be presented at the conference.
913
DEVELOPMENT OF LABORATORY TESTS FOR THE PHYSICAL 
DURABILITY OF LONG-LASTING INSECTICIDAL BEDNETS
Stephen C. Smith1, Jan P. Ballard2, Teresa J. White2
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2North Carolina State University, College of Textiles, Raleigh, NC, United 
States
A key performance attribute of long-lasting insecticidal nets (LLINs) is 
durability. According to the WHO, $3.8 billion could be saved between 
2011 and 2020 if LLIN longevity can be increased from 3 years to 5 
years. Although technical advances in LLIN longevity have focused on 
insecticide retention, there is growing evidence that the net fabric can also 
deteriorate rapidly in many settings. As insecticide resistance becomes a 
greater concern, the ability of LLINs to maintain physical integrity during 
years of use becomes increasingly important. Despite this, no laboratory 
test method yet exists to evaluate the physical durability of LLINs and 
researchers must conduct multi-year comparison studies of LLINs in the 
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field to acquire durability data. The objective of the present work is to 
develop one or more laboratory tests that can be used to evaluate how 
well LLINs withstand realistic physical challenges, using standard textile 
testing equipment. The focus has been on measuring the susceptibility 
of fabrics to deterioration after suffering initial damage by rodents or hot 
surfaces. Modifications of standard bursting strength, tensile strength, 
tear resistance, and abrasion resistance test methods have been evaluated 
for reproducibility and consistency with the results of field studies. This 
investigation has also provided insight into the mechanisms of LLIN 
deterioration and possible strategies for improving durability.
914
MODELING THE EFFECTS OF VECTOR CONTROL 
INTERVENTIONS IN REDUCING MALARIA TRANSMISSION 
AND DISEASE BURDEN
Nakul Chitnis, Olivier Briet, Thomas Smith
Swiss Tropical and Public Health Institute, Basel, Switzerland
Malaria interventions are usually prioritized using efficacy estimates 
from intervention trials, without considering the context of existing 
intervention packages or long term dynamics. Currently, long lasting 
insecticidal nets (LLINs) and indoor residual spraying (IRS) form the 
mainstay of most malaria control programs. However, in the face of 
emerging resistance in mosquitoes and a push to elimination, extensions 
and new combinations of these interventions are being considered, along 
with the development of novel interventions, such as outdoor traps, 
and a revival of older interventions such as larval source management. 
We use numerical simulations of an ensemble of mathematical models 
of malaria in humans and mosquitoes to provide robust quantitative 
predictions of the effectiveness and cost-effectiveness of combinations of 
these interventions, in reducing transmission, morbidity and mortality. We 
estimate reductions in entomological inoculation rate, prevalence, clinical 
cases, and malaria deaths from simulations of different coverage levels of 
LLINs, IRS, larval control, and outdoor traps. We simulate scenarios with 
various vector distributions, and transmission and health system settings. 
Our results suggest that sustained coverage of one or two vector control 
interventions reduces malaria prevalence through the first two or three 
campaigns but does not lead to continually increasing gains beyond 
that. However, in some settings, even with sustained coverage, clinical 
incidence of malaria increases as the population loses its naturally acquired 
immunity. In some low to medium transmission settings, our simulations 
suggest that high coverage of both LLINs and IRS can lead to interruption 
of transmission; however, larval control or outdoor traps are necessary 
when a separate population of mostly outdoor biting mosquitoes exists. 
We can simultaneously capture in mathematical models the dynamics 
of mosquito ecology, malaria epidemiology, human demography, health 
systems effects, and control interventions. Fitting an ensemble of models 
to data leads to plausible quantitative predictions, with accompanying 
uncertainty ranges, of the effects of a comprehensive set of different 
interventions in reducing and potentially interrupting transmission.
915
MARKET COMPETITION AND CUSTOMER DEMAND 
DETERMINE STOCKING PATTERNS AND RETAIL PRICES OF 
ACTS IN PRIVATE DRUG SHOPS IN TANZANIA
Peter S. Larson1, Prashant Yadav1, Jessica Cohen2, Sarah Alphs1, 
Jean Arkedis3, Julius Massaga4
1University of Michigan, Ann Arbor, MI, United States, 2Harvard University, 
Cambridge, MA, United States, 3Results for Development, Washington, 
DC, United States, 4National Institute for Medical Research, Dar es Salaam, 
United Republic of Tanzania
Many sub-Saharan African households utilize the private sector as a 
primary source of treatment for malaria episodes. Cost, however, is 
reported to be a major impediment to shop level stocking of effective 
anti-malarials such as ACTs. The Affordable Medicines Facility - malaria 
(AMFm), an innovative financing mechanism hosted by the Global Fund, 
is a unique supply side subsidy designed to increase availability of ACTs in 
eight pilot countries including Tanzania. A series of shop level surveys of 
private drug retailers in two regions of Tanzania aimed to discover supply 
and demand side factors which determine availability and reported retail 
sale price of subsidized ACTs in private shops. Accredited Drug Dispensing 
Outlets (ADDOs) in the Rukwa and Mtwara regions were surveyed 
between Feb 2011 and May 2012. Surveyors noted whether subsidized 
ACTs were being sold and recorded retail prices. Shop attendants were 
asked a battery of questions including malaria knowledge, source of 
drug supply, and participation in training programs. Exit interviews with 
customers at the ADDOs provided data on the type and price of the 
antimalarial purchased. Trends and extent of ACT stocking over time and 
space were described using statistical and spatial methods. Supply side 
determinants of ACT stocking were assessed using distance to reported 
medicine supplier. Competition from surrounding providers was assessed 
using the location of retail shops and public reproductive health clinics 
(RCH). GIS layers for surrounding population were used to estimate the 
size of catchment populations. Remoteness and distance to wholesale 
sources of medicines were not found to be associated with ACT stocking 
patterns. Shop size and population were found to be highly associated 
with ACT stocking. Proximity to other shops stocking ACTs (p=.04) 
and increased number of competing shops (p=.006) were statistically 
significantly associated with an increased likelihood of stocking ACTs 
in Rukwa. Similarly, presence of RCH clinics determined stocking. High 
numbers of proximal shops was also associated with increased prices 
charged for ACTs. Stocking of ACTs and prices charged were both higher 
in areas along Lake Rukwa than in other areas of similar distance from 
urban areas and population size. The AMFm program appears to have 
resulted in increased availability of ACTs, though shop level factors also 
influence stocking and prices charged.
916
INDUCIBLE INSULIN-LIKE PEPTIDE SYNTHESIS IN ANOPHELES 
STEPHENSI: A MECHANISM FOR PLASMODIUM MEDIATED 
IMMUNOSUPPRESSION
Jose E. Pietri, Shirley Luckhart
University of California, Davis, Davis, CA, United States
The insulin-like peptides (ILPs) and their respective signaling and regulatory 
pathways are highly conserved across diverse phyla. Previously, we 
reported that infection with the human malaria parasite, Plasmodium 
falciparum, induces ILP transcription in the midgut of Anopheles stephensi, 
suggesting that the ILPs are produced in response to infection-associated 
signals and modulate some aspects of sporogonic development. 
In particular, our data revealed that soluble factors derived from P. 
falciparum, but not from bacteria or fungi, can induce ILP transcription 
and secretion in An. stephensi cells. This induction was dependent on 
insulin/insulin-like growth factor signaling (IIS) through MEK-ERK and 
PI3K-AKT activation. Additionally, knockdown of an infection-induced 
ILP in vivo resulted in enhanced immune effector gene expression and 
decreased parasite survival in P. falciparum infected mosquitoes. Together, 
these data suggest that Plasmodium-specific factors signal through IIS to 
induce immunosuppressive ILPs in the midgut, a critical tissue for parasite 
development. The ILPs should be considered, therefore, important targets 
in future efforts to engineer Plasmodium-resistant mosquitoes.
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AGE AND MALARIA RISK DETERMINE INSECTICIDE TREATED 
NET USE NEAR LAKE VICTORIA, MBITA DISTRICT, KENYA
Peter S. Larson1, Noboru Minakawa2, Gabriel O. Dida3, Mark L. 
Wilson1
1University of Michigan, Ann Arbor, MI, United States, 2Nagasaki 
University, Nagasaki, Japan, 3Kenya Medical Research Institute, Nairobi, 
Kenya
Despite scaled-up coverage of insecticide treated nets (ITNs) in malarious 
areas of sub-Saharan Africa, proper and regular ITN use remains 
inadequate. An understanding of what determines ITN use could help 
improve effectiveness. In early 2011, a household-level, questionnaire-
based survey of ITN practices was conducted following a mass distribution 
program. The goal was to assess post-intervention Plasmodium infection, 
and whether households used ITNs to protect target groups such as 
pregnant women and children. Following a complete enumeration of 
all households (~3,340), each one was censused for all residents and 
surveyed. Pre-school children were tested for presence of parasites using 
PCR methods. Questions of household heads involved who slept under 
what ITN the previous night, as well as age and sex. Data analysis involved 
spatial methods and regression models tailored to account for non-
linear patterns in age-related ITN use. GIS methodologies were used to 
determine spatial patterns of ITN use and malaria cases. Information on 
12,095 individuals aged 90 years old was gathered, of which ~25% were 
<5 years of age. More than half (56%) of people reported not sleeping 
under an ITN the previous night. Age was an important determinant of ITN 
use. Adults over 30 and infants sleep under ITNs more than children and 
young adults. The distribution of age and ITN use followed a significant 
(p <0.001) nonlinear pattern, decreasing from birth to age 18, increasing 
to and remaining constant after age 30. This pattern was significant even 
when accounting for confounding factors. Differences in gender were 
not significant for any age group, but women between the ages of 15 
and 30 tended to use ITNs more than males. Household-level clusters 
of Plasmodium infections were associated with fewer children sleeping 
under nets, and were geographically located in wet, low lying areas closer 
to the lake, despite high levels of net use and possession. Though ITNs 
were found to be effective in reducing Plasmodium infections, spatially, 
evidence suggests that net possession and use were highest in areas 
prone to nuisance mosquitoes and possible perception of high malaria 
risk. Results suggest that ITN use may be high among some members of 
higher-risk groups, however there is inadequate coverage among young 
and school-age children. Efforts to further scale up ITN possession and 
programs to focus messages regarding proper use remain necessary
918
SHIFTING FROM BLANKET TO TARGETED INDOOR RESIDUAL 
SPRAYING FOR MALARIA CONTROL IN ZANZIBAR: A NOVEL 
APPROACH FOR INTEGRATED MANAGEMENT OF MALARIA 
VECTORS
Shabbir Lalji1, Abdullah R. Salum1, Abdullah A. Suleiman2, Abdul-
wahid H. Al-mafazy2, Rosemary Lusinde1, Peter McElroy3, Mahdi 
Ramsan1, Uche Ekenna1, Jessica M. Kafuko3, Fabrizio Molteni1
1RTI International, Dar-es-Salaam, United Republic of Tanzania, 2Zanzibar 
Malaria Control Programme, Zanzibar, United Republic of Tanzania, 
3President’s Malaria Initiative, Dar-es-Salaam, United Republic of Tanzania
Zanzibar (1.2 million population) has significantly reduced Plasmodium 
falciparum prevalence to less than 1% over six years through scale-up 
of multiple malaria interventions, including indoor residual spraying 
(IRS) and long-lasting insecticidal nets (LLINs). Between 2006 and 2011 
six rounds of blanket IRS with lambda-cyhalothrine were applied to 
210,000 structures. A policy to transition from blanket to targeted 
IRS was agreed to by Ministry of Health and partners in 2009 pending 
universal coverage of LLINs, establishment of a weekly surveillance system 
for diagnostically confirmed malaria cases, and an insecticide resistance 
mitigation plan (IRMP). In 2012 universal coverage of LLINs was achieved, 
weekly malaria surveillance was scaled-up to all 142 public health 
facilities with complete (100%) and timely (77% by Friday) reporting, 
and an IRMP was introduced. Malaria incidence was calculated for each 
health facility catchment area as the number of confirmed P. falciparum 
cases per 1000 population per year and used as the primary indicator 
for selecting locations for targeted IRS. Incidence for all of Zanzibar in 
2011 was 2.4/1000/yr (95% CI, 2.3-2.5/1000/yr). The peak transmission 
period incidence was 5.6/1000/yr (95% CI, 5.4-5.8/1000/yr) during May 
to August compared to 0.7 and 0.9/1000/yr during January to April and 
September to December, respectively. We defined three risk strata: A) 
<0.3 cases/1000/yr; B) 0.3-15 cases/1000/yr; and C) >15 cases/1000/yr. 
Category A received no targeted IRS, category B one round, and category 
C two rounds. Based on the seasonal incidence data, the first targeted 
round of IRS with bendiocarb was completed in March 2012 for 120,000 
structures (category B and C). A second round will target 15,000 of 
these same structures (category C) in September 2012. Zanzibar has met 
policy prerequisites to transition from blanket to targeted IRS. Weekly 
surveillance data will be monitored to assess whether targeted IRS can 
further reduce malaria transmission. These findings will help inform other 
malaria control programs considering a scale-down IRS after universal LLIN 
coverage is achieved.
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STRENGTHENING COMMUNITY SYSTEM FOR MALARIA 
CONTROL: THE CONTEXT OF GLOBAL FUND GRANT IN 
SENEGAL
Sylla Thiam1, Mamadou Lamine Diouf2, Moussa Thior3, Mame 
Birame Diouf4, Cheikh Thiam2, Ouleye Tall Beye2, Ibrahima Diallo2, 
Fatou Ba Fall2, Medoune Ndiop2, Moustapha Cisse2, Cheikh Tacko 
Diop2
1AMREF HQ, Nairobi, Kenya, 2Programme National de Lutte contre 
le Paludisme, Dakar, Senegal, 3Ministere de la Sante, Dakar, Senegal, 
4Intrahealth, Dakar, Senegal
Community involvement in health programming aims to achieve 
improved outcomes of interventions to deal with major health challenges 
such as HIV, tuberculosis and malaria. This is vital for making progress 
towards universal access to health care and meeting the Millennium 
Development Goals. Support for community-level and NGO programming 
is a key component of Global Fund grants. However, there remains 
lack of evidence and lessons learned about how Community System 
Strengthening (CSS) can be developed, effectively implemented and 
linked to the formal health system in a malaria endemic country. This 
paper reports Senegal’s National Malaria Control Programme experience 
on CSS using Global Fund opportunity. Available information generated 
between 2005 and 2010 from the program database, annual reports, 
reports to the Global fund, partners reports, program performance 
review reports, surveys and published articles were reviewed. The Global 
Fund framework for CSS was used to analyze the malaria program 
contribution. Sixty nine District Health Teams (DHTs)- through District 
Community Networks Against Malaria- and 16 NGOs were involved as 
sub recipients to implement community based interventions. A total of 
34,628 community volunteers were trained to carry out sensitization 
and awareness campaigns, distribute nets, and destroy breeding sites. 
A further 3,176 community health workers (in the health huts) and 861 
Home Care Providers (HCPs) in remote areas were involved in malaria 
case management using RDT and ACT. In this process, local capacity 
was built and stakeholders involved in the entire process from planning 
to assessment. ITN coverage increased among children under five from 
9.7% in 2005 to 45% in 2010. Between 2009 -2010, 12,582 suspected 
malaria cases were managed by HCPs, 93% of whom were tested with an 
RDT. Among those tested, 37% had a positive RDT, 97% of whom were 
treated and got cured. CSS by building capacity of local communities and 
actively involving them in improving their own health is a key means to 
control malaria and sustain gains in resource poor countries.
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IMPACT OF COMMUNITY SCREENING AND TREATMENT OF 
ASYMPTOMATIC CARRIERS OF PLASMODIUM FALCIPARUM 
WITH ARTEMETHER-LUMEFANTRINE ON ASYMPTOMATIC 
AND GAMETOCYTE CARRIAGE: A 12-MONTH, CLUSTER-
RANDOMIZED STUDY IN SUB-SAHARAN AFRICA
Alfred B. Tiono1, Alphonse Ouédraogo1, Bernhards Ogutu2, 
Amidou Diarra1, Sam Coulibaly1, Marc Cousin3, Christine Remy3, 
Amitava Mukhopadhyay4, Issiaka Soulama1, Sodiomon B. Sirima1, 
Kamal Hamed5
1Centre National de Recherche et de Formation sur le Paludisme, 
Ouagadougou, Burkina Faso, 2Walter Reed Project-Centre for Clinical 
Research, Kenya Medical Research Institute, Nairobi, Kenya, 3Novartis 
Pharma AG, Basel, Switzerland, 4Novartis Healthcare Private Limited, 
Hyderabad, India, 5Novartis Pharmaceuticals Corporation, East Hanover, 
NJ, United States
Human to mosquito transmission of Plasmodium falciparum depends on 
the presence of sexual stage parasites, gametocytes, in the peripheral 
blood. Interventions in asymptomatic carriers (ACs) aiming to reduce 
disease transmission should also be effective against gametocytes. 
This 12-month, controlled, parallel, cluster-randomized (18 clusters: 9 
intervention, 9 control) study was conducted in Burkina Faso to evaluate 
the impact at the community level of systematic screening and artemether-
lumefantrine (AL)/AL dispersible treatment of RDT-detected ACs during 
three community screening campaigns (CSCs 1-3). CSCs 1-3 occurred 
before the rainy season and CSC4 occurred after, marking the end of 
the study. Symptomatic malaria episodes were treated with AL or an 
alternative in both arms during the study. The prevalence of microscopy-
confirmed ACs in the intervention and control arms was 42.8% vs. 
47.5%; 4.1% vs. 35.7%; 2.8% vs. 32.2% and 34.4% vs. 37.8% at CSC1, 
2, 3 and 4, respectively. The proportion of gametocyte carriers (GCs) was 
evaluated by microscopy in all subjects at CSCs 1-4 in the intervention 
arm and in a randomly selected 40% subset of the control arm, and by 
qRT-PCR at CSC4 in 1,999 randomly selected subjects across both arms. 
The overall proportion of GCs in the intervention and control arms was 
9.5% vs. 10.2%, 0.6% vs. 5.5%, 0.4% vs. 5.8% and 4.8% vs. 5.1% at 
CSC1, 2, 3 and 4, respectively. The prevalence (least square mean (SE)) of 
microscopy-confirmed GCs at CSC4 in the intervention arm was 4.9 (0.41) 
vs. 5.1 (0.41) in the control arm (p=0.7208). Prevalence of GCs at CSC4 as 
assessed by qRT-PCR was around 8 times greater in both arms compared 
to microscopy (49.7% vs. 6.0% intervention; 47.3% vs. 5.4% control). 
In this community-setting study, the intervention arm showed greater 
reductions in the prevalence of ACs and GCs than the control arm at CSCs 
2 and 3, relative to CSC1 (p<0.0001). However, AC and GC prevalence 
rose thereafter in the intervention arm to reach a level similar to the 
control arm at CSC4 (p=NS).
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ONLINE INTERACTIVE PLATFORM FOR MAPPING REPORTS OF 
INSECTICIDE RESISTANCE IN MALARIA VECTORS
Tessa B. Knox1, Helen Pates Jamet2
1Vestergaard Frandsen (East Africa), Nairobi, Kenya, 2Vestergaard Frandsen 
SA, Lausanne, Switzerland
Insecticide-based interventions including indoor residual spraying and 
treated bed nets have led to significant reductions in malaria morbidity 
and mortality. However, the emerging and rapid spread of resistance 
to all available classes of public health insecticides threatens current 
malaria vector control efforts. The Global Plan for Insecticide Resistance 
Management released by the WHO in May 2012 contained guidance on 
the rationale and implementation of strategies for preserving the efficacy 
of current tools, which included utilization of insecticide resistance data 
for informing vector control decisions. There has long been a need for 
a comprehensive global resistance database to aggregate data currently 
scattered across many sources in order to facilitate a coordinated response 
across the malaria-stakeholder community. IR Mapper was developed 
to address this need (www.irmapper.com); this free online resource 
consolidates published information from WHO susceptibility tests on 
Anopheles malaria vectors from 1959 to date. Information is provided via 
a user-friendly interface that allows users to project data on maps based 
on selected vector species, insecticide classes and types. Susceptibility 
data are viewable based on old WHO susceptibility categories or using the 
new categories as recommended from May 2012. Resistance mechanism 
data are similarly presented, with links to original data sources provided 
along with other key study information. The utility of this resource will 
be demonstrated using examples from two large-scale malaria control 
programs in Africa.
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SEROPREVALENCE OF TOSCANA VIRUS INFECTIONS AMONG 
RURAL POPULATIONS IN AZERBAIJAN
Jason M. Blaylock1, Emilya Nasirova2, Afrail Ismayilov2, Eric 
Garges1, Luis J. Martinez1
1Walter Reed Army Institute of Research, Silver Spring, MD, United States, 
2Republican Anti-Plague Station, Azerbaijan Republic Ministry of Health, 
Baku, Azerbaijan
The sandfly fever viruses are endemic to the Mediterranean region and 
well known causes of human illness there. The Toscana virus (TOSV) 
serotype displays a unique neurotropism and can cause a meningitis or 
meningoencephalitis in some cases. Little is known about the geographic 
distribution of Toscana virus outside of the Mediterranean basin. While the 
Phlebotomus spp. sandfly fever vector has been associated with visceral 
leishmaniasis in Azerbaijan, the presence of TOSV infection in this region 
has never been assessed. In Azerbaijan, the etiology of febrile illnesses and 
cases of meningitis are underreported due to low healthcare utilization 
and lack of laboratory diagnostics. However, public health officials suspect 
high rates of arboviral infections along the Azerbaijan-Russia border. 
Previous studies have attempted to document the seroprevalence of 
several zoonotic infections in this region, however no studies to-date 
have evaluated the prevalence of TOSV infection there. We obtained 
755 serum samples that were previously accessed from adults from the 
villages of Guba, Gusar, and Xachmaz as part of a cross-sectional study 
[USAMRIID HUC FY07-31 (APS TNK 004)(WRAIR 1435)] and analyzed the 
prevalence of TOSV antibodies using an IgG TOSV detection kit [DIESSE, 
Siena, Italy]. The subject population included 796 adults over the ages of 
18 years, 72% of who were less than 50 years of age, 56.4% of whom 
were female, and 75.3% of Azerbaijani ethnicity. We found a total of 18 
positive samples, resulting in a seroprevalence of 2.38%. This initial study 
is the first to document the presence of TOSV infection in the Republic of 
Azerbaijan. Although the majority of TOSV infections are asymptomatic, 
further testing may be warranted for suspected cases in which subjects 
present with fevers, headaches, and/or symptoms of meningitis or 
meningoencephalitis of unknown etiology. This study also helps to 
establish a need for further epidemiologic and surveillance studies in this 
region.
923
DETECTION OF EASTERN EQUINE ENCEPHALOMYELITIS 
VIRUS RNA IN NORTH AMERICAN SNAKES
Andrea M. Bingham1, Sean P. Graham2, Nathan D. Burkett-
Cadena1, Gregory S. White1, Thomas R. Unnasch1
1University of South Florida, Tampa, FL, United States, 2Auburn University, 
Auburn, AL, United States
The role of non-avian vertebrates in the ecology of Eastern Equine 
Encephalitis virus (EEEV) is unresolved, but mounting evidence supports 
a potential role for snakes in the EEEV transmission cycle, especially as 
over wintering hosts. To determine rates of exposure and infection, we 
examined serum samples from wild snakes at a focus of EEEV in Alabama 
for viral RNA using RT-PCR. Two species of vipers, the Copperhead 
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(Agkistrodon contortrix) and the Cottonmouth (Agkistrodon piscivorus), 
were found to be positive for EEEV RNA using this assay. Prevalence of 
EEEV RNA was more frequent in seropositive snakes than seronegative 
snakes. RT-PCR positivity in cottonmouths peaked in April and September. 
Body size and sex ratios were not significantly different between infected 
and uninfected snakes. These results support the hypothesis that snakes 
are involved in the ecology of EEEV in North America, possibly as winter 
maintenance hosts for the virus.
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A LABORATORY CONFIRMED CASE OF JAMESTOWN 
CANYON VIRUS ENCEPHALITIS IN A QUEBEC RESIDENT WITH 
TRAVEL HISTORY TO MAINE AND NEW HAMPSHIRE
Michael A. Drebot1, Kristina Dimitrova1, Maya Andonova1, 
Stephen Turner2, Bouchra Serhir3, Michel Couillard3, Cecile L. 
Tremblay3
1National Microbiology Laboratory, Public Health Agency of Canada, 
Winnipeg, MB, Canada, 2Hopital Fleury, Montreal, QC, Canada, 
3Laboartoire de sante publique du Quebec - Institut national de sante 
publique du Quebec, Montreal, QC, Canada
Jamestown Canyon virus (JCV) is a mosquito-borne arbovirus belonging to 
the California serogroup (CSG) of bunyaviruses. JCV is widely distributed 
throughout North America, however, reports of human JCV infection with 
associated febrile and neurological disease are rare. We report a recent 
laboratory confirmed case of JCV encephalitis in a Montreal, Quebec 
resident with travel history to Maine (ME) and New Hampshire (NH). The 
patient was a 53 year old male who presented with symptoms of fever, 
headache and chills 10 days after returning from a camping trip in ME and 
NH in mid August, 2011. Several days later he was hospitalized and his 
illness progressed to an altered mental state comprising of confusion and 
difficulty speaking suggestive of encephalitis. He had trouble breathing 
and was intubated. He was hospitalized for approximately a month 
during which blood was collected and lumbar punctures performed. 
Cerebrospinal fluid (CSF) testing indicated normal protein and glucose 
with the presence of a low leukocyte count. Serological testing of acute 
and convalescent serum collected three weeks apart gave a 4-fold rise in 
specfic neutralizing antibody to JCV (640 to 2560). Using a CDC-based 
IgM ELISA the acute and convalescent serum samples were positive 
for JCV IgM. Testing of acute and convalescent CSF for JCV antibodies 
also indicated a positive IgM result for JCV and a seroconversion by 
neutralization testing (range 0 -16). Significantly lower or negative cross 
reacting titres were observed for related CSG viruses such as snowshoe 
hare and La Crosse viruses and no antibodies were detected to other 
arboviruses such as West Nile, eastern equine encephalitis, or Powassan 
virus. Based on several laboratory case definition criteria our results 
indicate that the patient’s febrile and neurological symptoms were 
associated with an infection of JCV. The incubation period of JCV is 
believed to range from 3 to 14 days and the travel history of the patient 
is consistent with exposure to JCV infected mosquitoes in ME or NH. It is 
also possible that he may have been infected in Quebec since symptom 
onset did occur several days after his return to Canada. Based on available 
CDC CSG virus case data no confirmed cases of JCV illness have been 
documented in ME or NH previously. Our findings underscore that JCV 
can cause serious neurinvasive disease such as encephalitis and should be 
considered when an arbovirus infection is suspected in this region of North 
America.
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VIRAL ETIOLOGIES OF DIARRHEA AMONG CHILDREN 
ATTENDING LWAK MISSION HOSPITAL IN ASEMBO, 
WESTERN KENYA
Petronella Ahenda1, Zipporah Ng’ang’a2, Sandra Panchalingam3, 
Allan Audi4, Anthony Gichangi5, Daniel Feikin6, Joseph Oundo5, 
Robert Breiman5
1Kenya Medical Research Institute-Centers for Disease Control and 
Prevention, Nairobi, Kenya, 2Jomo Kenyatta University of Agriculture and 
Technology, Juja, Kenya, 3University of Maryland, Baltimore, MD, United 
States, 4Kenya Medical Research Institute- Centers for Disease Control and 
Prevention, Kisumu, Kenya, 5Centers for Disease Control and Prevention, 
Nairobi, Kenya, 6Johns Hopkins Bloomberg School of Public Health, 
Baltimore, MD, United States
Enteric viruses are important causes of gastroenteritis in young children 
globally. Most etiologic studies in developing countries have focused on 
hospitalized children with a paucity of outpatient cases. We characterized 
the etiologic distribution, epidemiology and clinical characteristics 
for diarrhea-associated viruses in children less than fourteen years of 
age living in a rural area in western Kenya. Two-hundred and six stool 
specimens collected between January 2007 and June 2010, from children 
≤14 years old with diarrhea, who visited the study clinic for population-
based infectious disease surveillance in Asembo, were screened for 
enteric viruses. Enzyme immunoassays were used to detect rotavirus 
and adenovirus, and reverse transcriptase multiplex polymerase chain 
reaction (RT-PCR) assay was used for norovirus, astrovirus and sapovirus. 
At least one viral agent was detected in 26.7% (55/206) of specimens; 
rotavirus was detected in 13.6% (28/206), norovirus in 6.3% (13/206), 
adenovirus in 4.9% (10/206), astrovirus in 2.9% (6/206) and sapovirus in 
1.5% (3/206) respectively. Viral co-infection was shown in 9.1% (5/55) 
of positive specimens, with 4 of 55 co-infections attributable to rotavirus 
dual infections. Ages of the children ranged from 3 months to 14 years 
(mean age = 4.6 years; median = 2.5 years). About one third (32.6%) of 
the specimens with a virus detected were from children less than 2 years 
of age. The main clinical symptom of the children from whom a virus 
was detected was fever (78.6%). These findings suggest that at least five 
enteric viruses are potentially important agents for diarrhea in this rural 
site in western Kenya. Defining clinical and epidemiologic characteristics 
predictive of viral etiology may have implications for the management of 
diarrhea in children in Kenya and similar settings.
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IDENTIFICATION OF NEUTRALIZING ANTIBODY EPITOPES ON 
CHIKUNGUNYA VIRUS ENVELOPE PROTEIN
Kristen M. Kahle1, Rachel Fong1, Suganya Selvarajah2, Kimberly-
Anne Mattia1, Trevor Barnes1, Joseph Rucker1, Cheryl Paes1, 
Graham Simmons2, Benjamin J. Doranz1
1Integral Molecular, Inc., Philadelphia, PA, United States, 2Blood Systems 
Research Institute, San Francisco, CA, United States
To obtain anti-Chikungunya (CHIKV) Envelope monoclonal antibody 
(MAb) epitope maps at the resolution of individual amino acids, we 
individually mutated 920 residues of CHIKV (S27 strain) Envelope protein 
(E2/E1) to alanine, expressed each mutant in human cells, and analyzed 
them for effects on antibody reactivity and viral infectivity. This ‘Shotgun 
Mutagenesis’ approach offers the capability of mapping both linear and 
conformational epitopes, even for structurally complex proteins including 
oligomeric and glycosylated Envelope proteins such as CHIKV E2/E1. The 
neutralizing human anti-CHIKV MAbs used in our studies were derived 
from infected patient B-cells using phage display library panning against 
purified CHIKV virus like particles (VLPs) and from B-cell cloning. Critical 
amino acids required for the binding of each MAb were identified and 
visualized on the E2/E1 protein structure. We also determined the binding 
affinity and kinetics of these MAbs to intact CHIKV VLPs on a biosensor. 
Our goal is to map epitopes on CHIKV Env protein, determine how they 
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contribute to neutralization of infection, and how they relate to protein 
function. We expect that this approach will help define the range of 
immunodominant structures on CHIKV Env and identify novel neutralizing 
antibody epitopes that can be used for the development of improved 
therapeutics, diagnostics, and vaccine candidates.
927
DEVELOPMENT OF AN IRES-BASED VACCINE FOR WESTERN 
EQUINE ENCEPHALITIS VIRUS
Nicholas A. Bergren, Rodion V. Gorchakov, Shannan L. Rossi, 
Kenneth Plante, Scott C. Weaver
University of Texas Medical Branch, Galveston, TX, United States
Western equine encephalitis virus (WEEV), is a member of the family 
Togaviridae, genus Alphavirus, has a single-stranded, positive-sense RNA 
genome, and is an important mosquito-transmitted human and veterinary 
pathogen in North and South America. Infection with WEEV can result in 
severe neurological sequelae in human survivors, with an economic impact 
ranging from 21,000 to 3 million dollars per case. WEEV is also considered 
a bioterroism agent since aerosolized virus causes high primate mortality. 
Regrettably, there is no vaccine or antiviral therapies to aid in mitigating 
a natural outbreak, bioterrorist attack, or accidental lab exposure. The 
objective of this study was to develop a safe and efficacious WEEV 
vaccine. Two different live-attenuated WEEV vaccines were engineered 
via the introduction of an internal ribosomal entry sequence (IRES) from 
encephalomyocarditis virus (EMCV), to control translation of the structural 
(WEEV/IRESv1) or capsid (WEEV/IRESv2) protein(s). Previous research 
shows the IRES element from EMCV cannot initiate efficient translation in 
arthropod cells, making this vaccine unable to be propagated in its natural 
transmission cycle. Serial passaging in Vero cells showed no reversion to a 
wild-type-like phenotype; however, several mutations were observed in the 
structural genes that provided for higher titers in cell culture. WEEV/IRESv1 
and WEEV/IRESv2 were tested for immunogenicity and attenuation in 
relevant murine models. Our results suggest that our IRES-dependent live-
attenuated vaccine for WEEV merits further study and this vaccine could 
be used for the development of an emergency vaccine that can be used 
during a natural outbreak, bioterrorism attack, or accidental lab exposure.
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DISTRIBUTION OF KILLER CELL IMMUNOGLOBULIN-LIKE 
RECEPTORS (KIR) GENES IN AN ADMIXED PERUVIAN 
POPULATION
Sandra S. Morales1, Daniel Clark2, Elsa Gonzalez1, Eduardo 
Gotuzzo1, Michael J. Talledo1
1Institute of Tropical Medicine Alexander von Humboldt Universidad 
Peruana Cayetano Heredia, Lima, Peru, 2Laboratorios de Investigación y 
Desarrollo (LID), Universidad Peruana Cayetano Heredia, Lima, Peru
KIR are glycoproteins located on the surface of NK cells. These receptors 
are classified into two groups according to their cytoplasmic domain, 
which transduces inhibitory or activating signals, and consequently 
modulates NK cell function and most likely the susceptibility to diseases 
or infections. We studied the distribution of KIR genes in 363 Peruvian 
HTLV-1-infected individuals using two ethnic classification methods: 1) a 
questionnaire, which defined the participants as Andean (both parents 
born in the Andes) or Mestizo (only one parent born in the Andes); and 
b) ancestry informative markers (AIM), which allowed classifying the 
whole population into three groups according to their ethnic admixture 
proportions. DNA was obtained from blood samples of each individual and 
KIR genotyping was carried out using PCR-SSP. No significant differences 
were observed in gender and age according to the Andean/Mestizo 
classification, whereas significant differences were found when the ethnic 
admixture proportion criterion was applied. The frequency of KIR2DS3, 
KIR2DS4 and KIR2DL3 were statistically different between Andeans 
and Mestizos. When using ethnic admixture proportion, significant 
differences were observed for KIR3DL1 and KIR2DS4s in addition to those 
genes, among the three groups defined. No significant differences were 
detected in haplotypes and inhibitory-activating KIR genes using either the 
questionnaire or AIM-based classification. AIM helps minimizing both the 
bias in ethnic group definition and the effects of population stratification, 
and therefore should be used in order to avoid false results when 
searching for gene-disease associations in admixed populations.
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NOROVIRUS INFECTION IN PERU
Maria E. Silva, Giannina Luna, Carlos A. Figueroa, Erik J. Reaves, 
Juan F. Sanchez, Kimberly A. Edgel, Matthew R. Kasper, Drake H. 
Tilley, Paul C. Graf, Andres G. Lescano, Daniel G. Bausch
Naval Medical Research Unit - 6, Bellavista, Peru
Norovirus (NoV) is one of the most frequent causes of outbreaks and 
sporadic cases of gastroenteritis worldwide. Although rarely fatal, NoV 
transmission has important economic repercussions, including loss of 
work days and incurrence of costly medical care. The incidence of NoV 
gastroenteritis is usually highest in adults. Although well-studied in 
industrialized countries, few data are available on NoV in the developing 
world. We report NoV surveillance data from 3 distinct regions and 
populations in Peru. The first two surveillance populations and areas 
were healthy children <5 years old in rural communities near the town 
of Pisco (coastal desert) in 2009 and in Loreto District (Amazon forest) 
in 2010. The third target population and surveillance area was from a 
9-year prospective cohort study of diarrheal illness among Peruvian military 
recruits at the Vargas-Guerra Army Training Base in the city of Iquitos, also 
in the Amazon. At each site, fecal samples were collected and sent to the 
U.S. Naval Medical Research Unit-6 laboratory in Lima for testing for NoV 
by real-time PCR. From Pisco, NoV was found in 27 (9%) of 294 samples. 
Five (19%) were genotype I and 22 (81%) II. From Loreto, 32 (11%) of 
290 samples were positive_10 (31%) genotype I and 22 (69%) genotype 
II. From the Vargas-Guerra Training base, 49 (25%) of 200 samples were 
positive_6 (12%) for genotype I, 38 (78%) for genotype II, and 5 (10%) 
co-infection with both genotypes. Our results indicate that NoV circulates 
in both pediatric and adult populations in Peru and that genotype II 
predominates. Interestingly, infection was common even in the healthy 
children. Epidemiologic studies are underway to explore the significance 
of the NoV infections in children and the ultimate incidence of disease. 
In addition, we are undertaking further molecular characterization and 
phylogenetic analysis of NoV strains in Peru.
930
SEROPREVALENCE OF ALPHAVIRUSES AND FLAVIVIRUSES 
IN FREE-RANGING GAME ANIMALS AND NON-HUMAN 
PRIMATES IN THE CONGO BASIN
Rebekah J. Crockett1, Erin Borland1, Mike Cranfield2, Ann 
Powers1
1Centers for Disease Control and Prevention, Fort Collins, CO, United 
States, 2Mountain Gorilla Veterinary Project, Baltimore, MD, United States
Vector-borne and zoonotic pathogens have comprised a significant 
proportion of the emerging infectious diseases in humans in recent 
decades. The role of many wildlife species as reservoirs for arthropod-
borne viral pathogens is poorly understood. We aimed to investigate the 
exposure history of various African wildlife species from the Congo Basin 
to mosquito-borne flaviviruses (Flaviridae: Flavivirus) and alphaviruses 
(Togaviridae: Alphavirus) by testing previously-archived serum samples. 
In total, sera from 24 African forest buffalo (Syncerus caffer nanus), 34 
African elephants (Loxodonta africana), 40 duikers (Cephalophus and 
Philantomba species), 25 mandrills (Mandrillus sphinx), 32 mountain 
gorillas (Gorilla beringei beringei), five Grauer’s gorillas (Gorilla beringei 
graueri), two L’hoest’s monkeys (Cercopithecus lhoesti), two golden 
monkeys (Cercopithecus kandti), and three chimpanzees (Pan troglodytes) 
sampled between 1991 and 2009 in the Congo basin were tested for 
antibodies against chikungunya virus (CHIKV) (Togaviridae: Alphavirus), 
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o’nyong-nyong (ONNV) (Togaviridae: Alphavirus), West Nile virus (WNV) 
(Flaviridae: Flavivirus), dengue 2 virus (DENV-2) (Flaviridae: Flavivirus), 
and yellow fever virus (YFV) (Flaviridae: Flavivirus) by plaque reduction 
neutralization test. Specific neutralizing antibodies against ONNV were 
found in African forest buffalo in the Democratic Republic of the Congo 
(DRC) and Gabon, duikers in the DRC, and mandrills in Gabon, providing 
novel evidence of enzootic circulation of ONNV in these countries. In 
addition to ONNV, African forest buffalo in the DRC and Gabon had been 
exposed to CHIKV, WNV, and DENV-2, while mandrills in Gabon were also 
seropositive for CHIKV, DENV-2, WNV, and YFV. One hundred percent 
of elephants tested had a very strong neutralizing antibody response to 
WNV. This study also represents the first arbovirus serosurvey of gorillas, 
of which 4/32 (12.5%) were seropositive for either an alphavirus and/
or flavivirus. Our results demonstrate a high prevalence of neutralizing 
antibodies against these arboviruses in wildlife in the Congo basin.
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SIMIAN FOAMY VIRUS AND HERPES VIRUS IN CAPTIVE NEW 
WORLD PRIMATES IN PERU
Bruno M. Ghersi1, Ana Patricia Mendoza2, Hugo Razuri1, Ada 
Romero1, Andrew Bennett3, William M. Switzer4, Hongwei Jia4, 
Joe Zunt5, Daniel G. Bausch1, Joel M. Montgomery4
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Society, Lima, Peru, 3Tulane School of Public Health and Tropical Medicine, 
New Orleans, LA, United States, 4Centers for Disease Control and 
Prevention, Atlanta, GA, United States, 5University of Washington, Seattle, 
WA, United States
Many species of New World primates (NWPs) exist in Peru and are 
frequently illegally captured for pet trade, traditional medicine, or 
consumption. Government confiscation and placement of these animals 
has led to extreme crowding in zoos and rescue and rehabilitation centers, 
providing ideal conditions for animal-human transmission of zoonotic 
pathogens. Simian foamy viruses (SFV) are retroviruses found in high 
prevalence in various simian species. Infection has occurred in humans 
exposed to Old World monkeys and apes in captivity and in nature. 
Previous reports show genetically distinct SFV variants among NWPs but 
these data are limited to small numbers of captive monkeys from genera 
Cebus, Saimiri, Ateles, and Callithrix. Herpes viruses are ubiquitous agents 
that infect a variety of animals, with co-evolution between each unique 
herpes virus and its reservoir species. Herpes viruses are easily transmitted 
from their reservoirs to accidental hosts through direct contact and 
fomites, often resulting in a fatal outcome. We assessed the prevalence 
of SFV and herpes virus infection in captive NWPs to help assess the risk 
of infection of these zoonotic viruses to humans with exposure to these 
animals. Serum samples were collected and tested for antibodies to 
SFVs by enzyme immunoassay, with confirmatory Western blot analysis 
(antibody in retroviruses correlates with active virus infection), and for 
herpes virus by PCR. Sixty (38%) of 157 tested NWPs were antibody 
positive for SFV, including animals from the genera Alouatta, Aotus, 
Ateles, Callicebus, Callithrix, Cebus, Lagothrix, Pithecia, Saguinus and 
Saimiri. Twenty-one (15%) of 144 tested NWPs were PCR positive for 
herpes virus. Molecular characterization of the viruses is ongoing to 
identify the specific viruses and, in the case of the herpes viruses, whether 
they are human or NWP species. Our results show a high prevalence of 
SFV and herpes viruses in captive NWPs in Peru. We plan follow-up studies 
to explore the prevalence of human infection to these viruses among 
Peruvians in contact with captive NWPs.
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FULL LENGTH SEQUENCING AND GENOME ASSEMBLING 
STRATEGIES OF DISTINCT ARBOVIRUSES USING 
PYROSEQUENCING DATA
Marcio Roberto T. Nunes, Keley Nunes, Valéria Lima Carvalho, 
Jedson Cardoso, João Vianez, Sueli Rodrigues, Eliana Pinto da 
Silva, Helena Vasconcelos, Alice Nunes Queiroz, Daisy Elaine da 
Silva, Clayton Silva, Pedro Vasconcelos
Evandro Chagas, Ananindeua-Para, Brazil
The current work describes different strategies to obtain complete 
genomes for arboviruses. A total of 176 arbovirus isolates (20 Mayaro, 
30 dengue-1, 30 dengue-2, 30 dengue-3, 18 dengue-4, 30 Oropouche, 
12 yellow fever, 3 ungrouped arboviruses and 1 of each Guama, Catu, 
and Bimiti viruses) were cultured in VERO cells or newborn mice and 
used as source for obtaining the RNA. Supernatant of infected VERO 
cells or mice brain suspensions were pre-treated with DNAse/RNAse 
for removing of host DNA/RNA contaminants. Non-treated and pre-
treated suspensions were then submitted to the RNA extraction. For 
dengue, Oropouche, and Mayaro viruses a set of specific primers were 
designed to produce large amplicons (including UTR and ORFs) through 
a long amplification using commercial kits. Large amplicons were gel 
purified, and used for sequencing using the pyrosequencing method. For 
unknown viruses, the shot-gun methodology was applied for generation 
of random viral complementary genomic fragments. The genomes were 
assembled using distinct software (Newbler, Mira and Geineious pro) and 
methodologies (reference mapping and de novo assembling strategy). 
A computational pipeline was created and automated to remove all 
possible host contaminant sequences before viral genome assembling. 
Regardless the nature of the RNA (segmented or non-segmented), the 
complete sequences were obtained for all 176 isolates. The reducing of 
host contaminant DNA/RNA increased substantially the number of reads 
for a given virus, as well as the genome coverage. Comparisons among 
non-treated and pre-treated samples revealed that pre-treated samples 
increased the viral genome coverage in 40% in size and in 50% in depth. 
A mean of 120 x coverage was reach and few gaps were found within 
the ORFs. Gaps were closed by specific Sanger sequencing. Mostly of the 
uncovered regions corresponded to the UTRs which were recovered using 
the RACE strategy. Three computationally algorithmic were used improving 
the genome assembling closing eventual gaps. The dengue, Oropouche, 
Mayaro and yellow fever virus isolates had their genomes confirmed 
using the Blast algorithmic; the results for unknown viruses have revealed 
two different rhabdoviruses and one orthobunyavirus. The combination 
of sample pre-treatment, long RT-PCR or de novo sequencing, and 
bioinformatic analyzes represent powerful tool for rapid sequencing, 
assembling and identification of known and new arboviruses.
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HERD IMMUNITY AND POTENTIAL VACCINE IMPACT ON 
OUTBREAKS OF HAND FOOT AND MOUTH DISEASE IN 
SOUTHEAST ASIA
Tiffany L. Bogich1, Sebastien Ballesteros2, Jonathan L. Zelner1, 
Hoang Quoc Cuong3, Jeremy Farrar3, Eddie Holmes4, Tran Tinh 
Hien3, Alex Cook5, Cameron Simmons3, Ottar Bjornstad4, C. 
Jessica E. Metcalf6, Nguyen van Vinh Chau3, Bryan T. Grenfell2, H. 
Rogier van Doorn3
1National Institutes of Health Fogarty International/Princeton University, 
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States, 3Oxford University Clinical Research Unit, Ho Chi Minh City, 
Vietnam, 4Pennsylvania State University, University Park, PA, United 
States, 5National University of Singapore, Singapore, Singapore, 6Oxford 
University, Oxford, United Kingdom
Hand Foot and Mouth Disease (HFMD) is typically a mild and self-limiting 
childhood infection caused by any number of viruses in the Enterovirus 
genus of the Picornaviridae family, with the most commonly implicated 
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pathogens being Coxsackievirus A16 (CA16) and Enterovirus 71 (EV71). 
Increasingly, outbreaks of HFMD, particularly those caused by EV71, 
have garnered the attention of the public, clinicians and national and 
international health agencies. Recently, there has been an alarming 
increase in the number of patients and an increase in the number of cases 
complicated by central nervous system and cardiopulmonary involvement 
and deaths in young children in countries across South East Asia. Epidemic 
patterns are complex, though large outbreaks tend to be cyclical, 
occurring every 2 to 3 years. With vaccine in development, the question 
remains whether HFMD caused by CA16 or EV71 is an immunizing 
infection and whether infection by one pathogen confers protection from 
infection by the other. Using over a decade of weekly infection case data 
from Japan and Singapore, we find that the case data are consistent with 
the pathogen acting as an immunizing infection with a strong signature 
of herd immunity. Preliminary simulations indicate that vaccinations could 
succeed at limiting epidemics. We validate these findings with multiannual 
infection case data from other countries in the region. Our finding that 
HFMD acts qualitatively as an immunizing infection is promising for the 
success of future vaccination efforts for the control of this disease. Further 
surveillance and regional cooperation including analysis of epidemiological, 
clinical, and virological data sets for Hand Foot and Mouth Disease would 
help guide future control strategies and inform policy.
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HANTAVIRUS RODENT RESERVOIRS IN BULGARIA
Mustafa A. Aboualy1, Iva Christova2, Hristo Dimitrov3, Emad W. 
Mohareb1
1NAMRU-3, Cairo, Egypt, 2National Centers of Infectious and Parasitic 
Diseases, Sofia, Bulgaria, 3University of Plovdiv, Plovdiv, Bulgaria
Hantaviruses are a group of RNA viruses belonging to the Bunyaviridae 
family, genus Hantavirus, and their natural reservoirs are wild rodents. 
Hantaviruses are the global emerging diseases, with evolving strains 
detected throughout the world. Different serotypes as Seol (SEO), Dobrava 
(DOB), Pumuula (PUU) and Hantaan (HTN) were detected in the Balkan 
region. Human disease causes from DOBV in Bulgaria were recently 
confirmed. In a previous study on hospital-based acute febrile illness 
cases, we detected PUUV IgM using ELISA (Progen) and DOBV neutralizing 
antibody by PRNT. In this study we conducted rodent surveillance in 
areas with documented human cases to identify the circulating strains of 
Hantaviruses. Rodents were trapped starting May 2011 through March 
2012 for two successive night patterns per month. Temperature and 
humidity were monitored at specific GPS coordinates recorded for trapping 
sites. A total of 705 rodents from 2 different sites (Plovdiv and Burgas) 
were trapped. Fourteen different rodent species were collected during the 
study period. Serum samples and organs (lung, spleen and kidneys) were 
collected. An organ pool, preserved with RNA-later, was homogenized 
under BSL3 conditions, followed by RNA extraction using Qiagen products. 
Real-time RT-PCR for DOBV and PUUV testing was performed on rodents 
collected in May, June and October (n=224), of which three DOBV and 
no PUUV position samples were detected. All DOBV was found in male 
Apodemus flavicollis species (susceptible to DOBV) collected in June: two 
from Plovdiv and one from Burgas. Screening of the remaining rodent 
collection is still in progress, and analysis of temporal conditions and 
abundance of species may provide a potential outbreak prediction model.
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EVALUATION OF VIRUS STRAINS AND THE EFFECT OF E1 
MUTATIONS ON THE EXPRESSION OF CHIKUNGUNYA VIRUS-
LIKE PARTICLES
John W. Balliet, Ryan Swoyer, James M. Wagner, Jennifer Girard, 
Jessica A. Flynn, Sha Ha, Jian He, Shyamsundar Subramanian, 
Danilo R. Casimiro
Merck & Co., Inc., West Point, PA, United States
A challenge to the development and manufacture of affordable vaccines 
for a global market is reducing the cost of goods required for vaccine 
production. Due to the inverse relationship between the productivity 
of antigen expression and cost, increasing the efficiency of antigen 
production is one strategy used to reduce cost. In collaboration with the 
NIH, we are developing a chikungunya virus (CHIKV) vaccine based on 
transient expression of ORF2 in human cells to produce CHIKV virus-like 
particles (VLPs), as reported previously. In order to minimize the cost of 
goods, we have tested two strategies to increase the levels of CHIKV 
VLPs in culture supernatants. First, we evaluated the levels of CHIKV 
VLPs among 10 different CHIKV strains. Expression of strain 37997 ORF2 
yielded the highest levels of CHIKV VLPs in the culture media, which was 
consistent with the study by Akahata, et al. Six strains including LR2006 
OPY-1 and S27 exhibited low levels of VLPs, while two strains, ALSA-1 
and Nagpur, failed to produce any detectable VLPs. Western blotting 
demonstrated a defect in p62 processing and low levels of E1 compared 
to strain 37997. As an alternate strategy for increasing VLP productivity, 
we tested the hypothesis that increasing the stability of the E2-E1 
heterodimer by reducing the threshold pH for conformational changes 
in E1 that lead to membrane fusion may result in increased CHIKV VLP 
production. To test this hypothesis, we introduced 3 different E1 mutations 
that were shown to decrease the pH of fusion of another alphavirus. We 
found that those mutations increased the levels of VLPs in culture media 
after transient transfection. Moreover, additional substitutions for each 
of those 3 residues have identified several other mutants with enhanced 
VLP productivity. Current efforts are underway to determine if combining 
the mutations will further increase CHIKV VLP productivity. Work is also in 
progress to better understand the effect of these mutations on the stability 
of the E2-E1 heterodimer.
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MOLECULAR CHARACTERIZATION OF ANTIVIRAL 
SUSCEPTIBILITY OF INFLUENZA A ISOLATES OBTAINED IN 
KENYA FROM 2008 TO 2011
Meshack Wadegu1, Wallace Bulimo1, Rachel Achilla1, Janet 
Majanja1, Silvanos Mukunzi1, Finnley Osuna2, James Njiri1, Janet 
Nyambura1, Julia Wangui1, Benjamin Opot1, Steven Ocholla1, Rose 
Nyawira1, Eyako Wurapa1
1USAMRU-Kenya, Nairobi, Kenya, 2USAMRU-Kenya/KEMRI, Nairobi, Kenya
Presently, there are two main classes of antivirals in use which function 
by inhibiting specific steps within the virus replication cycle: M2 inhibitors 
block the uncoating of the virus through acidification of the interior of the 
virion. In neuraminidase inhibition, inhibitor molecules mimic NA’s natural 
substrate and bind to the active site, preventing NA from cleaving host 
cell receptors and releasing new virus. The study characterized antiviral 
susceptibility of the 2008-2011 influenza A strains using known molecular 
markers in neuraminidase (NA) protein. In the 2008-2009, 2009-2010 and 
2010-2011 influenza seasons, a total of 836 viruses were isolated. 344 
(41%) were influenza A/H3N2, 144 (17%) seasonal influenza A/H1N1 and 
348 (42%) belonged to the pandemic influenza A/ H1N1 strain. A total 
of 108 (13%) isolates were analyzed for susceptibility to NA inhibitors. In 
the year 2008, 33 influenza A/H3N2 and 11 seasonal influenza A/H1N1 
were included in the genotypic characterization assay for neuraminidase 
inhibitor resistant mutations. Sequence assembly and alignment revealed 
absences of molecular markers of neuraminidase inhibitor drug resistance 
(Y275) in influenza A/H3N2. 64% (7) of the 2008 seasonal influenza A/
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H1N1 isolates had resistant marker H275Y. 4 (36%) of the seasonal 
A/ H1N1 isolates, lacked the drug resistant marker depicting sensitivity 
to the class of drugs. Genetic analysis of the 48 pandemic influenza 
A/ H1N1 strains in 2009 showed that all were sensitive to oseltamivir 
through possession of histidine at position 274 of the neuraminidase 
protein sequence. The same pattern was duplicated in 2 of the pandemic 
influenza A/ H1N1 isolates analyzed in the year 2010. All the 2011, 
14 isolates belonging to influenza A/H3N2 subtype lacked the H275Y 
substitution in the neuraminidase protein. Genotypic data obtained in 
this study demonstrate antiviral resistance in seasonal influenza A/H1N1 
viruses isolated in Kenya in 2008-2009 through possession of H275Y (N1 
numbering) marker in the neuraminidase protein.
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APPLICATION OF IN VIVO IMAGING IN THE 
CHARACTERIZATION OF OLFACTORY INFECTION OF MICE 
WITH WEEV
Aaron T. Phillips1, Charles B. Stauft1, Tawfik A. Aboellail1, Ann 
M. Powers2, Ken E. Olson1
1Colorado State University, Fort Collins, CO, United States, 2Division 
of Vector-Borne Infectious Diseases, Centers for Disease Control and 
Prevention, Fort Collins, CO, United States
Isolates of western equine encephalitis virus (WEEV) can cause severe 
disease in both humans and animals, and may serve as a model for 
other neurovirulent alphaviruses. Infection of the McMillan strain (McM) 
of WEEV leads to high mortality in an outbred CD-1 mouse model. An 
infectious recombinant WEEV.McM expressing firefly luciferase (FLUC) 
was developed to characterize CNS infection after intranasal exposure. 
Correlative relationships were determined between bioluminescence 
and both viral titer and immunological markers of WEEV.McM/FLUC. 
Histopathological examination of tissue was guided by corresponding 
images and revealed that neuroinvasion occurred primarily through 
the olfactory tract. Olfactory bulb neurons were initial targets and 
led to the infection of the anterior olfactory nucleus, basal ganglia, 
hypothalamus, amygdala, thalamus, hippocampus, and cerebrum. IHC 
staining showed intense neurotropism with very few supportive cells 
infected. Neuronal processes were highly stained for FLUC expression 
and presented patterns consistent with dissemination of virus through 
neuronal connectivity. Immunopositive axons were often seen in areas 
connecting immunopositive foci, even when foci were separated by 
substantial distances. An additional route of neuroinvasion through 
the trigeminal nerve pathway was observed and resulted in significant 
reporter expression within the brainstem (pons). Although recombinant 
virus was observed to be attenuated when compared to wild-type virus 
in both replication kinetics and induction of immunological markers of 
disease, manifestation of disease was comparable. Therefore, we feel 
that this system provides a quantifiable determination of WEEV infection. 
This may prove beneficial to future assessments of antiviral strategies 
aimed at treating disease arising from olfactory infection with New World 
alphaviruses.
938
SEVERITY OF ACUTE RESPIRATORY INFECTIONS ASSOCIATED 
WITH RESPIRATORY SYNCYTIAL VIRUS, GUATEMALA, 2008-
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Respiratory syncytial virus (RSV) is a major cause of acute respiratory 
infections. The epidemiology of RSV in all age groups has not been well 
described in Central America, particularly regarding disease severity. We 
aimed to address these knowledge gaps with surveillance data from 
Guatemala. We conducted active surveillance of ambulatory visits due 
to influenza-like illness (ILI: cough or sore throat and measured fever 
>38°C) and hospitalizations due to acute respiratory infections (ARI: sign 
of infection and a respiratory sign or symptom) in Santa Rosa (Nov 2007-
Mar 2012), Quetzaltenango (Feb 2009-Mar 2012), and Guatemala City 
(Nov 2009 - Apr 2011). Nasopharyngeal swab specimens were tested 
for RSV using real-time reverse-transcription polymerase chain reaction. 
Among ARI cases, we measured associations between RSV-positivity and 
indicators of severity using linear and logistic regression, adjusted for age, 
gender, surveillance site, and year. To test for effect modification by age, 
we added an interaction term for RSV-positivity and age <5 years to the 
models. We enrolled and tested for RSV 7919 patients; 5626 met the ARI 
and 2293 the ILI case definitions. In persons <5 years of age (n=5009), 
the proportion of cases RSV-positive was higher among ARI (34%) than ILI 
(17%); in person ≥5 years of age (n=2910), the proportions were similar 
for ARI and ILI (7%). Among ARI, RSV-positivity was associated with lower 
oxygen saturation (-0.9; 95% CI: -0.4, -1.4) and lower odds of admission 
to intensive care unit (OR=0.7; 95% CI: 0.6, 0.8), mechanical ventilation 
use (OR=0.70; 95% CI: 0.54, 0.91), and death in hospital (OR=0.69; 
95% CI: 0.48, 1.00). We found a lower OR for death associated with 
RSV in persons <5 years of age (p=0.017). RSV infection is more common 
among hospitalized ARI compared to ILI cases in young children and ARI 
patients present with lower oxygen saturation if they are RSV-positive, 
both which suggest RSV is associated with more severe disease. However, 
other findings suggest RSV-positive cases are less severe. Further analysis is 
required to understand whether RSV infection causes more severe disease 
than other pathogens.
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TACKLING A GLOBAL CHALLENGE ON DOMESTIC GROUND: 
GEOGRAPHIC AND DEMOGRAPHIC ANALYSES OF TB IN 
ORANGE COUNTY, CA
Amruta Dixit1, Curtis Condon2, Ryan Ramos2
1University of California Irvine, Irvine, CA, United States, 2County of 
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Orange County, California carries one of the country’s highest burdens 
of tuberculosis (TB) at a rate of 6.4 cases per 100,000 population in 
2009. In this generally affluent county marked by pockets of poverty, 
the sociodemographic makeup of the populace was discerned through 
the use of GIS technology. We carried out a retrospective cohort study 
of all TB cases diagnosed in Orange County, CA from 2005 to 2009 and 
of all TB hospitalizations from 2005 to 2008 and performed geographic 
and demographic analyses on the data. Based on global trends, we 
expected the burden to be highest in the poorest portions of the county 
as well as in those with high immigrant populations. We found the 
highest incidences of both TB cases and TB hospitalizations in the city 
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of Santa Ana. As the poorest city in the county, Santa Ana (per capita 
income $16,891), had a case rate of 9.65 per 100,000 population. The 
highest case rate by city was found in Westminster (23.76 per 100,000 
population). Foreign-born patients treated by the county represented 
85.4% of all TB cases, placing the burden largely on the immigrant 
population of the county. There were clear relationships between relative 
risks & case rates and per capita income of the city [R= 0.423 and R= 
0.434, respectively]. Relative risk ratios indicated that males [1.49], Asians 
[8.55], and seniors (65 yrs+) [3.34] were at greatest risk for a TB infection. 
The relative risk for a TB infection in an Asian male aged 65 years or older 
was 21.6. At greatest risk for hospitalization for a TB infection: males 
[1.43], Asians [4.17], and seniors [4.52]. The relative risk of an Asian 
male aged 65 years or older in the county being hospitalized due to TB 
was 17.4. More than 71% of all TB hospitalizations were government- 
funded with total charges exceeding $29.4 million over 4 years. These 
data suggest that the burden of TB in Orange County warrants continued 
attention and additional resources and also demands a change in policy 
with regards to the domestic handling of global health issues.
940
INDIVIDUAL LEVEL RISK FACTORS FOR SECONDARY 
TRANSMISSION OF INFLUENZA-LIKE ILLNESS: SECONDARY 
DATA ANALYSIS FROM THE BANGLADESH INTERRUPTION OF 
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Pavani Kalluri Ram1, Manoshi Islam2, Kaniz Jannat2, Margaret 
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Respiratory infections are a leading cause of mortality worldwide. 
Understanding risk factors for secondary transmission to close contacts 
will facilitate development of interventions to prevent respiratory 
pathogen transmission. We describe index case-patient and susceptible 
contact risk factors for secondary transmission of influenza-like illness 
(ILI) in the control arm of a randomized controlled trial evaluating the 
impact of handwashing promotion on ILI in Bangladesh. We identified 
index case-patients with ILI (fever in persons < 5 years old, and fever 
with cough or sore throat in persons ≥5 years old). Susceptible contacts 
were persons without respiratory symptoms at enrollment living in 
household compounds of index case-patients. Compounds included 
index case-patient households and≥1 secondary households. We recorded 
demographics and behaviors among all contacts, and frequency of 
interaction with index case-patient in a subset. We conducted daily ILI 
surveillance from the day after enrollment to 10 days after resolution of 
index case-patient symptoms. We used logistic regression to evaluate 
risk factors for ILI, adjusting standard errors for clustering of illness in 
households and compounds. In compounds of 185 index case-patients, 
1477 (91%) of 1615 contacts enumerated were susceptible and took part 
in surveillance. We detected 111 (8%) secondary cases of ILI. Index case-
patient demographics were not associated with ILI in contacts. Contacts 
with ILI were more frequently < 2 years old (OR=7.5, 95% CI=3.6 – 15.9), 
and 2 to < 5 years old (OR=4.7, 95% CI=2.6 – 8.6) than contacts without 
ILI. After age group adjustment, reported frequent daily interaction with 
the index case-patient was the only significant individual-level risk factor: 
ORadj=1.9, 95% CI=1.1 – 3.5. Sex, parental relationship, living in same 
household or sleeping in same room as index case-patient, smoking, 
and time spent in cooking space were not associated with ILI overall or 
in age group-stratified analyses. In this low-resource setting, young age 
and frequent interaction with ill persons were significant risk factors 
for susceptibility to household ILI transmission. These data underscore 
the need to distance young children from persons ill with respiratory 
symptoms. Studies should assess feasibility and efficacy of distancing 
between household members as a strategy to minimize transmission of 
respiratory infections to the most vulnerable.
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A COMMUNITY RANDOMIZED CONTROLLED TRIAL OF AN 
INTEGRATED HOME-BASED INTERVENTION IMPROVING 
HOUSEHOLD-AIR POLLUTION, DRINKING WATER QUALITY 
AND HYGIENE IN RURAL PERU
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Hector Verastegui2, Daniel Mäusezahl1
1Swiss Tropical and Public Health Institute, University of Basel, Basel, 
Switzerland, 2Instituto de Investigacion Nutricional, Lima, Peru
Diarrhoea and acute lower respiratory infections are leading causes 
of childhood mortality. Simple low-cost interventions have proven 
efficient in reducing diarrhoea and severe pneumonia; however, an 
integrated package provides opportunities for synergism. We conducted 
a community-randomised controlled trial in 51 rural communities in 
Peru to evaluate an environmental home-based intervention package 
(IHIP) in reducing acute lower respiratory infections, diarrhoeal disease 
and preventing malnutrition in children under 36 months of age. All 
homes used open fires and 80% had access to piped, untreated water 
supplies. E.coli was found in drinking water in 66% of the households. 
The proportion of stunted children was 55%. In the intervention arm 
an improved stove (OPTIMA) was installed and members were trained in 
the correct use and proper maintenances; a solar disinfection of drinking 
water (SODIS) method was established; and a water faucet with a kitchen 
sink was installed and handwashing practices were promoted. Diarrhoea, 
respiratory (weekly) and anthropometric (every two months) surveillance 
was done at home during a 12 months period. To reduce potential impact 
of non-blinding bias, the control arm received a psychomotor stimulation 
programme, We randomized 51 communities and enrolled 534 children. 
Baseline characteristics were balanced between study arms: The rate of 
diarrhoeal episodes in children in the intervention was 2.8 episodes per 
child per year as compared to 3.1 episodes in the control arm. The relative 
rate was 0.78 (95%CI: 0.58-1.05). Similarly, care takers in the intervention 
group reported fewer days of diarrhoea (mean 4.9 vs. 6.4 days per year; 
OR: 0.71, 95% CI: 0.47-1.06). No effect on acute lower respiratory 
infections or child’s growth rates was observed. In conclusion we found no 
evidence for synergistic effects associated with the intervention package. 
Introducing several interventions and messages simultaneously may have 
overwhelmed the households and compromised use, operation and 
maintenance of all components.
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ACTIVE HOUSEHOLD-BASED SURVEILLANCE AND REGIONAL 
VARIATION IN INCIDENCE OF INFLUENZA IN PERU
Yeny O. Tinoco1, Hugo Rázuri1, Ernesto Ortiz1, Candice Romero1, 
Maria L. Morales1, Patricia Breña1, Abel Estela1, Erik J. Reaves1, 
Erick S. Halsey1, Alberto Laguna-Torres1, Jorge Gomez2, Marc-Alain 
Widdowson3, Eduardo Azziz-Baumgartner3, Timothy M. Uyeki3, 
Robert H. Gilman4, Daniel G. Bausch1, Joel M. Montgomery5
1U.S. Naval Medical Research Unit Six, Lima, Peru, 2General Directorate of 
Epidemiology, Lima, Peru, 3Influenza Division, Centers for Disease Control 
and Prevention, Atlanta, GA, United States, 4Johns Hopkins Bloomberg 
School of Public Health, Baltimore, MD, United States, 5Division of Global 
Disease Detection, Centers for Disease Control and Prevention, Nairobi, 
Kenya
Most estimates of the disease burden of influenza rely on passive sentinel 
surveillance at health clinics and hospitals. These estimates lack population 
denominators necessary for calculations of incidence, especially of milder 
disease, potentially leading to underestimates of the true burden. In 
2009 we implemented active community-based household surveillance 
in 4 ecologically distinct regions of Peru: coastal desert (Lima), dry 
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forest (Tumbes), highlands (Cuzco) and rainforest (Puerto Maldonado). 
Approximately 7200 people in 1500 randomly selected households are 
visited 3 times a week. Nasopharyngeal swabs are taken from persons 
with influenza-like illness (ILI) and tested for influenza virus by RT-PCR. 
Here we report the incidence and seasonal patterns for the first 1.5 years 
(June 2009-December 2010) comprising 9344 person-years (py) of follow-
up. The overall influenza incidence was 14/100py, with a 95% confidence 
interval (CI) of 13-15. Of these, 6.5/100py (CI 6-7) sought care, 1/1000py 
(CI 0.5-2) required hospitalization, and one died. Although surveillance 
started after the peak of the pandemic, the observed incidence was still 
higher in 2009 (16/100py, CI 15-18) than 2010 (13/100py, CI 12-14). The 
highest incidence was observed in ages 6 months-12 years (31/100py, 
CI 29-33), followed by 13-17 years (17/100py, CI 15-20), <6 months 
(13/100py, CI 7-25), and >17 years (6/100py, CI 6-7). Tumbes consistently 
showed the highest incidence (19/100py, CI 17-20), followed by Lima 
(17/100 py, CI 15-18), Puerto Maldonado (12/100 py, CI 11-13), and 
Cuzco (9/100 py, CI 8-10). The proportion of ILI due to influenza was 18% 
in ages <5 years, 46% in ages 5-17 years, and 30% in persons >17 years. 
Peak incidence was June-December in Lima and Cuzco and September-
January in Tumbes and Puerto Maldonado, with a second peak in 
Tumbes during June-July. We estimate that 3.8 million people in Peru had 
influenza in 2009-2010. Furthermore, incidence and temporal patterns 
vary significantly by region and will require region-focused prevention and 
control strategies.
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INCIDENCE OF HUMAN METAPNEUMOVIRUS IN RURAL AND 
URBAN POPULATIONS IN KENYA, 2006-2011
Victor Omballa1, Leonard Cosmas1, Allan Audi1, Gilbert Kikwai1, 
Juliette Ongus2, Dean Erdman3, Joe Oundo1, Godfrey Bigogo1, 
Daniel Feikin4, Barry Fields1, Robert Breiman1, Kariuki Njenga1
1Centers for Disease Control and Prevention-Kenya, Nairobi, Kenya, 
2Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya, 
3Centers for Disease Control and Prevention, Atlanta, GA, United States, 
4Centers for Disease Control and Prevention-Kenya, Baltimore, MD, United 
States
Human metapneumovirus (hMPV) is a suspected cause of acute 
respiratory tract infections, mostly in young children, the elderly and 
immunocompromised patients. We investigated the incidence of hMPV 
in Kenya using longitudinal, population-based surveillance in two sites; 
two villages (total population = 28,000) in Kibera urban slum located in 
Nairobi City together comprising one site and in thirty-three villages in a 
rural Asembo community (total population = 26,000) in western Kenya 
as the second site. Between 1st October 2006 and 24th March 2011, 
nasopharyngeal and oropharyngeal swabs collected from consenting 
patients meeting the case definitions for either hospitalized severe acute 
respiratory infection or outpatient influenza like illness were tested for 
hMPV by real time Reverse Transcription polymerase chain reaction (RT-
PCR). Incidence rates were calculated as the number of hMPV cases by 
person-years of observation (pyo) per site with adjustments for patients 
meeting the case definition at study clinics who were not swabbed and 
for participants who sought medical attention at non-study clinics. The 
HIV status was included in analysis for patients aged >18 years. Seventeen 
(n = 17) hMPV isolates were sequenced at the 347bp F-gene fragment 
for subtyping. Of 9000 cases tested from both sites, 614 (6.8%) were 
positive for hMPV, consisting of 345/4284 (8.1%) in Kibera and 269/4716 
(5.7 %) in Asembo. In Kibera, the adjusted rates were highest in children 
< 12 months [99.6/1000 pyo (95% CI 80.9 - 122.6)] and lowest in those 
>50 years: [0.7/1000 pyo (95%CI 0.1 - 5.3)]; in Asembo, the adjusted 
rates were highest in children aged 12 - 23 months [62.7/1000 pyo 
(95%CI 62.6 - 62.8)] and lowest in those aged in 18 - 34 years [14.6/1000 
pyo (95%CI 14.5 - 14.7)]. In Kibera, 33% (14/43) of the hMPV-positive 
patients ≥ 18 years were also positive for HIV whereas in Asembo, 40% 
(12/30) of hMPV positive cases were positive for HIV. The clinical symptoms 
associated with hMPV included fever, cough, and runny nose. On genetic 
analysis, 5 of 17 (29 %) Kenya viruses belonged to subgroup A, and 12 
(71%) viruses to subgroup B. No A1 subgroup viruses were detected. Thus 
hMPV incidence was higher in children aged ≤5 years in both study sites 
and incidence rates decreased with increasing age.
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ROLE OF TEMPERATURE, HUMIDITY AND RAINFALL ON 
INFLUENZA TRANSMISSION IN GUATEMALA, EL SALVADOR 
AND PANAMA
Radina P. Soebiyanto1, Nivaldo Linares-Perez2, Luis Bonilla3, 
Jorge Jara3, John McCracken3, Eduardo Azziz-Baumgartner4, 
Marc-Alain Widdowson4, Richard Kiang1
1NASA Goddard Space Flight Center, Greenbelt, MD, United States, 
2Influenza Program, Centers for Disease Control and Prevention Regional 
Office for Central America Region, Guatemala, Guatemala, 3Centro 
de Estudios en Salud, Universidad del Valle de Guatemala, Guatemala, 
Guatemala, 4Centers for Disease Control and Prevention Influenza Division, 
Atlanta, GA, United States
Worldwide, seasonal influenza causes about 500,000 deaths and 5 
million severe illnesses per year. The environmental drivers of influenza 
transmission are poorly understood especially in the tropics. We aimed 
to identify meteorological factors for influenza transmission in tropical 
Central America. We gathered laboratory-confirmed influenza case-counts 
by week from Guatemala City, San Salvador Department (El Salvador) 
and Panama Province from 2006 to 2010. The average total cases per 
year were: 390 (Guatemala), 99 (San Salvador) and 129 (Panama). 
Meteorological factors including daily air temperature, rainfall, relative 
and absolute humidity (RH, AH) were obtained from ground stations, 
NASA satellites and land models. For these factors, we computed 
weekly averages and their deviation from the 5-yr means. We assessed 
the relationship between the number of influenza case-counts and the 
meteorological factors, including effects lagged by 1 to 4 weeks, using 
Poisson regression for each site. Our results showed influenza in San 
Salvador would increase by 1 case within a week of every 1 day with 
RH>75% (Relative Risk (RR)= 1.32, p=.001) and every 1°C increase in 
minimum temperature (RR=1.29, p=.007); but it would decrease by 1 
case for every 1mm-above mean weekly rainfall (RR=0.93,p<.001) (model 
pseudo-R2=0.55). Within 2 weeks, influenza in Panama was increased 
by 1 case for every 1% increase in RH (RR=1.04, p=.003), and it was 
increased by 2 cases for every 1°C increase of minimum temperature 
(RR=2.01, p<.001) (model pseudo-R2=0.4). Influenza counts in Guatemala 
had 1 case increase for every 1°C increase in minimum temperature in the 
previous week (RR=1.21, p<.001), and for every 1mm/day-above normal 
increase of rainfall rate (RR=1.03, p=.03) (model pseudo-R2=0.54). Our 
findings that cases increase with temperature and humidity differ from 
some temperate-zone studies. But they indicate that climate parameters 
such as humidity and temperature could be predictive of influenza activity 
and should be incorporated into country-specific influenza transmission 
models.
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RANDOMIZED, DOUBLE-BLINDED, PHASE 2 TRIAL OF WR 
279,396 (PAROMOMYCIN AND GENTAMICIN) FOR THE 
TREATMENT OF CUTANEOUS LEISHMANIASIS CAUSED BY 
LEISHMANIA PANAMENSIS
Nestor Sosa1, Capitán Zeuz Capitán1, Javier Nieto1, Melissa 
Nieto1, José Calzada1, Hector Paz1, Mara Kreishman-Deitrick2, 
Karen Kopydlowski2, Diane Ullman2, William McCarthy2, Janet 
Ransom3, Chuck Scott3, William Ravis4, Max Grogl5
1Gorgas Institute, Panama City, Panama, 2U.S. Army Medical Materiel 
Development Activity, Fort Detrick, MD, United States, 3Fast-Track Drugs 
and Biologics, North Potomac, MD, United States, 4Auburn University, 
Auburn, AL, United States, 5Walter Reed Army Institute of Research, Silver 
Spring, MD, United States
This randomized double-blinded Phase 2 trial included 30 patients (17 
adults and 13 children ages 5 to 17 years) with Leishmania panamensis 
cutaneous leishmaniasis (CL). Patients were randomly allocated (1:1) to 
receive once daily topical treatment with WR 279,396 (15% paromomycin 
+ 0.5% gentamicin) or Paromomycin Alone (15% paromomycin) for 20 
days. Patients were followed for pharmacokinetics (PK), safety and efficacy 
for six months. Blood for paromomycin and gentamicin PK parameters 
was collected from adult subjects after the first days’ and last days’ drug 
application. The primary efficacy endpoint was cure of a parasitologically 
confirmed index lesion, defined as at least 50% reepithelialization of 
the lesion by Day 63 and 100% reepithelialization by Day 100 with no 
relapse. The index lesion cure rate after 6 months follow-up was 13/15 
(87%) for WR 279,396 and was 9/15 (60%) for Paromomycin Alone (p 
= 0.099). When all treated lesions were evaluated for cure, the final cure 
rate for WR 279,398-treated patients was the same, but the final cure 
rate for Paromomycin Alone-treated patients was lower at 8/15 (53.3%; 
p = 0.046). Both creams were well tolerated with mild application site 
reactions including erythema (20%), edema (13.3%), and pain (6.7%) 
being the most frequent adverse event in the WR 279,396 group, which 
were slightly higher in the Paromomycin Alone group. PK data showed 
that there is limited paromomycin and gentamicin systemic absorption 
thus avoiding drug accumulation and toxicity. The increased final cure 
rate in the WR 279,396 group in this small Phase 2 study suggests 
that the combination product may provide greater clinical benefit than 
paromomycin monotherapy against L. panamensis CL. The excellent 
tolerability and low systemic drug exposure suggests that WR 279,396 
may offer an alternative to more toxic systemic therapies for CL.
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A PROSPECTIVE REFERRAL HOSPITAL STUDY OF SEVERE 
PLASMODIUM KNOWLESI MALARIA IN SABAH, MALAYSIA: 
HIGH INCIDENCE BUT NO MORTALITY WITH EARLY 
REFERRAL AND ARTESUNATE THERAPY 
Bridget E. Barber1, Timothy William2, Matthew J. Grigg1, 
Jayaram Menon3, Nicholas M. Anstey1, Tsin W. Yeo1
1Menzies School of Health Research, Darwin, Northern Territory, Australia, 
2Infectious Diseases Department, Queen Elizabeth Hospital, Kota Kinabalu, 
Sabah, Malaysia, 3Department of Medicine, Queen Elizabeth Hospital, 
Kota Kinabalu, Sabah, Malaysia
The simian parasite Plasmodium knowlesi is a common cause of severe 
malaria in Malaysian Borneo, and high case-fatality rates have been 
reported with chloroquine and/or quinine treatment. We compared risk, 
spectrum and outcome of severe disease from P.knowlesi, P.falciparum 
and P.vivax following the introduction of early referral and intravenous 
artesunate for all severe malaria. From September 2010-October 2011 we 
prospectively recorded clinical and laboratory features of non-pregnant 
patients ≥12 years-old admitted to Queen Elizabeth Hospital (QEH), Sabah, 
with PCR-confirmed malaria monoinfection. Standardised referral (4+ 
parasite-density and/or any severity-criterion) and intravenous artesunate 
was instituted at district hospitals. Severe malaria (modified-WHO 2010 
criteria) occurred in 38/130 (29%) patients with P. knowlesi, 15/122 
(12%) with P. falciparum and 7/43 (16%) with P. vivax. Severity criteria 
in knowlesi malaria included hyperparasitemia (>100,000 parasites/µL, 
N=18), respiratory distress (N=14), jaundice (N=20), acute renal failure 
(N=9), hypotension (N=13), metabolic acidosis (N=4), anaemia (N=2) and 
abnormal bleeding (N=2). Severe knowlesi malaria occurred in 27/57 
(47%) patients ≥50 years old compared to 11/73 (15%) <50 years. 
However using logistic regression, only parasite density independently 
predicted severe malaria, excluding hyperparasitemia as a sole severity-
criterion (OR [log-increase in density count] 2.01, p<0.0001). Nearly all 
(92%) patients with knowlesi malaria received artemisinin therapy; 36/38 
(95%) and 39/92 (42%) patients with severe and non-severe disease 
respectively received ≥1 dose of intravenous artesunate. Median parasite 
clearance-time was 2 days and no deaths occurred from any species. 
P.knowlesi is the commonest cause of severe malaria at QEH. Parasite 
density and schizontemia >10% were the only independent risk-factors 
for severity. Early treatment with artesunate was highly effective and 
associated with zero mortality.
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EFFECTIVENESS OF INTERMITTENT PREVENTIVE 
TREATMENT WITH SULFADOXINE-PYRIMETHAMINE IN 
PREGNANT WOMEN IN WESTERN KENYA: RESULTS OF AN 
OBSERVATIONAL STUDY
Peter O. Okuma
Centers for Disease Control and Prevention/KEMRI, Kisumu, Kenya
Intermittent preventive treatment with sulfadoxine pyrimethamine (IPTp) 
remains a key strategy for malaria prevention in pregnant women living in 
malaria endemic regions. However, increasing SP resistance threatens IPTp 
effectiveness. We assessed the effectiveness of IPTp in an area of western 
Kenya where Plasmodium falciparum resistance to SP is high. From August 
2008 to June 2009, women presenting to deliver at two district hospitals 
were enrolled in a cross-sectional survey. We collected information on 
obstetric history, use of IPTp, insecticide treated nets, and antimalarial 
treatment during pregnancy. At delivery, we measured the prevalence 
of maternal anemia (Hb< 8g/dL), peripheral parasitemia, placental 
parasitemia (impression smear) and low birth weight (LBW) by number 
of IPTp doses received by self-report or as recorded in the antenatal card. 
Overall 977 HIV-negative women were enrolled. Of these 637 (65%) were 
gravidae 1 or 2 and 340 (35%) were gravidae 3+. Among gravidae 1 or 
2, anemia prevalence in women who received no IPTp was 14%, 1 dose: 
11%, 2 doses: 7% and 3+ doses: 2% (p<0.01). Peripheral parasitemia 
was 19% for no IPTp, 12% for 1 and 2 doses and 7% for 3+ doses 
(p=0.07). Placental parasitemia was 22% for no IPTp, 12% for 1 dose, 
13% for 2 doses and 8% for 3+ doses (p=0.04). Among gravidae 1/2, 
we found no reduction in LBW by IPTp doses administered (p=0.73). 
Among multigravidae, significant trends by number of SP doses received 
were not observed for anemia, or peripheral or placental parasitemia but 
were associated with reduced LBW (p=0.02). Among gravidae 1 or 2, but 
not multigravidae, having received more doses of IPTp was significantly 
associated with lower prevalence of maternal anemia, peripheral 
parasitemia and placental parasitemia. In multigravidae, IPTp resulted 
in reduced prevalence of LBW. During this time period, IPTp remained 
beneficial in this area of western Kenya, despite high SP resistance.
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INVASIVE STAPHYLOCOCCUS AUREUS INFECTIONS IN 
CHILDREN IN THE TROPICAL TOP END OF AUSTRALIA: 
CLINICAL AND MICROBIOLOGICAL EPIDEMIOLOGY
Daniel Engelman1, Alexandra Hofer1, Joshua Davis2, Jonathan R. 
Carapetis2, Steven Y. Tong2
1Royal Darwin Hospital, Darwin, Australia, 2Menzies School of Health 
Research, Darwin, Australia
Previous studies report very high incidence of Staphylococcus aureus 
bacteraemia in adult Aboriginal populations in tropical northern Australia. 
There are few studies describing incidence or outcomes in children. We 
aimed to describe the clinical and microbiological epidemiology of invasive 
S. aureus infections in children. We conducted a retrospective review for 
all cases of bacteraemia and sterile site infection, for children under 15 
years, in the Top End of Australia over a four year period (2007–2010). 
Forty-four cases (9 neonatal, 35 paediatric) were identified. The annual 
incidence of invasive S. aureus was 27.9 cases per 100,000 population 
and was significantly higher in the Aboriginal population (incidence rate 
ratio [IRR] compared to non-Aboriginal population: 5.3 [95%CI 2.5-12.6]). 
Among non-neonatal cases, the annual incidence was 22.2 per 100,000 
population (Aboriginal 46.6, non-Aboriginal 4.4, IRR: 10.6 [95%CI 3.8-
41.4]). There were significant differences between the neonatal and 
paediatric groups. Neonatal cases were all born prematurely, typically with 
significant comorbidities and episodes were often intravascular catheter 
related and nosocomially acquired. There was one death. Of the 35 
paediatric (non-neonatal) cases, 17% had pre-existing comorbidities, 14% 
were malnourished and 11% were nosocomial. Major foci of infection 
were bone and joint (57%) and pleuropulmonary (17%); endocarditis was 
uncommon (6%). The median length of stay was 23 days (mean 27, SD 
16.6, range 2-68). 14% were readmitted within 1 year for related reasons. 
There were no deaths. There were 9 cases (26%) due to community-
associated MRSA strains. Molecular genotyping results will be presented. 
There was no difference in severity or outcome between infections due to 
MRSA and MSSA. In conclusion, the annual incidence of invasive S. aureus 
infection in this study is the highest described in any paediatric population. 
Almost 1 in 2000 Aboriginal children develop invasive disease each 
year. Late onset sepsis in premature infants is the main neonatal cause. 
Most paediatric cases were community acquired and severe, yet rates of 
mortality, endocarditis and readmission were low.
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TRYPANOSOMA CRUZI SURVIVAL FOLLOWING STORAGE: 
IMPLICATIONS FOR TISSUE TRANSPLANTATION-DERIVED 
TRANSMISSION
Diana Martin1, Brook Goodhew1, Shawn Hunter2, Jan 
Zajdowicz3, Scott Brubaker4
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Community Tissue Services, Kettering, OH, United States, 3Rocky 
Mountain Tissue Bank, Aurora, CO, United States, 4American Association 
of Tissue Banks, McLean, VA, United States
Trypanosoma cruzi, the causative agent of human Chagas disease, is 
typically transmitted via the feces of a reduviid bug vector following 
a blood meal. Infection can also occur through infected blood and 
tissue products. An estimated 300,000 individuals in the United States 
are infected with T. cruzi and six cases of transmission through organ 
donation have been reported. The potential for transmission by tissue 
transplantation is considered herein. Tissue recovered for transplantation, 
in contrast to solid organ transplants, undergoes a range of storage 
and processing procedures depending on the tissue type. At the outset, 
tissues do not have to be recovered from a beating-heart or live donor, 
but instead may be removed from the donor up to 24 hours after 
asystole. Once removed, tissues are often stored and eventually undergo 
some degree of processing, which can include lyophilization, irradiation, 
and various sterilization techniques. As an example, heart valves are 
cryopreserved and undergo minimal processing, whereas other tissue may 
be stored as is at -80 C for as long as five years. The ability of infected 
tissue to transmit T. cruzi is likely related to the ability of T. cruzi to survive 
these processing and storage conditions. We examined the viability of T. 
cruzi parasites after room temperature and cold storage conditions. T. cruzi 
trypomastigotes were unaffected by 24 hours at room temperature, both 
in cell cultures and when spiked into whole blood to mimic decomposition 
following asystole. Parasite-infected cells stored up to 5 days at 4 C proved 
100% viable after re-culture, whereas only 2 of 8 cultures stored 28 days 
at 4 C became culture-positive. A significant decrease in parasite viability 
was observed in samples stored up to 120 days at -80 C in the absence of 
cryopreservation, yet some live, infective parasites were recovered. These 
data demonstrate the heartiness of T. cruzi following cold storage. Studies 
are underway to examine the effects of more rigorous tissue processing 
procedures on T. cruzi viability.
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A SYSTEMATIC REVIEW AND META-ANALYSIS OF MALARIA 
AND SEXUALLY TRANSMITTED AND REPRODUCTIVE TRACT 
INFECTIONS IN PREGNANCY IN SUB-SAHARAN AFRICA: 
OPPORTUNITIES FOR ANTENATAL INTERVENTION
R. Matthew Chico, Philippe Mayaud, Cono Ariti, David Mabey, 
Carine Ronsmans, Daniel Chandramohan
London School of Hygiene and Tropical Medicine, London, United 
Kingdom
Malaria and sexually transmitted infections/reproductive tract infections 
(STIs/RTIs) in pregnancy are direct and indirect causes of stillbirth, 
prematurity, low birth weight, and maternal and neonatal morbidity and 
mortality. Novel use of diagnostic tools and/or drugs may improve birth 
outcomes with the impact depending on the prevalence of malaria and 
STI/RTI. PubMed, MEDLINE, EMBASE, the World Health Organization 
International Clinical Trials Registry, and reference lists were searched 
for studies reporting malaria, syphilis, Neisseria gonorrhoeae, Chlamydia 
trachomatis, Trichomonas vaginalis, or bacterial vaginosis among pregnant 
women attending antenatal care facilities in sub-Saharan Africa. Included 
studies were conducted in 1990-2011 with open enrollment. Studies 
from South Africa, where malaria is no longer endemic, were excluded. 
Point prevalence estimates were corrected for diagnostic precision. 
A random-effects model meta-analysis was then applied to produce 
pooled prevalence estimates. A total of 171 studies met inclusion criteria, 
providing 307 point prevalence estimates for malaria or STIs/RTIs. The 
pooled prevalence estimates (95% confidence intervals; n=positive 
diagnoses) among studies in 1990-2011 in East and Southern Africa 
were as follows: syphilis 4.5% (3.9,5.1; n=8,346), N. gonorrhoeae 
3.7% (2.8, 4.6; n=626), C. trachomatis 6.9% (5.1, 8.6; n=350), T. 
vaginalis 29.1% (20.9, 37.2; n=5,502), bacterial vaginosis 50.8% (43.3, 
58.4; n=4,280), peripheral malaria 32.0% (25.9, 38.0; n=11,688) and 
placental malaria 25.8% (19.7, 31.9; n=1,388). West and Central Africa 
prevalence estimates were as follows: syphilis 3.5% (1.8, 5.2; n=851), 
N. gonorrhoeae 2.7% (1.7, 3.7; n=73), C. trachomatis 6.1% (4.0, 8.3; 
n=357), T. vaginalis 17.8% (12.4, 23.1; n=822), bacterial vaginosis 37.6% 
(18.0, 57.2; n=1,208), peripheral malaria 38.2% (32.3, 44.1; n=12,242) 
and placental malaria 39.9% (34.2, 45.7; n=4,658). In conclusion, the 
dual prevalence of malaria and STIs/RTIs in pregnancy among women who 
attend antenatal care facilities in sub-Saharan Africa is considerable, with 
the combined prevalence of curable STIs/RTIs being equal to, if not greater 
than, malaria.
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ANSWERING THE MAIL: USING A CASE-BASED MODEL TO 
TEACH TELECONSULTATION SKILLS TO INFECTIOUS DISEASE 
FELLOWS
Andrew Letizia, Tim Whitman, Michael Zapor, David Byers, Greg 
Martin, Rose Ressner, Glenn Wortman, Josh Hartzell
Walter Reed National Military Medical Center, Bethesda, MD, United States
The United States Military has offered a vast array of teleconsultative 
services to assist health care providers (HCP) deployed in remote areas of 
the world via e-mail. The Infectious Diseases Teleconsult system (IDTS) has 
been an effective tool in optimizing care for Service Members overseas. 
Despite the continuing development of telemedicine in both civilian and 
military communities, we are unaware of any standardized education 
given to HCP prior to participating in this method of consultation. Giving 
medical recommendations via a teleconsult system requires unique skills 
not used in the standard clinical setting. Consultants provide advice 
without questioning or examining the patient and must understand 
system constraints unique to the patient’s location (i.e. isolated mountain 
top in Afghanistan or remote village in West Africa). Cases referred to the 
IDTS often involve diseases unique to tropical climates and the developing 
world that inexperienced providers may not recognize. To address this 
gap in medical education, the Infectious Diseases (ID) fellowship program 
at Walter Reed National Military Medical Center implemented a training 
program in 2011 that utilized a series of simulated patients based 
upon real teleconsults from the IDTS system. Ten cases were chosen to 
highlight classic infectious diseases that have been common consults 
such as cutaneous Leishmanisis, Q fever and malaria. The simulated cases 
are administered via e-mail to an ID fellow who then has one hour to 
appropriately answer the teleconsult. The fellow is then given feedback 
on his/her ability to generate an accurate assessment and plan for the 
simulated case and the practicality of their advice considering the patient 
care setting. An overview of the case-based model, selected examples, and 
evaluation criteria will be reviewed. This educational process is an effective 
way to prepare ID fellows for the real-world experience of offering advice 
via a teleconsult service and has improved their knowledge base of 
infectious diseases in the developing world.
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MATERNAL HIV EXPOSURE OR MOTHER TO CHILD 
TRANSMISSION OF HIV AND RISK OF TUBERCULOSIS IN 
INFANTS
Grace Kaguthi1, Videlis N. Nduba1, Anja Van’t Hoog2, Kayla 
Laserson3
1Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and 
Prevention, Kisumu, Kenya, 2University of Amsterdam, Academic Medical 
Centre, Amsterdam, The Netherlands, 3Centers for Disease Control and 
Prevention, Center for Global Health/KEMRI, Atlanta, GA, United States
Infants born to HIV infected mothers who test HIV negative (seroexposed) 
and those that become HIV infected (seroreactive) are at an increased 
risk of progression from latent tuberculosis (TB) infection to disease. 
However, TB diagnosis in this group is challenging due to low utility of 
scoring systems and low tuberculin skin test (TST) sensitivity. We sought 
to document the incidence rates of TB disease among seroexposed and 
seroreactive babies, among an infant cohort under follow up to determine 
TB incidence. Infants aged 0-6 weeks were recruited from Western Kenya. 
HIV DNA PCR testing was offered at six weeks to all infants. Through 
follow up and sick visits, TB suspects were identified based on signs and 
symptoms and investigated for TB through gastric aspirates, sputum 
induction, chest radiographs, HIV tests and TST. Definite cases were were 
culture confirmed and probable cases had Keith Edward(KE) Scores of ≥7 
and/or suggestive chest radiographs. Of 2900 infants enrolled, 435 (15%) 
were seroexposed, including 75 (2.6%) seroreactive. Of 923 (32%) TB 
suspects, 174 (19%) out of 923 TB suspects were seroexposed, including 
43(25%) seroreactive. The mean TST induration among sero exposed 
and non exposed suspects was 5mm(SD=6) and 4mm (SD=5) p<0.01 
respectively. Additionally, mean KE score was 2.3 (SD2.4) and 1.6 (SD2.0) 
p<0.01 for seroexposed and non-exposed respectively. There were 48 TB 
cases, (incidence rate 1.44 per 100 person years) [95% CI (1.09, 1.91)], 
sixteen of these (33%) were among seroexposed infants RR 2.1 [95% 
CI(1.1,4.0)]. Out of ten definite TB cases, five (50%) were seroexposed 
(p=0.05). HIV exposure and infection was associated with increased 
risk of being diagnosed with tuberculosis. HIV infected mothers have 
increased risk of developing TB and exposing their babies to TB infection. 
Rigorous antenatal screening for tuberculosis in HIV infected mothers 
is recommended to protect their infants from early latent infection and 
progression to TB disease.
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INCREASED RATES OF RESPIRATORY AND DIARRHEAL 
ILLNESSES AMONG HIV-NEGATIVE INDIVIDUALS ≥5 LIVING 
WITH HIV-INFECTED INDIVIDUALS IN AN URBAN SLUM 
(KIBERA) OF NAIROBI, KENYA
Joshua M. Wong1, Dhillon Nyachieo2, John M. Williamson3, 
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Njuguna5, Lucy Nganga-Wanjiku6, Rebecca Bunnell7, Warren 
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Control and Prevention, Division of Global HIV/AIDS, Nairobi, Kenya, 
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For some acute illnesses in HIV-infected patients, prolonged pathogen 
shedding, symptom duration, and other socioeconomic factors potentially 
contribute to increased incidence. Using data from a prospective, 
population-based infectious disease surveillance system of acute illnesses 
and a cross-sectional HIV serosurvey conducted in the urban slum of 
Kibera, Kenya, we calculated incidence of influenza-like illness (ILI), 
diarrhea, and non-specific febrile illness among 2,105 HIV-negative 
household contacts of HIV-infected participants and 13,747 participants 
living within exclusively HIV-negative households during 2008. Of the 
4,285 household in which a test was performed, 83.8% had only HIV-
negative tests, 13.5% had 1 HIV-positive test, and 2.7% had more than 
1 HIV-positive test; untested adults were not included in the analysis. 
We stratified household contacts by number of HIV-infected individuals 
in households and modeled it as a continuous variable to determine 
a dose-dependent relationship. For children and adults ≥5 years old, 
incidence was significantly increased for ILI (incident rate ratio [IRR], 1.47; 
95% confidence interval [CI], 1.07:1.99; p<0.05), and diarrhea (IRR, 
1.41; CI, 1.11:1.77; p<0.05) in HIV-negative household contacts of HIV-
infected residents when compared with rates in HIV-negative persons 
living in households without an HIV-infected resident. The risk for illness 
among HIV-negative persons was directly proportional to the number of 
HIV-infected people living in the home for ILI (IRR, 1.40; CI, 1.03:1.88; 
p<0.05), diarrhea (IRR, 1.36; CI, 1.11:1.67; p<0.01), and non-specific 
febrile illness (IRR, 1.15; CI, 1.02:1.29; p<0.05). There was no evidence 
for a similar pattern of increased incidence in a parallel analysis among 
children <5 years old. Since treatment and support for HIV-infected 
individuals reduces their incidence of infections, future interventions 
ensuring that HIV-infected persons are receiving appropriate care may help 
to reduce infections for all household members.
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RUSH TO JUDGMENT: SOURCES OF CONFOUNDING IN STI-
HIV PREVENTION TRIALS
Larry Sawers1, Eileen Stillwaggon2
1American University, Washington, DC, United States, 2Gettysburg College, 
Gettysburg, PA, United States
Substantial evidence indicates that sexually transmitted infections (STIs) 
promote HIV transmission and acquisition by producing genital ulcers, 
inflammation, and viral shedding. Ten randomized controlled trials in sub-
Saharan Africa (SSA) examined effects of STI control on HIV incidence. 
One produced statistically significant results. Consequently, support for 
STI treatment for HIV prevention has faded. We conducted an intensive 
review of methods and outcomes of the 10 STI-control trials in SSA and 
subsequent analyses. All 10 trials reveal potentially serious confounding 
from multiple untreated genital morbidities. Some trials studied the 
impact of treating bacterial STIs on HIV incidence; others studied 
treatment of viral STIs. None studied both. None examined treatment of 
genital morbidity from other causes that could enhance HIV transmission 
or acquisition. The trials excluded consideration of fungal STIs. None 
considered genital ulceration and inflammation from non-sexually 
transmitted pathogens, such as Schistosomiasis hematobium (highly 
prevalent in SSA), and from ulcers caused by abrasions infected with 
streptococci or staphylococci, also common. Treating one type of genital 
morbidity may have little effect on HIV incidence when there is untreated 
genital morbidity from multiple sources. Furthermore, 8 trials reported the 
same or lower levels of risky sexual behavior in the control arm as in the 
treatment arm or reported the same or larger reductions in risky behaviors 
among controls. (Two trials did not report on sexual behavior.) That could 
have resulted from the trials’ successful interventions in the control arm 
or from spontaneous reductions in risky behavior prompted by the trial. 
Confounding by genital morbidity of multiple etiologies, behavioral 
change, and other factors in the 9 trials lacking statistically significant 
results renders those trials unable to inform HIV-prevention policy. Given 
abundant evidence that STIs promote HIV spread, STI treatment should be 
considered an important method for reducing HIV incidence in SSA and 
elsewhere.
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HIV STIGMA AS A BARRIER TO RECEIVING HIV CARE AT 
A GENERAL HOSPITAL IN LIMA, PERU: A CASE-CONTROL 
STUDY
Carla V. Valenzuela1, Aaron Kipp2, Cesar Ugarte3, Jorge Paz3, 
Juan Echevarria3), Eduardo Gotuzzo3
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Poor retention in care may increase the risk of morbidity, mortality, and 
community HIV transmission. The role of HIV stigma in poor retention 
has not been well studied. The objective of this case-control study was to 
evaluate the association between HIV stigma and retention in care among 
HIV patients in Lima, Peru. We evaluated HIV-positive patients who were 
diagnosed and/or initiated care at a general hospital between 2005-2010, 
with inclusion based on status of care by March 31, 2011. Those retained 
in care (n=150) had ≥ 2 documented medical care visits per year and were 
approached and interviewed privately in clinic during their appointment. 
Those not retained in care (n=55) had no documented visits for ≥ 1 year 
and home visits were used to locate them and conduct interviews. The 
Berger HIV stigma scale was used to quantify the 4 domains of stigma: 
enacted stigma (ES), disclosure concerns (DC), negative self-image (NSI), 
and concern with public attitudes (CPA). Each domain had 5 items with 
higher scores indicating higher stigma (score range 0-15). Multivariable 
logistic regression was used to calculate adjusted odds ratios (OR) and 
95% confidence intervals (CI) for being out of care. Stigma was modeled 
as a continuous variable and linearity assumptions were assessed. Mean 
stigma scores were low for ES (6.1) and NSI (5.3) but high for DC (9.6) 
and CPA (9.0). ES and NSI had U-shaped associations with retention 
(odds of not being retained increased then decreased at higher stigma 
levels). DC and CPA showed linear associations. Patients who agreed to 
all items (score of 10) were more likely to not be retained than patients 
who disagreed to all items (score of 5) for ES (OR=2.36; 95% CI: 0.98, 
5.67), DC (OR=2.72; 95% CI: 1.11, 6.67), NSI (OR=1.82; 95% CI: 0.50, 
6.60), and CPA (OR=3.30; 95% CI: 1.37, 7.92). This study suggests that 
all aspects of HIV stigma, particularly concern with public attitudes, play a 
role in being out of care.
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DO PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY 
VIRUS (PLHIVS) HAVE MORE RISKY SEXUAL BEHAVIORS 
THAN UNINFECTED PEOPLE IN BURKINA FASO? A CASE-
CONTROL STUDY
Adama Baguiya1, Bertrand Méda1, Adja Mariam Ouédraogo1, 
Aristide Romaric Bado1, Damien De Walque2, Seni Kouanda1
1Research Institute for Health Sciences, Ouagadougou, Burkina Faso, 
2World Bank, Washington, DC, United States
Antiretroviral therapy has reduced mortality and morbidity due to HIV/
AIDS. Consequently, it is widely believed that PLHIV could keep new 
infections occurrence by their more risky sexual behaviors. This study 
aimed to compare PLHIVs’ sexual behaviors with those who are infected, 
and to determine factors that affect their condom use. We conducted 
a case-ontrol study involving all the PLHIVs and not infected people of 
the second round in Burkina Faso’s Treatment Accelerating Program 
assessment, from July to December 2009. This assessment involved PLHIVs 
(with their households) and households without PLHIV. Chi-square test 
was used to compare proportions with p<0.05 as statistically significant. 
Logistic regression was employed to determine associated factors of 
condom use. Two hundred ninety one PLHIVs and as many controls were 
interviewed in the 590 households. Seventy four percent of PLHIVs versus 
58.1% of controls were women (p< 0.001). Among men, 78.7% of PLHIV 
and 84% of controls had sex in the last twelve months (p>0.05). Among 
women, we had 48.1% versus 56.4% of PLHIV (p>0.05). three percent 
of PLHIV versus 13% of controls were not aware of their last sexual 
partner’s HIV status (p< O.05). Among PLHIV, 27.1% versus 67% of the 
controls had not used condom during their last sexual intercourse (p< 
0.001). Both men’s and women’s group had presented the same difference 
(p<0.001). ART status was not associated with condom use (OR=1.2, 
95%CI=0.6-2.5). But, voluntary testing (OR=3.4, 95%CI=1.1-10.7) and 
knowing that the partner has had sex with another person during the 
last twelve months (OR =5.2, 95%CI=1.6-16.7) were associated with 
PLHIV’s condoms use. PLHIVs use condom more than uninfected and in 
general, they don´t have more risky sexual behaviors. Besides, condom use 
is not significantly affected by ART, so their availability doesn’t increase 
risky behaviors and therefore must be improved. This argument could be 
considered to strengthen public awareness campaigns against stigma and 
discrimination against PLHIVs in Burkina Faso.
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RELATIVE EXPRESSION OF CCR5 AND CXCR4 BY CD14+ 
MONOCYTES AND CD4+ T CELLS IN HIV-1-EXPOSED AND 
-INFECTED CHILDREN WITH PLASMODIUM FALCIPARUM 
MALARIA
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We and others have previously shown that Plasmodium falciparum-derived 
hemozoin (PfHz) promotes dysregulation of CCR5 and CXCR4, and their 
cognate ligands in monocytes and CD4+ T cells, resulting in increased HIV-
1 replication. To further explore these molecular interactions, we examined 
the relative expression of CCR5 and CXCR4 on CD14+ monocytes and 
CD4+ T cells through flow cytometric analyses on cells collected from 
children (age, 2.6-33.6 mos; n=67) from western Kenya categorized into 
the following groups: 1) P. falciparum negative and HIV-1 negative [mal(-
)/HIV-1(-), n=11]; 2) P. falciparum positive and HIV-1 negative [mal(+)/
HIV-1(-), n=33]; 3) P. falciparum positive and HIV-1 exposed [mal(+)/HIV-
1(exp), n=20]; and 4) P. falciparum positive and HIV-1 positive [mal(+)/
HIV-1(+), n=3]. Proportions of CD14+CXCR4+ cells were elevated in 
mal(+)/HIV-1(+) children compared to the mal(-)/HIV-1(-) group (P=0.048). 
However, proportions of CD14+CXCR4+ cells were reduced in the 
mal(+)/HIV-1(+) children relative to mal(+)/HIV-1(-) (P=0.039) and mal(+)/
HIV-1(exp) (P=0.077) groups. In addition, expression of CD3+CXCR4+ 
and CD3+CD4+CCR5+ cell subsets were lower in the mal(+)/HIV-1(+) 
group compared to mal(+)/HIV-1(exp) children (P<0.05 for both). Further 
analyses in the combined population of malaria-infected children revealed 
that CD3+CXCR4+ cells were inversely correlated with the percentage 
of monocytes containing PfHz (ρ=-0.883, P=0.020). Taken together, the 
preliminary results presented here suggest that CXCR4 and CCR5 are 
dysregulated in children co-infected with malaria and HIV-1, and that 
altered expression may be driven, at least in part, through acquisition of 
PfHz by monocytes.
958
AN EVALUATION OF TB AND HIV PROGRAM INTEGRATION 
AT PRESIDENT’S EMERGENCY PLAN FOR AIDS RELIEF 
(PEPFAR)-SUPPORTED MILITARY HOSPITALS IN NIGERIA
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Tuberculosis (TB) presents an important health problem and comorbidity 
among patients seen at sites supported by the President’s Emergency 
Plan for AIDS Relief (PEPFAR) in Nigeria. The objective of this evaluation 
was to use the TB cohort review process indicators to assess TB and 
HIV program integration at PEPFAR sites within the Nigerian Ministry 
of Defense (NMOD). The cohort review methods used were modified 
from those described previously by the Centers for Disease Control and 
Prevention. The sites were all affiliated with the NMOD and included 
clinics in Abuja, Lagos (2 sites), Makurdi, and Kaduna. At each site, the 
study team reviewed each TB case in detail with the assistance of the TB 
case manager, verifying key clinical outcomes. TB case managers were 
interviewed for qualitative information about the processes involved in TB 
care at each facility. 175 cases were reviewed at the 5 PEPFAR-supported 
sites. The sites evaluated were found to have substantial variability in 
outcomes. Treatment completion seen in this study (72%) was lower than 
that reported nationally (83%) and was lower than the WHO 2015 goal 
of (85%). Of particular concern, HIV patients were less likely to complete 
therapy (58%) than HIV negative patients (85%). The lack of contact 
investigation and TB case finding supports the low case detection rate 
reported nationally (20%). Similarly, the lack of LTBI treatment is consistent 
with the low proportion of treatment among eligible HIV patients (<5%) 
seen nationally. This is the first report of the cohort review methodology 
being applied to assess TB program integration within a PEPFAR 
population. Assessments of TB program integration through the cohort 
review can benefit the PEPFAR program by increasing staff awareness and 
accountability for patient outcomes, improving case management and 
investigation of contacts, improving monitoring and evaluation practices, 
and revealing program strengths and weaknesses. This evaluation has 
provided data to fill some of the gaps related to integration of TB control 
in a PEPFAR population.
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THE JOINT EFFECTS OF EFFICACY AND COMPLIANCE: A 
STUDY OF HOUSEHOLD WATER TREATMENT EFFECTIVENESS
Kyle S. Enger1, Kara L. Nelson2, Joan B. Rose1, Joseph N. 
Eisenberg3
1Michigan State University, East Lansing, MI, United States, 2University of 
California, Berkeley, CA, United States, 3University of Michigan, Ann Arbor, 
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The effectiveness of interventions to control infectious disease is related 
to the intrinsic efficacy of the interventions in removing pathogens, and 
how people comply with the interventions. However, little is known about 
the quantitative relationship between compliance and effectiveness, which 
is particularly important for household water treatment (HWT). Although 
many HWT methods are highly efficacious at inactivating pathogens, 
their effectiveness within actual communities is decreased by imperfect 
compliance. To assess the effectiveness of HWT on childhood diarrhea 
incidence via drinking water for three pathogen types (bacterial, viral, 
and protozoan), we developed a quantitative microbial risk assessment 
(QMRA) model. We examined the relationship between log10 removal 
values (LRVs) and compliance with HWT for scenarios varying by: baseline 
incidence of diarrhea; etiologic fraction of diarrhea by pathogen type; 
pattern of compliance; and size of randomly scheduled contamination 
spikes in source water. The benefits of increasing LRVs are strongly linked 
to compliance. For perfect compliance, diarrheal incidence decreases as 
LRVs increase. However, when compliance is incomplete in the scenarios 
we considered, there are diminishing returns from increasing LRVs at 
the community level. Higher LRVs are more beneficial if: contamination 
spikes are large; contamination levels are high in general; or the pattern of 
compliance includes some people who comply perfectly. The effectiveness 
of an HWT intervention at the community level may be limited by 
low compliance, such that the benefits of high LRVs are not realized. 
Therefore, patterns of compliance with HWT should be measured during 
HWT field studies and HWT dissemination programs. Studies of pathogen 
concentrations in a variety of developing country source waters should 
also be conducted. Guidelines are needed for measuring and promoting 
compliance with HWT, in addition to the recently published WHO HWT 
efficacy recommendations.
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SPATIOTEMPORAL DYNAMICS OF CHOLERA EPIDEMICS IN 
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1Department of Environmental Sciences, The Higher Institute of the Sahel 
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In the year 2010, the Far North Region of Cameroon experienced its 
most severe cholera outbreaks in the last four decades with about 9,400 
reported cases and 600 deaths. This study describes the spatiotemporal 
dynamics of cholera epidemics from 1996 to 2010 using epidemiological 
data from this region, including reported cholera cases from 28 health 
districts, and environmental parameters such as temperature, relative 
humidity, rainfall and access to clean water. The data were entered into a 
geographical information system for further analysis. Regression analysis 
methods were used to analyze the data. The spatiotemporal patterns 
of the incidence rate were analyzed and associated with environmental 
factors to explore the determinant factors of the dynamics of cholera 
epidemics. The results revealed that there were three major epidemic 
periods and specific hotspots during the last 15 years. The annual 
dynamics showed a seasonal pattern coinciding with the wet seasons 
and significant differences in both incidence and timing by health 
districts. The spatial pattern revealed higher incidence rate in health 
districts in proximity with water bodies and in periurban areas. The study 
also revealed a connection with outbreaks in the neighboring countries 
of Chad and Nigeria. This study presents information related to the 
epidemiology and spatiotemporal pattern of cholera epidemics that can be 
used to help public health services plan prevention and control strategies 
against the spread of this disease.
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THE RELATIONSHIP BETWEEN DISTANCE TO HOUSEHOLD 
WATER SOURCE AND MODERATE-TO-SEVERE DIARRHEA IN 
YOUNG CHILDREN IN THE GLOBAL ENTERICS MULTI-CENTER 
STUDY (GEMS), KENYA, 2009-2011
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Water sources for rural households in the developing world are often 
located away from the home. Fetching water can be a substantial burden 
that can negatively affect household water quantity and quality, thereby 
increasing diarrheal disease risk. We visited households of 127 randomly 
selected pairs of case and age-, gender-, and village-matched controls 
enrolled in the GEMS study of moderate-to-severe diarrhea (MSD) in 
Kenya. We asked households to guide field teams from their home to their 
water source, and this path was captured as spatial data using GPS units. 
If no guide was available, we used GPS coordinates of the home and the 
water source to estimate distances. We compared GPS-sourced data to 
self-reported data in GEMS about round trip times spent to collect water, 
and evaluated each type of measurement as a predictor of MSD using 
conditional logistic regression. The paths recorded were a median of 1.18 
(range 1.00 - 2.49) times the length of the straight line distances between 
their start and endpoints. Self-reported collection times were significantly 
correlated with the log-transformed distance measurements via GPS 
(Spearman correlation coefficient =0.80, p <0.01). The median recorded 
distance to water source was 196m (range: 1 - 1775m); 89 (35%) 
households were within 50m, all of which also reported the source to be 
in the household area. Collection times of 30 - 59 minutes were reported 
by households of 24 cases (median distance 561m, range 100 - 1775m) 
and 8 controls (median 562m, range 197 - 981m), and the odds of MSD 
were significantly higher vs. those with no travel (p <0.01). Collection 
times longer than 1 hour were reported for 12 cases (median distance 
744m, range 148 - 1466m) and 3 controls (median distance 530m, range 
460 - 1048m) and were significantly associated with MSD (p=0.02). These 
data suggest that distances traveled by households in rural Kenya to fetch 
water varied widely, that self-reported water collection times are correlated 
with measured distances, and that these may be useful in multivariate 
analyses of risk factors for MSD.
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RELATIONSHIP BETWEEN USE OF WATER FROM 
COMMUNITY-SCALE WATER TREATMENT REFILL KIOSKS 
AND CHILDHOOD DIARRHEA IN JAKARTA
Laura C. Sima, Desai M. Mayur, Kathleen M. McCarty, 
Menachem Elimelech
Yale University, New Haven, CT, United States
In developing countries, safe piped drinking water is generally unavailable, 
and bottled water is unaffordable for most people. Purchasing drinking 
water from community-scale decentralized water treatment and refill 
kiosks (referred to as isi ulang depots in Indonesia) is becoming a common 
alternative. This study investigates the association between diarrhea risk 
and water kiosks. We monitored daily diarrhea status and water source for 
1,000 children aged 1--4 years in Jakarta, Indonesia, for up to 5 months. 
Among children in an urban slum, rate of diarrhea per 1,000 child-days 
varied significantly by primary water source: 8.13 for tap water, 3.60 
for bottled water, and 3.97 for water kiosks. In multivariable Poisson 
regression analysis, diarrhea risk remained significantly lower among water 
kiosk users (adjusted rate ratio [RR] = 0.49, 95% confidence interval [CI] = 
0.29--0.85) and bottled water users (adjusted RR = 0.44, 95% CI = 0.21-
-0.94), compared with tap water users. Purchasing water from low-cost 
water kiosks is associated with a reduction in diarrhea risk similar to that 
found for bottled water.
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FOOD PREPARATION PROCESSES AND HYGIENE PRACTICES 
IN RURAL BANGLADESH: OPPORTUNITIES TO IMPROVE 
HANDWASHING INTERVENTIONS
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Leontsini2, Pavani K. Ram3, Peter J. Winch2, Shahana Parveen1, 
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Bangladesh, 2Johns Hopkins Bloomberg School of Public Health, Baltimore, 
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In rural Bangladesh handwashing with soap during food preparation 
is associated with reduced child diarrhea, but we have limited data 
characterizing food preparation and related handwashing to inform 
behavior change interventions. This study explored the steps of food 
preparation, related handwashing opportunities, community perceptions 
and current practices regarding handwashing during food preparation. 
In 3 rural Bangladeshi villages, we conducted 12 in-depth interviews, 12 
unstructured observations and 12 video observations with caregivers, 
and 3 focus group discussions with household heads on handwashing 
related to food preparation. Eating, preparing and serving food with bare 
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hands was common in the study communities. Varieties of mashed foods, 
salads and mixed dried foods that involved direct hand contact, which 
are not further cooked, were popular in rural Bangladesh. Mashed foods 
are prepared by boiling vegetables or dried fish, then peeling, mashing 
and mixing with raw ingredients using bare hands. Salad preparation 
involved cutting raw vegetables and mixing them by hand. For mixed dried 
foods puffed rice and dried snacks are hand-mixed with raw ingredients. 
Participants perceived that handwashing with soap was only necessary if 
hands were covered with visible dirt. Most respondents reported that they 
wash their hands with water during food preparation, but we observed 
that out of 54 opportunities to wash hands, participants washed hands 
with soap 2 times, with water alone 9 times, rinsed hands or hands came 
into contact with water 26 times, and did not wash hands 17 times. Food 
preparation was often interrupted by other tasks that could contaminate 
the preparer’s hands, after which they continued food preparation without 
washing hands. Participants cited that absence of soap in appropriate 
place is a potential barrier to wash hands with soap. Caregivers do 
not usually wash their hands with soap during food preparation in 
rural Bangladesh. Food preparation is a complex, multi-step, often 
interrupted process where villagers do not recognize moments of high 
risk of environmental contamination as a time to wash hands with soap. 
Identifying the highest risk food preparation steps and prioritizing those 
when handwashing with soap is important will help focus handwashing 
interventions. Bringing soap and water together in the food preparation 
area may make it easier to wash hands with soap during such high risk 
moments.
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INACTIVATION OF HELMINTH IN A SOLAR CONCENTRATOR
Andrew M. Foote1, Emily Woods1, Fernando Fredes2
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More than 1 billion people worldwide are infected with helminths. Typical 
pit latrines and composting conditions do not inactivate helminths in fecal 
matter effectively. By concentrating solar energy and reaching pathogen 
inactivation temperatures (50°C and higher), a solar concentrator, with 
projected capital costs of $0.30 per person per year, has the potential to 
inactivate helminths in fecal matter. The goal of this work was to evaluate 
the efficacy of a solar concentrator in inactivating helminth in fecal 
matter and meet World Health Organization (WHO) guidelines for safe 
disposal and reuse of fecal matter. Inactivation was assessed by evaluating 
the viability of Toxocara canis eggs. T. canis is a helminth in the same 
taxonomic order as Ascaris lumbricoides, which is a WHO indicator for safe 
fecal disposal and reuse. Three trials were conducted from December 2011 
through February 2012 in Santiago, Chile. The first two trials evaluated 
T. canis viability daily. To calculate the inactivation rate for the solar 
concentrator unit, the third trial evaluated T. canis viability hourly. In each 
trial, T. canis eggs were isolated from canine fecal matter, concentrated, 
placed in semi-permeable tea bags (1,500 eggs each) and inoculated into 
40 liters of fresh canine fecal matter. T. canis eggs were inoculated into 
two control conditions: indoors in the dark and in a mimic pit latrine. At 
the end of each trial, eggs were incubated and classified as viable if they 
contained a motile larva. In all 3 trials, temperatures reached 60°C at the 
center and 70°C at the edges of the solar concentrator for at least 4 hours 
daily. During all three trials, after one day in the solar concentrator, the 
die-off of eggs was greater than 99%. In the third trial, the inactivation 
rate was 0.67 Log10 eggs/hr
 and there was 99% inactivation after 4 hours. 
These results suggest that a solar concentrating unit can be used to rapidly 
inactivate helminths in fecal matter, and therefore, fecal matter treated by 
a solar concentrator can be safely disposed and reused on edible crops.
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CONTINUED ENVIRONMENTAL FECAL CONTAMINATION 
FOLLOWING IMPLEMENTATION OF SANITATION HARDWARE
Sania Ashraf1, Faruqe Hussain1, Elli Leontsini2, Leanne Unicomb1, 
Stephen P. Luby3
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Even with latrines available, child and animal feces are often found in 
and around households in rural Bangladesh. These feces may contain 
important gastrointestinal pathogens. We piloted child potties and 
a customized hoe like tool (sani scoop) to measure their impact on 
environmental fecal contamination. We distributed child potties in 104 
rural households with children <3 years of age. All households in study 
household compounds were given sani scoops to encourage hygienic 
disposal of child feces in latrines and animal feces in designated pits. 
Local health promoters encouraged using scoops and potties in these 
households through nurture and disgust themed messages. Field workers 
administered a 3 month follow-up survey that included participant 
reported frequency of use, and field worker observation of the presence 
and condition of hardware and presence of animal and human feces 
around the household. We used in-depth interviews and focus group 
discussions with mothers from these communities to identify the barriers 
to using the hardware. Reported use of potties (67%) and sani scoops 
(89%) for child defecation events were high. Little difference in the 
presence of human feces was detected 3 months after receiving the 
intervention (19/96; 20%) compared to baseline (16/104; 16%), and to 
control households (22%). Similarly animal feces were found in 87/104 
(84%) of intervention households at 3 months compared to 92/96 (96%) 
at baseline and 99% in control compounds. During in-depth interviews 
participants reported incomplete potty training, inconsistent potty use and 
delays in disposing feces because of their many other household tasks. 
Ubiquitous poultry and other domestic animals regularly produced fresh 
feces. The utility of cow dung as biofuel led to conflict over ownership 
of feces and appropriate handling. Perceptions of child and some animal 
feces as harmless limited household’s motivation to dispose of feces. 
Though potties and sani scoops had high acceptability and self-reported 
use, most households maintained high levels of observable feces at follow-
up. Although improving disposal of child feces is often mentioned as part 
of sanitary interventions, additional research is needed to develop practical 
strategies to reduce contamination in a child’s household environment.
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LOOKING BEYOND KDR: THE EMERGENCE OF A NEW 
MUTATION, N1575Y, IN THE SODIUM CHANNEL OF 
ANOPHELES GAMBIAE AND ITS ROLE IN INSECTICIDE 
RESISTANCE
Christopher M. Jones1, Fiacre R. Agossa2, Toé K. Hyacinthe1, 
David Weetman1, Hilary Ranson1, Martin James Donnelly1, Craig S. 
Wilding1
1Liverpool School of Tropical Medicine, Liverpool, United Kingdom, 2Centre 
de Recherche Entomologique de Cotonou, Cotonou, Benin
Insecticide resistance is a major threat to malaria vector control. In 
Anopheles gambiae, resistance to pyrethroid and DDT insecticides is 
strongly associated with the mutations L1014F and L1014S within the 
para voltage-gated sodium channel (VGSC). Across much of West Africa, 
1014F frequency approaches fixation. Here, we document the emergence 
of a mutation, N1575Y, within the linker between domains III-IV of the 
VGSC. In data extending over 40 kbp of the VGSC 1575Y occurs on only 
a single long-range haplotype, also bearing 1014F. The 1014F-1575Y 
haplotype was found in both M and S molecular forms of An. gambiae 
in West/Central African sample sites separated by up to 2,000 km. In 
Burkina Faso M form, 1575Y allele frequency rose significantly from 0.053 
to 0.172 between 2008 and 2010. Extended haplotype homozygosity 
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analysis of the wild-type 1575N allele showed rapid decay of linkage 
disequilibrium (LD), in sharp contrast to the extended LD exhibited by 
1575Y. A haplotype with long-range LD and high/increasing frequency 
is a classical sign of strong positive selection acting on a recent mutant. 
1575Y occurs ubiquitously on a 1014F haplotypic background, suggesting 
that the N1575Y mutation compensates for deleterious fitness effects of 
1014F and/or confers additional resistance to insecticides. Haplotypic tests 
of association suggest the latter: The 1014F-1575Y haplotype confers a 
significant additive benefit above 1014F-1575N for survival to DDT (M 
form P = 0.03) and permethrin (S form P = 0.003). DNA-based diagnostics 
are supplementing phenotypic bioassays as a proactive means of detecting 
resistance alleles at low frequency. The discovery of N1575Y at an 
early stage highlights the importance of continual monitoring for novel 
resistance mutations and its spread should be monitored closely.
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THE EVOLUTION OF RESISTANCE TO CARBAMATES AND 
ORGANOPHOSPHATE INSECTICIDES IN ANOPHELES 
GAMBIAE
Luc S. Djogbénou1, David Weetman2, Roch Dabiré3, Guillaune 
Ketoh4, Fabrice Chandre5, Mylène Weill6, Martin Donnelly2
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4URET/Université de Lomé, Lomé, Togo, 5Laboratoire de Lutte contre les 
Insectes Nuisibles/IRD, MIVEGEC, Montpellier, France, 6Institut des Sciences 
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Determining the number of origins of insecticide resistance-associated 
mutations is important not only from an evolutionary perspective but 
also for modelling its spread, which is increasingly important for the 
implementation and monitoring of malaria vector control programmes. 
In the mosquito Anopheles gambiae s.s., the main African vector of 
malaria, organophosphate (OP) and carbamate resistance is strongly 
associated with a single amino-acid substitution (G119S) in the insecticide 
target site, acetylcholinesterase 1 (Ace-1). This mutation apparently 
incurs a high fitness cost in the absence of insecticidal pressure. Recently, 
a duplication of the Ace-1 locus was observed in An. gambiae, which 
results in a wildtype and resistant-associated allele occurring on the same 
haplotype (Ace-1D). It is proposed that the Ace-1D haplotype is in effect a 
‘‘fixed’’ heterozygote that may confer similar levels of resistance but with 
reduced fitness effects. We have screened for diversity in and around the 
Ace-1 locus in mosquitoes from a large number of sites in West Africa. 
We present data showing a selective sweep centred on the Ace-1 locus 
and extending for approximately 1MB in both centromeric and telomeric 
directions. Targeted sequencing of the Ace-1 locus has revealed the first 
evidence of multiple origins of the resistance allele and a potentially 
more complex of pattern of duplication, with potentially important 
consequences for vector control involving OPs and carbamates.
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VECTOR CONTROL IN WEST OF TANZANIA
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Kagera region on the western side of Lake Victoria had the highest malaria 
burden in Tanzania according the 2007 Malaria Indicator Survey. To reduce 
malaria transmission an annual round of indoor residual spraying (IRS) has 
been conducted since 2007 initially with lambdacyhalothrin (pyrethroid) 
and more recently with bendiocarb (carbamate). A campaign of universal 
coverage of long lasting insecticidal nets (LLIN) was carried out in 2011. 
The emergence of resistance could threaten the future of these two 
interventions. As a component of a cluster randomized trial comparing 
the combination of LLIN and IRS versus LLIN alone the distribution of 
vectors and prevalence of insecticide resistance is being monitored. From 
April to December 2011, monthly Anopheles collection using CDC light 
traps was carried out across 40 villages in the area. Resistance monitoring 
was carried out on An. gambiae s.l. using WHO cylinder test. CDC 
bottle bioassays with synergists examined the involvement of metabolic 
resistance. Species identification and prevalence of knock down resistance 
(kdr) was confirmed using real time PCR TaqMan assay. A total of 5844 
Anopheles mosquitoes were collected over seven months, of these 67% 
were collected in April, two months after spraying with pyrethroid. 
81.8% were An.gambiae s.s. and 17.2% were An. arabiensis. East kdr 
mutation which is associated with pyrethroid and DDT resistance was 
present at high frequency in An.gambiae s.s. (97%) but only at 5% in 
An.arabiensis. Mortality in WHO resistance tests ranged from 0% to 
38% for lambdacyhalothin, 12% to 40% for DDT, and 84% to 100% 
for bendiocarb. Result from the CDC bottle assay suggested the presence 
of elevated level of oxidases and esterases. East kdr mutation seems to 
have reached fixation in the An.gambiae s.s population. High phenotypic 
resistance to pyrethroid was observed. In contrast to neighbouring Kenya 
where An.gambiae s.s. nearly disappeared after vector control despite high 
kdr frequency, An.gambiae s.s. remains predominant in Kagera even with 
high coverage of pyrethroid IRS and LLINs.
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DISSECTING THE MOLECULAR BASIS OF PYRETHROID 
RESISTANCE IN FIELD POPULATIONS OF THE MAJOR 
MALARIA VECTOR ANOPHELES FUNESTUS IN SOUTHERN 
AFRICA 
Jacob M. Riveron, Helen Irving, Miranda Ndula, Kayla G. Barnes, 
Charles S. Wondji
Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Anopheles funestus is a major malaria vector in Southern Africa. It remains 
unclear whether the many reports of pyrethroid resistance in this region 
have the same underlying mechanisms spreading between countries 
through gene flow or if different mechanisms occurred independently. To 
elucidate these questions we dissected the molecular basis of pyrethroid 
resistance in three countries, Mozambique, Malawi and Zambia. 
Microarray analysis using an Agilent chip identified three main P450 genes 
associated with permethrin resistance (CYP6P9a, CYP6P9b and CYP6M7) 
but with significant differences in expression patterns between countries. 
Other genes potentially implicated involved a short chain dehydrogenase 
and other P450s such as CYP6AA4 and CYP9J14. The most upregulated 
gene in Mozambique is CYP6P9b with a fold-change (FC) >88, then 
CYP6P9a (FC~60) and CYP6M7 (FC~25). Interestingly in Malawi, CYP6P9a 
is the most upregulated gene (FC~69) then CYP6P9b (FC~30) and last 
CYP6M7 (FC~12) while in Zambia, CYP6M7 is the top upregulated gene 
(FC~37) before CYP6P9a (FC~15) and CYP6P9b (FC~11). The overall 
higher fold-change in Mozambique correlates with the higher level of 
resistance in this country. The upregulation of these genes was validated 
by qRT-PCR. Polymorphism analysis of these 3 genes and surrounding 
microsatellite markers detected selective sweep signatures for CYP6P9b 
and CYP6P9a but less for CYP6M7. Transgenic In vivo expression of 
CYP6P9a and CYP6P9b using the GAL4/UAS system indicated that both 
genes confer resistance in Drosophila to permethrin and deltamethrin. 
In vitro metabolism assays with recombinant proteins of both genes in 
E coli cells showed that CYP6P9a and CYP6P9b both metabolise Type I 
(permethrin) and Type II (deltamethrin and λ-cyhalothrin) pyrethroids but 
not Etofenprox or DDT. The cloning of the 6kb cDNA of the VGSC gene 
identified rare clones with potential kdr mutations which remain to be 
confirmed in field populations. Overall, these results suggest the presence 
of different resistance fronts in populations of An. funestus in Southern 
Africa.
295
www.astmh.org
970
EVOLUTION OF INSECTICIDE RESISTANCE AND MALARIA 
POSITIVITY RATES IN ANOPHELES GAMBIAE AFTER 
INTRODUCTION LONG LASTING INSECTICIDE TREATED BED 
NETS IN DIELMO, SENEGAL
Mamadou Ousmane Ndiath, Cheikh Sokhna, Jean François 
Trape
Institut de Recherche pour le Developpement, Dakar, Senegal
Despite many efforts in basic and applied research, malaria remains, 120 
years after Plasmodium discovery, one of the major health problems, 
particularly in Africa. Among the different strategies used, vector control is 
an important component of malaria control. Insecticide-treated nets (ITNs) 
and indoor residual spraying (IRS) represent the front-line tools for malaria 
vector control. However as a real arms race, anophelines mosquitoes 
develop more and more resistance. The aim of this study was to identify 
changes in the principal malaria vectors in Dielmo (Senegal) that occurred 
before (2006 to July 2008) and after (August 2008 to December 2011) 
the implementation of LLIN’s. Adult mosquitoes were collected by HLC 
monthly from January 2006 to December 2011 and by PSC during the 
rainy season. Mosquitoes were identified down to their species and 
sub-species by PCR. The presence of circumsporozoite protein (CSP) of 
P. falciparum and the blood meal origin was detected by ELISA, and kdr 
mutations were investigated by PCR. From January 2006 to December 
2011, 855 (62.0%) An. gambiae s.l. and 5,190 (36.3%) An. funestus were 
collected during 744 man night captures. No An. gambiae HBR variations 
was observed during periods before and after the implementation of LLINs 
(12.0 An./man/night vs. 11.8 before), whereas An. funestus present all 
year round before LLINs disappeared after. Before the implementation of 
LLINs, CSP rate was not significantly different between kdr groups (4.55% 
in RS group and 3.83% in SS group, p=0.6) or in taxa groups (p=0.6). 
After August 2008, a significant difference was observed among kdr 
groups with significantly more CSP positive specimens in the RR group 
(25.45%) than in RS (14.67%) or SS groups (p<0.001). A significant 
difference in CSP rate was also observed between taxa groups (p=0.004) 
with more infected mosquitoes in An. gambiae S form. No specimen 
with L1014S kdr mutation was identified along the study. This study 
demonstrates the exceptional adaptability of An. gambiae s.l. to the 
presence of insecticide inside the houses.
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FOLLOWING UNIVERSAL COVERAGE OF LONG-LASTING 
INSECTICIDAL NETS IN BENIN
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Behavioural modification of malaria vectors in response to vector control 
methods is of great concern. We investigated whether full coverage of 
Long-Lasting Insecticide-treated mosquito Nets (LLIN) may induce a switch 
in biting behaviour in Anopheles funestus, a major malaria vector in Africa. 
Human landing collections were conducted indoor and outdoor in two 
villages (Lokohouè and Tokoli) in Southern Benin prior, 1 year and 3 years 
after implementation of universal LLIN coverage. Outdoor Biting Rates 
(OBR) and Median Catching Times (MCT, the hour for which 50% of An. 
funestus mosquitoes were collected) were compared. The resistance status 
of An. funestus to deltamethrin insecticide was monitored using bioassays. 
MCT of An. funestus switched from 02:00 in Lokohoué and 03:00 in 
Tokoli to 05:00 after 3 years (Mann-Whitney p-value<0.0001). In Tokoli, 
OBR increased from 45% to 68.1% (OR=2.55;95CI 1.72-3.78;p<0.0001) 
1 year after the universal coverage whereas OBR was unchanged in 
Lokohoué. In this latter place, however, the proportion of An. funestus 
that bites after dawn (06:00) was 26%. Bioassays showed no resistance 
to deltamethrin. In conclusion, this study provides evidence for a switch in 
malaria vectors biting behaviour following the implementation of LLIN at 
universal coverage. We show first evidence for a diurnal activity of a major 
malaria vector in Africa. These changes may reflect phenotypic plasticity or 
selection of genetically inherited traits and may have direct consequences 
on the burden of malaria in Africa. These findings highlighted the need for 
alternative strategies for better targeting outdoor malaria vectors.
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QUANTIFYING THE MOSQUITO’S SWEET TOOTH: MODELING 
ATTRACTIVE TOXIC SUGAR BAIT FOR VECTOR CONTROL
John M. Marshall1, Michael T. White1, Yosef Schlein2, Gunter C. 
Muller2, John C. Beier3
1Imperial College London, London, United Kingdom, 2Hebrew University, 
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Current vector control strategies focus largely on indoor measures, such 
as long-lasting insecticide treated nets (LLINs) and indoor residual spraying 
(IRS); however mosquitoes frequently feed on sugar sources outdoors, 
inviting the possibility of novel control strategies. Attractive toxic sugar 
bait (ATSB), either sprayed on vegetation or provided in outdoor bait 
stations, has been tested in Mali and Israel and has been shown to 
significantly reduce mosquito densities in these settings. We fitted models 
of mosquito population dynamics to data from these experiments to gain 
a better quantitative understanding of mosquito sugar feeding behavior 
and the potential of ATSB to control mosquito populations. In Mali, we 
estimate that 42% of female mosquitoes in the experimental setting fed 
on ATSB solution per day, dying within three hours of ingesting the toxin. 
A model incorportating the number of gonotrophic cycles completed by 
female mosquitoes found a higher feeding rate for younger mosquitoes 
and a slower rate for older mosquitoes.This model was extended to 
assess the role of ATSB as part of an integrated vector management (IVM) 
program. Our simulations suggest that an IVM program based on on both 
ATSB and LLINs/IRS is likely to cause substantial reductions in mosquito 
density as multiple stages of the mosquito’s lifecycle are targeted. In 
addition, ATSB is expected to be particularly effective against Anopheles 
arabiensis, which is relatively exophilic and therefore less affected by IRS 
and LLINs. ATSB has a benefit over larvacides in the sense that it skews 
the age distribution towards younger mosquitoes, which is beneficial 
for malaria control because only older mosquitoes have time to acquire, 
incubate and transmit the parasite. These encouraging results suggest that 
ATSB should be seriously considered as a promising component in future 
IVM malaria control strategies.
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A POTENTIAL ROLE FOR URIC ACID IN ENDOTHELIUM 
ACTIVATION AND DAMAGE IN PLASMODIUM FALCIPARUM 
MALARIA
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Inflammatory cytokinemia and systemic endothelial activation are central 
to the pathogenesis of Plasmodium falciparum (Pf) malaria. Recently, 
Pf-derived uric acid (UA) - in both its soluble and precipitated forms 
- was shown to activate human immune cells in vitro, and elevated 
plasma UA levels were associated with inflammatory cytokinemia and 
disease severity in children with malaria. A role for Pf-derived UA in 
endothelial inflammation has not been investigated. Since UA elevations 
are associated with endothelial inflammation in a variety of non-
malarial diseases, we hypothesized that elevated UA levels contribute to 
endothelial activation and damage in P. falciparum malaria. To test this, 
we measured levels of UA and soluble forms of intercellular adhesion 
molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-
1), E-Selectin, thrombomodulin (TM), tissue factor (TF) and vascular 
endothelial growth factor (VEGF) in the plasma of 567 Malian children 
(aged 6 months - 17 years) with uncomplicated malaria (UM, N=489) 
and non-cerebral severe malaria (NCSM, N=68). In 69 of these children, 
we measured these same factors during their malaria episode and twice 
when they were healthy (before and after the transmission season). 
We found that levels of UA, sICAM-1, sVCAM-1, sE-Selectin and sTM 
increased significantly during a malaria episode, returning to ’healthy’ 
levels at the end of the transmission season (p<0.0001). In children with 
UM, UA levels correlated significantly with those of sICAM-1 (r =0.255, 
p<0.0001) and sTM (r=0.175, p=0.0005). To test the possibility that Pf-
derived UA precipitates activate EC, we co-cultured 3D7-infected red 
blood cells (PfRBCs) with primary microvascular endothelial cells (MVECs) 
with or without uricase, which degrades UA. Our preliminary results show 
that PfRBCs stimulate MVECs to release IL-6 and IL-8 in a dose- and time-
dependent manner and that uricase abrogates the production of these 
cytokines. Our data suggest that parasite-induced elevations in UA levels 
contribute to malaria pathogenesis by causing endothelial activation and 
damage
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Babesiosis is a zoonosis caused by tick-transmitted intraerythrocytic 
protozoa of the Phylum Apicomplexa. Some specific stages of 
apicomplexan parasites, such as sporozoites of Plasmodium falciparum 
and tachyzoites of Toxoplasma gondii, invade their target host cells using 
a unique, active process known as gliding motility. However, it is not 
thoroughly understood how the merozoites of Babesia parasites target 
and invade the host red blood cells (RBCs), and the gliding motility has 
so far not been observed in the parasite. In this study, we revealed the 
gliding motility of B. bovis merozoites by time-lapse video microscopy. 
The recorded images delineated that the processes included egress of 
the merozoites from the infected RBC, gliding motility, and succeeding 
invasion into new RBCs. Based on these images, the gliding motility 
of B. bovis merozoites was similar to the helical gliding of Toxoplasma 
tachyzoites. The trails left by the merozoites were detected by indirect 
immunofluorescence assay using antiserum against B. bovis merozoite 
surface antigen 1. This first report of gliding motility in B. bovis is 
notable and significant for the apicomplexan parasites since merozoites 
of Plasmodium parasites do not glide on the substrate. Furthermore, 
inhibition of gliding motility by actin filament polymerizer or depolymerizer 
indicated that this movement was driven by actomyosin-dependent 
process. In this study, we also revealed the timing of breakdown 
of parasitophorous vacuole through time-lapse image analysis. The 
membrane-stained bovine RBCs showed formation and breakdown of 
parasitophorous vacuole within ten minutes. Moreover, recent studies in 
Plasmodium have highlighted the essential role of the thrombospondin 
related anonymous/adhesive protein (TRAP) family in the gliding and cell 
invasion of the parasites. Currently, we are in the process of investigating 
the role of the TRAP-family in the gliding motility of Babesia merozoites.
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THE ROLE OF MACROPHAGES IN SCHISTOSOMAL BLADDER 
PATHOGENESIS
Chi-Ling Fu, Kim Thai, Justin Odegaard, Michael Hsieh
Stanford University School of Medicine, Stanford, CA, United States
Schistosoma haematobium infects 112 million people, rendering it 
the most prevalent cause of schistosomiasis worldwide. Chronic S. 
haematobium infection (urogenital schistosomiasis) leads to approximately 
150,000 deaths annually from urinary tract fibrosis-induced obstructive 
renal failure, making it one of the deadliest worm infections globally. 
Despite the major human impact of urogenital schistosomiasis, the 
mechanisms of S. haematobium egg-triggered, urinary tract granuloma-
associated pathogenesis remain ill-defined. Parallels may be drawn from 
mouse models of Schistosoma mansoni infection, wherein egg granuloma-
associated macrophages play a central role in liver pathogenesis. However, 
the involvement of macrophages in schistosomal bladder pathogenesis 
is unknown. To address this deficiency, we have employed our recently 
developed mouse model of urogenital schistosomiasis, as reported 
previously. Eight to 12 week old female mice underwent bladder wall 
microinjection with various single doses of S. haematobium eggs. 
Macrophages were systemically and locally killed by intraperitoneal, 
bladder intramural, and transurethral administration of macrophage-
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depleting agents. Serial microultrasonography revealed zones of decreased 
echogenicity in the periphery of egg granulomas in macrophage-
depleted versus -replete mice, suggestive of relative hypocellularity. This 
was confirmed by histology, which revealed hypocellular cavitations in 
macrophage-depleted granulomas, less fibrosis, and fewer infiltrating 
leukocytes. None of the control vehicle-treated mice receiving eggs 
died, whereas 60% of macrophage-depleted mice receiving high 
doses of eggs died by day 11 post-egg injection, indicating a crucial 
role for macrophages in prevention of detrimental systemic effects of 
helminth exposure. Our results confirm a critical role for macrophages 
in schistosomal bladder pathogenesis, even in the setting of a single 
exposure to S. haematobium eggs. This suggests that macrophages 
may be a suitable therapeutic target for advanced schistosomal bladder 
pathogenesis.
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DEVELOPMENTAL AND SPATIAL EXPRESSION OF ANTIGENIC 
GLYCANS BY LARVAL STAGES OF SCHISTOSOMA MANSONI
Cornelis H. Smit, Angela van Diepen, Dieuwke Kornelis, Manfred 
Wuhrer, André M. Deelder, Cornelis H. Hokke
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Many glycans of schistosomes are differentially expressed during the 
parasite’s lifecycle. In human infections, antibodies are produced against 
antigenic schistosome glycans, which might form promising novel vaccine 
targets. Schistosome larvae, up to several days old, appear most vulnerable 
to immune attack, but their glycosylation is poorly characterized. In 
this study we determined the structure and localisation of the antigenic 
glycans expressed by early developmental stages of S. mansoni ranging 
from invading cercariae to transformed schistosomula and mature worms, 
with the objective of identifying antigens exposed to the immune system 
of the host. The protein-linked glycans from 14 different lifecycle stages 
were isolated and profiled using a mass spectrometry-based analysis 
strategy. Although N-glycans were continuously present during the 
whole lifecycle, our analysis indicated a gradually changing N-glycome 
during development. Expression of immunogenic glycan elements such 
as core-xylose and LeX-antennae are abundant in cercariae and shortly 
after transformation to schistosomula, but expression decreased after 3 
days of maturation. On the other hand, glycans with LDN termini become 
abundant in the adult stages. O-glycan expression, often with similar 
antennae motifs as N-glycans, strongly diminishes after transformation 
of the cercariae, but becomes abundant again in eggs. Using a glycan-
microarray constructed of schistosome-derived glycans, we determined 
the fine-specificity of a panel of anti-carbohydrate monoclonal antibodies 
obtained from schistosome-infected mice. Application of these mAbs 
in immunofluorescence microscopy assays of the infective cercariae and 
1-3 day schistosomula stages of S. mansoni indicated that some glycan 
epitopes (e.g. LDN, F-LDN, F-LDN-F) identified in the structural studies are 
expressed at the surface throughout development, whereas others such 
as the LeX-motif appear at the surface only after transformation. These 
observations further underline the potential of specific glycans as targets 
for immune attack.
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NEMATODE AUTOPHAGY REGULATES WOLBACHIA 
POPULATIONS AND IDENTIFIES A NOVEL MODE-OF-ACTION 
FOR ANTI-FILARIAL TREATMENT
Denis Voronin, Darren Cook, Andrew Steven, Mark J. Taylor
Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Filarial nematode parasites are amongst the most important neglected 
parasitic diseases of humans and animals. Over 150 million individuals 
are infected with lymphatic filariasis and onchocerciasis and heartworm 
is an important pathogen of dogs and cats. A new target for anti-filarial 
treatment is the obligate mutualistic endobacteria Wolbachia. Depletion 
of Wolbachia with antibiotics induces defects in nematode development, 
fertility and viability. In order to identify novel mechanisms to deplete 
Wolbachia as part of the A-WOL drug discovery and development 
programme, we investigated the role of activating host nematode 
autophagy to control bacterial populations. Our studies revealed that 
periods of rapid bacterial population growth and expansion were 
accompanied by activation of the autophagy pathway and that chemical 
and genetic manipulation of this pathway could directly regulate bacterial 
populations at an equivalent level to antibiotic treatment. The activation 
of the autophagy by using drugs or small-molecules resulted in Wolbachia 
reduction in both in vitro and in vivo treated Brugia malayi. The induction 
of the host nematode intracellular autophagy defence mechanism 
can therefore be considered as a novel mode-of-action, which delivers 
bactericidal activity that can be used to develop improved drugs and 
regimes for anti-filarial treatment.
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FUNCTIONAL REDUNDANCY IN PLASMODIUM 
HEMOGLOBINASES AND PARASITE DEVELOPMENT INSIDE 
RETICULOCYTES WITHOUT HEMOGLOBIN DEGRADATION
Jingwen Lin1, Elena Aime2, Mohammed Sajid1, Blandine Franke-
Fayard1, Frans Prins3, Philippe E. Van den Steen4, Katrien Deroost4, 
Roberta Spaccapelo2, Chris J. Janse1, Shahid M. Khan1
1Department of Parasitology, Leiden University Medical Center, Leiden, The 
Netherlands, 2Department of Experimental Medicine, University of Perugia, 
Perugia, Italy, 3Department of Pathology, Leiden University Medical Center, 
Leiden, The Netherlands, 4Laboratory of Immunobiology, Rega Institute for 
Medical Research, University of Leuven, Leuven, Belgium
Clinical symptoms of malaria infection manifest when the Plasmodium 
parasites replicates in host red blood cell. During this intraerythocytic 
cycle, the parasite ingests and catabolizes up to 75% of the host cell 
homoglobin (Hb). The hemoglobin is broken down by a number of 
proteases in a semi-order cascade in an acidic, Plasmodium-specific, 
digestive food vacuole (DFV). Whether this degradation is essential for 
parasite survival has not been established. To characterize biological 
roles of various hemoglobinases residing in digestive food vacuole, we 
attempted targeted gene disruption of all the predicted hemoglobinases in 
the rodent model P. berghei and found that most of them are functionally 
redundant. We have also created a double gene-deletion mutant, 
∆pm4∆bp2, lacking expression of both plasmepsin-4 (equivalent to P. 
falciparum plasmepsin I, II, III and IV) and bergheipain-2 (equivalent to P. 
falciparum falcipain-2a, 2b and 3), which are thought to be involved in 
initial cleavage of Hb. Despite severe growth and virulence attenuation, 
the parasites are able to develop into mature schizonts in reticulocytes. 
These schizonts produce either no or vastly reduced levels of hemozoin, 
the crystallized product formed by detoxification of heme that is released 
early in Hb digestion. This was confirmed by examining hemozoin 
deposition in both liver and spleen of ∆pm4∆bp2 infected mice, which 
was greatly reduced compared to wildtype infected mice. The cerebral 
complication (CM) sensitive C57BL/6 mice were able to clear the infection 
without visible CM manifestation and survive later wild-type challenge. 
Our results show that Hb digestion may not be essential for parasite 
growth in reticulocytes. These findings have implications for the design 
of drugs against DFV enzymes and for possible mechanisms that underlie 
Plasmodium resistance to drugs, the majority of which target Hb digestion 
and heme detoxification.
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BIOCHEMICAL CHARACTERIZATION OF UFSP, THE UFM1 
ASSOCIATED PEPTIDASE IN LEISHMANIA DONOVANI
Sreenivas Gannavaram, Hira L. Nakhasi
U.S. Food and Drug Administration, Bethesda, MD, United States
Leishmaniasis is a spectrum of diseases caused by protozoan parasites 
belonging to several different Leishmania species. There are no effective 
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vaccines against leishmaniases. Currently available therapeutic regimens 
are often limited in effectiveness due to unwarranted side effects and 
rapidly emerging drug resistance. Therefore, the quest for a novel 
vaccine and therapeutic targets acquires urgency towards controlling 
leishmaniases. Ubiquitin and ubiquitin like protein modifiers (Ubls) regulate 
a variety of biological functions ranging from endocytosis, membrane 
trafficking, protein kinase activation, DNA repair and chromatin dynamics. 
Studies of Ubl functions in human parasitic organisms are limited. Recently, 
we described the existence of a novel Ubl named ubiquitin-fold modifier 
1 (Ufm1) that conjugates to parasite proteins in Leishmania donovani. To 
elucidate the enzymatic activities associated with Ufm1 conjugation, we 
identified a putative Ufsp in the trypanosomatid genomes. Biochemical 
analysis of L. donovani Ufsp showed that this protein possesses the 
3’hydrolase activity necessary for processing the precursor Ufm1 into a 
conjugatable form. To examine the effects of abolition of Ufm1 processing 
activity, we generated a L. donovani knock out mutant lacking the Ufsp. 
Analysis of the Ufsp mutant revealed that lack of this protein results 
in the absence of processing of precursor Ufm1. We also showed that 
Ufsp null mutant results in reduced survival of L. donovani in infected 
human macrophages suggesting a role for this protein in Leishmania 
pathogenesis. This growth defect was reversed by re-expression of wild 
type but not the mutant of the catalytic cysteine (cys>ser) in the Ufsp 
indicating the essential nature of this protease for Ufm1 conjugation 
reactions. Therefore, Leishmania Ufsp has the potential to be a novel drug 
target. Further, Ufsp-/- parasites also provide an opportunity to explore 
such parasites as live attenuated vaccine candidates.
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MOLECULAR AND FUNCTIONAL STUDIES OF THE 
SCHISTOSOMA MANSONI VENUS KINASE RECEPTORS 
SMVKR1 AND SMVKR2: POTENTIAL ROLES IN LARVAL 
DEVELOPMENT AND OOGENESIS
Mathieu Vanderstraete1, Nadege Gouignard1, Edith Browaeys2, 
Silke Leutner3, Marion Morel1, Svenja Beckmann3, Christoph G. 
Grevelding3, Katia Cailliau2, Colette Dissous1
1Center of Infection and Immunity of Lille, Lille, France, 2EA 4479, IFR 
147, Universite Lille 1 Sciences et Technologies, Villeneuve d’Ascq Cedex, 
France, 3Institute for Parasitology, Justus-Liebig-University Giessen, 
Giessen, Germany
Venus kinase receptors (VKRs) form a new family of receptor tyrosine 
kinases. Atypically, VKRs contain an extracellular Venus Flytrap (VFT) 
domain, a ligand-binding domain activated by small molecules such 
as aminoacids. Vkr genes are found in diverse eumetazoan genomes, 
from cnidarians to echinoderms and are particularly well conserved 
in protostomian species, as reported previously. In the platyhelminth 
Schistosoma mansoni, two VKRs have been previously described, SmVKR1 
and SmVKR2. Quantitative RT-PCR as well as in situ hybridization indicated 
a large expression of both genes in larval stages and in female ovaries. 
RNA interference experiments performed on sporocysts and adult worms 
further confirmed the implication of SmVKRs in larval development 
and oogenesis. Using Xenopus laevis oocytes for protein expression, 
we demonstrated that SmVKR1 could bind and be activated by amino 
acids, mainly by L-Arginine, whereas SmVKR2 activation was triggered by 
calcium ions. In order to decipher the downstream signalling pathways 
of SmVKR1 and SmVKR2, we have started to identify binding partners 
of these receptors by the screening of an adult worm cDNA library using 
the yeast two-hybrid system. Our results suggest that both SmVKR1 and 
SmVKR2 participate in cytoskeleton rearrangement and in developmental 
mechanisms. Potential substrate/adapters for SmVKR1 have been 
identified and their function in the activation pathway of the receptor is 
under investigation.
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DETECTING CRYPTIC GENETIC EXCHANGE IN TRYPANOSOMA 
CRUZI TCI
Louisa A. Messenger1, Martin S. Llewellyn1, Tapan 
Bhattacharyya1, Oscar Franzen2, Michael D. Lewis1, Juan-David 
Ramirez3, Hernan J. Carrasco4, Bjorn Andersson2, Michael A. 
Miles1
1London School of Hygiene and Tropical Medicine, London, United 
Kingdom, 2Karolinska Institutet, Stockholm, Sweden, 3Universidad de los 
Andes, Bogota, Colombia, 4Universidad Central de Venezuela, Caracas, 
Bolivarian Republic of Venezuela
Clonal propagation is considered to be the predominant mode of 
reproduction among many parasitic protozoa. However, this assumption 
may overlook unorthodox, infrequent or cryptic sexuality. Trypanosoma 
cruzi, the causative agent of Chagas disease, is known to undergo 
non-Mendelian recombination in vitro, while evidence of natural 
genetic exchange is more limited. T. cruzi displays remarkable genetic 
heterogeneity and is recognized as a complex of six discrete typing units 
(DTUs). Infection with T. cruzi is life-long and can lead to a spectrum of 
pathological complications. However, the relationship between specific 
clinical outcomes and parasite genotype remains elusive. The availability 
of whole genome sequences has driven advances in high-resolution 
genotyping techniques and re-invigorated interest in exploring the 
genetic diversity present within the various DTUs. We developed a highly 
resolutive mitochondrial multilocus sequence typing (mtMLST) scheme, 
which was evaluated against current nuclear typing tools using isolates 
belonging to the oldest and most widely occurring lineage TcI. In parallel, 
we exploited read depth data, generated by Illumina sequencing of the 
mitochondrial genome from the TcI reference strain to investigate the 
existence of mitochondrial heteroplasmy (heterogeneous mitochondrial 
genomes in an individual cell) in T. cruzi and resolve its role as a potential 
source of genotyping error. Comparison of nuclear and mitochondrial 
data uncovered multiple novel mitochondrial introgression events among 
disparate geographical populations as well as between major T. cruzi 
DTUs. Illumina sequencing data from the TcI genome strain revealed 
multiple different mitochondrial genomes within an individual parasite 
(heteroplasmy) that were, however, not sufficiently divergent to represent 
a major source of typing error. mtMLST provides a powerful approach to 
genotyping at the sub-DTU level. This strategy will facilitate attempts to 
resolve phenotypic variation in T. cruzi and to address epidemiologically 
important hypotheses in conjunction with intensive spatio-temporal 
sampling. The observations of gross nuclear-mitochondrial phylogenetic 
incongruence indicate that genetic recombination is geographically 
widespread and continues to influence the natural population structure of 
TcI, a conclusion which challenges the traditional paradigm of clonality in 
T. cruzi.
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A PLASMODIUM VIVAX GENETIC CROSS TO INVESTIGATE 
MOLECULAR DETERMINANTS OF CHLOROQUINE RESPONSE
Juliana M. Sa1, Sarah R. Kaslow1, Jiangbing Mu1, Evan Kessler1, 
Soundarapandian Velmurugan2, Adam Richman2, Yonas F. Abebe2, 
Eric R. James2, B. K. Sim2, Stephen L. Hoffman2, Robert W. 
Gwadz1, Thomas E. Wellems1
1National Institutes of Health, Rockville, MD, United States, 2Sanaria Inc., 
Rockville, MD, United States
To investigate determinants of Plasmodium vivax chloroquine (CQ) 
resistance we have generated a genetic cross between two parasite lines 
with distinct CQ responses. A chimpanzee was infected with a mixture 
of these parental lines to produce infectious gametocytes for cross-
fertilization in Anopheles mosquitoes. Recombinant sporozoites from the 
infected mosquitoes were purified and cryopreserved and subsequently 
used to re-inoculate the same chimpanzee after it was completely cured 
of the parental lines infection. When parasitemia was detected in the 
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re-inoculated chimpanzee, pools of mixed intraerythrocytic recombinant 
progeny were collected and inoculated into Aotus monkeys. Progeny in 
these pools showed responses spanning the range of the parental lines, 
including some parasites surviving a total CQ dose of 15 mg/kg (5 mg/kg/
day x 3 days). Comparison of genetic markers in the mixed progeny before 
and after CQ treatment identifies regions of chromosomes that may be 
subject to linkage group selection and contain possible candidate genes. 
The P. vivax ortholog of the P. falciparum CQ resistance transporter gene 
(pfcrt ortholog, pvcrt-o) resides in one of these chromosome regions.
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ARTEMISININ RESISTANCE IN PLASMODIUM FALCIPARUM 
IS ASSOCIATED WITH AN ALTERED PATTERN OF 
TRANSCRIPTION
Sachel Mok1, Mallika Imwong2, Kek-Yee Liong1, Zhaoting Lin1, 
Wai-Hoe Chin1, Joan Sim1, Poravuth Yi3, Mayfong Mayxay4, 
Kesinee Chotivanich2, Bruce Russell5, Duong Socheat3, Paul N. 
Newton4, Nicholas P. Day6, Nicholas J. White6, Peter R. Preiser1, 
François Nosten7, Arjen M. Dondorp6, Zbynek Bozdech1
1School of Biological Sciences, Nanyang Technological University, 
Singapore, Singapore, 2Department of Molecular Tropical Medicine and 
Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, 
Thailand, 3The National Center for Parasitology, Entomology, and Malaria 
Control, Phnom Penh, Cambodia, 4Wellcome Trust-Mahosot Hospital-
Oxford University Tropical Medicine Research Collaboration, Mahosot 
Hospital, Vientiane, Lao People’s Democratic Republic, 5Singapore 
Immunology Network, Agency for Science Technology and Research, 
Singapore, Singapore, 6Mahidol-Oxford Research Unit, Faculty of Tropical 
Medicine, Mahidol University, Bangkok, Thailand, 7Shoklo Malaria 
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The emergence of artemisinin resistance in Western Cambodia and 
spread of resistance evidenced by the recent report of resistance in 
neighboring Thai-Myanmar border are major obstacles to the global 
containment and elimination of malaria disease. Although several 
genome-wide association studies on artemisinin resistance have been 
carried out proposing candidate genes, yet no definite molecular makers 
of artemisinin resistance have been commonly identified by the various 
research groups and none validated so far. Using DNA microarrays, we 
characterized the transcriptional profile of the ex-vivo intra-erythrocytic 
stage of total 36 parasite isolates from patients collected from 2008 to 
2010 from Laos, Pailin, Western Cambodia and Thai-Myanmar border, 
of which 15 are resistant to artemisinin as reflected by increased parasite 
clearance half-lives. Features of the profile associated with artemisinin 
resistance include reduced expression of metabolic and cellular pathways 
such as glycolysis, pentose phosphate pathway, protein sythesis, DNA 
replication and redox metabolism in early stages. In contrast, protein 
synthesis related functions including cytoplasmic translation, transcription 
and chaperone-assisted protein folding genes have increased expression 
in the schizont stage. Hence, artemisinin resistance may be associated 
with lower metabolic ativity of the ring stage that leads to decreased 
drug activation and simultaneously, increased protein syntheis, folding 
and turnover, that compensate the loss of proteins damage caused by the 
drug. In addition, we observed the differential expression of several key 
regulatory proteins that may underline the observed transcription profile. 
The transcriptional profiles of a further 73 samples including 53 Pailin, 
18 Lao and 2 Thai isolates from the ongoing TRAC (Tracking Resistance 
to Artemisinin Collaboration) study has been generated and analyzed 
and results will be discussed. In order to identify CNVs associated with 
resistance, we performed comparative genomic hybridizations using 
genomic DNA sequentially isolated from the same clinical samples and 
found several genes with copy number variations (CNV) associated with 
increased clearance half life. The involvement of these CNVs in resistance 
as well as their relation to the differential transcriptional profile associated 
with resistance phenotype will be reviewed and discussed.
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ADAPTIVE EVOLUTION OF A RING UBIQUITIN LIGASE 
MEDIATES REDUCED DRUG SENSITIVITY IN PLASMODIUM 
FALCIPARUM
Ulf Ribacke1, Mackenzie Bartlett1, Saurabh D. Patel1, Niroshini 
Senaratne1, Daniel J. Park2, Manoj T. Duraisingh1, Pardis C. Sabeti2, 
Sarah K. Volkman1, Dyann F. Wirth1
1Harvard School of Public Health, Boston, MA, United States, 2Harvard 
University, Cambridge, MA, United States
The main obstacle to the eradication efforts of Plasmodium falciparum 
is the parasite’s genome plasticity enabling adaptation to selective 
pressure exerted by its human host. This has led to the lack of vaccines 
inducing sterile immunity and a growing dilemma of resistance to 
existing antimalarials. Recent population genetics approaches have 
revealed several regions of the genome to be under positive selection, 
thereby providing candidate loci needed to be scrutinized for their role in 
parasite biology. A surprisingly large number of the encoded molecules 
are putatively involved in ubiquitylation arguing that post-translational 
modification through ubiquitylation is a major pathway for parasite 
adaptation. We have here characterized a RING ubiquitin ligase (PFF1325c) 
with one non-synonymous SNP (D113N) under recent positive selection. 
Recombinant wild type and mutant protein was expressed and were 
both shown to mediate formation of ubiquitin chains in reactions with 
human conjugating enzymes UbcH5a-c. This proves PFF1325c to be a 
true ubiquitin ligase and gives important clues to which conjugating 
enzymes are likely interactors within the parasite. To directly assess the 
influence of the D113N mutation on parasite biology, we introduced 
the two different allelic variants into different parasite genomes. No 
difference in growth was detected for the allelic variants under normal 
in vitro growth conditions. However, a clear shift in IC50 to chloroquine 
(CQ) and amodiaquine (ADQ) was observed, with parasites carrying the 
mutant allele being less sensitive. To capture the evolutionary benefits of 
the mutant allele under drug pressure, parasite clones were matched in 
competition experiments with or without CQ and ADQ. Parasites carrying 
the mutant allele clearly outcompeted their wild type counterparts at 
sub-lethal drug concentrations and recrudesced faster after exposure 
to lethal concentrations of drug. Our data suggest modification of the 
ubiquitylation cascade to be an important adaptive response and a novel 
contributor to drug resistance in P. falciparum.
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EX VIVO ANTIMALARIAL DRUG SUSCEPTIBILITY OF 
PLASMODIUM FALCIPARUM IN WESTERN, NORTHERN AND 
EASTERN CAMBODIA, 2011
Pharath Lim1, Dalin Dek2, Vorleak Try2, Sokunthea Sreng2, Seila 
Suon2, Sivanna Mao3, Chantha Sopha4, Baramey Sam5, Elizabeth 
A. Ashley6, Arjen M. Dondorp6, Nicholas J. White6, Jennifer M. 
Anderson1, Chanaki Amaratunga1, Rick M. Fairhurst1
1Laboratory of Malaria and Vector Research, National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 
MD, United States, 2National Center for Parasitology, Entomology and 
Entomology (CNM), Phnom Penh, Cambodia, 3Sampov Meas Referral 
Hospital, Pursat, Cambodia, 4Makara 16 Referral Hospital, Preah Vihear, 
Cambodia, 5Ratanakiri Referral Hospital, Ratanakiri, Cambodia, 6Mahidol-
Oxford Research Unit, Faculty of Tropical Medicine, Mahidol University, 
Bangkok, Thailand
Artesunate (ART) plus mefloquine (MQ) was introduced as first-
line treatment for Plasmodium falciparum malaria in Cambodia in 
2001. In 2009, P. falciparum resistance to ART+MQ was reported in 
Western Cambodia, prompting the National Malaria Control Program 
to recommend dihydroartemisinin (DHA) + piperaquine (PPQ) for this 
region. In recent years, however, there have been few reports on the ex 
vivo susceptibility of P. falciparum to these and other antimalarial drugs 
in W. Cambodia or elsewhere in the country. To establish profiles of ex 
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vivo antimalarial drug susceptibility in W. Cambodia, and compare them 
with those in Northern and Eastern Cambodia, we obtained P. falciparum 
isolates directly from patients with uncomplicated malaria. Using a SyBR-
Green I-based method, we measured the ex vivo susceptibility of 252 
parasite isolates to 6 antimalarial drugs: chloroquine (CQ), MQ, quinine 
(QN), PPQ, ART and DHA. Data from 80% (203/252) of these assays were 
interpretable for ≥ 4 drugs. The proportions of parasite isolates showing 
reduced ex vivo susceptibility to CQ, MQ, QN and PPQ in W. Cambodia 
were 98%, 22%, 4% and 10%, respectively. The same proportions in 
N. Cambodia were 97%, 20%, 7% and 7% and in E. Cambodia were 
84%, 5%, 0% and 10%. Reduced ex vivo susceptibility to ART and 
DHA was not observed in the 3 regions. The ex vivo mean IC50 (GM IC50) 
values for CQ, MQ, QN, ART and DHA were significantly higher in W. 
and N. Cambodia than in E. Cambodia (p<0.001). However, there were 
no significant differences in the ex vivo GM IC50 values for PPQ between 
these regions. We detected significant positive correlations between MQ 
and ART (r=0.54, p<0.001), MQ and DHA (r=0.32, p<0.001), QN and 
ART (r=0.62, p<0.001) and QN and DHA (r=0.42, p<0.001). Our data 
indicate that reduced P. falciparum susceptibility to MQ and PPQ is present 
in all 3 regions of Cambodia. In different regions of Cambodia, where 
either DHA-PPQ or ART+MQ are the recommended treatments, studies to 
monitor the clinical efficacy of these drugs is warranted.
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DEVELOPMENT OF ARTESUNATE RESISTANCE IN VIVO USING 
A PLASMODIUM FALCIPARUM HUMANIZED MURINE MODEL 
OF MALARIA
María B. Jiménez-Díaz1, Sara Viera1, Javier Ibáñez1, Noemí Magán-
Marchal1, Helena Garuti1, Lorena Cortés-Gil1, Vanessa Gómez1, 
Teresa Mulet1, Francisco-Javier Gamo1, Laura M. Sanz1, Didier 
Leroy2, Leonard D. Shultz3, David M. Wilson1, Iñigo Angulo-
Barturen1
1GlaxoSmithKline I+D, SL, Tres Cantos (Madrid), Spain, 2Medicines for 
Malaria Venture, Geneva, Switzerland, 3The Jackson Laboratory, Bar 
Harbor, ME, United States
Development of resistance against artemisinin-combination therapies 
(ACTs) is a major threat for the control and eradication of malaria. 
Humanized murine models of malaria allow the growth of Plasmodium 
falciparum in human erythrocytes engrafted into mice. In this work we 
show that the P. falciparum murine model can be used to analyze the 
development of resistance against antimalarials. Treatment failure with 
artesunate was observed after suboptimal therapy in thirteen serial 
passages whereas atovaquone required two, which is compatible with 
their corresponding propensity to generate resistance. The artesunate 
resistant strain showed a marked decrease in the parasite reduction ratio 
(PRR) whereas the atovaquone resistant strain showed almost complete 
resistance to treatment in vivo. None of the resistant strains showed 
measurable impairment of proliferative capacity in vivo. Interestingly, in 
contrast with atovaquone, the reduction of susceptibility to treatment 
with artesunate was not associated with reduced susceptibility in vitro. 
Therefore, these results suggest that the P. falciparum humanized model 
can be a valid model to study the development of resistance caused by 
sub-therapeutic treatment.
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ARTEMETHER-LUMEFANTRINE SELECTS FOR MALARIA 
PARASITES WITH DECREASED LUMEFANTRINE SENSITIVITY 
ALTHOUGH PARASITES REMAIN SENSITIVE TO THIS 
REGIMEN IN TORORO, UGANDA
Patrick K. Tumwebaze1, Jessica Bloome2, Oswald Byaruhanga1, 
Christine Nakazibwe1, Andrew Walakira1, Jaffer Okiring1, Samuel 
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1Makerere University-University of California San Francisco Research 
Collaboration, Kampala, Uganda, 2University of California, San Francisco, 
CA, United States, 3Dominican University, San Rafael, CA, United States
Artemisinin-based combination therapies (ACTs) may select for malaria 
parasites with decreased drug sensitivity. We studied the sensitivity of 
parasites from children enrolled in treatment and prevention trials in 
Tororo, Uganda from June, 2010 to February, 2012. When Plasmodium 
falciparum malaria was diagnosed, blood was obtained, parasites 
(286 isolates) were cultured with serial dilutions of chloroquine (CQ), 
monodesethylamodiaquine (AQ), quinine (QN), dihydroartemisinin (DHA), 
lumefantrine (LM), or piperaquine (PQ) for 72 h, and ex vivo sensitivities 
were assessed by HRP-2-based ELISA. Sensitivities (nM) to CQ (median 
IC50 486.2; IQR 206.5-748.8), AQ (83.3; 58.4-132.4), PQ (20.3; 7.6-47.5) 
and QN (126.4; 74.9-196.3) varied widely; parasites were highly sensitive 
to LM (2.7; 0.97-6.7) and DHA (1.7; 1.0-2.8). IC50 values for 4 successive 
quartiles, each with 71-73 isolates collected over ~4 months, varied 
little for control strains (3D7 IC50s 0.54-1.8 nM) and all drugs except 
LM and PQ. For PQ, sensitivity decreased after the first quartile (median 
IC50 6.5), but was then stable (26.6-32.0). For LM, IC50s were low, but 
increased consistently (successive quartiles 1.1, 2.3, 3.5, and 6.2, p<0.05 
for all comparisons except 2nd-3rd quartiles). Receiving monthly DHA-
PQ in a prevention trial was not associated with changes in PQ sensitivity 
compared to those receiving placebo. Having received artemether-LM (AL) 
within 60 days as treatment for a prior episode of malaria was associated 
with decreased sensitivity to LM (median IC50 1.59 for those without 
[n=84] vs. 3.24 for those with [n=119] recent AL; p=0.022 [GEE regression 
with log IC50 values]), but no significant change in sensitivity to the other 
study drugs. In summary, recent isolates of P. falciparum in Tororo were 
highly sensitive to components of AL, the national treatment regimen, but 
treatment with AL selected for parasites with decreased sensitivity, and 
overall sensitivities decreased from 2010 to 2012. Longitudinal surveillance 
of sensitivities of parasites under different selective drug pressures 
continues.
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WHAT DETERMINES PARASITE CLEARANCE: A POOLED 
ANALYSIS OF FREQUENT PARASITE COUNTS AFTER 
TREATMENT WITH AN ARTEMISININ DERIVATIVE ALONE OR 
IN COMBINATION WITH OTHER ANTIMALARIALS
Kasia Stepniewska1, Jennifer A. Flegg1, Francois Nosten2, Rick 
M. Fairhurst3, Arjen M. Dondorp4, Duong Socheat5, Anders 
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Parasite clearance (PC) is considered to be the most robust measure of 
antimalarial effect and is a key component to characterize artemisinin 
resistance. The dynamics of PC following artemisinin treatment are 
influenced by several factors other than parasite susceptibility including 
host immunity, initial parasite biomass, and partner drug efficacy. It is 
critically important to control for such potential confounding factors 
to identify changes over time in PC due to reduced parasite drug 
susceptibility. We have pooled parasitaemia data collected at least 
every 12 hours from individual patients who participated in completed 
studies. The WWARN Parasite Clearance Estimator was used to produce 
standardized estimates of parasite half-life (HL). The effects of covariates 
such as artesunate dose, partner drug, transmission intensity, year and 
location of study, age and baseline characteristics on PC were examined 
in a regression model and the relationship between treatment outcome 
and HL was evaluated in a subset of patients with efficacy data available 
using Cox regression. Random effects or frailty were used to account for 
study effect. Fourteen studies with 4655 patients in Cambodia, Thailand, 
Laos, Bangladesh, Mali, Tanzania and Kenya were included in the analysis. 
Clinical outcome was evaluated in 8 studies with 702 patients during 42 
(4 studies) or 63 days (4 studies) follow-up period. The median (range) of 
estimated HLs was 3.2h (0.6 - 21.4). Estimates varied significantly between 
study location and year (p<0.001), with median HLs ranging 1.9-6.9 h 
between studies. Among 696 patients with available efficacy outcomes, 
twenty four had PCR-confirmed recrudescence and slower PC (p<0.001) 
with a median (range) HL of 6.8h (2.5-11.1) compared to 3.3h (0.9-
12.2) in cured patients. HL was not affected by initial parasite count or 
patient age but was longer in patients with gametocytes, low haematocrit 
or prolonged fever at enrollment. This analysis provides key reference 
baseline data to characterize antimalarial resistance and understand 
factors affecting measurement of PC.
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DEFINING THE ELUSIVE ARTEMISININ RESISTANCE 
PHENOTYPE IN VITRO
Amanda Hott, Lindsay Morton, Kansas Sparks, Debora Casandra, 
Matthew Tucker, Dennis E. Kyle
University of South Florida, Tampa, FL, United States
Artemisinin resistance has emerged in Cambodia and Thailand and is 
observed clinically as a reduced parasite clearance rate in vivo following 
treatment with an artemisinin derivative alone or in combination. Recent 
evidence suggests the in vivo phenotype is linked to heritable genetic 
trait(s), yet to date a clear artemisinin resistance phenotype in vitro has 
not been defined. This is in direct contrast to experience with other 
antimalarial drugs where in vitro drug resistance was clearly evident in 
cultured parasites either before or simultaneously with the advent of 
clinical resistance. Through a series of studies we have begun to define the 
elusive artemisinin resistance phenotype in vitro. First we generated stable 
artemisinin resistant lines of Plasmodium falciparum, cloned them, and 
used these clones to assess new in vitro phenotype assays. Secondly we 
applied the new assays to culture adapted isolates of P. falciparum from 
Cambodia and Thailand. Isolates with evidence of artemisinin resistance 
in vitro were immediately cloned and characterized. Results from these 
studies suggest that both the in vitro generated resistant lines and clones 
of Cambodian P. falciparum express stable resistance to artemisinin 
derivatives in vitro. Interestingly, the highest level of resistance in all 
resistant lines was to artelinic acid (AL), a compound that has never been 
used clinically. We found 4-8 fold resistance to AL in each of the resistant 
lines as compared to 3-5 fold resistance to artemisinin. A reduced level of 
resistance (2-3 fold) was consistently observed for dihydroartemisinin. In 
addition, each of the artemisinin resistant lines expressed the artemisinin-
induced ring stage dormancy phenotype in which the resistant line 
recovered more rapidly from dormancy than artemisinin susceptible 
parasites. These new artemisinin resistance phenotypes can be used to 
monitor emerging resistance in the field and to accelerate the discovery of 
drug resistance mechanism(s) in stable, culturable, clonal lines.
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FALCIPARUM AT DELIVERY AND IMPROVED PREGNANCY 
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Antibodies against VAR2CSA, the variant surface antigen binding 
to placental chondroitin sulfate A, have been suggested to mediate 
protection against Plasmodium falciparum in pregnancy, although some 
studies have indicated that these antibodies at delivery are markers of 
exposure to P. falciparum. We hypothesized that variations in parasite 
exposure and HIV infection affect levels of antimalarial antibodies and also 
their associations with pregnancy outcomes. We measured IgGs against 
placental and pediatric isolates, VAR2CSA (DBL2X, DBL3X, DBL5ε, DBL6ε) 
and other blood stage antigens (DBLγ, DBLα, MSP1, AMA1, EBA175) in 
plasmas from 293 Mozambican pregnant women at delivery. The number 
of antigens recognized by IgG in plasma (breadth of recognition) was 
higher in women with placental infection (adjusted rate ratio [aRR]=1.59, 
95%CI[1.44-1.77]), in women living close to the river (aRR=1.16, 
95%CI[1.02-1.32]), in HIV-infected women pregnant during the rainy 
season (aRR=1.82, 95%CI[1.15-2.86]) and in HIV-infected women not 
receiving intermittent preventive treatment (IPTp; aRR=1.39; 95%CI [1.1-
1.72]). HIV-infection attenuated the parity-dependent increase of IgGs 
against placental and pediatric isolates, DBLγ and AMA1 (p for interaction 
between HIV and parity≤0.046). Among women who had a malaria 
episode during pregnancy, high antibody level against VAR2CSA (DBL3X 
and DBL6ε), placental and paediatric isolates and AMA1 were associated 
with increased weight and gestational age of the newborns (p≤0.036). 
Anti-parasite IgGs in women at delivery are sensitive to factors influencing 
malaria exposure and are affected by HIV infection, probably through its 
impact on the longevity of antibody responses. Reducing the variability 
of parasite exposure by including in the analysis only women with proven 
exposure during pregnancy allows the identification of IgGs against 
merozoite antigens, VAR2CSA and other variant surface antigens that may 
contribute to reduce the adverse effects of malaria in pregnancy.
302
www.astmh.org
991
CD44 IS A FUNCTIONALLY RELEVANT RECEPTOR FOR 
ADHERENT PLASMODIUM FALCIPARUM IN THE PLACENTA
Simon O. Owino, Briana Flaherty, Demba Sarr, Samantha Burton, 
David S. Peterson, Julie M. Moore
University of Georgia, Athens, GA, United States
Plasmodium falciparum infected red blood cells (iRBCs) accumulate in the 
maternal blood space of the placenta during malaria infection, culminating 
in pathological consequences deleterious to pregnancy success. The fetal 
cell in contact with maternal placental blood is a syncytialized epithelium 
called syncytiotrophoblast (ST). ST has a rich supply of low sulfated 
chondroitin sulfate A (CSA), a principle ligand for VAR2CSA parasite 
protein, present on the surface of placenta-adherent iRBCs. It is critical to 
examine the role CSA-bearing proteoglycans on ST play in anchoring iRBCs 
as well as their potential role as signaling molecules. Because it is known 
that STs are immunologically active in the presence of CSA-adherent 
iRBCs, here we examined the role of CD44 proteoglycan, a known CSA-
bearing molecule with a transmembrane cytoplasmic domains adept at 
signaling functions. STs membrane proteins (SMPs) were extracted from 
cultured primary cells as well as whole placental preparations. SMPs 
were incubated with CSA-adherent and non-adherent iRBCs; binding of 
CD44 was specific to CSA-adherent iRBCs as observed by flow cytometry. 
CD44 from SMPs pre-treated with chondroitinase ABC lost significant 
iRBC binding activity. In vitro exposure of primary ST to CSA-adherent 
iRBCs promoted upregulated expression of CD44 as detected by ELISA, 
and immunohistochemical staining for CD44 antigen in placental tissue 
from Kenyan women showed a significant increase in expression of this 
adherence receptor coincident with active placental malaria. Current 
efforts are exploring the activation state of CD44 following exposure of ST 
to CSA-adherent iRBCs, as well as the impact of CD44 knockdown by RNA 
interference on malarial activation of ST. In summary, this work provides 
evidence that CD44 proteoglycan is an in vivo receptor for VAR2CSA-
expressing iRBCs, the expression of which is modulated by malarial 
infection, and may additionally serve as a signaling molecule, promoting 
an ST response to placental malaria.
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CHRONIC INFECTIOUS EXPOSURE DURING PREGNANCY 
AFFECTS NEONATAL B CELL SUBPOPULATIONS
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Chronic infections during pregnancy can expose the fetus to antigens that 
affect fetal B cell development. We hypothesize that resultant changes in 
B cell subpopulations may affect the infant’s susceptibility to infection and 
disease. To investigate this, we examined cord blood B cell subpopulations 
and B cell responses to non-specific polyclonal activation in neonates 
with and without exposure to chronic prenatal infections. We developed 
six-color flow cytometry panels to differentiate subpopulations of B cells 
from cord blood mononuclear cells (CBMC) isolated from North American 
and Kenyan neonates. North American neonates had no prenatal chronic 
infectious exposures. Kenyan neonates examined had evidence of prenatal 
HIV, cytomegalovirus (CMV), P falciparum malaria or no infectious 
exposures. Proportions of B cell subpopulations were compared between 
the exposure groups. Additionally, we examined the ability of B cells in 
each group to respond to polyclonal activation in culture. We found that 
neonates exposed to chronic prenatal infections (HIV, CMV and malaria) 
displayed higher levels of atypical (CD19+CD27-CD21-IgD-) and activated 
(CD19+CD27+CD21-IgD-) memory B cells compared to Kenyan non-
exposed and North American neonates. Little differences were appreciated 
in naive B cell (CD19+CD21+CD27-CD10-) or classic isotype switched 
memory B cell (CD19+CD27+CD21+IgD-) populations. Neonates exposed 
to HIV had a lower proportion of CD5+ B cell compared to all other 
groups. Polyclonal activation of B cells resulted in subtle shifts in CD5 
and TLR2 expression, which were similar among the exposure groups. 
The results of our study suggest that the presence of chronic infections 
during pregnancy affects B cell development, leading to increased levels 
of atypical and activated memory B cells. The functional effects of these 
differences will need to be further investigated.
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THE SUPPRESSION OF MALARIA ANTIGEN-SPECIFIC 
RESPONSES BY REGULATORY T CELLS ACQUIRED IN UTERO 
PERSISTS INTO EARLY CHILDHOOD
Christopher L. King1, Ruth Nyakundi2, Elton Mzungu3, Peter 
Mungai1, Indu Malhotra1
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Msambweni, Kenya
Prenatal exposure to malaria blood stage antigens has been associated 
with impaired malaria-Ag-specific Th1-type immune responses in early 
childhood as well as increased risk of malaria infection. Here we examined 
the hypotheses that tolerogenic fetal natural (CD25hi, FoxP3+CD4+) and 
adaptive (high IL-10) regulatory T cells develop in utero, and that these 
cells persist into early childhood, impairing T cell-assisted production 
of protective antibody to malaria blood stage antigens. We show that 
depletion of CD25hiCD4+ T cells or neutralization of IL-10 in cord blood 
is associated with 2.3 to >10 fold increased IFNγ production by and/or 
proliferation of malaria blood stage-specific lymphocytes in samples from 
newborns of a subgroup of malaria infected women; otherwise these 
newborns (classified as putatively tolerant, N=10) show weak or absent 
malaria Ag-driven proliferation or IFNγ production. By contrast, offspring 
of women uninfected with malaria (not exposed, N=24) or offspring who 
develop a malaria Ag-driven predominantly Th1-type response in the 
face of maternal prenatal malaria infection (exposed-sensitized, N=13) 
fail to show consistent augmentation of lymphocyte proliferation and/or 
IFNγ production with CD25hiCD4+ depletion and/or IL-10 neutralization. 
Repeat examination of these same children at 12 to 24 months of age 
shows persistence of these phenotypes, with putatively tolerant offspring 
showing an overall increased lymphocyte proliferation with CD25hiCD4+ 
depletion and enhanced IFNγ production with IL-10 neutralization 
compared to children identified as exposed-sensitized or not exposed (p= 
0.006, 0.01 and p=0.02, 0.009 respectively). Thus, in utero exposure to 
malaria blood-stage antigens can induce a form of immune tolerance 
that is probably regulatory T cell-mediated and likely modulates malaria 
antigen-specific immune responses throughout early childhood.
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INTERACTIONS BETWEEN THE GENETIC DIVERSITY OF 
PLASMODIUM FALCIPARUM INFECTIONS AND BREADTH 
OF ANTIBODY RESPONSES IN RELATION TO IMMUNITY TO 
MALARIA
Josea K. Rono1, Faith H. Osier1, Leah Faraja2, Ingegerd Rooth2, 
Anna Färnert3
1Kenya Medical Research Institute-Wellcome Trust Research Programme, 
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In areas of high malaria transmission, the presence of asymptomatic 
infections with genetically diverse Plasmodium falciparum clones is 
associated with reduced risk of malaria by a yet unknown mechanism. 
Asymptomatic P. falciparum parasitemia can modify the association 
between antibodies to both merozoite and variant red blood cell surface 
antigens and the risk of malaria. Antibody responses to merozoite antigens 
are short-lived in the absence of continued infection. Considering these 
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observations and the step-wise reduction in risk of malaria with increasing 
breadth of antibody responses to merozoite antigens, we hypothesize that 
the presence of genetically diverse P. falciparum infections interacts with 
antibody responses to enhance the acquisition of immunity to malaria. To 
test this hypothesis, we have studied a longitudinally followed population 
in an area of high malaria transmission in Tanzania. A cross-sectional 
survey was conducted in March and April of 1999, just before the rainy 
season in which whole blood was collected. All the participants were 
monitored in the subsequent 40 weeks and episodes of malaria were 
recorded by a passive case detection system. We assessed the genetic 
diversity of P. falciparum infections at baseline by genotyping the P. 
falciparum merozoite surface protein 2 (msp2) gene by fluorescent PCR 
and capillary electrophoresis. We measured antibody levels to four of the 
leading malaria vaccine candidate antigens; 2 alleles of MSP-2, two alleles 
of MSP-3, two alleles of apical merozoite antigen 1, and the 19-kilodalton 
fragment of MSP-1 using a multiplex platform. Increasing breadth of 
antibody responses and presence of increasing number of genetically 
distinct clones at baseline were associated with reduced risk of malaria 
both individually and when analyzed in combination. These findings 
suggest that in an area of high malaria transmission, genetic diversity and 
antibody responses are additive or synergistic in conferring protection from 
malaria.
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USE OF TETRAMER STAINING TO ENUMERATE AND 
CHARACTERIZE MALARIA ANTIGEN-SPECIFIC CD8+ T-CELLS 
INDUCED IN VOLUNTEERS IMMUNIZED WITH ADENOVIRUS 
SEROTYPE 5 PLASMODIUM FALCIPARUM MALARIA 
VACCINES
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Protection against pre-erythrocytic stages of malaria is believed to be 
mediated in part by cytotoxic T-lymphocyte (CTL) responses against 
epitopes of protective antigens presented by HLA on the surface of 
infected liver cells. Because IFN-γ secreting CD8+ T cells have been 
implicated in protection against pre-erythrocytic stage malaria through 
IFN-γ-mediated induction of nitric oxide to kill intra-hepatic stage malaria 
parasites, it has become common practice to attempt to associate 
the magnitude of malaria vaccine-induced and CTL-mediated IFN-γ 
production with protective immunity, since antibody responses are usually 
poor. However, malaria antigen-specific CD8+ T-cells might kill infected 
hepatocytes by non-IFN-γ mediated mechanisms, such as the direct killing 
of hepatocytes through release of perforin and granzyme. In order to 
establish the total magnitude of the vaccine-induced CD8+ T cell response, 
we have identified putative CD8+ T-cell epitopes on CSP and AMA-1, 
using PBMC samples from volunteers immunized with a single dose of 
serotype 5 adenovirus expressing two malaria antigens, CSP and AMA1 
(AdCA). We next prepared a series of tetramers, each consisting of one 
of seven HLA-A or five HLA-B class I molecules and each presenting 
one of 16 distinct CSP epitopes or one of 11 distinct AMA-1 epitopes. 
We then used the tetramer staining technique to label and thereby 
enumerate the total number of malaria antigen-specific CD8+ T cells in 
immunized HLA-A*01:01+ and HLA-B*18:01+ volunteers. We have also 
demonstrated that malaria tetramer-positive CD8+ T cells obtained three 
weeks post immunization express high levels of the CD38 and HLA-DR 
activation markers, raising the possibility that these markers might serve 
as a surrogate to detect multiple antigen-specific CD8+ T cells induced by 
whole parasite vaccines where the majority of antigens have not yet been 
identified. Work is also ongoing to carry out tetramer staining, ELISpot, 
and intracellular staining assays using pre-vaccination and post vaccination 
PBMC samples to look for comparability of results generated from the 
different assays.
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GENERATION OF NOVEL “HUMAN-IMMUNE-SYSTEM” 
HUMANIZED MOUSE STRAINS CO-EXPRESSING HLA CLASS 
I AND CLASS II MOLECULES IN NOD.RAGKO.IL2RGCKO 
BACKGROUND
Sai Majji1, Rebecca Danner1, Eileen Villasante1, Thomas L. Richie1, 
Teodor D. Brumeanu2, Sofia A. Casares1
1U.S. Military Malaria Vaccine Program/Naval Medical Research Center, 
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The current animal models that are used to test approaches that target 
the immune system (i.e., vaccines) are imperfect and accounts for many 
faileures when human vaccines are tested in clinical trials. Development of 
humanized mouse models able to generate a surrogate human immune 
system is a highly pursued goal for investigating human immunology 
and for testing human vaccines. We previously showed that humanized 
mice expressing HLA class II (DR4) molecules in NOD.RagKO.IL2RgcKO 
background and infused with HLA-DR-matched human hematopoietic 
stem cells, develop a functional human immune system and respond to 
vaccination (PLoS One 6:e19826, 2011). While the frequency of human 
CD4 T cells, B cells, and dendritic cells in blood and lymphoid organs of 
humanized DRAG mice was similar to that in humans, the frequency of 
human CD8 T cells was however lower. This was attributed to the lack 
of HLA class I expression in humanized DRAG mice, since HLA class I 
molecules are required for thymic selection and survival of human CD8 
T cells. Herein we have generated a new humanized mouse strain co-
expressing HLA class I (A2) and HLA class II (DR4) molecules in NOD.
RagKO.IL2RgcKO background, and provide evidence for human immune 
cell reconstitution as well as function of human CD8 T cells upon infusion 
of HLA-matched human hematopoietic stem cells.
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QTL MAPPING OF PLASMODIUM FALCIPARUM GENES THAT 
ALLOW EVASION OF THE MOSQUITO IMMUNE SYSTEM
Alvaro Molina-Cruz, Amy Alabaster, Lois Bangiolo, Ashley Haile, 
Jared Winikor, Lindsey Garver, Corrie Ortega, Carolina Barillas-
Mury
National Institutes of Health, Bethesda, MD, United States
The mosquito Anopheles gambiae L3-5 strain is capable of eliminating 
some lines of Plasmodium falciparum but not others. This elimination 
involves the mosquito immune complement-like system. A Quantitative 
Trait Loci (QTL) mapping was carried out to identify the P. falciparum 
gene(s) that allow some parasite strains to evade the A. gambiae 
immune system. The gene mapping was done in a P. falciparum cross 
between 2 lines that differ in their survival in A. gambiae L3-5; GB4 
successfully infects the mosquito while 7G8 is mostly eliminated by 
melanotic encapsulation. Phenotyping of parental lines and progeny lines 
for survival/encapsulation in A. gambiae L3-5 presented only the two 
parental phenotypes. QTL analysis identified one main significant locus 
in chromosome 13 associated with the phenotype. Refined mapping 
of recombination sites in informative progeny lines narrowed down the 
locus to a region encompassing 41 genes. The QTL locus in chromosome 
13 was confirmed independently by linkage group selection analysis of 
surviving oocysts from an infection of the mosquito using the non-cloned 
progeny of the GB4 x 7G8 cross. Analysis of ookinete gene expression 
of the QTL 41 genes identified 8 genes with at least 4 fold difference 
between GB4 and 7G8 lines. Sequencing the coding region of the QTL 
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41 genes identified 15 genes with non-synonymous polymorphisms 
between GB4 and 7G8 lines. Based on the expression differences and 
sequence polymorphisms, 5 candidate genes were selected for detailed 
genetic analysis by testing phenotype changes between survival and 
encapsulation, after allele replacement in P. falciparum. Identification of 
P. falciparum gene(s) that allow evasion of the mosquito immune system 
may be important to understand malaria transmission and could be a 
target for transmission blocking strategies.
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EVIDENCE OF RECOMBINATION IN THE X-CHROMOSOME 
CENTROMERIC REGION IN ANOPHELES GAMBIAE 
MOLECULAR FORMS FROM AN AREA OF PUTATIVE 
SECONDARY CONTACT
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Anopheles gambiae M and S molecular forms are typically strongly 
reproductively isolated and clearly identifiable based on a SNP in the 
multi-copy IGS rDNA region, co-segregating with the single-copy 
insertion of a SINE element located approximately 1 Mb apart from the 
X-centromeric IGS region. However, an area of putative secondary contact 
has been recently detected at the westernmost extreme of M and S 
range. Preliminary indications of discordant M and S genotypes at the 
two X-linked markers near the centromere in female samples suggests 
that introgression and inter-locus recombination may be occurring in 
this area. This hypothesis is intriguing because recombination is known 
to be highly reduced in centromeric regions, and this is believed to have 
played a significant role in the incipient speciation process ongoing 
within A. gambiae. Here we present data from M and S female (N=275) 
and male (N=392) samples collected in Safim village in Guinea Bissau. 
Notably, males provide the opportunity to separate recombination, as 
distinct from heterozygosity, along the hemizigous X-chromosome. 
Results from IGS and SINE PCR-genotyping show: i) a 22% frequency of 
SINE MS-heterozygotes in females (consistent with previous data) and an 
absence of heterozygotes in males (as expected for a single-copy X-linked 
marker); ii) a 34% and 9% frequency of IGS MS-heterozygous pattern 
in females and males, respectively, strongly supporting the occurrence of 
recombination within even the most centromere-proximal region of the 
X chromosome; iii) the occurrence of discordant SINE/IGS genotypes in 
12% and 18% of SINE-M and SINE-S females, respectively, and in 10% 
of SINE-M and SINE-S males, showing that recombination is occurring in 
both molecular forms. Moreover, multilocus SNP analysis carried out on a 
subsample of males provides estimates of recombination along the whole 
X-chromosome and novel original insights on M and S form status in their 
putative secondary contact zone.
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Anopheles gambiae s.s. is considered to be in the process of incipient 
speciation into two molecular forms (M and S), originally defined by a 
single pericentromeric rDNA-IGS marker on the X chromosome. The 
molecular forms are sympatric throughout much of west and central 
Africa, but show broad bionomic differences which can extend malaria 
transmission in time and space. Genetic differentiation between M and S 
forms tends to be concentrated into genomic islands, which are resilient 
to gene flow. However, this genomic heterogeneity varies markedly 
between areas in line with levels of contemporary gene flow, most 
notably in Guinea-Bissau where the highest levels of inter-form gene 
flow are observed. Using Illumina Goldengate genotyping and whole 
genome resequencing we investigated the stability of M/S differentiation 
in Guinean samples collected in 1993 and in 2010. In the older samples 
genomewide differentiation, though very heterogeneous, clearly 
partitioned the molecular forms suggesting at least partial reproductive 
isolation. In the recent samples general M-S differentiation has decreased 
and a more complex within-population structure has emerged, with 
groupings exhibiting different degrees of resemblance to ‘typical’ M and 
S forms. Instability in population structure is not unexpected in an area 
of such high gene flow, but we also show adaptation-driven changes 
in genomic differentiation between the molecular forms from low gene 
flow areas. These data highlight that the dynamics of genome divergence 
in Anopheles gambiae speciation are occurring in real time, making the 
speciation process of relevance to contemporary control programmes.
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THE GENETIC BASIS OF HUMAN HOST CHOICE IN THE 
MALARIA VECTOR ANOPHELES GAMBIAE
Giri Athrey1, Theresa K. Hodges1, Luciano Cosme1, Willem 
Takken2, Michel A. Slotman1
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The predominant malaria vector Anopheles gambiae s.s preferentially 
takes it blood meals from human hosts, often at rates as high as 90% in 
natural populations. The adaptation of these mosquitoes to human hosts 
has a genetic basis in the olfaction system, which includes several key gene 
families - the odorant receptors (ORs), odorant binding proteins (OBPs) 
and ionotropic receptors (IRs). To identify An. gambiae genes responsible 
for human host preference, we conducted a quantitative trait loci (QTL) 
mapping experiment based on introgressive backcrosses between the 
anthropophilic An. gambiae and the zoophilic An. quadriannulatus, in 
which F1 females were backcrossed to An. quadriannulatus males. These 
backcross females were subjected to a host-choice experiment in an 
olfactometer in which they were presented with a human and cow odor. 
Only individuals that selected the same odor on three consecutive days 
were included in the experiment. A total of ~15,000 individual backcross 
females were run through host-choice experiments, resulting in two pools 
totaling 432 mosquitoes with divergent host preferences. We are using 
24 microsatellite markers to genotype individuals from the two pools 
and performed QTL analysis using R/QTL. Preliminary results based on 13 
markers identified one highly significant QTL that explains 16% of the 
phenotypic variance. This QTL region is estimated to span a 10 Mb region 
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and contains several ORs, OBPs and IRs. These genes are candidates for 
being involved in the adaptation of An. gambiae to its human host and 
were sequenced in six anopheline species to identify those that show 
evidence of positive selection. 
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DENGUE 2 INFECTION ALTERS MICRORNA EXPRESSION IN 
AEDES AEGYPTI
Corey Campbell, Ann Hess, Gregory D. Ebel
Colorado State University, Fort Collins, CO, United States
Emerging studies show that important avenues in the post-transcriptional 
regulation of gene expression occur via small RNA regulatory pathways. 
Non-coding RNAs (ncRNAs) are key features of these pathways, and 
critical molecules involved in their biogenesis and function are conserved 
in plants, insects and mammals. To identify products of anti-viral RNA 
interference in vector mosquitoes, deep sequencing small RNA (sRNA) 
libraries were prepared from DENV2-fed Ae. aegypti females (RexD strain) 
and matched un-infected controls at 2, 4, and 9 days post-infection (dpi). 
An earlier publication described DENV2-derived viral sRNAs (viRNAs) across 
three size classes: unusually small RNAs (usRNAs) (14-19nts), canonical 
siRNAs (20-24nts), and piRNAs (25-30nts) (Hess et al, BMC Microbiology, 
2011). In the present analysis, these libraries were mined to determine 
whether substantive changes occur in mosquito microRNA (miRNA) levels 
during DENV2 infection. Reads were aligned to mIRBase release 17 hairpin 
database (mirbase.org). MiRNAs with over 50 reads across treatment 
groups and showing > 2 fold-changes were chosen for further study. Our 
analysis reveals that significant changes to specific miRNA levels occur in 
DENV2-infected mosquitoes compared to un-infected controls. Moreover, 
some miRNAs showed coordinated enrichment or depletion at both 2 
and 4 dpi, substantiating the hypothesis that they are important to the 
establishment of virus infection, whether by being exploited by the virus or 
as part of an anti-viral mechanism. Coordinately co-regulated miRNAs or 
*miRNAs include miR155, mIR2755, miR281 and miR277, among others. 
miRNAs were classified by type: conserved (homologous to previously 
reported miRNAs), *miRNA (complementary to miRNA), non-canonical 
or unclassified. Although the precise part played by each differentially 
expressed miRNA remains to be elucidated, orthologous miRNAs in other 
animals are important effectors of cellular differentiation, neurogenesis, 
transcriptional regulation, nutritional metabolism and the regulation of 
apoptosis. Our results show an intriguing new way in which major cellular 
processes of mosquitoes respond to arbovirus infection.
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GENETIC REGULATION OF VECTOR MOSQUITO SALIVARY 
GLAND DEVELOPMENT
Molly Duman Scheel1, Chilinh Nguyen2, Zeinab Annan1, Emily 
Andrews1, Christy Le2, Longhua Sun2, Anthony Clemons2, David 
W. Severson2
1Indiana University School of Medicine South Bend at Notre Dame, South 
Bend, IN, United States, 2University of Notre Dame, Notre Dame, IN, 
United States
Understanding mosquito salivary gland development is critical given the 
importance of this tissue in blood feeding and pathogen transmission. 
Our recent survey of the mosquito genomes indicated that mosquitoes 
have orthologs of many genes that regulate embryonic salivary gland 
development in Drosophila melanogaster, a well-characterized insect 
genetic model organism. The expression patterns of a large subset 
of these genes were assessed during development of Aedes aegypti, 
an emerging model for vector mosquito development. These studies 
revealed that the early stages of Ae. aegypti salivary gland development 
significantly differ from that of D. melanogaster. We are now using an 
RNAi knockdown strategy to investigate the roles of genes expressed in 
the developing Ae. aegypti salivary gland. Functional characterization of 
cyclic-AMP response element binding protein A (crebA) indicates that 
this gene encodes a key regulator of secretory function in the Ae. aegypti 
salivary gland. These studies highlight the need for further analysis of 
mosquito developmental genetics and may foster comparative studies of 
salivary gland development in additional vector insect species.
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MEDUSA: A NOVEL GENE DRIVE SYSTEM FOR CONFINED 
SUPPRESSION OF MOSQUITO POPULATIONS
John M. Marshall1, Bruce A. Hay2
1Imperial College London, London, United Kingdom, 2California Institute of 
Technology, Pasadena, CA, United States
Following successful field trials of sterile GM mosquitoes designed to 
control dengue fever, interest is now growing in the use of gene drive 
systems, such as X-shredders, capable of inducing a population crash as 
they spread. These systems hold much promise for wide-scale disease 
control; however issues arise from their potential to spread across 
international borders. We propose a novel gene drive system, Medusa, 
capable of inducing a local population crash without spreading into 
neighboring populations. Medusa consists of four components - two at a 
locus on the X chromosome and two at a locus on the Y chromosome. A 
maternally-expressed, X-linked toxin and a zygotically-expressed, Y-linked 
antidote suppress the female population because only males can protect 
themselves against the effects of the toxin. A zygotically-expressed, 
Y-linked toxin and a zygotically-expressed, X-linked antidote ensure 
that the two constructs are always inherited together. We use simple 
population genetic models to explore the dynamics of the Medusa system. 
An all-male release is preferred since males don’t bite and, if released 
over two generations, Medusa is expected to induce a population crash 
within seven generations for modest release sizes. Re-invasion of wild 
mosquitoes can lead to the population eventually rebounding; however 
this can be prevented by small, regular releases of Medusa males. The 
Medusa system could serve as a proof of principle for invasive population 
suppression systems such as X-shredders. We describe molecular solutions 
to chromosomal anomalies that could interfere with Medusa dynamics.
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VACCINATION WITH EXCRETORY/SECRETORY PRODUCTS 
CONFERS PARTIAL PROTECTION IN A MURINE MODEL OF 
FILARIASIS
C. Paul Morris, Marina Torrero, Kristin Killoran, Edward Mitre
Uniformed Services University of the Health Sciences, Bethesda, MD, 
United States
Infection with filarial worms can cause severe and debilitating diseases 
in both humans and animals. While many vaccine candidates have been 
studied in filariasis, our understanding of protective immune responses in 
a permissive model to filariasis is incomplete. In this study, we evaluated 
preparations of worm antigens for protection against challenge infection 
in the BALB/c Litomosoides sigmodontis model. The fractions included 
LS, soluble antigens of a homogenate of adult worms, and ES, excretory/
secretory products of adult female worms. 6-8 week old female BALB/c 
mice were given 3 intraperitoneal injections of 10 micrograms LS or ES 
with CpG/Alum and subsequently challenged with 40 infectious larvae 
subcutaneously. 8 weeks after infection mice were euthanized and 
parasite burdens were determined. Mice that were vaccinated with LS 
antigen showed no significant protection against challenge infection 
compared to control mice. Mice vaccinated with ES product, however, 
harbored 60% fewer adult worms than control mice. While mice 
vaccinated with LS and ES produced similar levels of IgG antibodies to 
both antigen preparations, analysis by western blot demonstrated that 
ES vaccinated mice recognized different ES proteins than LS-vaccinated 
mice. Currently, we are in the process of conducting mass spectroscopy 
to identify a ~160kda protein that was strongly preferentially recognized 
by ES-vaccinated mice. No substantially large differences were observed 
between the two vaccinated groups with regards to lymphocyte 
